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CHAPTER1. GENERAL INTRODUCTION 
This dissertation seeks to improve C2H2 zinc finger protein (ZFP) engineering 
through computational and experimental studies. Engineered ZFPs that are able to bind any 
desired DNA sequence in a genome have great potential for basic biological research and 
biomedical applications.  Current methods to engineer ZFPs are either unreliable, due to 
high failure rates, or inaccessible to some researchers, due to high demands of labor, time 
and expertise.  
We created a web-accessible database that organizes zinc finger modules (ZFMs) 
and ZFPs from our lab, our collaborators’ labs and the literature. This database helps 
researchers by providing information about the existence of ZFMs or ZFPs and their 
performance in DNA binding. We then described rules that govern the interaction of ZFPs 
and DNA by analyzing the finger sequences in the ZFM pools created by Oligomerized 
Pool ENgineering (OPEN), a recently developed, reliable, rapid and publicly available ZFP 
engineering method.  These rules will be valuable in the improvement of the OPEN 
method and the understanding of the interaction between engineered ZFPs and DNA.  
INTRODUCTION 
C2H2 ZFMs  
The C2H2 ZFM, which was discovered in transcription factor TFIIIA from 
Xenopus laevis [1], is the most abundant DNA-binding motif in eukaryotic organisms. 
Each C2H2 ZFM, with the pattern of X2CX2-4CX12HX2-8H (X refers to any amino acid), 
comprises about 30 amino acids that fold into a stable ββα structure through hydrophobic 
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interactions and coordination of a zinc ion by two conserved cysteine and two conserved 
histidine residues.  
When binding to DNA, the ZFM directs the N-terminus of the α-helix into the 
major groove of the DNA. As shown by the crystal structures of DNA-protein complexes 
and biochemical studies, each ZFM typically recognizes three contiguous base pairs of a 
DNA sequence, with the amino acid residues at positions -1, +3 and +6 (called key residues) 
relative to the beginning of the α-helix contacting the nucleotides at the 3’-end, middle and 
5’-end of a triplet target respectively [2-5].  
In addition to the key residues of the helix, the residue at position +2 also makes 
direct contact with DNA in some instances. This contact is made to a base on the other 
strand of DNA, complementary to the 5’-nucleotide of the target triplet recognized by the 
preceding finger. This cross-strand interaction extends the binding site of a two-finger array 
from 6 to 7 bases and results in target site overlap (TSO) between adjacent fingers. In most 
instances, this cross-strand interaction is made by Asp at position 2 (Asp2) of a α-helix to 
nucleotide A or C on the other strand, by forming hydrogen bonds with the amino groups at 
either adenine N6 or cytosine N4, which have similar stereochemistry  [3, 6]. This contact 
specifies the 5’-nucleotide of the triplet preceding it to be T or G. Although the TSO made 
by Asp2 triggered some suggestions that ZFMs may more generally recognize 4bp target 
subsites, results of many studies showed no significant TSO made by amino acids other 
than Asp2 [7-9].  Moreover, Asp2 does not always make TSO contact. For instance, some 
finger modules with cognate target 5’-ANN-3’ still recognize their cognate target despite 
the presence of Asp2 in the neighboring finger.  
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Unlike key residues, non-contact residues at position 1 and 5 are usually involved in 
direct or water-mediated contact to the phosphate backbone.   The residue at position 4 is 
usually a conserved Leu, which is believed to pack in the hydrophobic core of the ZFM and 
helps stabilize its structure. Although the non-contact residues do not contact nucleotides 
directly, they are sometimes important in structure and in recognition. For example, in a 
study of human gene targeting with designed zinc finger nucleases (ZFNs), Porteus et al. 
[10] assembled two ZFNs that recognize the same binding site, one with modules from 
Sangamo BioSciences Inc. [11], and the other with the proposed recognition code [12]. 
Although there are no differences in key residues, the one constructed with modules was 
10-fold more efficient than the one constructed with just the recognition code. 
ZFP and its binding to DNA  
ZFMs are strung together in tandem arrays to construct ZFPs that can bind extended 
DNA sequences. The binding affinity is crucial for an engineered ZFP to work. To be 
biologically useful, three fingers are typically assembled together to recognize a 9-bp DNA 
sequence. Well-designed three-finger proteins can bind target sites with affinities in the 
nanomolar range.   With a typical linker, when the number of modules increases from 
three, affinity doesn’t increase significantly. This is because the periodicity of B-form DNA 
doesn’t quite match the periodicity of the ZFP, so more strain is generated when the number 
of fingers increases.  Typically, the consensus linker sequence TGEKP is suitable to enable 
all the fingers in a three-finger protein to contact DNA in the major groove [13]. To some 
extent, the difference in periodicity between DNA and a ZFP can be decreased by changing 
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the linker sequence when linking more than three fingers in tandem to construct ZFPs.   
The in vivo binding activity of a ZFP depends on the status of the target site. When 
the target site is on a plasmid and typically not packaged into chromatin, the activity is 
determined by the in vitro binding affinity. For example, Kang [14] showed that generally, 
the in vivo functional activity has a good relationship with the in vitro binding activity of 
the ZFPs.   When target sites are integrated into chromatin or when working with an 
endogenous gene, chromatin accessibility is also an important factor that affects the 
activity of engineered ZFPs. Zhang et al. [15] showed that engineered zinc finger 
transcription factors work better in regions that can be digested by DNaseI. Beltran et al. 
[16] also found that the activities of artificial zinc finger transcription factors targeted to 
different sites of the promoter of the oncogene maspin showed differences in regulating a 
reporter gene on a plasmid versus the endogenous gene. The zinc finger transcription factor 
that showed the highest up-regulating activity of the plasmid reporter was not the best 
transcription factor for the endogenous gene. Testing target site accessibility before 
designing ZFPs is a good way to ensure in vivo function of ZFPs.  
Despite the importance of binding affinity in evaluating the efficacy of ZFPs, 
comparison of binding affinities is not straightforward. This is due to the fact that 
experimental protocols differ among laboratories and even among different experiments in 
the same laboratory. In addition, it is hard to control the folding and solubility of the ZFP, so 
the exact concentration of active ZFP is hard to determine.  Folding and solubility can be 
affected by buffer conditions as well as by the primary amino acid sequence of different 
ZFPs.  
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Specificity is another crucial factor for an engineered ZFP to be useful in vivo. For 
example, increasing the binding specificity is one way to decrease the cytotoxicity of 
customized ZFPs, since it is believed that the cytotoxic effect is caused by “off-target” 
binding (binding to DNA sequences other than the desired binding site). Comparison of 
specificity can be even more difficult than comparison of affinity because very different 
methods are used to measure the specificity. The easiest way to measure specificity is to 
include competitor DNA in gel shift experiments and calculate the ratio between specific 
and nonspecific binding. Calculating the ratio of binding affinities to cognate sites and 
mutated sites is another way to measure specificity. Finally, when selecting binding sites 
using phage display, the base ratio at each position can be used to evaluate specificity.  
In addition to the accessibility of the target due to chromatin structure, in vivo ZFP 
binding is also regulated by ZFP or DNA modifications. ZFP modifications that affect 
binding include acetylation and phosphorylation.  Acetylation of lysine in the linker 
region of the zinc finger domain can activate or repress the binding of zinc finger to its 
target site [17]. Phosphorylation on threonine/serine residues in the linker region usually 
inhibits ZFPs from binding to DNA [18].  
DNA methylation usually affects the interaction between DNA and protein. The 
negative correlation between gene activity and DNA CpG methylation in promoter regions 
has been well established. For example, γ-globin gene expression was affected by the 
methylation status of its promoter, but not by extensive methylation in the coding region 
[19, 20]. Thus, it appears that methylation suppresses gene expression by interfering with 
the binding of transcription factors to DNA, either by altering chromatin structure or by 
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sterically impeding the binding of transcription factors. Based on this notion, efforts were 
made to investigate the effects of methylation on the binding of ZFPs to their target sites. 
Studies with Sp1 and YY1 showed that these ZFPs could bind and activate their target 
genes in both the CpG methylated and unmethylated states [21, 22]. Similar effects of DNA 
methylation on the binding of ZFPs to DNA were also demonstrated for dam methylation. 
For instance, Sugimoto et al. [23] found that a GATA-type ZFP (whose binding domain is a 
C4 ZFP) bound to its target with or without dam methylation, but the binding affinity was 
enhanced by adenine methylation of the target site. In the selection of C2H2 ZFPs using the 
bacterial two-hybrid method, Joung et al. also found that dam methylation affected the 
binding of ZFPs (data not published).  It seems that the hydrophobic interaction between 
the methyl-group and amino-acid side chains helps the binding in the methylated state. One 
evidence for this interaction came from the fact that identical fingers were selected for 
recognizing 5mC and T in the target [24]. Isalan and Choo [25] further showed that 
cross-strand recognition is necessary to distinguish 5mC and T. 
It appears that DNA methylation has different effects on the binding of DNA by 
ZFPs and by other kinds of DNA-binding proteins. Actually, contrary findings exist for 
both cases. For instance, Rossi et al. [26] found that a bZIP type protein can bind to 
methylated promoters and activate the expression of the genes it controls. On the other 
hand, Choo [24] showed that some phage-selected zinc finger domains can distinguish 
5mC and C and thus have different binding ability to methylated and unmethylated targets. 
This same study also showed that some fingers only bound either 5mC or C, while others 
bound both bases equally well. Some recent studies demonstrated that natural zinc fingers 
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differentially recognize methylated and unmethylated CpG sequences and play an 
important role in regulating the expression of the target gene in vivo [27] . CTCF 
(CCCTC-binding factor), an eleven-finger protein, bound to unmethylated CpG-rich 
regions and repressed target gene expression by blocking the activity of the enhancer [28, 
29]. In contrast,  Kaiso, a three-finger protein, bound to its target when methylated [30] 
and this binding repressed expression of genes with methylated CpG promoters [30, 31].  
Applications of ZFPs  
With tailor-made sequence specificity, ZFPs are potent tools for biological research, 
agricultural engineering and biomedical applications. The utilization of ZFPs was 
summarized in several reviews. The engineering of polydactyl zinc finger transcription 
factors was recently reviewed by Beerli and Barbas [32].  Klug [33] summarized the 
recent application of ZFPs for human therapeutics, and several researchers have reviewed 
the applications of ZFNs [34-39].  
By binding to specific sites, ZFPs by themselves can serve as steric barriers for 
enzymes that work on DNA, or they can compete with other DNA-binding proteins for 
binding sites. By binding to a virus replication origin, artificial ZFPs can block the binding 
of the replication proteins and thus decrease the replication of the virus in plants [40] or in 
humans [41].  
When fused with various effector domains, ZFPs can direct these domains to 
desired DNA loci, and result in DNA modifications in a site-specific manner. Effector 
domains that have been fused with ZFPs include methytransferases, resolvases, integrases, 
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transcription activators or repressors, and endonucleases. Site-specific methytransferases 
can be constructed by fusing methytransferase domains with custom ZFPs. Targeted 
methylation of oligonucleotides that contain specific binding sites for engineered ZFPs was 
observed both in vitro [42] and in vivo [43]. Artificial recombinases constructed by fusing a 
catalytic domain of resolvase with the DNA binding domain of the natural ZFP zif268 
catalyzed efficient recombination specifically at the zif268 binding site [44]. When 
wild-type HIV integrase was fused with ZFPs, the resulting artificial zinc finger integrase 
biased the integration of viral DNA near the ZFP target site [45, 46].  
Zinc finger transcription activators and repressors generated by fusing activation or 
repression domains to the site-specific engineered ZFPs have been used to selectively 
target genes to switch them off and on. This technology has been studied to inhibit or 
activate genes involved in various diseases [16, 47-49].  
Among the site-specific DNA reagents created by linking ZFPs and effector 
domains, ZFNs may be the most potent and most widely used for biological research, 
biomedical applications and agricultural engineering. ZFNs are chimeric proteins that 
comprise one site-specific ZFP and one non-specific cleavage domain from the FokI 
restriction endonuclease. FokI requires dimerization to cut DNA, so two ZFP DNA-binding 
domains are needed for ZFNs to be functional. When two ZFP domains bind to two specific 
half sites 5, 6, or 7 base pairs away, two FokI domains dimerize and form an active 
endonuclease complex to cut double-stranded DNA. The double-stranded breaks (DSBs) 
generated by ZFNs can be used to increase gene targeting frequency through homologous 
recombination (HR). Gene targeting, which utilizes HR to make directed DNA sequence 
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modifications, has low frequency, on the order of 10-6. Studies show that DSBs can 
stimulate homologous recombination [50-55]. ZFN-induced site-specific DSBs can also be 
used to induce mutagenesis through non-homologous end joining (NHEJ). To date, ZFNs 
have been used in many organisms, such as Drosophila, worms, zebra fish, rats, plants and 
human cells [56-65]. 
One concern related to ZFN technology is their cytotoxic effects [10, 50, 66]. It is 
believed that the main reason for this toxicity is the result of “off-target” binding. When the 
nuclease domain was inactivated by point mutation, ZFNs did not cause toxicity in flies 
[67]. Three strategies have been published to reduce toxicity: (1) increase the specificity of 
the ZFPs used to create the ZFN; (2) reduce the formation of the homodimer ZFN pairs by 
reconstructing the FokI dimerization interface [68, 69]; (3) regulate ZFN protein levels 
using small molecules [70].   
Methods of engineering ZFMs and ZFPs 
With the many potential uses of ZFPs for both basic science and clinical 
applications, it is important to have a feasible, efficient and cost-effective method to 
engineer ZFPs.  Since the discovery of ZFM [1], different schemes to construct engineered 
ZFPs have been developed, including rational design, modular assembly (also called 
parallel selection), sequential selection, bipartite selection and bacterial based two-hybrid 
selection.  Each method has advantages and disadvantages.   
Efforts have been made to obtain fingers that recognize all of the 64 possible triplets 
using parallel selection [11, 71-73]. In this method, the residues of the recognition helix of 
the middle finger in a three-finger array are randomized and then variants recognizing new 
triplets are selected using phage display. Since this selection process doesn’t take account a 
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particular context, all of the fingers can be selected in parallel. After all of the fingers that 
recognize different triplets are selected, they can be mixed and matched together to 
construct proteins that recognize extended DNA sequences. To date there are three sets of 
zinc finger modules available: 1) Sangamo BioScience researchers identified fingers 
recognizing all of 5’-GNN-3’ and a few of 5’-ANN-3’, 5’-CNN-3’ and 5’-TNN-3’ triplets 
using phage display, targeted mutagenesis and SELECT methods[11, 15, 74]; 2) the Barbas 
group constructed another set of modules, which recognize all of 5’-GNN’-3’, most of 
5’-ANN-3’, 5’-CNN-3’ and a few 5’-TNN-3’ triplets [71-73, 75, 76]; 3) Toolgen, Inc., 
isolated a set of naturally occurring ZFMs from human transcription factors  [11, 71-73, 
77].  The advantage of this method is that once fingers recognizing all 64 triplets are 
selected and optimized, engineered proteins can be constructed in a matter of hours. The 
publication of the standardized protocol for engineering ZFPs using the repository of zinc 
finger encoding plasmids created by Zinc Finger Consortium and provided through 
Addgene plasmid service [78] makes the modular assembly approach even easier. The 
disadvantage of this method is that it assumes that the fingers and corresponding binding 
subsites are completely modular (i.e., the efficacy of the ZFMs is not affected by the 
context). As demonstrated in systematic studies, ZFPs assembled with these modules for 
sites composed of all GNN subsites have higher success rate [100% [9], 60% [77] and 56% 
[79]] , while those for sites composed of two, one or no GNNs resulted in much lower 
success rate [79]. A most recent systematic study comparing the naturally occurring 
(Toolgen) modules with the engineered (SGMO and Barbas) modules showed that 
naturally occurring ZFMs are much more effective [80]. This result suggests that modular 
assembly success rate can be improved by enhancing the efficacy of the modules.   
In order to overcome the limitations of parallel selection and to take TSO into 
account when constructing ZFPs, Pabo and colleagues developed a sequential selection 
method [81] that adds and optimizes one new finger into the new protein at a time. When a 
three-finger protein needs to be constructed, three steps are required. In the first step, the 
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two fingers at the 5’-end with known binding specificities are used as anchors and the 
3’-end finger is randomized and selected. In the second step, one of the anchor fingers is 
replaced with the newly selected finger and another randomized library is appended at the 
3’end. This process continues until the new protein with desired target site is created. An 
advantage of this method is that each finger in a protein is selected in the context of the 
previous fingers. The primary disadvantage is that each finger in a multiple-finger protein 
needs multiple cycles of selection and amplification, so the procedure is time-consuming 
and labor-intensive.  
To address the TSO issue of parallel selection and to reduce the labor-intensiveness 
of sequential selection, a bipartite selection method was developed [82]. This method 
randomizes and selects one-and-a-half fingers of a three-finger protein; that is, it 
simultaneously randomizes the positions from adjacent fingers. In order to reduce labor, 
only a subset of the 20 amino acids is used in randomization to reduce the library size. After 
selection, the two libraries for each one-and-a-half site are recombined and selected to get 
the three-finger protein. This method maximizes context-dependent effects and reduces 
labor required for the selection and amplification; however, multiple rounds of selection 
and amplification are still needed for the selection of the one-and-a-half finger libraries 
using phage display.  
An alternative to bacterial phage display-based selection is a bacterial two-hybrid 
(B2H) method, an in vivo, cell-based selection technique [83]. Using B2H as the selection 
method, Hurt et al. developed a directed domain shuffling method to engineer ZFPs [84]. 
This method takes into account the potential interfinger context effects and involves two 
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steps. In the first step, master randomized libraries are generated for each triplet subsite 
from the framework protein by fixing two fingers and randomizing one finger and then 
selecting against the target subsite under low stringency. In the second step, the selected 
master randomized libraries are recombined to form the recombined library and then the 
recombined library is subjected to selection using the whole target site of interest.  This 
method is faster than phage display-based selection methods since it does not require 
multiple rounds of selection and amplification of libraries. In order to make this method 
easier and more accessible to the academic research community, Joung’s lab and the Zinc 
Finger Consortium are constructing the master libraries (“pools”) and making them 
publicly available. This domain shuffling method is named as OPEN (Oligomerized Pool 
Engineering) and the protocol is described in Maeder et al. [85]. 
By analyzing the natural and engineered zinc fingers and their targets, recognition 
codes have been proposed based on the preference of amino acids for contacting certain 
DNA bases [86, 87]. The idea of the recognition codes assumes that there is a relationship 
among residues at specific positions of the α-helix and nucleotides at particular positions of 
the corresponding target site. ZFPs generated using recognition code can’t address the 
position-dependence of fingers and anticipated protein-DNA interactions and thus are not 
as good as those that are generated through selection methods [8].  
In summary, both modular assembly and selection methods have advantages and 
disadvantages. By providing the information about ZFMs and ZFPs through a 
web-accessible database and by characterizing the binding properties of ZFMs and ZFPs to 
their target DNA sequences, we are aiming to help researchers generate ZFPs using the 
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methods they prefer (i.e., modular assembly or OPEN).   
 DISSERTATION ORGANIZATION 
This dissertation has four chapters and four appendices. Chapter 1 is a general 
introduction about the properties of ZFMs and ZFPs and methods to engineer them. 
Chapter 2 is a paper published in Nucleic Acid Research in which the development and 
content of a web-accessible zinc finger database are described [88]. Chapter 3 is a paper to 
be submitted to Nucleic Acids Research, in which we sequenced the OPEN pools, analyzed 
the finger sequences in each pool, and revealed important rules that govern the binding of 
ZFPs to DNA. Chapter 4 is a general conclusion and description of future work, including 
wet-lab experiments and computational analysis to test the rules generated here and to 
improve the OPEN methods. Appendix A is a paper published in Nature in 2009 that 
demonstrated the high frequency modifications in tobacco SurR genes enhanced by 
engineered ZFNs [59]. I analyzed the tobacco genome sequences altered by the DSB repair 
pathway. I also assembled and tested some of the zinc finger arrays that were used to 
generate the ZFNs.  Appendix B is a paper published in Molecular Cell in 2008 that 
demonstrated the efficacy of the OPEN method by comparing gene modification 
frequencies caused by modular-assembled ZFNs and OPEN-generated ZFNs [89]. I 
assembled and tested some of the zinc finger arrays. Appendix C is a manuscript published 
in Nature Methods in 2008 in which the success rate of the publicly available ZFMs was 
systematically tested [79]. I tested the B2H fold activation of some of the arrays. Appendix 
D is a paper published in Nature Protocols in 2006 explaining the protocol to generate 
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ZFPs by modular assembly. The modules provided in this paper were published by other 
researchers [11, 15, 71, 72, 74, 75, 77], cloned into plasmids by the Zinc Finger Consortium 
and provided to the public through Addgene (http://www.addgene.org/pgvec1) [78]. I 
cloned some of the plasmids and provided some text for the manuscript.   
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CHAPTER2. ZINC FINGER DATABASE (ZiFDB): A 
REPOSITORY FOR INFORMATION ON C2H2 ZINC 
FINGERS AND ZINC FNGER ARRAYS 
A paper published in Nucleic Acid Research 2009 
Fengli Fu, Jeffry D. Sander, Morgan Maeder, Stacey Thibodeau-Beganny, 
J. Keith Joung, Drena Dobbs, Leslie Miller and Daniel F. Voytas 
ABSTRACT 
Zinc fingers are the most abundant DNA-binding motifs encoded by eukaryotic 
genomes and one of the best understood DNA-recognition domains. Each zinc finger 
typically binds a 3-nt target sequence, and it is possible to engineer zinc-finger arrays 
(ZFAs) that recognize extended DNA sequences by linking together individual zinc 
fingers. Engineered zinc finger proteins have proven to be valuable tools for gene 
regulation and genome modification because they target specific sites in a genome. 
Here we describe ZiFDB (Zinc Finger Database; http://bindr.gdcb.iastate.edu/ZiFDB), 
a web-accessible resource that compiles information on individual zinc fingers and 
engineered ZFAs. To enhance its utility, ZiFDB is linked to the output from ZiFiT—a 
software package that assists biologists in finding sites within target genes for 
engineering zinc-finger proteins. For many molecular biologists, ZiFDB will be 
particularly valuable for determining if a given ZFA (or portion thereof) has previously 
been constructed and whether or not it has the requisite DNA-binding activity for their 
experiments. ZiFDB will also be a valuable resource for those scientists interested in 
better understanding how zinc-finger proteins recognize target DNA.  
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INTRODUCTION 
The C2H2 zinc-finger motif is approximately 30 amino acids in length and 
conforms to the pattern (F/Y)-X-C-X2–5-C-X3-(F/Y)-X5-ψ-X2-H-X3–5-H, where X 
is an amino acid and ψ is a hydrophobic residue (1). The amino acids fold into a ββα 
structure, which is stabilized by a zinc ion coordinated by the two conserved cysteine 
and histidine residues. In binding DNA, each finger typically recognizes three 
adjacent nucleotides: amino acids at positions -1, +3 and +6 (relative to the beginning 
of the α-helix) contact nucleotides at the 3’-end, middle and 5’-end of the target 
nucleotide triplet. Zinc fingers can function as monomers, making it possible to link 
zinc fingers together in extended arrays that recognize unique DNA sequences. Such 
artificial or engineered zinc-finger arrays (ZFAs) are often fused to effector domains 
(e.g. transcriptional activation domains or nucleases), and engineered zinc-finger 
fusion proteins are proving increasingly valuable reagents for gene regulation and 
genome modification (2).  
A simple approach for engineering ZFAs is known as ‘modular assembly’, 
wherein individual fingers are joined together to create an array that recognizes a 
novel target sequence. To facilitate modular assembly, efforts have been made to 
obtain zinc fingers that recognize all 64 possible triplets. Approaches to create such a 
finger archive have included parallel selection from random libraries (3–7), rational 
design (8, 9) and characterization of naturally occurring zinc-finger proteins (10). 
Zinc fingers have thus far been identified that recognize all 16 GNN triplets as well as 
most CNN, ANN and some TNN triplets. Modular assembly assumes that individual 
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zinc fingers are not influenced by neighboring fingers in an array. However, 
systematic testing of a large number of ZFAs constructed with available zinc-finger 
modules resulted in success rates of 56%, 20%, 4% and 0% for 9-bp target sites 
composed of three, two, one or no GNN triplets, respectively (11). It is clear from this 
work that zinc fingers are not always modular and that a better understanding of 
context-dependent effects is needed to increase the reliability of modular assembly.  
To minimize the context dependence associated with modular design, 
sequential selection (12), bipartite selection (13) and bacterial-based selection 
methods have been described (14, 15). These methods typically involve screening 
large libraries of ZFA variants. The few arrays in the library that recognize a specific 
target with high affinity and specificity are identified using phage display or a 
bacterial two-hybrid system in which target binding activates expression of a reporter 
gene. An advantage of these selection-based strategies is that context-dependent 
effects are addressed through the process of selection. Selection-based approaches, 
however, require considerable molecular biological expertise and are time consuming. 
Recently, a selection platform was described, called OPEN (Oligomerized Pool 
ENgineering), that overcomes shortcomings of traditional selection-based methods in 
that it is simpler and faster; it is also much more effective than modular assembly (11, 
16). However, even the simplified OPEN strategy remains more labor-intensive and 
difficult to perform than modular assembly. 
Because many scientists are interested in generating zinc-finger proteins for 
gene regulation and genome modification, we implemented a Zinc Finger Database 
(ZiFDB)—an archive of information about zinc fingers and engineered ZFAs. The 
database is one of several, integrated resources provided by the Zinc Finger 
Consortium (http://www.zincfingers.org), a group of academic laboratories dedicated 
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to improving methods for engineering ZFAs and developing new applications for their 
use. The Consortium has previously created a repository of zinc-finger encoding 
plasmids which simplify and facilitate modular assembly of ZFAs (17). Consortium 
labs also developed and validated the OPEN platform for ZFA engineering (11, 16). 
Further, Consortium-supported software, called ZiFiT (Zinc Finger Targeter), allows 
users to scan DNA sequences to identify potential sites for which ZFAs might be 
engineered by either modular assembly or OPEN (18). A particularly important 
feature of ZiFDB is its linkage to ZiFiT, which allows users to readily determine if 
particular ZFAs have been previously made by other investigators that recognize a 
target sequence of interest.  
DATABASE CONTENTS  
Zinc Fingers  
ZiFDB currently contains 716 zinc fingers, each of which is assigned a unique 
numerical designator. The database was initially populated with fingers generated and 
characterized by four different research groups:  
(1) Sangamo BioSciences: Sangamo Biosciences designed zinc fingers that recognize 
GNN triplets at each of the three positions in a three-finger array (7). It is assumed 
that these fingers function optimally in the position for which they were designed. 
Sangamo has also generated several zinc fingers that recognize non-GNN triplets, 
and these are also included in the database (17, 19, 20).  
(2) Barbas laboratory: The Barbas laboratory at the Scripps Research Institute 
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developed a large number of zinc fingers that recognize diverse nucleotide triplets. 
The fingers are presumed to be modular and function at any position within a ZFA 
(3, 4, 6, 21).  
(3) Toolgen: Toolgen Inc. assembled a collection of zinc fingers derived from 
naturally occurring zinc-finger proteins encoded in the human genome (10).  
(4) Joung laboratory: The Joung laboratory at Massachusetts General Hospital used 
the OPEN platform to generate a large number of ZFAs (16). All of these ZFAs 
are three finger domains that recognize a 9-bp target. Unique zinc fingers 
comprising ZFAs generated by OPEN are also included in the database. 
In some cases, investigators have used the DNA-recognition helices from the 
above fingers within the context of a different zinc-finger backbone. In ZiFDB, such 
fingers are given a different numerical designator, since the backbone may affect 
zinc-finger function. The following information is provided for each zinc finger: 
(1) Triplet target:  The sequence is provided for the cognate 3-bp DNA target of each 
finger.  
(2) Recognition helix: The sequence is provided for the seven amino acids that 
constitute the recognition helix: positions -1 to +6 relative to the start of the 
α-helix that contacts DNA in the finger. 
(3) Position within a three-finger array: As indicated above, some fingers were 
designed to function optimally at certain positions within a three-finger array. The 
fingers described by Sangamo BioSciences, for example, were selected at 
different positions within a three-finger protein, and the recognition helices for the 
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same triplet target at different positions in a three finger protein usually differ (7). 
These differences are likely due to position and context-dependent effects. In 
addition, the fingers generated by OPEN were selected to function in a specific 
position within a three finger protein (16). The database records position 
information for the fingers described by Sangamo BioSciences and generated by 
OPEN. By convention, finger 1 (F1) specifies the 3’-triplet in a 9-bp target, F2 
specifies the middle triplet and F3 specifies the 5’-triplet. 
(4) Source: The name of the group that generated the zinc finger is provided. The 
groups at present include the Barbas and Joung laboratories, Sangamo 
BioSciences (SGMO) and ToolGen. 
(5) Amino acid sequence: The amino acid sequence of the entire finger is provided. 
(6) Article: A link to the relevant citation is provided so the user can get more detailed 
information about a particular finger. 
(7) Experiment: A link directs the user to information describing the method used to 
generate the finger, relevant functional data and other observations made by the 
experimenter. 
Zinc-finger arrays 
At present, ZiFDB houses 652 three-finger arrays collected from the published 
literature. Although engineered ZFAs of four or more fingers have been reported, the 
engineering platforms for which the Zinc Finger Consortium has developed reagents 
are only designed for constructing three-finger arrays. Larger arrays, therefore, are 
currently not supported by ZiFDB. Each three-finger array in the database has a 
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unique numerical designator, and the following information is provided: 
(1) Identification numbers (IDs) of the component fingers: The IDs correspond to the 
zinc-finger designator and are hyperlinks that allow a user to look up detailed 
information about individual fingers in an array.  
(2) Binding subsites: These sequences correspond to the 3-bp nucleotide target of the 
corresponding component finger.  
(3) Recognition helix: For each finger in an array, the sequence is provided of the 
seven amino acids that make up the recognition helix.  
(4) Article: A link to the relevant citation is provided so the user can get more detailed 
information about that array. 
(5) Experiment: A link is provided to information describing the method used to 
generate the arrays and relevant functional data or other observations made by the 
experimenter. 
DATABASE INTERFACE 
To retrieve information about a particular zinc finger, any combination of three 
search criteria can be used: triplet target, finger position and/or finger source. By 
providing partial information, a list of all fingers matching the input is returned 
(Figure 1). By clicking the link in the article or experiment column, detailed 
information about related citations or experiments is displayed. 
When searching for information about an array, the user provides the 
nucleotide triplets (subsites) recognized by each finger in the array. The database 
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returns not only the arrays recognizing the three input subsites, but also arrays 
matching any two of three triplet subsites (Figure 2). This partial information may 
inform the design of novel ZFAs by providing the user with a two finger protein that 
could be modified and tested for function. For arrays that match only two of the input 
subsites, the matching subsites and their recognition helices are colored in red for easy 
identification. The output also provides the amino acid sequence of the array, IDs for 
each finger in the array and IDs for related articles or experiments. By clicking the 
relevant ID, the user is directed to information on specific fingers, articles or 
experiments. 
 
Figure 2.1 Sample output from the finger search page when GGG is provided as the 
target and the position and source are left blank. 
 
 31
 
Figure 2.2 Sample output returned when searching for arrays with the binding site 
5’-GAAGGCGGC-3’. 
 INTERFACE WITH PRE-EXISTING ZIFIT SOFTWARE 
To enhance its utility, ZiFDB is interfaced directly with ZiFiT—a web 
accessible software package that assists biologists with zinc-finger protein design 
(http://bindr.gdcb.iastate.edu/ZiFiT/) (16, 18). ZiFiT provides users with a list of 
target sites within their DNA sequence of interest as well as the corresponding 
Consortium-developed reagents available for engineering the ZFAs. Target site 
hyperlinks within the ZiFiT output directly query ZiFDB to determine if any 
previously constructed arrays exist that bind to completely or partially matched target 
sequences. In addition, ZiFiT users can query ZiFDB for finger information for a 
 32
specific triplet subsite by clicking on the triplet. Thus, ZiFiT and ZiFDB work 
synergistically to aid in ZFA design. 
IMPLEMENTATION 
ZiFDB stores zinc-finger information as a set of objects defined by Java 
classes. The atomic information is contained in two main classes (Zinc Finger and 
Zinc Finger Array). Both classes reference additional Article and Experiment classes. 
The Article class includes the title, journal, volume, page, year and authors for the 
article being represented. The Experiment class includes information on the submitter, 
assay, results and other comments provided by the author or submitter. The authors of 
articles and experiments are organized using an Author class. Each finger or array 
object can be associated with multiple Articles or Experiments. The objects 
representing the Java classes are mapped to a MySQL version 4.0.15 database using 
Hibernate.  
Apache Tomcat version 5.5.15 is used as the servlet engine for the web site. 
The web application uses Struts 1.2 to implement the Model-View-Controller (MVC) 
pattern. Java Server Pages (JSP) are used to implement the user’s view. The web 
application was developed using Eclipse 3.0. 
CONCLUSION 
ZiFDB is one of an increasing repertoire of tools for zinc-finger protein 
engineering provided by the Zinc Finger Consortium. ZiFDB houses information on 
individual zinc fingers, including the 141 zinc-finger modules currently made 
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available as a clone library by the Consortium. Importantly, the database also provides 
users with information on ZFAs and their target sequences, and we believe this feature 
will be particularly valuable for the rapidly growing number of molecular biologists 
interested in generating ZFAs for modification or regulation of their genome locus of 
interest. Further, analysis of the data housed in ZiFDB will also likely provide new 
insight into how zinc-finger proteins recognize their DNA targets, which, in turn, may 
lead to additional improvements in ZFA engineering. 
FUTURE PERSPECTIVE 
Future versions of ZiFDB will allow users to directly input information on 
novel zinc fingers or ZFAs. To ensure data quality, a shadow database will be created 
that is associated with the persistent database. Users will be permitted to submit data 
to the shadow database where it will be held pending approval by the curator and 
subsequent loading into the persistent database. This feature will ensure that the 
database capitalizes upon new information generated by the scientific community, 
including unpublished ZFAs, and thereby should expand the utility of the database. 
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CHAPTER 3. ANALYSIS OF REAGENTS DEVELOPED 
FOR OLIGOMERIZED POOL ENGINEERING (OPEN) 
REVEAL INSIGHTS INTO INTERACTIONS BETWEEN 
ZINC FINGER PROTEINS AND DNA 
A paper to be submitted to Nucleic Acid Research 
 
Fengli Fu, J. Keith Joung, and Daniel F. Voytas 
ABSTRACT 
Oligomerized Pool ENgineering (OPEN) is a publicly available, selection-based 
method for making zinc finger proteins.  Two separate genetic selections are used in 
OPEN.  In the first, low stringency selections are used to generate maximum 95 zinc 
finger variants that recognize a specific nucleotide triplet in a 9 bp target site.  In the 
second, the zinc finger variants for each triplet are recombined to create a plasmid library 
encoding ~106 three finger arrays.  This library is screened under high stringency 
conditions to identify arrays that bind a 9 bp target site with high affinity and specificity.  
We sequenced 68 OPEN pools (each of 95 zinc finger variants) by 454 pyro-sequencing 
and compared the resulting zinc finger archive to the more than 1000 OPEN-derived zinc 
finger arrays.  Our analyses revealed several insights into how zinc fingers recognize 
DNA:  1) the DNA recognition code is less complex than expected, and each nucleotide in 
the 9 bp target is contacted by one or at most a few different amino acids (positions -1, +3 
and +6 in the recognition helix of the zinc finger); 2) amino acid sequence diversity is also 
remarkably low for non-contact amino acids in the recognition helix (positions +1, +2 and 
+5); 3) target site overlap (i.e. the recognition of 4 bp), which is caused by aspartic acid in 
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position +2, only occurs when the subsite is GNG; 4) there is an inverse relationship 
between the charge of the contact and non-contact residues determined by the base 
composition of the target:  as the number of purines in the target increases, the total charge 
of the contact residues becomes more positive, whereas the total charge of the non-contact 
residues becomes more negative; 5) a finger position effect is supported by the lack of 
common fingers among the pools for the same triplet at different positions in the three 
finger array and the fact that there are more common contact residue sets between fingers 2 
and 3 than between fingers 2 and 1.  To explore whether these rules aid in engineering zinc 
finger proteins, we altered the recognition helices of six non-functional zinc finger arrays 
made by modular assembly to conform to the consensus amino acid sequences derived 
from analysis of the OPEN reagents.  Two of the six proteins were rendered functional by 
the changes, suggesting that the rules can be used to improve the efficacy of zinc finger 
protein production.  Further, the lack of complexity of the OPEN pools suggests that the 
pool size can be significantly reduced, thereby streamlining the OPEN protocol. 
INTRODUCTION 
DNA-binding proteins play important roles in many biological processes through 
interactions with single or double stranded RNA or DNA. C2H2 zinc finger proteins (ZFPs) 
are the largest family of DNA-binding domains encoded by eukaryotic genomes. In 
accordance with their biological importance, considerable effort has been expended to 
understand the molecular mechanism by which C2H2 ZFPs bind nucleic acids.  More 
recently, this research has been motivated by the desire to engineer novel ZFPs – an 
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opportunity that was recognized when the first C2H2 zinc finger motif was discovered [1]. 
To date, the great potential of tailor-made ZFPs for gene and genome manipulation has 
been realized in organisms such as Drosophila, zebrafish, rats, plants and human cells 
[2-11].  However, in spite of the usefulness of engineered ZFPs for research and 
therapeutic applications, an easy and reliable method to generate functional ZFPs is still 
absent.  
One of the most widely used methods for constructing engineered ZFPs is modular 
assembly, in which predefined zinc finger modules (ZFM) are linked together into 
extended arrays.  Modular assembly is very easy to perform, and the average molecular 
biologist can create a ZFP for a desired target site in a matter of hours.  Underlying 
modular assembly is the idea that each finger binds to an independent 3 base pair target 
subsite:  amino acids at positions -1, +3 and +6 relative to the start of the α-helix contact 
the 3’-, middle and 5’-nucleotides of the triplet (Figure 3.1). To date, engineered ZFMs for 
all 16 GNN, ANN, CNN and some TNN triplets are available [12-17]. However, the ease of 
the strategy and the availability of the ZFMs do not ensure that functional ZFPs will be 
obtained.  A systematic test of three finger ZFPs assembled from the available ZFMs 
showed 56%, 20%, 6% and 0% success rates for target sites composed of all, two, one or no 
GNN subsites [18].  One of the possible reasons for the failure of modularly assembled 
ZFPs is that the predefined finger module is not really modular. For example, some fingers 
are known to bind to more than three bases through what is called target site overlap (TSO).  
For a ZFM that exhibits TSO, binding interferes with the target site of the adjacent ZFM.  
TSO, therefore, limits modularity by restricting situations to which it can be applied.  
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Figure 3.1 Engineered zinc finger proteins. The top figure shows the structure of a zinc 
finger.  The bracket denotes the DNA binding domain at the N-terminus of the alpha helix.  
The contact residues at -1, +3 and +6 positions are shown extending from the ribbon.  
 
In contrast to modular assembly, selection-based methods take context into 
consideration, and thus more reliably generate functional ZFPs.  However, selection-based 
methods are time-consuming and require considerable expertise to perform. Oligomerized 
Pool ENgineering (OPEN) is the newest generation of selection-based methods [19-21] 
(Figure 2).  Compared to previous selection platforms, OPEN can be performed relatively 
quickly because it uses pre-constructed zinc finger pools made by the Zinc Finger 
Consortium (http://www.zincfingers.org).  To fully enable OPEN, an archive of 192 zinc 
finger pools will be constructed (66 finger pools are currently available for 48 GNN 
subsites and 18 TNN subsites).  Each pool contains 95 ZFM variants that target a specific 
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subsite at a defined position within a three finger array.  The finger pools are derived by 
screening a library of three finger proteins that have two fingers fixed and that vary at a 
single position.  Binding is measured by a proteins ability to activate transcription of a 
reporter gene in bacteria.  When novel ZFPs are needed for a target sequence of interest, 
three finger pools are recombined to generate a second library of ZFP variants.  This 
library is then screened under high stringency to identify the zinc finger arrays that best 
recognize the target.  To date, over 1000 three finger arrays have been generated by OPEN 
for hundreds of different target sites.  
 
Figure 3.2 The OPEN (Oligomerized Pool Engineering) platform, a combinatorial-based 
selection method for making zinc finger arrays (Maeder et al., Mol. Cell, 31:294).  OPEN 
selections use an archive of pre-selected zinc finger pools, each containing a collection of 
fingers targeted to a different three base pair subsite at a defined position within the context 
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Figure 3.2 | continued of a three-finger protein. A  total of 192 finger pools (64 potential 
three bp subsites for each position in a three-finger protein) are required to fully enable 
OPEN.  To date, the Zinc Finger Consortium has created pools (each containing a 
maximum of 95 different fingers) targeted to 66 subsites (48 GNN subsites and 18 TNN 
subsites (Maeder et al., Mol. Cell, 31:294)). To perform an OPEN selection for a target site, 
appropriate finger pools from the archive are recombined to create a small library of 
variants (953 = 8.6 x 105 members for a three-finger domain). This library is then 
interrogated using a bacterial two-hybrid (B2H) selection system in which binding of a 
zinc-finger domain to its cognate site activates expression of selectable marker genes (Hurt 
et al., Proc. Natl. Acad, Sci. USA, 100:12271; 2003; Joung et al., Proc. Natl. Acad, Sci. 
USA, 97:7382; Maeder et al., Mol. Cell, 31:294).  
RESULTS AND DISCUSSION 
DNA sequencing of the OPEN pools 
454 pyro-sequencing was used to obtain DNA sequences for each of the 66 
available OPEN pools.  Each pool consists of 95 possible ZFM variants that recognize a 3 
bp subsite at a given position in a three finger ZFP.  The number of variants (i.e. 95) is an 
arbitrary number and was chosen for convenience in storing the clones comprising a pool in 
a 96-well plate.  Forty-eight of the pools represent ZFM variants that recognize all 
possible GNN subsites (i.e. the 16 possible GNN subsites at each of the three positions in a 
three finger protein).  An additional 18 pools recognize a subset of the 48 possible TNN 
subsites.  Out of convention, subsites are specified by the finger that binds to them:  
Finger 1 (F1) is the N-terminal most finger in a three finger protein. 
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Table 3.1 A summary of DNA sequences obtained by pyrosequencing the OPEN pools 
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and recognizes the 3’-most subsite; finger 2 (F2) recognizes the middle subsite, and finger 
3 (F3) recognizes the 5’-most subsite (Figure 2).  DNA representing each pool was 
PCR-amplified using bar-coded primers to distinguish the pools.  The primers also 
included priming sites for 454 sequencing.  The amplification products were quantified, 
mixed and subjected to 454 sequencing.  
The 454 sequencing run generated over 400,000 sequencing reads. The raw data 
was processed using the barcodes to partition the sequences into the various pools.  
Because the F1 and F2 subsites for the same sequence (e.g. GAA) used the same barcodes, 
these pools were distinguished by the fixed F1 or F2 recognition helices.  From the DNA 
sequences representing each pool, the seven amino acid recognition helices were then 
extracted.  For some F3 sequences, more than one F3 recognition helix was present due to 
insertions generated during library construction.  In such cases, only the recognition helix 
adjacent to F2 was extracted.  The number of total recognition helices ranged from 593 to 
12,826. The sequences for these recognition helices were further processed to identify only 
the unique recognition helices. “Bad” recognition helices were eliminated, namely those 
that contain stop codons due to mutations introduced during PCR amplification or DNA 
sequencing.  After processing, the number of unique “good” fingers ranged from 32 to 241 
(Table 3.1) and the number of bad fingers ranged from 0 to 56.  Because only PCR and 
sequencing-induced errors could be distinguished if they created stop codons, we estimated 
the PCR error rate for each pool based on sequence variations observed in the 48 base pair 
backbone sequence that was constant among all sequenced fingers.  The formula for error 
estimation is below:  
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EstimationOfUniqueBadFingers=
numberOfTotalUniquePoint Mutation
TotalNumberOfSequences* lengthOfSequence(48)
* lengthOfRH(21)*TotalNumberOfRH  
The PCR error rate ranged from 0 to 0.000852.  The error rate made it possible to 
predict the number of additional “bad” fingers in the dataset that contain mutations, and 
these estimates are listed in Table 1.  Note that some pools contain more fingers than the 
95 expected even after PCR error is taken into account.  One reason for this may be the 
way in which the pools were prepared:  each pool represents 95 bacterial colonies that 
survived low stringency selection; the colonies were not colony-purified and many are 
known to contain more than one plasmid that encodes a ZFM .  
The coverage of the pool sequences 
To test the comprehensiveness of the 454 pyro-sequencing, we took advantage of 
the selected zinc finger proteins, namely the >1000 three finger proteins generated by 
OPEN in our laboratories as of September 2009.  Theoretically, all of the selected zinc 
fingers that make up the OPEN arrays should be found within our 454 sequences.  
However, we observed a large number of missing selected zinc fingers in the 454 sequences 
(Table 3.2).  We considered three possible reasons for this: 1) The template sequences 
were lost during the preparation of the DNA mixture used for 454 sequencing; 2) Some of 
the fingers were mutated or contain sequencing errors; 3) The selected zinc fingers are not 
really found in the pools, but were ‘created’ during OPEN by PCR-induced mutations.  To 
better understand the reasons for the missing of  
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Table 3.2 The percentage of selected zinc fingers (SZF) in OPEN arrays that are not in the 
pool sequences. 
 
 
selected zinc fingers in the 454 sequences, DNA was individually prepared and sequenced 
from the 95 colonies with plasmids encoding the 95 zinc fingers for GAG_F1 and GAA_F2 
(hereafter referred to as plate sequences).  For GAG_F1, 93 plate sequences were obtained 
(one colony did not grow and one sequencing run failed) that represent 81 unique zinc 
fingers.  The OPEN arrays had 25 unique recognition helices for GAG_F1, and 19 were 
present both in the plate sequences and the 454 dataset (Table 3.3).  For GAA_F2, 90 plate 
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sequences were obtained (five colonies did not grow or couldn’t be sequenced), and 43 
unique recognition helices were found.  The OPEN arrays have 29 unique recognition 
helices for GAA_F2; 21 of these were found in the plate sequences and 23 were found in 
the 454 dataset (Table 3).  Further, over 95% of the plate sequences are present in the 454 
dataset for both GAG_F1 and GAA_F2 (see supplemental tables). These results 
demonstrate that the missing zinc fingers are due neither to errors in the preparation of the 
454 pyro-sequencing reagents nor to the processing of the 454 data.  Rather, it appears that 
PCR amplifications completed in the practice of OPEN likely generate additional sequence 
variation that effectively expanded the diversity of the pools.  
Amino acid diversity in the recognition helices of OPEN selected zinc 
finger proteins 
Another important source of information on how zinc finger proteins recognize 
DNA is the ever-expanding archive of zinc finger arrays generated by OPEN.  The amino 
acids that contact specific nucleotides at each position within a nine base pair target site 
were counted and the percentage of each amino acid was calculated (AAvs9bp) (Table 3.4). 
The amino acids specifying purines (A and G) are less diverse than those specifying 
pyrimidines (T and C).  It is also interesting to note that for purines, the consensus amino 
acids are the same for all of the fingers in a three finger protein, whereas for pyrimidines, 
the consensus amino acids differ at each of the three finger positions.  In the remaining 
sections, the data derived from the sequences of the OPEN pools and the OPEN arrays were 
both analyzed to identify emerging rules in DNA recognition by zinc finger proteins. 
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Table 3.3 Comparison of the coverage of plate sequenced and 454 pyro-sequenced pools 
for GAG_F1 and GAA_F2. 
GAG_F1  GAA_F2 
SF 
In plate 
seq 
In 454 
seq  SF 
In plate 
seq 
In 454 
seq 
KHHNLLR √ √  QKVNLAR √ √ 
KHSNLAR √ √  QGGNLTR √ √ 
KHSNLTR √ √  QQTNLAR √ √ 
KKTNLTR √ √  QSANLSR √ √ 
KLTNLTR √ √  QMSNLDR √ √ 
KPSNLER √ √  QAGNLSR √ √ 
KQSNLLR √ √  QATNLQR √ √ 
KQTNLRR √ √  QHTNLTR √ √ 
KTSNLAR √ √  QGTNLVR √ √ 
RGHNLER √ √  QQANLSR √ √ 
RMSNLDR √ √  QGANLVR √ √ 
RNTNLAR √ √  QTGNLLR √ √ 
RQMNLDR √ √  QNANLAR √ √ 
RQSNLSR √ √  QGANLTR √ √ 
RQTNLIR √ √  QEPNLLR √ √ 
RVSNLTR √ √  QRSNLAR √ √ 
TNNNLAR √ √  QQINLER √ √ 
TTHNLAR √ √  QRDNLGR √ √ 
TTHNLMR √ √  QRVNLAR √ √ 
TKHNLVR × ×  QNQNLAR √ √ 
TTSQLAR × ×  QLANLGR √ √ 
KRSNLTR × ×  QQTNLTR × √ 
RASNLTR × ×  QGGNLVR × √ 
KHSNLKR × ×  QAGNLRR × × 
RPHNLER × ×  QRTNLVR × × 
       QQTNLVR × × 
       QGSNLQR × × 
       QTGNLQR × × 
       QESNLVR × × 
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Table 3.4 The distribution of amino acids that contact specific nucleotides in a 9 bp target 
site.  Numbers in parentheses represent percentages.  The data is derived from the archive 
of OPEN arrays. 
F3 F2 F1  
5’ Middle 3’ 5’ Middle 3’ 5’ Middle 3’ 
A 
 N(88.27) 
G(4.59) 
T(3.57) 
Q(1.53) 
L(1.02) 
S(1.02) 
 
Q(95.86)
L(2.37) 
A(0.59) 
D(0.59) 
R(0.59) 
 N(95.05)
G(1.49) 
T(1.49) 
H(0.99) 
A(0.50) 
S(0.50) 
Q(96.02)
R(1.70) 
T(1.70) 
L(0.57) 
 N(73.25) 
R(8.77) 
T(6.58) 
A(6.14) 
H(1.75) 
G(1.32) 
P(0.88) 
K(0.44) 
M(0.44) 
Q(0.44) 
Q(28.57)
D(15.97)
R(12.61)
T(11.76)
N(9.24) 
L(7.56) 
E(5.88) 
K(2.52) 
H(1.68) 
I(1.68) 
V(1.68) 
T 
G(38.91) 
L(14.93) 
A(9.05) 
H(8.60) 
V(6.33) 
R(5.43) 
P(4.52) 
S(2.71) 
M(2.26) 
N(2.26) 
I(1.81) 
Q(1.36) 
K(0.90) 
S(32.88) 
A(26.03) 
G(17.81) 
V(8.22) 
T(7.53) 
R(4.11) 
P(2.05) 
L(1.37) 
Q(30.13)
V(27.56)
L(18.59)
I(10.90)
A(7.05) 
H(2.56) 
E(1.28) 
M(1.28)
G(0.64) 
 
V(40.71)
I(23.01)
T(14.16)
G(11.50)
R(6.19) 
L(2.65) 
A(0.88) 
E(0.88) 
V(35.71)
S(28.57)
G(27.92)
I(4.55) 
L(1.30) 
T(1.30) 
M(0.65)
 
L(41.70)
V(15.74)
S(13.19)
H(12.77)
Q(6.38) 
E(3.83) 
M(3.40)
I(1.28) 
T(0.85) 
A(0.43) 
P(0.43) 
L(24.76)
I(20.95)
R(11.43)
V(11.43)
T(8.57) 
M(7.62)
A(5.71) 
K(4.76) 
E(2.86) 
D(0.95) 
G(0.95) 
H(21.14) 
T(18.70) 
V(17.07) 
S(14.63) 
I(13.01) 
A(7.32) 
L(4.07) 
E(3.25) 
R(0.81) 
T(40.19)
R(13.55)
L(9.81) 
S(9.35) 
I(7.94) 
G(3.27) 
M(2.80)
Q(2.80) 
H(2.34) 
A(1.87) 
K(1.87) 
V(1.87) 
D(0.93) 
C  
N(18.78) 
A(13.20) 
G(13.20) 
T(13.20) 
D(12.18) 
M(9.64) 
S(8.12) 
V(4.57) 
L(4.06) 
I(1.02) 
R(1.02) 
P(0.51) 
Q(0.51) 
D(50.65)
E(16.02)
R(11.26)
A(8.32) 
K(7.36) 
Q(4.76) 
S(0.87) 
H(0.43) 
T(0.43) 
 T(49.34)
V(24.89)
S(17.47)
D(7.86) 
M(0.44) 
D(55.77)
L(16.54)
E(16.15)
R(9.62) 
A(0.38) 
G(0.38) 
K(0.38) 
Q(0.38) 
 
 D(33.76) 
T(32.49) 
G(8.44) 
A(5.91) 
N(4.64) 
S(4.22) 
V(4.22) 
E(3.80) 
Q(1.27) 
I(0.42) 
L(0.42) 
R(0.42) 
D(26.30)
A(22.02)
R(11.01)
E(10.40)
S(6.73) 
V(6.12) 
H(3.67) 
G(2.75) 
T(2.75) 
L(2.45) 
M(2.14)
N(1.53) 
K(1.22) 
G 
R(88.43) 
G(3.49) 
H(1.58) 
K(1.58) 
L(1.11) 
P(1.11) 
A(0.63) 
D(0.48) 
N(0.48) 
S(0.48) 
H(55.65) 
K(17.74) 
R(16.13) 
G(6.45) 
P(1.61) 
A(0.81) 
I(0.81) 
T(0.81) 
R(91.99)
V(3.14) 
Q(2.44) 
S(2.09) 
G(0.35) 
R(92.40)
N(6.65) 
A(0.27) 
T(0.27) 
G(0.14) 
K(0.14) 
S(0.14) 
H(73.68)
N(24.56)
G(1.75) 
R(91.38)
Q(8.05) 
T(0.57) 
R(83.65)
V(7.77) 
I(2.32) 
A(2.04) 
K(1.36) 
T(1.36) 
N(0.54) 
G(0.27) 
L(0.27) 
E(0.14) 
H(100) R(42.55)
K(29.79)
S(9.04) 
T(9.04) 
D(6.38) 
A(2.13) 
H(0.53) 
L(0.53) 
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Amino acid diversity in the DNA contact residues  
The 454 DNA sequences and zinc fingers in the OPEN arrays were first analyzed to 
evaluate the diversity of amino acids at positions -1, +3 and +6 of the recognition helix.  
The data was evaluated separately for each target subsite at each position in a three finger 
protein (see Table 3.S1). If a given amino acid appeared in both the 454 data and the OPEN 
fingers, we considered it to be a good candidate contact residue for that specific nucleotide 
at that defined position.  If a given amino acid only appeared in the 454 data and not in the 
OPEN fingers, we did not consider it further, no matter how frequently it was represented 
in the 454 data.  Occasionally, some amino acids only show up in the OPEN fingers, due to 
the fact that some OPEN fingers are not found in the 454 dataset (see previous section).  In 
most instances, we observe very little amino acid sequence diversity in residues that 
contact specific nucleotides at defined positions, especially for F2 and F3.  The consensus 
amino acids for contacting specific nucleotides are given in Tables 5 – 7.  In some cases, 
only a single amino acid is identified in the datasets as contacting a specific nucleotide (see 
Table 3.S1).  Below we describe in detail the trends observed in the diversity of amino acid 
sequences in the datasets that make specific DNA contacts.   
Guanine recognition 
Nucleotide 5’-G of the target subsite is contacted by amino acids at position +6 of 
the recognition helix.  In 42 out of the 48 cases, 5’-G is contacted by arginine.  Among the 
six exceptions, three F1s (GATag_F1, GGAg_F1 and GGTcg_F1), which are distinguished 
by different preceding nucleotides, have valine at position +6 (Table 3.5).  F1 preceded by 
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a G has the same target site nucleotide composition as most subsites for F2 and F3; however, 
the amino acids that contact 5’-G differ. Valine is an aliphatic amino acid and therefore 
hydrophobic.  This suggests that the DNA contact is not by strong hydrogen bonds, but 
rather by weak non-polar contacts. This may indicate that F1 is not as important as F2 and 
F3 in the binding of ZFPs to DNA.  In support of this, Choo et. al. [22] demonstrated that 
different fingers contribute differently to base-specific DNA contacts, and the order in their 
degree of contribution is F2>F3>F1.  This may be caused by the degenerate specificity 
that is expected to occur at the ends of the proteins [23]. Other amino acid sequence 
exceptions for G recognition are found in three F2 fingers (GGA_F2, GGG_F2 and 
GTG_F2).  In all cases, the amino acid at position +6 is Asparagine (Table 3.5).  This may 
be caused by the target site base composition effect. Since G at 3’- and middle uses 
positively charged amino acids consistently, this usage of N is to keep total charge not too 
high. A very similar diversity of amino acids were found that contact 3’-G.  Like 5’-G, 
3’-G is contacted by arginine with one exception:  in GGA_F1 the contact amino acid is 
lysine (Table 3.7).   
Unlike bases 5’-G and 3’-G, for which the contact residue is arginine in more than 
90% of the cases, when G is the middle base of the target subsite, it is contacted by either 
histidine or lysine.  The basis for this difference may be the size of the three amino acids. 
Histidine and lysine are smaller than arginine and thus fit better in the middle of the zinc 
finger α-helix than arginine.  Size of the contact residue may be particularly important 
because position +3 is nearer to the DNA than is either -1 or +6.  In 75% of the cases, 
guanine in the middle position is contacted by lysine at position F1; histidine is the contact 
residue in 75% of the cases at position F2 and F3 (Table 3.6).  This is a clear positional 
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difference that may explain why some fingers do not work at all positions. 
Adenine recognition 
Adenine in the middle position of the target subsite is consistently contacted by 
asparagine with one exception: arginine is used in GAT_F1 (Table 3.6).   For 3’-A of the 
target subsite, glutamine is usually used with several exceptions (Table 3.7). The difference 
of the contact residues between the middle and 3’-A of the target subsite is also likely due to 
the size the amino acids.  Asparagine is similar to glutamine in both structure and charge; 
however, asparagine is slightly smaller.   Like the difference in the contact residue 
between the middle G and the G at the 5’ and 3’ position, the smaller amino acid asparagine 
fits better between the DNA and the middle part of the recognition helix.   
Cytosine recognition 
Cytosine at the 3’ position of the target subsite is contacted by aspartic acid or 
glutamic acid with two exceptions (Table 3.7).  In contrast, when C is in the middle 
position, the amino acids at position +3 of the recognition helix are hydrophobic or weekly 
hydrophilic in 85% of the cases (Table 3.6).  
Thymine recognition 
Amino acid diversity in contact residues is particularly interesting when 
considering contacts to thymine.  For 3’-T, the contact residue is threonine for all of  
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Table 3.5 Consensus amino acids at position +6 of the recognition helices for both the 454 
sequences and OPEN fingers. 
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Table 3.6 Consensus amino acids at position +3 of the recognition helices for both the 454 
sequences and OPEN fingers. 
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Table 3.7 Consensus amino acids at position -1 of the recognition helices for both the 454 
sequences and OPEN fingers. 
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the four available F1s, whereas the corresponding residues are small hydrophobic amino 
acids (i.e. valine or leucine) for all F2s and F3s (Table 3.7). For T in the middle of the target 
subsite, the corresponding amino acids are small hydrophobic amino acids (i.e. valine or 
alanine) for all of the four F1s; however, the contact residue is serine for F2 and F3 (GTG is 
the only exception, for which the contact residues, like F1, are valine and alanine for F2 and 
F3 respectively).  These observations strongly bolster the hypothesis that position within 
the three finger array influences the contact residues of zinc finger proteins as does the 
position of specific bases in the target subsite.  
Patterns in charge distribution among contact residues.   
In addition to the individual amino acids that make contacts to individual 
nucleotides, the amino acid composition of all three contact residues appears to adhere to 
some rules.  The total charge of the three contact residues is typically constant. For 
example, the consensus contact residues for GAT are TRV for F1, VNR for F2 and INR for 
F3.  The amino acid at position +6 of F1 is the hydrophobic amino acid valine, instead of 
the more commonly used, positively charged and strongly hydrophilic amino acid arginine.  
Offsetting this change, the amino acid at position +3 is arginine instead of asparagine.  
Regardless of the actual amino acid composition, there is typically one positively charged 
amino acid (R), one non-polar amino acid (V or I) and one polar amino acid (T or N) (Table 
3.S1). Key amino acid composition for GCA shows a similar rule (Table 3.S1). Key amino 
acids for GCAa_F1 are RER, whereas those for GCAg_F1 are DQR.  Another possible 
explanation for this phenomenon is that key amino acids interact.  This was suggested in 
the computational analyses conducted by Liu, et al. [24] for C2H2 zinc finger proteins.  
This study showed that interaction between key amino acids affects the binding of zinc 
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finger proteins to DNA target sites [24]. Another evidence for this pattern is shown in the 
5’G contact residues in the GGA_F2, GGG_F2 and GTG_F2. These three uses Asparagine 
(N), instead of the consensus Arg.   
Amino acid diversity at non-contact positions  
Unlike the contact amino acids, the amino acids in the recognition helix at 
non-contact positions (+1, +2 and +5) are much more diverse (Table 3.S2).  Nonetheless, 
one amino acid predominates in most instances in both the 454 sequences and the OPEN 
fingers.  We hypothesize that the predominant amino acid is very likely the most 
appropriate one to enable target site recognition for a given finger in a three finger protein.  
The predominant non-contact amino acids are organized and displayed in Tables 3.8 – 3.10.   
Comparisons among the three non-contact positions showed that amino acids at the 
different positions usually belong to different classes with respect to their biochemical 
properties. Position +1 is predominantly the basic amino acids R and K (Table 3.8).  The 
amino acids at position +2 are usually hydrophilic, which includes moderately hydrophilic, 
polar amino acids, strongly hydrophilic acidic amino acids and positively charged amino 
acids (Table 3.9).  In contrast to positions +1 and +2, amino acids at position +5 for all 
finger subsites include residues from all four amino acid classes (Table 3.10).  The 
observed differences in amino acid diversity at different positions may be due to the 
different roles these amino acids play.  Positions 1 and 5 are often involved in direct or 
water-mediated contacts with the DNA phosphate backbone, whereas position 2 can 
participate in target site overlap.  
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Amino acid diversity at non-contact positions is also affected by the base 
composition of the target subsite.  This trend is apparent at both positions +1 and +5, but 
not at position +2.  At position +1, the ratio of the basic amino acids R and K increases 
with an increase of the ratio of pyrimidines in the target subsite (Table 3.8). For instance, in 
the fingers for the target subsites that contain two pyrimidines (GCC, GCT, GTC and GTT), 
R and K are used in 10 out of 12 cases; non-polar amino acids are used in the other two 
cases.  Similarly, the percentage of the polar amino acids increases with an increase of the 
purine content in the target subsite.  In no case were acidic amino acids (D and E) selected 
for position +1 of the recognition helices. Comparing GNG with other subsites revealed 
that D is the highest or second highest amino acid at position 2 of fingers for GNG, whereas 
D hardly occurred in fingers for all other triplet subsites (Table 3.9; Table 3.S2, see also the 
discussion of target site overlap below).   
 As at position +1, amino acids at position +5 are also affected by the composition 
of the target subsites (Table 3.10). Positively charged amino acids R and K predominate at 
position +5 of the fingers that bind to GCC, GCT, GCT and GTT. At position +5 of fingers 
that bind to the target subsites that contain one pyrimidine, amino acids from 4 different 
groups were chosen with even probability.  In contrast, for target subsites that are made up 
only of purines, small non-polar amino acids were usually chosen.  The usage of R and K 
at position +5 of the fingers for GGA is an exception to the rule. For F1 and F2, this 
exception may be due to the unusual contact amino acids at -1, which instead of R, were V 
and N, respectively.  The purpose of this unusual amino acid usage may be to keep the 
total charge of that part of the recognition helix positive.  Another interesting observation 
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for the amino acids at +5 is that when the target subsite contains nucleotide T in the middle 
or 3’ position, threonine is used at most situations. 
In considering the rules described above, it is evident that the total charge of the 
amino acids at positions +1, +2 and +5 is also affected by the target subsite composition. 
The total charge of the amino acids at these three finger positions specifying target subsites 
that contain one purine, two purines and three purines is typically positive, neutral, and 
negative, respectively.  This trend for the non-contact residues is opposite to what is 
happening to the charges of the contact residues (positions -1, +3 and +6).  Among the 
contact residues, G is usually contacted by positively charged amino acids; A is usually 
contacted by the amide amino acids N or Q; C and T are usually contacted by acidic amino 
acids D and E, the hydroxyl amino acid S, or the sulfonyl-containing amino acid T.  
Therefore, the total charge of the contact residues increases with an increase in the number 
of purines.  This inverse relationship between the charges of the contact and non-contact 
residues indicates that the overall charge of the recognition helix does not vary much. The 
recognition helix tends to be slightly positively charged in order to form a tighter complex 
with DNA, which is negatively charged due to the phosphate groups present in the 
ribose-phosphate backbone.   
 
Target site overlap   
Both the co-crystal structure of Zif268 and its cognate target (5’-GCGTGGGCG-3’) 
[25] and experimental studies [26] showed that aspartic acid at position +2 of F3 contacts 
adenine on the opposite strand, which is complementary to the 5’-T of the F2 subsite.  
Aspartic acid in F3, therefore, makes overlapping contact to the subsite of the preceding 
finger.  
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Table 3.8 Consensus amino acids at position +1 of the recognition helices 
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Table 3.9 Consensus amino acids at position +2 of the recognition helices. 
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Table 3.10 Consensus amino acids at position +5 of the recognition helices 
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We examined the occurrence of aspartic acid in all 16 GNN subsites at three 
different positions and observed a clear difference between GNG subsites and all others 
(Table 3.11).  For all GNG subsites, especially those at position F2 and F3, aspartic acid is 
the highest or second highest amino acid at position +2.  In contrast, for all of the other 
triplets, aspartic acid did not occur at all or only very rarely at position +2 (Table 3.11; 
Table 3.S2).  Since in all previous studies that suggested target site overlap between F2 
and F3 [25, 26] the target subsite for F3 was GCG, we concluded that the target site overlap 
caused by aspartic acid at +2 only occurs when the subsite is GNG.  
 
Amino acid diversity in fingers that recognize the same triplet at 
different positions 
Since the structure of DNA is one factor affecting the binding of zinc finger 
proteins, it is reasonable to hypothesize that different recognition helices will recognize 
different nucleotide triplets depending on their position in a three finger protein.  To 
explore this hypothesis, the pool sequences were analyzed to compare amino acid diversity 
in the recognition helices for fingers that bind the same triplet target at each of three 
different positions in a three finger protein.  For a given nucleotide triplet, there are no or 
only a few common fingers between the pools at two different positions (Figure 3.3).  This 
result suggests that unique fingers specify the same target site at different positions in a 
three finger protein.  This result seems to conflict with a previous study conducted by 
Ramirez et. al [18], in which 56% of the ZFPs assembled with Barbas GNN fingers were  
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Table 3.11 Amino acid distribution at position +2 in OPEN selected fingers. 
  GAA GAC GAG GAT GCA GCC GCG GCT 
AA F2 F3 F2 F3 F2 F3 F2 F3 F2 F3 F2 F3 F2 F3 F2 F3
A 6 0 4 0 0 0 2 1 0 1 0 0 0 0 0 2 
C 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
D 1 0 0 0 15 21 0 1 0 0 0 0 19 16 3 0 
E 0 1 10 0 3 2 1 0 8 0 0 0 3 1 11 0 
F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
G 6 2 10 3 0 0 0 7 5 9 1 0 0 0 0 4 
H 0 0 0 0 0 0 18 5 0 0 0 0 0 0 4 5 
I 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
L 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
N 0 3 0 0 0 0 0 0 0 9 0 0 0 0 0 12
P 1 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Q 1 0 1 0 0 0 0 0 0 0 0 0 0 0 3 3 
R 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 
S 4 1 16 1 0 2 0 3 0 0 13 3 0 0 4 1 
T 7 2 0 0 0 0 0 0 2 1 5 1 0 0 0 0 
V 2 4 0 0 0 0 0 0 0 2 0 0 0 0 0 0 
W 0 0 0 0 0 2 0 0 0 1 0 0 0 0 0 0 
Y 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
    
  GGA GGC GGG GGT GTA GTC GTG GTT 
AA F2 F3 F2 F3 F2 F3 F2 F3 F2 F3 F2 F3 F2 F3 F2 F3
A 1 1 1 0 0 0 0 1 1 0 0 0 0 1 0 0 
C 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
D 0 3 2 2 3 15 0 0 0 0 1 0 4 8 0 0 
E 1 1 4 0 9 3 0 0 0 0 0 0 6 0 0 0 
F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
G 0 2 1 5 0 1 0 1 0 2 0 1 1 0 0 2 
H 0 0 1 1 0 7 22 15 0 3 0 0 3 0 1 1 
I 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
L 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
M 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
N 0 0 0 0 0 1 0 0 0 3 0 0 0 0 0 1 
P 8 1 0 0 0 0 0 0 0 2 0 0 0 0 0 0 
Q 0 3 0 0 0 0 4 4 0 0 0 0 1 0 0 0 
R 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 
S 0 2 7 6 0 1 0 1 3 1 5 2 0 0 4 1 
T 2 2 0 0 0 0 0 0 0 4 0 6 0 2 0 0 
V 1 0 0 9 0 0 0 0 1 1 0 0 0 0 0 1 
W 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
Y 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
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Figure 3.3 The number of unique recognition helices in three different pools for a single 
nucleotide triplet. 
 
functional, suggesting that there should be ~50% fingers in common among F2 and F1 or 
F2 and F3. 
If just the recognition helix contact residues are considered, there are some fingers 
that appear in two or all of the three of the pools (Figure 3.4). The number of fingers with 
common contact residues between F2 and F3 is usually larger than the number of common 
contact residues between F1 and F2, suggesting a finger position-effect.  The contact 
residues of F2 and F3 are within the protein-DNA complex, whereas the contact made to 
the 3’-end of F1 is on the outside of the protein-DNA complex, and this may explain why 
F2 and F3 are more similar than F2 and F1 [22].   A specific example of finger position 
effect can be observed when the specified nucleotide is T.  For subsite GNT, the optimal 
amino acid at position +3 for F1 is consistently threonine, whereas the optimal amino acid 
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for F2 and F3 is valine or leucine.  In summary, the lack of common fingers among the 
pools for the same triplet at different positions in the three finger array and the fact that 
there are more common contact residue sets between F2 and F3 than between F2 and F1 
supports the existence of a finger position effect.  
 
Figure 3.4 The number of contact residue sets in three different pools for a single 
nucleotide triplet. 
Comparisons between the zinc fingers in the pools and the public zinc 
finger modules  
Comparisons were also made between recognition helices found in the fingers of 
the OPEN pools and the modules generated by Sangamo BioSciences and the Barbas 
laboratory.  The contact residues in the Sangamo BioSciences and Barbas modules are 
usually found in the pools with only a few exceptions. In contrast, the amino acid 
sequences for the complete recognition helices of the modules are usually not in the pools 
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(Table 3.12). Once again, the absence of these recognition helices conflicts with previous 
studies conducted by Ramirez et al. [18] and Sander et al. [27]. In both of these studies, 
ZFPs assembled with the modules resulted in an ~50% success rate.  
Table 3.12 Comparisons of recognition helices and contact residues between zinc finger 
modules and fingers in the OPEN pools; X denotes absence; check denote presence.   
 
Improving ZFP engineering through ‘informed’ modular assembly  
In the study of Ramirez, et al., which assessed the effectiveness of modular 
assembly, 41% of modularly assembled ZFPs for target sites composed of three GNN 
subsites were non-functional [18].  We evaluated the amino acid composition of ZF arrays 
assembled for six randomly selected sites for which modular assembly failed.  In all six 
instances, the amino acid composition of the arrays differed from the consensus amino 
acids derived from analysis of the OPEN reagents (Table 3.13).  The contact residues of 
the six arrays were changed to match the consensus contact residues in the OPEN reagents; 
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however, this experiment was performed before all of the data described in this study was 
available, and so only two of the six arrays match the current contact residue consensus.  
In vivo function of the modified ZF arrays was tested using a bacterial two-hybrid assay.  
Interestingly, the binding activity increased significantly for the two arrays that best 
matched the consensus residues; the four arrays that were not improved have amino acids 
that most vary from the consensus (Table 3.14).  We believe that the newly calculated 
consensus tables are more representative, and thus very likely the binding affinity could be 
improved for the four ZFPs that still lack activity.  Our success suggests that the reagents 
generated by OPEN produce better fingers than the traditional selection methods used to 
generate the Sangamo and Barbas finger modules. Further, the amino acid sequences of the 
arrays can be modified to conform with the other rules identified in this study that pertain to 
the optimum amino acid composition of all residues within the recognition helix. 
Table 3.13 Comparison of the key amino acids from the OPEN arrays and the OPEN pools. 
Amino acids that are highlighted as red are those that are consistent between the OPEN 
arrays and pool sequences, whereas those that are highlighted as purple are optimal only for 
the OPEN pools. Amino acids marked as orange are the consensus residues in OPEN arrays, 
and the second or third most frequently used residues in the OPEN pools.  
Binding sites Modular key residues (F3F2F1) Modified key residues(F3F2F1) 
5'-GCC-GCA-GTGt-3'  RDD RDQ RER RND RTQ RH(V/I)R 
5'-GTA-GTT-GGCt-3' RSQ RST RHD RSQ RSV RKS 
5'-GCA-GTC-GCTt-3'  RDQ RAD RET RTQ RVD RDT 
5'-GCA-GTC-GACt-3' RDQ RAD RND RTQ RVD RND 
5'-GAC-GGC-GCTt-3' RND RHD RET RND RKE RAT 
5'-GCA-GCT-GGGt-3'  RDQ RET RKR RTQ RTV RHR 
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Table 3.14 Improving the function of modularly assembled ZFPs using consensus contact 
residues identified in OPEN zinc finger arrays. Amino acids that were replaced are 
highlighted in red.  
B2H fold activation 
Original ZFP Modified ZFP Binding sites 
Modular key 
residues 
(F3F2F1) 
Modified key 
residues 
(F3F2F1) Fold STD Fold  STD 
5'-GCC-GCA-GTGt-3'  RDD RDQ RER RND RTQ RHR 1.14 0.03 3.30 0.38 
5'-GTA-GTT-GGCt-3' RSQ RST RHD RSQ RVL RHD 0.88 0.13 1.04 0.09 
5'-GCA-GTC-GCTt-3' RDQ RAD RET RNQ RVD RDT 0.92 0.16 2.12 0.03 
5'-GCA-GTC-GACt-3'  RDQ RADRND RNQ RVD RND 0.63 0.09 0.90 0.05 
5'-GAC-GGC-GCTt-3' RND RHD RET RND RHD RDT 1.59 0.42 1.49 0.24 
5'-GCA-GCT-GGGt-3'  RDQ RET RKR RNQ RTL RHR 1.64 0.05 1.41 0.24 
 
Streamlining OPEN selections 
Compared with modular assembly, OPEN significantly increases the success rate 
for making functional ZFPs. The selection process, however, is laborious and 
time-consuming, and requires ~8 weeks for an expert to perform.  If the OPEN pool sizes 
can be reduced, the time could also be reduced significantly.  For example, reduction of 
pools from 95 members to 25 members would reduce the size of libraries from ~106 to ~104 
members.  The findings in this study suggest that the pool size can be reduced while still 
keeping OPEN’s high success rate.  The low levels of observed amino acid sequence 
diversity at contact and non-contact positions suggests that one or a few amino acids can be 
selected for each position of the recognition helix.  The tables of amino acid sequence 
diversity in this study could guide the number and type of amino acids that should be 
chosen for each position.   We anticipate that performing OPEN with reduced sequence 
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pools will meet with high degrees of success and will make this method for zinc finger 
protein engineering more user-friendly. 
MATERIALS AND METHODS 
Barcode and primer design 
Generation of the zinc finger pools was previously described [20]. Each plasmid in 
the pool contains two fixed fingers and one variable finger, which we were aiming to 
characterize by 454 pyro-sequencing.  Since the 454 platform can sequence a maximum of 
250 bp (the length of the three finger array is ~300 base pair), two sets of barcodes were 
designed.  One set was used for the F1 and F2 pools (the same barcode was used for the 
same variable subsite in the F1 and F2 pools); another set was used for the F3 pools.  F1 
and F2 pools were sequenced using a specific primer consisting of the 454 primer A and the 
barcode.  The 454 primer A was used for the sequencing reaction and the barcode was 
used to specify the pools.  Similarly, F3 pools were sequenced using a specific primer 
comprised of 454 primer B and a barcode.  The forward primer has 22 nucleotides that are 
complementary to the sequence right before F1.  The backward primer used for PCR 
amplifications has 22 nucleotides complementary to the sequence right after F3.  
PCR amplification DNA preparation for 454 sequencing 
Using the pool plasmids as templates, the fingers were amplified by the specific 
primers and the common backward (for F1 and F2 pools) or the forward primer (for F3 
pools). Pfx DNA polymerase (Invitrogen) was used in the PCR amplification. After 
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optimizing amplification reactions, 7.5µl of 10x Pfx buffer and 25ng of template were used 
in a 50µl reaction. Fifteen cycles of PCR amplification (94℃, 55℃ and 68℃) were 
conducted for each pool and the PCR products were gel purified using a Qiagen PCR gel 
purification kit.  The purified PCR products were quantified using the Quant-itTM 
PicoGreen® dsDNA reagent and kits (Invitrogen). To make the final sequencing mix, the 
same amount of DNA molecules from each pool was combined together to a total final 
concentration of 200,000 molecules/µl in 1xTE buffer.  The F1 and F2 DNA were 
combined to form one mix, becaue F1 and F2 pools for a specific triplet utilize the same 
barcode. All of the F3 were combined to form another final mix. 100µl of each final mix 
was sent to the 454 sequencing facility to be amplified and sequenced. The final mix of F1 
and F2 was sequenced with 454 primer A and the final mix of F3 was sequenced with 454 
primer B. 
Modification of non-functional zinc finger arrays to conform to OPEN 
rules 
Six binding sites for which non-functional ZFPs were assembled in a previous 
study [18] were selected for improvement. They are 5'-GAC-GGC-GCT-3', 
5'-GCA-GCT-GGG-3', 5'-GCA-GTC-GAC-3', 5'-GCC-GCA-GTG-3', 
5'-GTA-GTT-GGC-3' and 5'-GCA-GTC-GCT-3'.  The ZFPs recognizing these sites were 
assembled using Barbas finger modules.  Using plasmids encoding finger modules 
assembled by the Zinc Finger Consortium as templates, various primers were designed to 
introduce amino acid substitutions and restriction sites as needed (e.g. BamHI). One 
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constant forward primer was designed for all of PCR amplification of the modified fingers.  
ZFPs were created as described in [28].   After assembly, the ZFPs were cloned into the 
B2H expression vector and the B2H fold activation were determined as described [29]. 
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SUPPLEMENTAL DATA 
Table 3.S1 The amino acids distribution at key positions -1, +3 and +6. 
 GAA   
 F1  F2  F3   
Pos -1 Pool SZP  Pool SZP  Pool SZP   
A 1 0  2 0  9 0   
C 0 0  0 0  0 0   
D 0 0  0 0  3 0   
E 0 0  2 0  8 0   
F 0 0  0 0  0 0   
G 2 0  0 0  6 0   
H 10 1  0 0  1 0   
I 5 2  0 0  0 0   
K 1 0  0 0  0 0   
L 12 6  1 0  11 2   
M 0 0  0 0  1 0   
N 9 0  0 0  0 0   
P 0 0  0 0  4 0   
Q 24 11  79 29  51 16   
R 3 0  0 0  2 0   
S 4 1  0 0  1 0   
T 21 3  0 0  1 0   
V 6 0  0 0  1 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +3:           
A 3 0  0 0  0 0   
C 0 0  0 0  0 0   
D 0 0  0 0  2 0   
E 0 0  0 0  0 0   
F 0 0  0 0  0 0   
G 0 0  0 0  4 0   
H 4 0  0 0  2 0   
I 0 0  0 0  0 0   
K 0 0  0 0  0 0   
L 0 0  0 0  2 0   
M 0 0  0 0  1 0   
N 79 24  84 29  86 18   
P 0 0  0 0  0 0   
Q 0 0  0 0  0 0   
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Table 3.S1 continued 
R 11 0  0 0  1 0   
S 0 0  0 0  0 0   
T 1 0  0 0  1 0   
V 0 0  0 0  0 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +6:           
A 0 0  0 0  0 0   
C 0 0  0 0  0 0   
D 0 0  0 0  0 0   
E 0 0  0 0  0 0   
F 0 0  0 0  0 0   
G 0 0  0 0  3 0   
H 0 0  0 0  0 0   
I 1 0  0 0  0 0   
K 1 0  0 0  0 0   
L 0 0  0 0  2 0   
M 1 0  0 0  1 0   
N 0 0  0 0  1 0   
P 0 0  0 0  0 0   
Q 0 0  0 0  1 0   
R 79 24  84 29  89 18   
S 0 0  0 0  0 0   
T 0 0  0 0  0 0   
V 16 0  0 0  2 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
           
 GAC   
 F1  F2  F3   
Pos -1 Pool SZP  Pool SZP  Pool SZP   
A 0 0  0 0  0 0   
C 0 0  0 0  0 0   
D 25 8  47 27  16 3   
E 28 7  18 4  3 1   
F 0 0  0 0  0 0   
G 0 0  2 0  5 0   
H 1 0  0 0  2 0   
I 0 0  0 0  0 0   
K 0 0  0 0  1 0   
L 2 0  28 9  2 0   
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Table 3.S1 continued 
M 0 0  2 1  0 0   
N 1 1  0 0  0 0   
P 0 0  0 0  0 0   
Q 1 0  1 0  9 0   
R 4 0  0 0  1 0   
S 0 0  0 0  0 0   
T 3 0  0 0  0 0   
V 0 0  0 0  0 0   
W 0 0  0 0  0 0   
Y 1 0  0 0  0 0   
Pos +3:           
A 0 0  0 0  0 0   
C 0 0  0 0  0 0   
D 0 0  0 0  1 0   
E 0 0  0 0  2 0   
F 0 0  0 0  0 0   
G 0 0  0 0  0 0   
H 0 0  0 0  2 0   
I 0 0  0 0  0 0   
K 1 0  0 0  0 0   
L 0 0  0 0  0 0   
M 0 0  0 0  0 0   
N 65 16  97 41  30 4   
P 0 0  0 0  0 0   
Q 0 0  1 0  0 0   
R 0 0  0 0  1 0   
S 0 0  0 0  1 0   
T 0 0  0 0  2 0   
V 0 0  0 0  0 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +6:           
A 0 0  0 0  1 0   
C 0 0  0 0  0 0   
D 0 0  0 0  0 0   
E 0 0  0 0  0 0   
F 0 0  0 0  0 0   
G 0 0  0 0  3 0   
H 1 0  0 0  1 0   
I 2 0  0 0  0 0   
K 0 0  0 0  0 0   
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Table 3.S1 continued 
L 0 0  1 0  1 0   
M 0 0  0 0  1 0   
N 0 0  0 0  1 0   
P 0 0  1 0  0 0   
Q 0 0  0 0  1 0   
R 63 16  96 41  28 4   
S 0 0  0 0  0 0   
T 0 0  0 0  1 0   
V 0 0  0 0  0 0   
W 0 0  0 0  1 0   
Y 0 0  0 0  0 0   
           
 GAG   
 F1  F2  F3   
Pos -1 Pool SZP  Pool SZP  Pool SZP   
A 0 0  0 0  5 0   
C 0 0  0 0  0 0   
D 0 0  0 0  1 0   
E 0 0  0 0  4 0   
F 0 0  0 0  0 0   
G 0 0  2 0  4 0   
H 1 0  1 0  2 0   
I 1 0  0 0  0 0   
K 19 11  2 0  1 0   
L 0 0  0 0  2 0   
M 0 0  0 0  0 0   
N 1 0  0 0  0 0   
P 0 0  0 0  1 0   
Q 0 0  2 0  0 0   
R 24 9  92 18  75 24   
S 1 0  0 0  1 1   
T 6 5  0 0  2 0   
V 0 0  0 0  2 2   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +3:           
A 0 0  14 1  2 0   
C 0 0  0 0  0 0   
D 1 0  1 0  0 0   
E 0 0  0 0  2 0   
F 0 0  0 0  0 0   
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Table 3.S1 continued 
G 0 0  34 0  16 1   
H 0 0  3 0  14 1   
I 0 0  0 0  2 0   
K 0 0  0 0  2 0   
L 0 0  1 0  4 1   
M 0 0  0 0  0 0   
N 50 24  36 17  40 23   
P 0 0  0 0  1 0   
Q 0 1  3 0  6 1   
R 2 0  1 0  5 0   
S 0 0  5 0  2 0   
T 0 0  1 0  4 0   
V 0 0  0 0  0 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +6:           
A 0 0  0 0  2 0   
C 0 0  0 0  0 0   
D 0 0  0 0  1 0   
E 0 0  1 0  1 0   
F 0 0  0 0  0 0   
G 0 0  0 0  4 0   
H 0 0  0 0  2 0   
I 1 0  0 0  1 0   
K 0 0  1 0  2 0   
L 0 0  0 0  4 0   
M 0 0  1 0  3 0   
N 0 0  0 0  0 0   
P 0 0  0 0  0 0   
Q 0 0  1 0  0 0   
R 49 25  93 18  75 27   
S 0 0  0 0  0 0   
T 2 0  2 0  2 0   
V 1 0  0 0  3 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
           
 GAT 
 GATa_F1 GATg_F1  F2  F3 
Pos -1 Pool SZP Pool SZP  Pool SZP  Pool SZP
A 6 0 0 0  0 0  2 0 
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Table 3.S1 continued 
C 0 0 0 0  0 0  0 0 
D 2 0 0 0  0 0  4 0 
E 2 0 1 0  0 0  16 2 
F 1 0 0 0  0 0  0 0 
G 1 0 0 0  0 0  6 0 
H 2 0 0 0  0 0  0 0 
I 0 0 0 0  4 2  11 1 
K 1 0 0 0  0 0  0 0 
L 2 0 0 0  17 4  39 8 
M 2 0 0 0  1 0  4 0 
N 6 0 4 0  0 0  7 0 
P 2 0 0 0  0 0  1 0 
Q 0 0 1 0  0 0  0 0 
R 7 0 3 0  0 0  2 0 
S 7 0 4 2  0 0  2 0 
T 40 3 44 3  0 0  1 0 
V 8 1 1 0  55 15  26 6 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
Pos +3:           
A 8 0 2 2  0 0  2 0 
C 0 0 0 0  0 0  0 0 
D 0 0 0 0  0 0  1 0 
E 0 0 0 0  0 0  3 0 
F 0 0 0 0  0 0  0 0 
G 3 0 0 0  0 0  3 0 
H 2 0 8 1  0 0  0 0 
I 1 0 0 0  0 0  0 0 
K 3 0 0 0  0 0  3 0 
L 3 0 0 0  0 0  2 0 
M 1 0 0 1  0 0  0 0 
N 5 0 3 0  77 21  97 17 
P 6 0 0 0  0 0  2 0 
Q 4 1 0 0  0 0  3 0 
R 46 3 44 1  0 0  3 0 
S 3 0 0 0  0 0  1 0 
T 1 0 0 0  0 0  0 0 
V 3 0 0 0  0 0  1 0 
W 0 0 0 0  0 0  0 0 
Y 0 0 1 0  0 0  0 0 
Pos +6:           
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Table 3.S1 continued 
A 7 0 0 0  1 0  1 0 
C 0 0 0 0  2 0  0 0 
D 1 0 0 0  0 0  1 0 
E 1 0 0 0  0 0  4 0 
F 0 0 0 0  0 0  0 0 
G 0 0 0 0  0 0  4 0 
H 0 0 0 0  1 0  2 0 
I 10 2 8 0  0 0  1 0 
K 2 0 0 0  0 0  1 0 
L 1 0 0 0  0 0  1 0 
M 0 0 0 0  0 0  0 0 
N 1 0 0 0  0 0  1 0 
P 1 0 0 0  0 0  2 0 
Q 1 0 0 0  0 0  0 0 
R 1 0 2 0  72 21  98 17 
S 0 0 0 0  1 0  3 0 
T 3 0 0 0  0 0  0 0 
V 60 2 48 5  0 0  2 0 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
           
 GCA 
 GCAa_F1 GCAg_F1  F2  F3 
Pos -1 Pool SZP Pool SZP  Pool SZP  Pool SZP
A 26 1 6 0  0 0  0 0 
C 0 0 0 0  0 0  0 0 
D 1 0 41 5  0 0  2 0 
E 1 0 9 0  0 0  1 0 
F 0 0 0 0  0 0  0 0 
G 10 0 2 0  0 0  0 0 
H 8 1 2 0  0 0  2 0 
I 4 0 0 0  0 0  0 0 
K 0 0 1 0  0 0  3 0 
L 36 0 2 0  0 0  1 0 
M 2 0 3 0  0 0  0 0 
N 10 1 8 1  0 0  0 0 
P 2 0 3 0  1 0  3 0 
Q 13 0 6 0  45 15  99 22 
R 48 9 2 0  1 0  10 0 
S 33 1 12 4  0 0  1 0 
T 32 0 11 0  0 0  0 0 
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Table 3.S1 continued 
V 13 0 2 0  1 0  0 1 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
Pos +3:           
A 3 0 1 0  0 0  5 0 
C 0 0 0 0  0 0  0 0 
D 14 2 14 1  3 0  20 0 
E 39 7 1 0  0 0  2 0 
F 0 0 0 0  0 0  0 0 
G 7 0 7 0  1 0  9 1 
H 0 0 0 0  0 0  0 0 
I 1 0 2 0  4 0  6 1 
K 5 0 0 0  0 0  0 0 
L 7 0 3 0  0 0  1 0 
M 6 0 5 0  1 0  2 0 
N 2 0 3 0  0 0  1 0 
P 0 0 2 0  0 0  1 0 
Q 90 4 56 8  0 0  1 0 
R 6 0 6 0  0 0  1 0 
S 24 0 1 0  0 0  11 2 
T 29 0 7 1  39 15  50 18 
V 6 0 2 0  0 0  12 1 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
Pos +6:           
A 1 0 2 0  0 0  4 0 
C 0 0 0 0  0 0  0 0 
D 0 0 0 0  0 0  0 0 
E 0 0 0 0  0 0  0 0 
F 0 0 0 0  0 0  0 0 
G 2 0 4 0  1 0  6 0 
H 2 0 0 0  0 0  1 0 
I 2 0 1 0  0 0  0 0 
K 3 0 0 0  0 0  0 0 
L 1 0 2 0  0 0  3 0 
M 2 0 0 0  0 0  0 0 
N 0 0 1 0  3 0  1 0 
P 0 0 3 0  1 0  0 0 
Q 2 0 0 0  1 0  3 0 
R 218 13 90 10  42 15  96 23 
S 0 0 2 0  0 0  5 0 
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Table 3.S1 continued 
T 1 0 3 0  0 0  1 0 
V 4 0 1 0  0 0  1 0 
W 1 0 1 0  0 0  1 0 
Y 0 0 0 0  0 0  0 0 
           
 GCC 
 GCCc_F1 GCCg_F1  F2  F3 
Pos -1 Pool SZP Pool SZP  Pool SZP  Pool SZP
A 3 0 4 0  0 0  2 0 
C 0 0 0 0  0 0  0 0 
D 14 5 52 5  41 17  15 4 
E 5 0 30 1  10 2  38 2 
F 0 0 0 0  0 0  0 0 
G 2 0 1 0  0 0  7 0 
H 15 2 0 0  0 0  1 0 
I 2 0 0 0  0 0  2 0 
K 9 0 1 0  0 0  0 0 
L 9 3 0 0  0 0  3 0 
M 4 2 1 0  0 0  0 0 
N 5 0 1 0  1 0  1 0 
P 2 0 1 0  0 0  3 0 
Q 2 0 0 0  3 0  8 0 
R 8 0 3 0  0 0  5 0 
S 3 1 5 1  0 0  1 0 
T 11 2 7 0  0 0  1 0 
V 6 2 0 0  0 0  3 0 
W 0 0 0 0  0 0  0 0 
Y 1 0 0 0  0 0  0 0 
Pos +3:           
A 6 1 9 1  0 0  5 0 
C 0 0 0 0  0 0  1 0 
D 50 10 23 2  0 0  6 0 
E 0 0 0 0  0 0  2 0 
F 0 0 0 0  0 0  0 0 
G 7 0 41 1  1 0  18 2 
H 0 0 0 0  0 0  2 0 
I 3 0 2 0  2 0  1 0 
K 1 0 0 0  0 0  1 0 
L 1 0 1 0  0 0  3 0 
M 1 0 1 0  1 0  3 0 
N 0 0 2 0  0 0  12 2 
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Table 3.S1 continued 
P 1 0 1 0  0 0  1 0 
Q 0 0 1 0  0 0  0 0 
R 8 0 0 0  0 0  13 0 
S 4 1 7 1  0 0  1 0 
T 19 5 15 2  16 3  10 1 
V 0 0 3 0  35 16  11 1 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
Pos +6:           
A 0 0 0 0  0 0  2 0 
C 0 0 0 0  0 0  0 0 
D 0 0 0 0  0 0  2 0 
E 0 0 0 0  0 0  1 0 
F 0 0 0 0  0 0  0 0 
G 0 0 1 0  0 0  7 0 
H 0 0 0 0  0 0  3 0 
I 1 0 0 0  0 0  3 0 
K 2 0 3 0  3 0  4 0 
L 0 0 0 0  0 0  3 0 
M 0 0 0 0  0 0  2 0 
N 0 0 0 0  3 0  0 0 
P 0 0 1 0  0 0  2 0 
Q 0 0 0 0  0 0  3 0 
R 85 17 94 7  48 19  47 6 
S 0 0 0 0  0 0  2 0 
T 2 0 0 0  0 0  4 0 
V 10 0 6 0  1 0  4 0 
W 1 0 1 0  0 0  1 0 
Y 0 0 0 0  0 0  0 0 
           
 GCG   
 F1  F2  F3   
Pos -1 Pool SZP  Pool SZP  Pool SZP   
A 3 0  1 0  1 0   
C 0 0  0 0  0 0   
D 1 0  0 0  2 0   
E 0 0  0 0  3 0   
F 0 0  0 0  0 0   
G 2 0  0 0  1 0   
H 1 0  0 0  3 0   
I 2 0  1 0  0 0   
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Table 3.S1 continued 
K 46 5  1 0  4 0   
L 6 0  0 0  0 0   
M 5 0  0 0  0 0   
N 2 0  0 0  2 0   
P 0 0  0 0  2 0   
Q 0 0  1 0  0 0   
R 161 14  106 22  96 17   
S 2 0  1 0  2 0   
T 7 0  2 0  2 0   
V 2 0  2 0  0 0   
W 1 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +3:           
A 8 0  0 0  12 0   
C 1 0  0 0  0 0   
D 18 3  14 5  7 5   
E 0 0  2 0  2 0   
F 0 0  0 0  0 0   
G 23 3  53 3  40 3   
H 0 0  0 0  0 0   
I 2 0  5 0  2 0   
K 0 0  0 0  1 0   
L 1 0  1 0  7 3   
M 0 0  3 0  8 1   
N 7 1  0 0  1 1   
P 2 0  1 0  5 0   
Q 2 0  1 0  4 1   
R 1 0  3 0  6 0   
S 16 1  10 4  12 2   
T 159 11  12 6  6 0   
V 1 0  9 4  5 1   
W 0 0  1 0  0 0   
Y 0 0  0 0  0 0   
Pos +6:           
A 0 0  0 0  9 0   
C 0 0  0 0  0 0   
D 0 0  0 0  0 0   
E 0 0  0 0  1 0   
F 0 0  0 0  1 0   
G 2 0  2 0  8 0   
H 1 0  0 0  5 0   
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Table 3.S1 continued 
I 9 0  0 0  5 0   
K 10 1  6 0  1 0   
L 2 0  0 0  2 0   
M 1 0  0 0  4 0   
N 1 0  1 0  7 0   
P 0 0  0 0  5 0   
Q 0 0  0 0  2 0   
R 194 18  103 22  46 17   
S 1 0  0 0  4 0   
T 5 0  2 0  7 0   
V 14 0  1 0  11 0   
W 1 0  0 0  0 0   
Y 0 0  0 0  0 0   
           
 GCT 
 GCTc_F1 GCTg_F1  F2  F3 
Pos -1 Pool SZP Pool SZP  Pool SZP  Pool SZP
A 13 1 15 2  0 0  4 0 
C 0 0 0 0  0 0  0 0 
D 2 0 3 0  1 0  0 0 
E 0 0 0 0  2 1  2 0 
F 0 0 0 0  1 0  0 0 
G 11 1 12 3  0 0  1 0 
H 5 3 2 0  21 6  1 0 
I 6 0 0 0  1 0  0 0 
K 6 0 2 0  1 0  0 0 
L 9 2 6 0  3 5  11 8 
M 5 2 0 0  0 0  1 0 
N 1 0 4 1  0 0  0 0 
P 1 0 2 0  0 0  0 0 
Q 6 0 20 5  4 3  2 1 
R 22 0 5 0  0 1  0 0 
S 8 1 14 3  0 0  0 0 
T 30 5 14 2  16 2  0 0 
V 3 0 4 0  54 7  44 18 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
Pos +3:           
A 25 2 37 8  0 0  0 0 
C 0 0 0 0  0 0  0 0 
D 1 0 3 2  6 5  8 6 
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Table 3.S1 continued 
E 0 0 3 0  1 0  0 0 
F 0 0 0 0  0 0  0 0 
G 18 1 23 5  3 0  5 0 
H 0 0 0 0  0 0  0 0 
I 7 2 0 0  0 0  0 0 
K 5 0 0 0  0 0  0 0 
L 2 0 1 0  0 0  0 0 
M 11 1 2 0  1 0  0 0 
N 3 0 0 0  1 1  0 0 
P 0 0 2 0  0 0  1 0 
Q 1 0 1 0  0 0  0 0 
R 1 0 2 0  0 0  1 0 
S 12 3 9 0  63 11  26 10 
T 36 5 14 1  29 8  24 10 
V 6 1 6 0  0 0  1 1 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
Pos +6:           
A 1 0 2 0  0 0  0 0 
C 1 0 0 0  1 0  0 0 
D 1 0 0 0  0 0  0 0 
E 0 0 1 0  0 0  1 0 
F 0 0 0 0  0 0  0 0 
G 2 0 1 0  1 0  1 0 
H 1 0 1 0  2 0  0 0 
I 0 0 1 0  0 0  0 0 
K 0 0 1 0  0 0  0 0 
L 0 0 1 0  1 0  0 0 
M 0 0 0 0  0 0  0 0 
N 0 0 0 0  0 0  0 0 
P 0 0 0 0  1 0  1 0 
Q 0 0 0 0  1 0  0 0 
R 115 15 83 16  97 25  63 27 
S 1 0 0 0  0 0  0 0 
T 1 0 0 0  0 0  0 0 
V 5 0 12 0  0 0  0 0 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
           
 GGA 
 GGAc_F1 GGAg_F1  F2  F3 
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Table 3.S1 continued 
Pos -1 Pool SZP Pool SZP  Pool SZP  Pool SZP
A 4 0 2 0  0 0  1 0 
C 0 0 0 0  0 0  0 0 
D 1 1 16 7  0 0  5 0 
E 0 1 3 0  0 0  1 0 
F 1 0 0 0  0 0  0 0 
G 1 0 1 0  0 0  1 0 
H 0 0 0 0  0 0  0 0 
I 0 0 3 0  0 0  0 0 
K 4 0 2 0  0 0  7 0 
L 0 0 2 0  0 0  2 0 
M 1 0 1 0  0 0  1 0 
N 9 1 1 0  0 0  2 0 
P 0 0 3 0  0 0  1 0 
Q 2 0 3 0  65 12  120 14 
R 45 3 1 0  3 1  3 1 
S 6 1 0 0  0 0  0 0 
T 32 3 4 0  0 0  1 0 
V 3 0 0 0  0 0  3 0 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
Pos +3:           
A 0 0 3 0  7 0  0 0 
C 0 0 0 0  0 0  0 0 
D 1 0 0 0  0 0  1 0 
E 0 0 1 0  0 0  1 0 
F 0 0 0 0  0 0  0 0 
G 2 0 6 0  0 0  8 0 
H 15 3 5 2  56 12  110 14 
I 0 0 0 0  0 0  0 0 
K 46 3 12 5  0 0  3 1 
L 0 0 0 0  0 0  5 0 
M 1 0 1 0  0 0  1 0 
N 1 2 1 0  0 1  1 0 
P 1 0 0 0  5 0  2 0 
Q 0 0 1 0  0 0  1 0 
R 40 2 7 0  0 0  3 0 
S 0 0 2 0  0 0  3 0 
T 0 0 1 0  0 0  4 0 
V 1 0 2 0  0 0  3 0 
W 1 0 0 0  0 0  0 0 
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Table 3.S1 continued 
Y 0 0 0 0  0 0  2 0 
Pos +6:           
A 1 0 0 0  0 0  4 0 
C 0 0 0 0  0 0  1 0 
D 1 0 1 0  2 0  0 0 
E 1 0 0 0  0 0  1 0 
F 0 0 0 0  0 0  0 0 
G 0 0 4 0  0 0  2 0 
H 0 0 0 0  1 0  0 0 
I 9 1 3 0  0 0  2 0 
K 0 0 0 0  0 0  1 0 
L 4 0 2 0  0 0  3 0 
M 1 0 1 0  0 0  0 0 
N 1 0 2 0  62 10  5 0 
P 2 0 0 0  0 0  3 1 
Q 0 0 0 0  0 0  3 0 
R 14 6 8 2  2 3  116 14 
S 0 0 1 0  0 0  2 0 
T 6 0 3 0  0 0  3 0 
V 68 3 17 5  0 0  2 0 
W 1 0 0 0  0 0  0 0 
Y 0 0 0 0  1 0  0 0 
           
 GGC 
 GGCa_F1 GGCc_F1  F2  F3 
Pos -1 Pool SZP Pool SZP  Pool SZP  Pool SZP
A 23 9 5 1  8 0  2 0 
C 0 0 0 0  0 0  0 0 
D 2 0 3 0  10 1  15 7 
E 1 0 1 0  62 9  29 4 
F 0 0 0 0  0 0  0 0 
G 1 0 3 0  9 0  5 0 
H 1 0 1 0  1 0  3 0 
I 0 0 0 0  1 0  0 0 
K 0 0 0 0  2 0  95 11 
L 0 0 1 0  23 4  1 0 
M 0 0 1 0  6 0  2 0 
N 0 0 2 0  1 0  1 0 
P 1 0 3 0  11 0  1 0 
Q 0 0 0 0  2 0  2 0 
R 3 0 19 0  11 3  4 2 
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Table 3.S1 continued 
S 8 4 43 3  1 0  1 0 
T 4 0 34 4  4 0  2 0 
V 6 1 7 1  4 0  2 0 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
Pos +3:           
A 0 0 2 0  11 0  4 0 
C 0 0 0 0  0 0  0 0 
D 0 0 0 0  4 1  1 1 
E 0 0 0 0  5 0  2 0 
F 0 0 0 0  0 0  0 0 
G 0 0 1 0  17 0  10 0 
H 5 0 2 0  34 5  32 9 
I 0 0 0 0  0 0  0 0 
K 45 14 108 9  21 9  9 2 
L 0 0 0 0  3 0  4 0 
M 0 0 0 0  1 0  1 0 
N 0 0 2 0  22 0  4 0 
P 0 0 1 0  3 0  5 0 
Q 0 0 0 0  7 0  4 0 
R 0 0 3 0  12 0  3 0 
S 0 0 0 0  3 1  60 8 
T 0 0 3 0  3 0  25 4 
V 0 0 1 0  9 1  1 0 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  1 0  0 0 
Pos +6:           
A 1 0 0 0  12 0  6 0 
C 0 0 0 0  0 0  0 0 
D 0 0 0 0  2 0  2 0 
E 0 0 2 0  3 0  4 0 
F 0 0 0 0  0 0  0 0 
G 0 0 3 0  13 0  19 2 
H 0 0 0 0  4 0  15 1 
I 5 0 12 0  1 0  3 0 
K 0 0 0 0  4 0  7 0 
L 1 0 1 0  5 0  7 0 
M 0 0 1 0  0 0  2 0 
N 0 0 0 0  3 0  19 5 
P 0 0 1 0  5 0  8 0 
Q 0 0 0 0  3 0  3 0 
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Table 3.S1 continued 
R 26 11 36 9  83 17  45 13 
S 0 0 1 0  4 0  11 1 
T 4 0 13 0  7 0  8 2 
V 13 3 53 0  6 0  5 0 
W 0 0 0 0  1 0  0 0 
Y 0 0 0 0  0 0  1 0 
           
 GGG   
 F1  F2  F3   
Pos -1 Pool SZP  Pool SZP  Pool SZP   
A 0 0  0 0  1 0   
C 0 0  0 0  0 0   
D 0 0  0 0  0 0   
E 0 0  0 0  0 0   
F 0 0  0 0  0 0   
G 0 0  0 0  1 0   
H 0 0  0 0  0 0   
I 0 0  0 0  0 0   
K 46 8  0 0  1 0   
L 0 0  0 0  0 0   
M 1 0  0 0  0 0   
N 1 0  0 0  0 0   
P 0 0  0 0  0 0   
Q 2 0  0 0  0 0   
R 42 12  74 12  78 29   
S 0 2  0 0  0 0   
T 7 0  0 0  0 0   
V 0 0  0 0  2 1   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +3:           
A 0 0  0 0  0 0   
C 0 0  0 0  1 0   
D 0 0  0 0  0 0   
E 0 0  0 0  0 0   
F 0 0  0 0  0 0   
G 1 0  0 0  14 4   
H 55 15  70 11  7 4   
I 0 0  0 0  0 0   
K 13 4  0 0  21 16   
L 0 0  0 0  1 0   
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Table 3.S1 continued 
M 0 0  0 0  0 0   
N 0 0  0 0  0 0   
P 0 0  2 1  1 0   
Q 0 0  1 0  0 0   
R 30 3  1 0  28 6   
S 0 0  0 0  1 0   
T 0 0  0 0  7 0   
V 0 0  0 0  2 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +6:           
A 5 1  0 0  4 2   
C 0 0  0 0  0 0   
D 0 0  1 0  5 2   
E 0 0  0 0  0 0   
F 0 0  0 0  0 0   
G 0 0  0 0  15 6   
H 1 0  0 0  2 2   
I 7 4  1 1  2 0   
K 3 1  1 1  3 0   
L 3 0  0 0  3 2   
M 1 0  0 0  5 0   
N 3 2  65 4  1 0   
P 0 0  0 0  7 3   
Q 3 0  0 0  1 0   
R 39 11  6 6  17 9   
S 1 0  0 0  4 1   
T 7 0  0 0  7 3   
V 26 3  0 0  7 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
           
 GGT 
 GGTc_F1 GGTg_F1  F2  F3 
Pos -1 Pool SZP Pool SZP  Pool SZP  Pool SZP
A 0 0 4 0  0 0  10 1 
C 0 0 0 0  0 0  0 0 
D 0 0 0 1  0 0  0 0 
E 1 0 1 0  9 3  1 0 
F 0 0 0 0  0 0  0 0 
G 0 0 6 0  0 0  1 0 
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Table 3.S1 continued 
H 0 0 0 0  21 3  11 3 
I 1 0 1 1  0 0  11 4 
K 3 0 0 1  0 0  4 0 
L 0 0 6 1  31 10  27 5 
M 0 0 7 1  4 5  4 2 
N 2 0 4 0  0 0  0 0 
P 1 0 1 0  0 0  2 0 
Q 0 0 3 1  19 4  11 1 
R 21 1 6 0  0 0  1 0 
S 1 0 11 0  1 0  1 0 
T 61 2 43 8  4 0  0 0 
V 0 0 1 0  10 1  15 6 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
Pos +3:           
A 0 0 3 0  0 0  4 0 
C 0 0 0 0  0 0  0 0 
D 0 0 1 0  0 0  1 0 
E 1 0 0 0  0 0  1 0 
F 0 0 0 0  0 0  0 0 
G 2 0 2 0  24 0  47 9 
H 0 0 13 4  29 19  16 10 
I 0 0 1 0  1 1  0 0 
K 12 2 31 5  0 0  4 0 
L 0 0 2 0  0 0  0 0 
M 1 0 3 0  0 0  0 0 
N 3 0 1 1  11 0  1 1 
P 0 0 3 0  1 0  2 0 
Q 0 0 1 0  7 2  1 0 
R 71 1 32 4  13 1  14 2 
S 0 0 1 0  11 3  6 0 
T 1 0 0 0  0 0  0 0 
V 0 0 0 0  1 0  2 0 
W 0 0 0 0  1 0  0 0 
Y 0 0 0 0  0 0  0 0 
Pos +6:           
A 0 0 3 2  1 0  7 0 
C 0 0 0 0  0 0  0 0 
D 0 0 1 0  0 0  2 0 
E 0 0 0 0  0 0  0 0 
F 0 0 0 0  0 0  0 0 
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Table 3.S1 continued 
G 0 0 0 0  1 0  9 1 
H 0 0 2 0  1 0  0 0 
I 19 1 9 2  1 0  1 0 
K 1 0 0 0  0 0  0 0 
L 3 0 2 0  0 0  2 0 
M 1 0 1 0  0 0  1 0 
N 0 0 0 0  0 0  3 0 
P 0 0 2 0  0 0  2 0 
Q 0 0 0 0  0 0  2 0 
R 7 0 4 2  83 25  62 20 
S 0 0 1 0  3 0  3 0 
T 4 0 6 0  9 1  3 1 
V 56 2 63 8  0 0  2 0 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
           
 GTA   
 F1  F2  F3   
Pos -1 Pool SZP  Pool SZP  Pool SZP   
A 3 0  0 0  5 0   
C 0 0  0 0  0 0   
D 1 0  1 0  2 0   
E 1 0  0 0  1 0   
F 0 0  0 0  0 0   
G 0 0  0 0  0 0   
H 0 0  0 0  0 0   
I 0 0  0 0  2 0   
K 0 0  0 0  1 0   
L 1 0  0 0  2 0   
M 0 0  0 0  0 0   
N 0 0  0 0  1 0   
P 0 0  0 0  2 0   
Q 63 8  71 5  88 16   
R 19 0  0 0  6 0   
S 3 0  0 0  2 0   
T 21 0  0 0  2 0   
V 0 0  0 0  3 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +3:           
A 46 6  0 0  19 3   
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Table 3.S1 continued 
C 0 0  0 0  0 0   
D 0 0  0 0  0 0   
E 0 0  0 0  2 0   
F 0 0  1 0  0 0   
G 1 0  0 0  10 0   
H 1 0  0 0  0 0   
I 6 0  9 0  1 0   
K 0 0  0 0  0 0   
L 9 0  0 0  2 0   
M 0 0  1 0  0 0   
N 1 0  0 0  4 0   
P 1 0  0 0  3 0   
Q 1 0  0 0  6 0   
R 1 0  0 0  27 4   
S 21 2  8 4  25 7   
T 3 0  3 0  13 2   
V 21 0  50 1  5 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +6:           
A 0 0  0 0  9 0   
C 0 0  0 0  1 0   
D 0 0  0 0  1 0   
E 0 0  0 0  1 0   
F 0 0  0 0  0 0   
G 1 0  0 0  18 2   
H 1 0  0 0  3 0   
I 1 0  0 0  1 0   
K 0 0  0 0  1 0   
L 0 0  0 0  2 0   
M 0 0  0 0  0 0   
N 2 0  65 1  4 0   
P 0 0  0 0  4 0   
Q 1 0  0 0  1 0   
R 92 8  7 4  60 12   
S 0 0  0 0  5 2   
T 0 0  0 0  5 0   
V 14 0  0 0  1 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
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Table 3.S1 continued 
 GTC   
 F1  F2  F3   
Pos -1 Pool SZP  Pool SZP  Pool SZP   
A 2 1  0 0  15 0   
C 0 0  0 0  0 0   
D 0 0  26 5  36 7   
E 0 0  1 0  15 2   
F 0 0  0 0  0 0   
G 4 0  0 0  0 0   
H 1 0  0 0  0 0   
I 0 0  0 0  2 0   
K 1 0  0 0  2 0   
L 1 0  0 0  1 0   
M 1 0  0 0  1 0   
N 6 2  1 0  2 0   
P 1 0  0 0  2 0   
Q 4 0  3 0  8 0   
R 5 0  0 1  5 0   
S 10 0  0 0  5 0   
T 89 10  1 0  2 0   
V 3 0  0 0  0 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  1 0   
Pos +3:           
A 6 0  0 1  13 1   
C 0 0  0 0  0 0   
D 0 1  0 0  1 0   
E 0 0  0 0  0 0   
F 0 0  0 0  1 0   
G 1 0  0 1  14 0   
H 0 0  0 0  3 0   
I 14 0  1 0  3 0   
K 1 0  0 0  1 0   
L 33 2  0 0  1 0   
M 3 0  1 0  2 0   
N 0 0  0 0  2 0   
P 0 0  0 0  12 3   
Q 0 0  0 0  3 0   
R 6 0  0 0  12 0   
S 5 1  3 3  19 4   
T 10 0  0 0  5 0   
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Table 3.S1 continued 
V 49 9  27 1  4 1   
W 0 0  0 0  0 0   
Y 0 0  0 0  1 0   
Pos +6:           
A 1 0  0 0  2 0   
C 0 0  0 0  0 0   
D 0 0  0 0  1 0   
E 0 0  0 0  4 0   
F 0 0  0 0  0 0   
G 1 0  0 0  8 0   
H 2 0  0 0  3 0   
I 18 0  0 0  2 0   
K 0 0  0 0  2 0   
L 3 0  0 0  4 0   
M 0 0  0 0  3 0   
N 0 0  2 0  0 0   
P 1 0  1 0  4 0   
Q 0 0  0 0  1 0   
R 72 13  27 6  58 9   
S 0 0  0 0  0 0   
T 2 0  0 0  3 0   
V 28 0  0 0  2 0   
W 0 0  2 0  0 0   
Y 0 0  0 0  0 0   
           
 GTG   
 F1  F2  F3   
Pos -1 Pool SZP  Pool SZP  Pool SZP   
A 4 0  0 0  3 0   
C 0 0  0 0  2 0   
D 0 0  0 0  3 0   
E 1 0  0 0  0 0   
F 0 0  0 0  0 0   
G 0 0  2 0  6 0   
H 0 0  2 0  1 0   
I 0 0  0 0  1 0   
K 5 0  0 0  0 0   
L 1 0  0 0  1 0   
M 1 0  0 0  1 0   
N 1 0  0 0  3 0   
P 1 0  0 0  4 0   
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Table 3.S1 continued 
Q 0 0  1 0  2 0   
R 167 25  89 15  134 12   
S 1 2  0 0  1 0   
T 1 1  0 0  2 0   
V 2 0  0 0  4 0   
W 1 0  2 0  1 0   
Y 0 0  0 0  0 0   
Pos +3:           
A 1 0  0 0  52 7   
C 0 0  0 0  1 0   
D 0 0  1 0  1 0   
E 2 0  0 0  2 0   
F 0 0  0 0  0 0   
G 4 0  1 1  31 0   
H 1 1  1 0  2 0   
I 36 10  41 1  3 0   
K 0 0  0 0  4 0   
L 6 1  1 1  2 0   
M 5 0  1 0  0 0   
N 1 0  0 0  18 1   
P 2 0  0 0  5 0   
Q 1 0  1 0  2 0   
R 1 0  0 0  17 0   
S 11 1  2 1  8 2   
T 18 3  2 0  11 0   
V 97 12  45 11  10 2   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +6:           
A 9 0  0 0  13 0   
C 0 0  0 0  0 0   
D 1 0  0 0  10 0   
E 0 0  0 0  7 0   
F 0 0  0 0  0 0   
G 1 0  0 0  25 1   
H 3 1  0 0  7 0   
I 32 1  0 0  2 0   
K 0 0  1 0  7 1   
L 11 1  0 0  7 0   
M 5 0  0 0  5 0   
N 12 7  93 12  9 1   
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Table 3.S1 continued 
P 1 0  0 0  10 1   
Q 4 0  0 0  6 0   
R 45 12  0 3  36 8   
S 1 0  2 0  7 0   
T 14 2  0 0  10 0   
V 47 4  0 0  8 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
           
 GTT   
 F1  F2  F3   
Pos -1: Pool SZP  Pool SZP  Pool SZP   
A 4 2  7 0  19 0   
C 0 0  0 0  0 0   
D 0 3  1 0  2 0   
E 0 0  4 0  3 0   
F 0 0  0 0  0 0   
G 5 0  0 0  2 0   
H 2 1  19 3  4 1   
I 2 0  7 0  6 1   
K 4 0  0 0  0 0   
L 4 0  1 0  4 0   
M 7 0  0 0  0 0   
N 13 1  0 0  0 0   
P 0 0  1 0  0 0   
Q 2 0  4 0  2 1   
R 7 1  0 0  2 0   
S 9 1  0 0  2 0   
T 40 8  21 0  10 0   
V 1 0  44 2  10 3   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +3:           
A 7 3  0 0  2 0   
C 0 0  0 0  0 0   
D 0 0  0 0  0 0   
E 0 0  0 0  2 0   
F 0 0  0 0  0 0   
G 1 2  2 0  1 0   
H 0 0  0 0  1 0   
I 9 2  0 0  0 0   
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Table 3.S1 continued 
K 0 0  0 0  0 0   
L 8 1  0 0  3 0   
M 2 1  0 0  0 0   
N 0 0  0 0  8 0   
P 7 0  0 0  4 0   
Q 1 0  1 0  0 0   
R 18 0  7 0  18 0   
S 4 2  98 5  26 5   
T 12 1  1 0  1 0   
V 31 5  0 0  0 1   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +6:           
A 0 0  0 0  2 0   
C 0 0  0 0  0 0   
D 0 0  0 0  0 0   
E 0 0  0 0  0 0   
F 0 0  0 0  0 0   
G 0 0  0 0  9 0   
H 0 0  1 0  6 0   
I 25 1  0 0  1 0   
K 0 0  0 0  0 0   
L 0 0  0 0  1 0   
M 0 0  0 0  2 0   
N 0 0  0 0  2 0   
P 0 0  0 0  7 0   
Q 0 0  1 0  1 0   
R 31 15  99 5  28 6   
S 1 0  2 0  3 0   
T 2 0  6 0  1 0   
V 41 1  0 0  3 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
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Table 3.S2 Amino acid distribution at non-contact positions +1, +2 and +5. 
 GAA   
 F1  F2  F3   
Pos +1: Pool SZP  Pool SZP  Pool SZP   
A 11 4  16 3  5 0   
C 0 0  0 0  0 0   
D 0 0  3 0  7 2   
E 0 0  6 2  4 1   
F 0 0  0 0  0 0   
G 7 1  15 6  26 3   
H 1 0  3 1  4 1   
I 0 0  0 0  1 0   
K 21 6  2 1  1 0   
L 4 2  6 1  2 0   
M 3 0  1 1  2 0   
N 4 1  3 2  4 1   
P 2 0  5 0  1 0   
Q 6 1  5 5  4 1   
R 20 5  11 4  12 4   
S 12 3  2 1  6 3   
T 6 1  6 2  16 2   
V 1 0  0 0  4 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +2:           
A 11 4  16 6  5 0   
C 0 0  0 0  0 0   
D 0 0  4 1  27 0   
E 0 0  4 0  13 1   
F 0 0  0 0  0 0   
G 2 0  14 6  14 2   
H 0 0  1 0  0 0   
I 1 0  2 1  0 0   
K 0 0  0 0  0 0   
L 0 0  0 0  0 0   
M 2 0  0 0  1 0   
N 5 0  0 0  9 3   
P 19 2  8 1  11 5   
Q 8 1  9 1  5 0   
R 0 0  0 0  1 0   
S 30 11  6 4  4 1   
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Table 3.S2 continued 
T 20 6  13 7  4 2   
V 0 0  7 2  5 4   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +5:           
A 13 7  15 6  7 0   
C 0 0  0 0  0 0   
D 1 1  8 1  4 2   
E 1 1  4 1  2 0   
F 0 0  0 0  0 0   
G 1 0  8 2  41 4   
H 5 1  0 0  5 0   
I 3 0  1 0  0 0   
K 8 1  0 0  2 0   
L 14 5  6 2  1 0   
M 2 0  2 0  2 0   
N 4 0  0 0  5 2   
P 0 0  0 0  3 0   
Q 7 2  3 3  1 0   
R 10 1  6 1  7 2   
S 3 0  8 3  6 3   
T 14 3  10 4  12 5   
V 12 2  13 6  1 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
           
 GAC   
 F1  F2  F3   
Pos +1: Pool SZP  Pool SZP  Pool SZP   
A 10 1  14 4  4 0   
C 0 0  0 0  0 0   
D 2 1  0 0  0 0   
E 8 5  2 2  2 0   
F 0 0  0 0  0 0   
G 1 1  10 5  12 2   
H 2 0  3 0  1 0   
I 0 0  1 0  0 0   
K 3 0  8 4  1 0   
L 5 1  2 1  0 0   
M 0 0  2 1  4 0   
N 3 0  6 1  0 0   
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Table 3.S2 continued 
P 11 4  10 4  3 1   
Q 12 2  10 5  6 1   
R 4 0  17 9  2 0   
S 2 0  10 4  0 0   
T 0 0  1 0  2 0   
V 3 1  2 1  1 0   
W 0 0  0 0  1 0   
Y 0 0  0 0  0 0   
Pos +2:           
A 17 4  9 4  4 0   
C 0 0  0 0  0 0   
D 0 0  1 0  3 0   
E 0 0  28 10  0 0   
F 0 0  0 0  0 0   
G 0 0  29 10  17 3   
H 1 0  2 0  0 0   
I 0 0  0 0  0 0   
K 0 0  1 0  0 0   
L 0 0  0 0  0 0   
M 0 0  0 0  1 0   
N 2 0  0 0  3 0   
P 5 0  0 0  2 0   
Q 0 0  1 1  2 0   
R 2 0  0 0  0 0   
S 34 11  25 16  3 1   
T 2 0  2 0  1 0   
V 3 1  0 0  1 0   
W 0 0  0 0  1 0   
Y 0 0  0 0  1 0   
Pos +5:           
A 5 1  20 9  1 0   
C 1 0  0 0  0 0   
D 0 0  0 0  1 0   
E 0 0  1 0  0 0   
F 0 0  0 0  2 0   
G 4 0  5 0  9 1   
H 2 0  1 0  0 0   
I 3 1  4 0  4 1   
K 3 2  3 4  0 0   
L 1 0  7 2  1 0   
M 0 0  4 0  4 1   
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Table 3.S2 continued 
N 3 1  2 2  2 0   
P 0 0  0 0  1 0   
Q 2 0  9 2  3 0   
R 36 11  18 10  2 1   
S 0 0  2 3  3 0   
T 1 0  15 9  2 0   
V 4 0  7 0  4 0   
W 1 0  0 0  0 0   
Y 0 0  0 0  0 0   
           
 GAG   
 F1  F2  F3   
Pos +1: Pool SZP  Pool SZP  Pool SZP   
A 1 1  8 2  7 5   
C 0 0  0 0  1 0   
D 0 0  5 1  6 0   
E 1 0  5 4  8 2   
F 0 0  0 0  0 0   
G 3 1  13 3  14 5   
H 7 4  0 0  4 3   
I 0 0  0 0  3 1   
K 2 2  4 1  9 0   
L 1 1  1 1  3 0   
M 1 1  1 0  4 1   
N 6 2  10 0  2 0   
P 6 2  9 2  5 1   
Q 9 5  4 2  5 2   
R 2 1  20 1  15 3   
S 2 0  7 0  6 0   
T 10 4  8 1  4 2   
V 2 1  4 0  4 2   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +2:           
A 1 0  0 0  6 0   
C 0 0  0 0  0 0   
D 0 0  82 15  57 21   
E 1 0  14 3  6 2   
F 1 0  0 0  0 0   
G 2 0  1 0  8 0   
H 15 6  0 0  3 0   
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Table 3.S2 continued 
I 0 0  0 0  0 0   
K 0 0  0 0  1 0   
L 1 0  0 0  1 0   
M 1 1  0 0  1 0   
N 5 1  0 0  2 0   
P 0 0  0 0  2 0   
Q 1 0  0 0  2 0   
R 0 0  1 0  3 0   
S 14 12  0 0  4 2   
T 11 5  1 0  1 0   
V 0 0  0 0  1 0   
W 0 0  0 0  1 2   
Y 0 0  0 0  1 0   
Pos +5:           
A 9 6  11 2  3 1   
C 0 0  0 0  1 0   
D 6 2  5 3  4 0   
E 3 3  8 1  7 3   
F 0 0  0 0  0 0   
G 1 0  15 6  18 4   
H 3 0  2 0  3 1   
I 1 1  5 0  4 1   
K 4 1  5 1  5 2   
L 8 2  5 0  5 0   
M 1 1  5 0  3 1   
N 1 0  5 0  5 2   
P 0 0  0 0  11 4   
Q 2 0  5 1  6 1   
R 3 1  7 0  7 2   
S 2 1  4 0  3 0   
T 7 6  8 0  13 5   
V 2 1  9 4  2 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
           
 GAT 
 GATa_F1 GATg_F1  F2  F3 
Pos +1: Pool SZP Pool SZP  Pool SZP  Pool SZP
A 10 1 1 0  15 2  8 2 
C 0 0 0 0  0 0  0 0 
D 0 0 0 0  3 0  1 0 
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Table 3.S2 continued 
E 4 0 0 0  0 0  4 1 
F 0 0 0 0  0 0  0 0 
G 11 1 8 0  6 0  33 3 
H 2 0 0 0  4 0  1 0 
I 0 0 0 0  0 0  0 0 
K 10 1 10 2  7 2  4 0 
L 2 0 0 0  3 1  10 1 
M 1 0 0 0  3 2  1 1 
N 9 0 10 1  6 2  13 1 
P 2 0 1 0  3 2  3 0 
Q 8 0 4 0  0 0  4 0 
R 21 1 12 1  15 7  17 6 
S 3 0 11 1  7 2  5 1 
T 2 0 1 0  4 0  11 1 
V 3 0 0 0  1 1  6 0 
W 1 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
Pos +2:           
A 0 0 0 0  6 2  11 1 
C 0 0 0 0  0 0  0 0 
D 0 0 0 0  0 0  3 1 
E 0 0 0 0  0 1  3 0 
F 0 0 0 0  0 0  0 0 
G 5 0 0 0  0 0  37 7 
H 0 0 0 0  68 18  11 5 
I 0 0 0 0  0 0  0 0 
K 0 0 0 0  0 0  2 0 
L 3 0 0 0  0 0  0 0 
M 1 0 0 0  0 0  1 0 
N 0 0 4 0  0 0  11 0 
P 5 0 0 0  1 0  7 0 
Q 69 4 54 5  0 0  3 0 
R 3 0 0 0  0 0  4 0 
S 0 0 0 0  0 0  17 3 
T 3 0 0 0  1 0  10 0 
V 0 0 0 0  0 0  1 0 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  1 0  0 0 
Pos +5:           
A 16 2 8 1  4 1  20 3 
C 0 0 0 0  1 0  0 0 
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Table 3.S2 continued 
D 10 0 8 2  0 0  1 0 
E 5 0 4 0  0 0  1 0 
F 0 0 0 0  0 0  0 0 
G 10 0 2 1  2 0  16 1 
H 3 0 3 0  3 2  4 0 
I 2 0 1 0  1 1  3 0 
K 1 0 1 0  13 5  5 1 
L 2 0 3 0  3 0  4 0 
M 5 1 3 0  1 0  4 0 
N 1 0 2 0  6 1  9 3 
P 0 0 0 0  1 0  2 0 
Q 6 0 5 0  4 1  1 0 
R 9 1 3 0  12 3  18 3 
S 2 0 4 0  5 0  9 2 
T 7 0 8 0  14 7  17 4 
V 10 0 3 1  6 0  6 0 
W 0 0 0 0  1 0  1 0 
Y 0 0 0 0  0 0  0 0 
           
 GCA 
 GCAa_F1 GCAg_F1  F2  F3 
Pos +1: Pool SZP Pool SZP  Pool SZP  Pool SZP
A 18 0 13 0  3 1  6 1 
C 0 0 0 0  0 0  0 0 
D 2 0 0 0  0 0  11 2 
E 1 0 0 0  0 0  4 0 
F 0 0 0 0  0 0  0 0 
G 19 2 12 0  22 4  46 8 
H 6 0 2 0  0 0  1 0 
I 0 0 0 0  2 0  3 0 
K 22 2 6 2  3 1  8 2 
L 1 0 1 0  0 0  0 0 
M 3 0 2 1  1 2  3 0 
N 29 1 3 0  1 1  7 1 
P 16 1 10 1  0 0  6 1 
Q 20 2 4 0  1 0  2 0 
R 73 4 24 4  3 1  3 0 
S 12 0 12 1  7 3  5 3 
T 16 1 19 1  5 2  15 5 
V 1 0 2 0  0 0  1 0 
W 0 0 0 0  0 0  1 0 
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Table 3.S2 continued 
Y 0 0 0 0  0 0  0 0 
Pos +2:           
A 22 1 30 2  0 0  4 1 
C 0 0 0 0  0 0  0 0 
D 0 0 2 0  3 0  4 0 
E 1 0 21 4  16 8  2 0 
F 0 0 0 0  0 0  0 0 
G 39 1 17 0  12 5  30 9 
H 34 0 6 0  1 0  3 0 
I 0 0 1 0  1 0  1 0 
K 0 0 1 0  1 0  2 0 
L 0 0 1 0  0 0  1 0 
M 0 0 0 0  0 0  0 0 
N 3 0 1 0  0 0  40 9 
P 9 0 2 0  1 0  0 0 
Q 39 6 2 0  2 0  15 0 
R 15 0 0 0  0 0  1 0 
S 61 1 12 2  0 0  3 0 
T 10 1 12 2  5 2  8 1 
V 5 3 2 0  5 0  7 2 
W 0 0 0 0  1 0  0 1 
Y 1 0 0 0  0 0  1 0 
Pos +5:           
A 19 1 28 4  1 0  5 0 
C 0 0 0 0  0 0  0 0 
D 12 1 10 2  0 0  2 0 
E 2 0 3 0  2 0  1 0 
F 0 0 0 0  0 0  0 0 
G 10 1 14 3  0 0  20 3 
H 5 0 4 0  1 1  1 0 
I 7 0 1 0  0 0  3 0 
K 16 2 2 0  20 9  5 3 
L 18 1 7 0  0 0  3 0 
M 8 0 1 0  0 0  5 2 
N 27 2 5 0  5 2  7 1 
P 1 0 0 0  0 0  10 0 
Q 4 0 2 0  0 0  0 0 
R 38 2 10 0  11 2  16 5 
S 6 0 8 0  2 1  8 0 
T 41 1 9 1  4 0  20 7 
V 25 2 6 0  2 0  15 2 
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Table 3.S2 continued 
W 0 0 0 0  0 0  1 0 
Y 0 0 0 0  0 0  0 0 
           
 GCC 
 GCCc_F1 GCCg_F1  F2  F3 
Pos +1: Pool SZP Pool SZP  Pool SZP  Pool SZP
A 9 2 12 0  0 0  4 0 
C 0 0 0 0  0 0  0 0 
D 0 0 2 0  0 0  2 0 
E 1 1 0 0  1 0  2 0 
F 0 0 0 0  0 0  0 0 
G 14 1 15 1  1 0  14 0 
H 3 0 3 0  6 0  2 2 
I 0 0 0 0  0 0  1 0 
K 6 2 5 1  2 1  19 1 
L 1 0 0 0  1 0  4 0 
M 0 0 1 0  0 0  1 0 
N 13 1 11 2  1 0  7 0 
P 6 1 3 0  2 3  3 1 
Q 7 1 0 0  0 0  5 1 
R 21 6 31 1  16 9  20 1 
S 9 1 17 1  13 4  3 0 
T 11 1 6 1  9 0  2 0 
V 0 0 0 0  3 2  0 0 
W 0 0 0 0  0 0  1 0 
Y 0 0 0 0  0 0  0 0 
Pos +2:           
A 2 0 15 0  2 0  4 0 
C 0 0 1 0  0 0  0 0 
D 1 0 0 0  0 0  3 0 
E 0 0 0 0  0 0  1 0 
F 0 0 0 0  0 0  0 0 
G 1 0 6 0  3 1  9 0 
H 0 0 3 0  0 0  2 0 
I 0 0 0 0  0 0  1 0 
K 26 6 1 0  0 0  7 0 
L 0 0 0 0  0 0  3 0 
M 0 0 0 0  1 0  0 0 
N 0 0 1 0  0 0  3 0 
P 7 2 2 1  3 0  2 0 
Q 2 0 6 0  0 0  2 0 
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Table 3.S2 continued 
R 32 6 46 5  0 0  35 2 
S 14 3 13 0  28 13  11 3 
T 14 0 12 1  18 5  5 1 
V 0 0 0 0  0 0  2 0 
W 2 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
Pos +5:           
A 5 0 9 0  3 1  14 2 
C 0 0 0 0  0 0  0 0 
D 11 3 11 1  0 0  2 0 
E 2 0 4 0  0 0  2 0 
F 0 0 0 0  0 0  0 0 
G 1 1 4 0  3 0  8 0 
H 2 0 3 0  2 0  4 0 
I 8 0 3 2  4 0  2 0 
K 1 0 10 0  20 8  9 1 
L 8 2 7 1  0 0  4 0 
M 2 1 2 0  0 0  2 0 
N 6 1 1 0  3 1  6 0 
P 0 0 0 0  0 0  1 0 
Q 2 0 3 0  1 0  3 0 
R 26 4 21 2  8 4  12 2 
S 3 0 2 0  1 1  5 1 
T 12 1 13 1  5 2  13 0 
V 11 4 13 0  5 2  3 0 
W 1 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
           
 GCG   
 F1  F2  F3   
Pos +1: Pool SZP  Pool SZP  Pool SZP   
A 12 2  12 3  8 1   
C 0 0  0 0  0 0   
D 1 0  5 1  6 0   
E 2 0  9 2  9 2   
F 0 0  0 0  0 0   
G 31 0  12 0  15 0   
H 19 2  0 0  8 1   
I 0 0  0 0  3 1   
K 21 3  6 2  9 2   
L 2 1  3 0  11 1   
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Table 3.S2 continued 
M 9 0  7 2  3 0   
N 35 2  4 0  14 1   
P 7 0  14 1  4 1   
Q 20 0  5 2  5 1   
R 35 5  21 6  8 3   
S 25 3  6 1  5 0   
T 21 1  7 2  9 2   
V 1 0  3 0  1 1   
W 0 0  1 0  0 0   
Y 0 0  0 0  0 0   
Pos +2:           
A 5 0  0 0  15 0   
C 1 0  0 0  0 0   
D 17 4  98 19  34 16   
E 5 0  10 3  15 1   
F 0 0  0 0  0 0   
G 6 1  3 0  4 0   
H 64 5  1 0  2 0   
I 5 1  0 0  1 0   
K 5 0  0 0  0 0   
L 39 2  0 0  1 0   
M 2 0  0 0  4 0   
N 33 4  1 0  1 0   
P 2 0  0 0  1 0   
Q 1 0  0 0  28 0   
R 12 2  2 0  4 0   
S 14 0  0 0  1 0   
T 27 0  0 0  5 0   
V 3 0  0 0  2 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +5:           
A 26 5  13 3  6 2   
C 0 0  0 0  0 0   
D 18 2  3 0  4 0   
E 2 0  6 2  4 0   
F 0 0  0 0  0 0   
G 2 0  13 3  14 7   
H 6 1  4 0  5 1   
I 10 1  5 0  1 0   
K 10 1  7 0  7 1   
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Table 3.S2 continued 
L 35 2  8 1  5 0   
M 6 0  6 0  4 0   
N 4 0  0 0  5 0   
P 6 2  1 0  13 2   
Q 13 2  3 0  4 0   
R 39 0  17 3  20 0   
S 9 0  2 0  10 0   
T 34 2  20 7  8 4   
V 21 1  7 3  8 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
 GCT 
 GCTc_F1 GCTg_F1  F2  F3 
Pos +1: Pool SZP Pool SZP  Pool SZP  Pool SZP
A 9 0 10 4  17 4  1 1 
C 0 0 0 0  0 0  0 0 
D 0 0 1 0  2 0  0 0 
E 0 0 0 0  1 1  0 0 
F 0 0 0 0  0 0  0 0 
G 13 1 22 2  3 0  32 9 
H 6 2 1 0  1 1  0 0 
I 0 0 0 0  0 0  0 0 
K 24 4 12 1  16 6  8 4 
L 1 0 2 0  2 0  0 0 
M 2 0 2 0  3 0  0 0 
N 12 2 8 0  10 2  1 0 
P 4 0 2 0  3 0  1 0 
Q 7 0 0 0  5 0  3 2 
R 30 3 30 6  33 7  9 5 
S 15 2 5 0  2 3  9 5 
T 5 1 6 3  2 0  2 1 
V 0 0 2 0  4 0  0 0 
W 0 0 0 0  0 1  0 0 
Y 0 0 0 0  0 0  0 0 
Pos +2:           
A 6 1 4 1  2 0  4 2 
C 0 0 0 0  0 0  0 0 
D 0 0 1 0  7 3  0 0 
E 2 0 1 0  79 11  0 0 
F 0 0 0 0  0 0  0 0 
G 2 0 2 0  2 0  15 4 
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Table 3.S2 continued 
H 0 0 5 0  4 4  7 5 
I 0 0 0 0  0 0  0 0 
K 1 0 0 0  0 0  0 0 
L 23 3 6 0  1 0  0 0 
M 0 0 0 0  0 0  0 0 
N 9 1 5 0  2 0  27 12 
P 8 2 0 0  0 0  0 0 
Q 44 5 70 13  0 3  6 3 
R 1 0 2 0  0 0  2 0 
S 15 2 1 0  7 4  3 1 
T 13 1 5 2  0 0  1 0 
V 4 0 1 0  0 0  1 0 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
Pos +5:           
A 15 2 7 1  3 0  7 1 
C 0 0 0 0  0 0  0 0 
D 13 2 12 2  0 0  0 0 
E 1 0 6 0  1 1  1 0 
F 0 0 0 0  0 0  0 0 
G 3 0 8 2  5 0  6 4 
H 7 0 1 0  0 0  2 2 
I 7 1 2 0  4 0  2 0 
K 4 2 10 0  25 13  5 1 
L 7 1 4 0  4 0  1 0 
M 1 0 1 0  2 0  0 0 
N 4 0 5 2  3 2  6 5 
P 0 0 1 0  0 0  1 0 
Q 9 0 12 2  6 1  4 2 
R 23 1 19 6  13 1  5 2 
S 3 0 3 1  4 1  10 4 
T 19 2 8 0  13 4  13 6 
V 12 4 4 0  21 2  3 0 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
           
 GGA 
 GGAc_F1 GGAg_F1  F2  F3 
Pos +1: Pool SZP Pool SZP  Pool SZP  Pool SZP
A 15 1 5 0  3 0  14 1 
C 0 0 0 0  0 0  0 0 
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Table 3.S2 continued 
D 1 0 0 0  1 0  4 0 
E 2 2 1 0  2 0  0 0 
F 0 0 0 0  0 0  0 0 
G 8 0 7 1  27 2  24 2 
H 3 1 0 0  0 0  6 0 
I 0 0 0 0  0 0  1 1 
K 11 0 6 4  2 1  10 1 
L 0 0 4 0  0 0  5 0 
M 0 0 1 0  4 1  9 1 
N 7 1 2 1  5 2  8 2 
P 5 0 0 0  0 0  8 0 
Q 14 1 4 0  0 0  9 1 
R 20 1 8 1  10 3  19 0 
S 15 3 0 0  8 3  13 3 
T 6 0 2 0  6 1  13 3 
V 1 0 2 0  0 0  5 0 
W 1 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
Pos +2:           
A 20 3 8 2  6 1  13 1 
C 0 0 0 0  0 0  0 0 
D 7 2 1 0  1 0  6 3 
E 3 0 0 0  0 1  7 1 
F 0 0 0 0  0 0  0 0 
G 1 0 3 0  0 0  25 2 
H 1 0 0 0  0 0  0 0 
I 1 0 2 0  1 0  4 0 
K 1 0 0 0  0 0  2 0 
L 0 0 6 0  2 0  1 0 
M 1 0 0 0  0 0  2 0 
N 2 0 0 0  0 0  11 0 
P 2 0 1 0  41 8  17 1 
Q 4 0 2 0  0 0  13 3 
R 2 0 3 0  4 0  2 0 
S 33 2 2 0  1 0  9 2 
T 29 3 13 5  5 2  22 2 
V 2 0 1 0  7 1  14 0 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
Pos +5:           
A 14 1 6 1  11 2  19 2 
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Table 3.S2 continued 
C 0 0 0 0  0 0  0 0 
D 8 1 3 0  5 1  8 1 
E 14 0 0 0  5 0  5 0 
F 0 0 0 0  0 0  0 0 
G 1 0 3 0  0 0  21 1 
H 1 0 0 0  0 0  4 0 
I 4 0 2 0  1 0  4 0 
K 4 1 2 0  10 4  9 5 
L 10 1 2 0  2 0  3 0 
M 2 0 2 0  0 0  1 0 
N 1 0 2 1  1 0  4 0 
P 1 0 2 0  1 0  11 0 
Q 8 0 1 0  0 0  4 0 
R 5 4 8 2  8 1  19 2 
S 3 0 3 1  2 0  14 2 
T 16 2 3 2  17 4  15 1 
V 17 0 3 0  5 1  7 1 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
           
 GGC 
 GGCa_F1 GGCc_F1  F2  F3 
Pos +1: Pool SZP Pool SZP  Pool SZP  Pool SZP
A 1 0 1 0  11 1  3 0 
C 0 0 0 0  0 0  0 0 
D 0 0 0 0  2 0  1 0 
E 0 0 0 0  3 0  2 1 
F 0 0 0 0  0 0  0 0 
G 2 0 3 0  18 0  21 3 
H 1 0 4 0  4 1  4 0 
I 0 0 0 0  2 0  3 0 
K 6 1 9 0  21 5  35 7 
L 0 0 3 0  6 0  4 0 
M 0 0 1 0  2 0  1 0 
N 1 1 12 1  10 1  31 6 
P 35 12 38 6  12 1  2 2 
Q 1 0 9 0  9 2  12 0 
R 3 0 13 2  37 3  30 2 
S 0 0 19 0  4 3  8 1 
T 0 0 11 0  4 0  7 1 
V 0 0 0 0  11 0  1 1 
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Table 3.S2 continued 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
Pos +2:           
A 4 0 4 0  13 1  18 0 
C 0 0 0 0  0 0  0 0 
D 3 0 1 0  2 2  1 2 
E 0 0 0 0  14 4  2 0 
F 0 0 0 0  0 0  1 0 
G 1 0 0 0  27 1  28 5 
H 2 1 2 0  2 1  3 1 
I 0 0 0 0  1 0  9 0 
K 0 0 0 0  3 0  2 0 
L 0 0 0 0  11 0  12 0 
M 0 0 0 0  4 0  3 1 
N 0 0 5 0  2 0  1 0 
P 0 0 1 0  2 0  4 0 
Q 0 0 0 0  9 0  2 0 
R 1 0 8 0  15 1  6 0 
S 37 13 80 9  35 7  7 6 
T 2 0 20 0  7 0  4 0 
V 0 0 2 0  8 0  62 9 
W 0 0 0 0  1 0  0 0 
Y 0 0 0 0  0 0  0 0 
Pos +5:           
A 13 3 20 1  10 1  7 1 
C 0 0 0 0  0 0  0 0 
D 4 1 14 5  3 0  5 0 
E 2 1 8 0  6 0  4 1 
F 0 0 0 0  0 0  0 0 
G 0 0 4 0  12 0  33 2 
H 0 0 1 0  1 0  4 1 
I 1 1 2 0  11 1  3 0 
K 5 2 5 0  33 7  19 5 
L 4 2 9 1  4 0  2 0 
M 2 1 5 0  6 0  5 1 
N 0 0 0 0  5 1  12 1 
P 0 0 0 0  5 0  4 1 
Q 1 1 11 0  3 1  15 1 
R 4 0 10 0  17 0  20 2 
S 1 0 3 0  1 0  5 1 
T 9 2 14 0  15 4  19 7 
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Table 3.S2 continued 
V 4 0 17 2  24 2  7 0 
W 0 0 0 0  0 0  1 0 
Y 0 0 0 0  0 0  0 0 
           
 GGG   
 F1  F2  F3   
Pos +1: Pool SZP  Pool SZP  Pool SZP   
A 8 1  10 1  2 0   
C 0 0  0 0  0 0   
D 0 0  1 0  4 2   
E 1 0  2 0  0 0   
F 0 0  0 0  0 0   
G 17 4  8 2  5 4   
H 4 0  1 1  6 0   
I 0 0  1 0  2 4   
K 14 5  4 0  8 5   
L 0 0  2 0  0 0   
M 0 0  2 0  1 1   
N 9 1  4 1  14 4   
P 5 0  2 0  2 0   
Q 3 0  8 1  3 1   
R 19 8  16 3  25 4   
S 15 3  3 0  3 2   
T 4 0  8 1  3 2   
V 0 0  2 2  5 1   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +2:           
A 3 3  29 0  6 0   
C 0 0  0 0  0 0   
D 15 4  3 3  18 15   
E 36 8  13 9  16 3   
F 0 0  0 0  0 0   
G 0 0  6 0  4 1   
H 5 2  0 0  15 7   
I 0 0  0 0  3 0   
K 2 0  0 0  1 0   
L 5 2  0 0  3 0   
M 0 0  3 0  1 0   
N 14 1  0 0  2 1   
P 0 0  6 0  0 0   
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Table 3.S2 continued 
Q 6 1  1 0  2 0   
R 0 0  2 0  0 0   
S 3 0  7 0  2 1   
T 10 1  4 0  6 0   
V 0 0  0 0  3 0   
W 0 0  0 0  1 1   
Y 0 0  0 0  0 1   
Pos +5:           
A 8 3  7 0  9 5   
C 0 0  0 0  0 0   
D 8 2  3 0  4 2   
E 1 0  6 0  7 2   
F 0 0  0 0  0 0   
G 3 1  7 1  20 9   
H 3 4  2 1  1 1   
I 5 0  5 1  0 0   
K 5 1  1 0  4 2   
L 8 0  3 1  1 0   
M 1 0  1 1  3 1   
N 1 0  4 1  5 1   
P 0 0  0 0  1 1   
Q 6 4  5 0  3 1   
R 23 5  4 0  6 0   
S 0 0  5 0  10 2   
T 16 0  10 2  2 0   
V 11 2  11 4  7 3   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
           
 GGT 
 GGTc_F1 GGTg_F1  F2  F3 
Pos +1: Pool SZP Pool SZP  Pool SZP  Pool SZP
A 4 0 8 0  9 2  5 0 
C 0 0 0 0  0 0  0 0 
D 0 0 2 0  2 1  1 1 
E 2 0 2 0  4 1  0 0 
F 0 0 0 0  0 0  0 0 
G 8 0 15 1  7 1  20 3 
H 3 0 1 1  1 0  1 0 
I 0 0 0 0  0 0  1 0 
K 14 0 23 4  20 9  7 5 
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Table 3.S2 continued 
L 0 0 3 0  0 0  3 0 
M 3 0 0 0  1 0  0 0 
N 9 1 6 2  9 2  8 4 
P 0 0 2 1  16 3  4 1 
Q 4 0 1 0  2 0  1 0 
R 21 1 15 2  25 5  21 2 
S 12 0 5 2  1 1  13 2 
T 11 1 8 1  2 1  12 2 
V 0 0 3 0  0 0  2 2 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
Pos +2:           
A 4 0 3 0  1 0  4 1 
C 0 0 0 0  0 0  0 0 
D 0 0 2 0  1 0  5 0 
E 0 0 1 0  0 0  0 0 
F 0 0 0 0  0 0  0 0 
G 0 0 2 0  0 0  13 1 
H 1 0 8 3  82 22  33 15 
I 0 0 1 0  0 0  1 0 
K 0 0 0 0  0 0  3 0 
L 0 0 1 0  0 0  1 0 
M 0 0 2 0  0 0  0 0 
N 0 0 2 1  0 0  2 0 
P 1 0 0 0  0 0  3 0 
Q 57 1 59 6  14 4  15 4 
R 1 0 2 0  0 0  5 0 
S 8 1 2 1  0 0  2 1 
T 17 1 5 3  0 0  8 0 
V 2 0 4 0  0 0  3 0 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  1 0  1 0 
Pos +5:           
A 11 1 6 4  6 0  13 2 
C 1 0 0 0  0 0  0 0 
D 7 1 5 1  3 1  4 2 
E 5 0 1 3  7 0  1 0 
F 0 0 0 0  0 0  0 0 
G 3 0 13 0  9 2  12 4 
H 3 0 1 0  1 0  4 1 
I 3 0 1 1  3 1  1 0 
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Table 3.S2 continued 
K 3 0 6 0  15 4  9 5 
L 7 0 6 0  0 0  2 0 
M 1 0 5 1  5 0  2 0 
N 3 0 2 1  1 0  7 2 
P 0 0 4 0  0 0  4 1 
Q 6 1 17 0  7 2  4 0 
R 9 0 6 0  4 0  12 3 
S 2 0 3 0  6 1  4 0 
T 17 0 9 2  17 7  15 2 
V 10 0 9 1  15 8  5 0 
W 0 0 0 0  0 0  0 0 
Y 0 0 0 0  0 0  0 0 
           
 GTA   
 F1  F2  F3   
Pos +1: Pool SZP  Pool SZP  Pool SZP   
A 20 1  1 0  6 1   
C 0 0  0 0  0 0   
D 1 1  0 0  1 0   
E 1 0  1 0  0 0   
F 0 0  0 0  0 0   
G 18 1  16 2  20 2   
H 6 0  1 0  4 1   
I 0 0  1 0  3 0   
K 4 2  9 0  19 4   
L 2 0  0 0  2 0   
M 2 0  1 0  6 1   
N 3 0  4 0  13 1   
P 12 0  0 0  8 1   
Q 13 2  0 0  3 0   
R 14 0  26 1  13 1   
S 10 1  8 2  7 2   
T 5 0  4 0  7 2   
V 1 0  0 0  4 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  1 0   
Pos +2:           
A 20 0  6 1  6 0   
C 0 0  0 0  0 0   
D 0 0  0 0  0 0   
E 0 0  0 0  3 0   
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Table 3.S2 continued 
F 0 0  0 0  0 0   
G 9 0  12 0  11 2   
H 3 0  4 0  18 3   
I 1 0  1 0  4 0   
K 0 0  0 0  2 0   
L 0 0  1 0  3 0   
M 1 0  0 0  1 0   
N 0 0  1 0  19 3   
P 3 0  11 0  7 2   
Q 40 4  0 0  4 0   
R 0 0  2 0  3 0   
S 26 4  6 3  7 1   
T 7 0  10 0  18 4   
V 2 0  18 1  11 1   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +5:           
A 12 1  3 0  11 2   
C 0 0  0 0  0 0   
D 9 1  3 0  4 0   
E 0 0  1 0  2 0   
F 0 0  0 0  0 0   
G 0 0  0 0  15 1   
H 5 0  2 0  5 0   
I 3 0  3 0  2 0   
K 8 1  12 1  4 1   
L 7 1  1 0  8 0   
M 3 0  1 0  3 0   
N 2 0  3 0  5 1   
P 0 0  0 0  6 1   
Q 5 0  0 0  14 3   
R 14 1  16 2  10 0   
S 11 1  1 0  10 3   
T 18 1  13 0  15 4   
V 15 1  12 2  3 0   
W 0 0  1 0  0 0   
Y 0 0  0 0  0 0   
           
 GTC   
 F1  F2  F3   
Pos +1: Pool SZP  Pool SZP  Pool SZP   
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Table 3.S2 continued 
A 11 1  1 0  5 0   
C 0 0  0 0  0 0   
D 2 0  0 0  2 0   
E 0 0  1 0  5 0   
F 0 0  0 0  0 0   
G 25 2  2 0  8 0   
H 6 1  2 1  2 0   
I 0 0  2 0  1 0   
K 15 1  0 0  13 0   
L 1 0  0 0  4 0   
M 4 1  0 0  2 0   
N 5 0  0 0  4 0   
P 8 1  4 3  4 2   
Q 4 0  1 0  7 1   
R 27 3  8 1  25 4   
S 10 1  11 0  4 2   
T 9 2  0 1  6 0   
V 1 0  0 0  5 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +2:           
A 21 8  9 0  12 0   
C 0 0  0 0  0 0   
D 1 0  0 1  2 0   
E 0 0  7 0  0 0   
F 0 0  0 0  0 0   
G 1 0  1 0  18 1   
H 0 0  0 0  1 0   
I 0 0  0 0  1 0   
K 3 0  0 0  3 0   
L 1 0  0 0  1 0   
M 1 0  0 0  2 0   
N 7 0  0 0  2 0   
P 2 0  0 0  4 0   
Q 13 0  0 0  3 0   
R 12 0  0 0  12 0   
S 17 2  14 5  13 2   
T 39 3  0 0  21 6   
V 10 0  1 0  2 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
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Table 3.S2 continued 
Pos +5:           
A 16 2  1 0  7 1   
C 0 0  0 0  1 0   
D 3 0  0 0  4 0   
E 2 0  0 0  0 0   
F 0 0  0 0  0 0   
G 3 0  0 0  10 0   
H 3 0  2 0  3 0   
I 0 0  1 0  1 1   
K 7 0  10 5  6 0   
L 12 2  0 0  4 0   
M 6 0  0 0  3 0   
N 7 1  1 0  11 2   
P 2 0  0 0  6 0   
Q 2 0  0 0  5 1   
R 34 5  8 1  17 3   
S 3 0  0 0  4 0   
T 19 3  5 0  12 1   
V 9 0  4 0  3 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
           
 GTG   
 F1  F2  F3   
Pos +1: Pool SZP  Pool SZP  Pool SZP   
A 10 1  8 2  7 0   
C 0 0  0 0  0 0   
D 1 0  0 0  4 0   
E 1 0  0 0  3 0   
F 0 0  0 0  0 0   
G 19 0  8 1  19 2   
H 6 1  1 0  4 1   
I 0 0  1 0  0 0   
K 18 5  6 2  21 2   
L 6 0  1 0  5 1   
M 6 1  1 1  5 1   
N 16 4  11 0  26 0   
P 10 1  4 1  1 3   
Q 15 4  1 0  15 0   
R 46 7  25 6  36 2   
S 14 2  10 1  6 0   
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Table 3.S2 continued 
T 17 2  16 1  11 0   
V 1 0  3 0  6 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +2:           
A 11 1  12 0  34 1   
C 1 0  0 0  0 0   
D 0 0  2 4  15 8   
E 6 0  20 6  13 0   
F 9 7  0 0  0 0   
G 19 1  7 1  10 0   
H 36 8  4 3  2 0   
I 1 0  1 0  5 0   
K 2 0  0 0  0 0   
L 5 0  0 0  5 0   
M 1 0  2 0  6 0   
N 13 1  11 0  1 0   
P 1 0  7 0  4 0   
Q 3 0  15 1  4 0   
R 2 0  2 0  9 1   
S 22 6  9 0  8 0   
T 48 3  2 0  29 2   
V 3 0  2 0  23 0   
W 2 0  0 0  1 0   
Y 1 1  0 0  0 0   
Pos +5:           
A 29 4  19 2  15 1   
C 0 0  0 0  0 0   
D 15 4  4 1  5 0   
E 7 0  5 1  3 0   
F 0 0  0 0  0 0   
G 4 1  3 1  26 4   
H 7 1  4 1  4 0   
I 4 2  5 0  5 0   
K 17 2  1 0  11 0   
L 11 2  2 0  3 0   
M 4 1  1 2  7 1   
N 10 0  2 1  17 1   
P 1 0  0 0  3 1   
Q 8 3  2 0  6 0   
R 45 2  8 0  12 0   
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Table 3.S2 continued 
S 3 1  3 0  15 1   
T 16 3  18 3  20 3   
V 5 2  19 3  17 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
           
 GTT   
 F1  F2  F3   
Pos +1: Pool SZP  Pool SZP  Pool SZP   
A 20 1  16 0  2 0   
C 0 0  0 0  0 0   
D 0 0  4 0  0 0   
E 0 0  4 1  0 0   
F 0 0  0 0  0 0   
G 9 1  7 0  13 2   
H 4 1  2 0  5 1   
I 0 0  0 0  1 0   
K 15 3  23 2  4 0   
L 1 0  1 0  2 0   
M 4 0  0 0  0 0   
N 13 4  18 0  9 2   
P 6 0  6 0  0 0   
Q 8 1  5 1  5 1   
R 5 3  16 1  18 0   
S 8 2  5 0  2 0   
T 7 1  2 0  1 0   
V 0 0  0 0  4 0   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +2:           
A 3 0  0 0  3 0   
C 0 0  0 0  0 0   
D 1 0  2 0  4 0   
E 0 0  7 0  3 0   
F 0 0  0 0  0 0   
G 4 0  0 0  11 2   
H 2 1  25 1  18 1   
I 2 0  0 0  1 0   
K 0 0  0 0  0 0   
L 3 0  0 0  1 0   
M 0 0  1 0  0 0   
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Table 3.S2 continued 
N 3 0  1 0  5 1   
P 12 1  0 0  2 0   
Q 17 5  0 0  4 0   
R 1 3  1 0  1 0   
S 19 1  60 4  5 1   
T 32 5  12 0  7 0   
V 1 1  0 0  1 1   
W 0 0  0 0  0 0   
Y 0 0  0 0  0 0   
Pos +5:           
A 7 1  4 0  4 0   
C 0 0  0 0  0 0   
D 1 2  4 0  1 0   
E 1 0  2 0  6 0   
F 0 0  0 0  0 0   
G 2 2  5 0  10 0   
H 2 0  1 0  0 0   
I 1 0  7 0  2 0   
K 14 1  16 1  5 0   
L 7 1  3 0  3 0   
M 1 0  4 0  2 0   
N 4 2  0 0  4 1   
P 1 0  0 0  2 0   
Q 1 0  7 0  1 0   
R 29 6  8 0  10 1   
S 2 0  5 0  0 0   
T 20 1  24 4  13 4   
V 7 1  19 0  2 0   
W 0 0  0 0  1 0   
Y 0 0  0 0  0 0   
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CHAPTER 4. GENERAL CONCLUSIONS 
ZIFDB PROVIDES VALUABLE INFORMATION ON C2H2 ZINC 
FINGERS AND ENGINEERED ZINC-FINGER ARRAYS 
Zinc fingers (ZFs) are approximately 30 amino acids in length and fold into a stable 
ββα structure. Seven amino acids comprise the recognition helix (designated positions -1 to 
+6), which enables the ZF to bind target DNA.  ZFs typically recognize three contiguous 
base pairs, with the amino acids at position -1, +3 and +6 of the recognition helix contacting 
the nucleotides at the 3’-, middle and 5’-end of the target triplet, respectively.  Novel ZFs 
can be engineered by altering the recognition helix to gain new binding specificities.  
Three different groups have engineered ZFs for all 64 possible triplets:  Sangamo 
BioSciences [1-3], the Carlos Barbas laboratory [4-8] and Toolgen Inc. [9].  By linking 
predefined ZFs in tandem, engineered zinc finger arrays (ZFAs) can be assembled that 
bind to novel, extended DNA sequences, and this method is referred as modular assembly.  
In order to facilitate ZFA engineering by modular assembly, the Zinc Finger Consortium 
has generated a clone library of all available ZFs and described a modular assembly 
protocol in Wright, et al. [10].  Further, the success rate of modular assembly was 
directly tested and found to have unexpectedly high failure rates for most target sites 
(Ramirez et al. 2009)  
OPEN (Oligomerized Pool ENgineering) is a rapid, publicly available 
selection-based method for ZFA engineering, which was recently developed by the Joung 
laboratory and other members of the Zinc Finger Consortium [11].  A large number of 
ZFAs selected using OPEN have been published, most of which are functional.  Further, 
the fingers comprising these ZFAs have greatly expanded the number of ZFs known to 
bind specific target sequences.   
In order to provide researchers with up-to-date information on ZFs and ZFAs 
generated by the Consortium, we created a web-accessible database (ZiFDB) [12].  In 
addition to the four collections of fingers and the OPEN ZFAs described above, we also 
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collected ZFs and ZFAs from the literature.  ZiFDB currently contains 877 ZFs and 759 
ZFAs.  The information for a ZF includes the DNA sequence of the target triplet, amino 
acid sequence of the recognition helix, amino acid sequence of the entire ZF, position of 
the ZF within a three finger array (if applicable), source of the ZF, and article or 
experiment that indicates its source.  The information for a ZFA includes identification 
numbers for its fingers, the binding subsites, the recognition helices and the article and/or 
experiment that describes its performance.  For many researchers, ZiFDB is a valuable 
tool for both determining whether a given ZFA (or portion thereof) has previously been 
constructed and whether or not it has the requisite DNA-binding activity for their 
experiments.  ZiFDB is also proving to be a valuable resource for those interested in 
understanding how zinc finger proteins recognize DNA sequences.  
USING ZINC FINGER RESOURCES TO BETTER UNDERSTAND 
ZF/DNA INTERACTIONS AND TO IMPROVE ZF ENGINEERING 
The rapidly expanding collections of ZFs and the ZFAs provide a unique 
opportunity to better understand how zinc finger proteins recognize DNA.  Such 
information also should make it possible to improve methods for zinc finger protein 
engineering.  OPEN uses predefined master libraries (pools) for each triplet at a specific 
position in a three finger array.  We sequenced 68 OPEN pools using 454 pyro-sequencing 
and compared the ZFs in the pools to the ZFs in the more than 1000 OPEN arrays generated 
to date.  Our analysis revealed several important rules regarding how ZFs bind to DNA: 
For a given nucleotide, there is typically only one or at most a few different contact 
amino acids that provide specificity.  Although the amino acids for non-contact positions 
are more diverse than those for contact residues, only one or a few amino acids 
predominate.  
Aspartic acid at position +2, which mediates recognition of a fourth base in the 
target, only occurs in fingers for the target triplet GNG. Although other examples of 
so-called ‘target site overlap’ (TSO) may exist, it has been assumed that only the extended 
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DNA recognition conferred by aspartic acid at position +2 is a hindrance to modular 
assembly [13].  Because this example of TSO only occurs when the adjacent nucleotide is 
A or C, TSO should not be a problem for modular assembly if GNG subsites are avoided 
with an adjacent A or C.  
The charge of the contact residues and the charge of the non-contact residues are 
affected by the target base composition, and they are inversely related.  That is, as the 
number of purines in the target subsite increases, the total positive charge of the contact 
residues increases, whereas the total charge of the non-contact residues becomes more 
negative.  
There is clear evidence for a finger position effect. First, there are no common 
fingers among the pools for the same triplet at different positions in a three finger array.  
Secondly, the optimal contact amino acids are often different for fingers that bind the same 
triplet at different positions in a ZFA.  For example, contact amino acids at position +3 for 
fingers specifying GCN, GGN and GTN are different at F1 from those at F2 and F3.  
Similarly, contact amino acids at position -1 for GNT at F1 differ from F2 and F3. This 
difference may result from the end-effect described for the ZFA-DNA complex [14].  
Finally, we were able to obtain some evidence that ZFA engineering can be 
improved using the data derived from the analysis of the OPEN pools and OPEN arrays.  
For example, in several previously constructed, non-functional ZFAs, we replaced the 
contact amino acids with consensus residues identified from analysis of the OPEN arrays.  
Two of the six ‘corrected’ ZFAs were shown to have DNA binding activity.  We believe 
that the information obtained from our studies can be more fully exploited to aid in the 
engineering of zinc finger proteins by helping 1) to decide which binding sites to choose, 2) 
to streamline OPEN selections and 3) to increase the success rate of modular assembly. 
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FUTURE DIRECTIONS 
Experimental tests 
For each GNN triplet at a defined position, a single finger will be designed using the 
optimal amino acids we describe for each residue in the recognition helix.  The amino acid 
composition of the recognition helix will be fine tuned using the rules that define the 
optimal total charge of the contact and non-contact residues as dictated by the base 
composition of the target.  The function of the optimized fingers will be tested in both 
“homoarrays” (a three finger array composed of only the finger of interest) and in 
“heteroarrays” that recognize target sequences with varying subsite composition.  These 
experiments should directly test the validity of the rules we describe and the likelihood that 
these rules can aid in ZF engineering. 
Computational tests 
For each GNN triplet, a set of fingers will be designed using the top three consensus 
amino acids for each contact position and the consensus amino acids for each non-contact 
position.  A supervised machine learning method will be used to test the likelihood that the 
designed zinc fingers are optimal. Since the OPEN pools were generated by selecting 
randomized libraries at low stringency, these fingers will be considered “good” fingers. 
Theoretically, fingers in the OPEN arrays that were obtained using high stringency 
selections with the recombined pool libraries should be “better” than those in the pools. 
Supervised machine learning will be used to test whether the designed fingers will be 
classified into the “better” class. 
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APPENDIX A. HIGH-FREQUENCY MODIFICATION OF 
PLANT GENES USING ENGINEERED ZINC-FINGER 
NUCLEASES 
A paper published in Nature 2009 
 
Jeffrey A. Townsend, David A. Wright, Ronnie J. Winfrey, Fengli Fu, Morgan L. 
Maeder, J. Keith Joung, & Daniel F. Voytas 
 
ABSTRACT  
An efficient method for making directed DNA sequence modifications to plant 
genes (gene targeting) is at present lacking, thereby frustrating efforts to dissect plant 
gene function and engineer crop plants that better meet the world’s burgeoning need for 
food, fiber and fuel. Zinc-finger nucleases (ZFNs)—enzymes engineered to create DNA 
double-strand breaks at specific loci—are potent stimulators of gene targeting1,, 2; for 
example, they can be used to precisely modify engineered reporter genes in plants3,4. Here 
we demonstrate high-frequency ZFN-stimulated gene targeting at endogenous plant genes, 
namely the tobacco acetolactate synthase genes (ALS SuRA and SuRB), for which specific 
mutations are known to confer resistance to imidazolinone and sulphonylurea herbicides5. 
Herbicide-resistance mutations were introduced into SuR loci by ZFN-mediated gene 
targeting at frequencies exceeding 2% of transformed cells for mutations as far as 1.3 
kilobases from the ZFN cleavage site. More than 40% of recombinant plants had 
modifications in multiple SuR alleles. The observed high frequency of gene targeting 
indicates that it is now possible to efficiently make targeted sequence changes in 
endogenous plant genes. 
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RESULTS AND DISCUSSION 
ZFNs were engineered that recognize SuR loci, using publicly available resources 
provided by the Zinc Finger Consortium6,7. The Consortium-sponsored ZFN architecture 
uses two zinc-finger arrays (ZFAs), each with three zinc-fingers that collectively 
recognize a 9 base pair (bp) target site (Supplementary Fig. 1a). The ZFAs are fused to a 
FokI nuclease domain, and a 5–7 bp spacer separates the target sites for the two arrays, 
allowing the nuclease to dimerize and cleave within the spacer. ZFA engineering is most 
robust for G-rich sequences8, and four such target sites were selected in SuRB for 
constructing ZFAs by modular assembly, namely the joining together of individual 
zinc-fingers with predetermined specificities (sites 815, 1071, 1853 and 1947) (Fig. 1a, 
Table A.S1)9. Thirty two ZFAs were constructed, and electrophoretic mobility shift 
assays identified three arrays with DNA binding activity, two of which bind half sites for 
the 815 target. This low success rate is consistent with previous findings that ZFAs 
constructed by modular assembly are often non-functional8. 
Oligomerized pool engineering (OPEN)—a method developed by the 
Consortium—uses genetic selections in bacteria to identify ZFA variants that recognize 
specific target sequences6 (Supplementary Fig. 1b). ZFAs made by OPEN typically show 
higher activity than those made by modular assembly, probably because the process of 
selection accommodates context-dependent interactions among neighboring zinc-fingers 
in the array6,10,11. OPEN was used to generate ZFNs for four sites (sites 865, 1853, 1947, 
2163), including two that had been targeted by modular assembly (Table A.S2). 
Functional left and right ZFAs were obtained for the 1853 target, for which modular 
assembly had failed, as well as for target 2163. The OPEN-derived ZFAs showed activity 
in bacterial two-hybrid assays7, in which binding of ZFAs upstream of a lacZ reporter 
gene activates expression (Table A.S2). 
To test whether the ZFAs function as ZFNs, an assay was developed that 
measures ZFN activity in yeast (Supplementary Fig. 2a). This assay uses a lacZ reporter 
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gene with a 125 bp internal DNA sequence duplication. The ZFN target site is cloned 
between the duplicated sequences, and cleavage of the target site creates a functional lacZ 
gene through repair of the break by single strand annealing. ZFN activity is assessed by 
quantitative measurements of ß-galactosidase activity. The six ZFAs for the 815, 1853 
and 2163 target sites functioned effectively as ZFNs (Fig. 2a). The 815 left and 1853 right 
arrays showed the most activity, comparable to activity observed with a ZFN designed 
from the well-characterized Zif268 ZFA2. 
ZFNs were tested against their endogenous targets in tobacco by measuring 
whether they create mutations by non-homologous end-joining (NHEJ) (Supplementary 
Fig. 2b). ZFN-encoding constructs were electroporated into tobacco protoplasts, and the 
relevant target sites in SuRA and SuRB were amplified by PCR and subjected to 
high-throughput pyrosequencing12. The fraction of unique sequence reads showing 
size-polymorphisms (consistent with imprecise repair by NHEJ) was normalized to 
controls (Fig. 2b, Table A.S3). Mutation frequencies were significantly higher for ZFN 
815 at both SuR loci. Interestingly, the high-estmutation frequencies were not at the 
intended target in SuRB, but rather at the corresponding sequence in SuRA, which differs 
by two nucleotides. Not only does the ZFN 815 (which was created by modular assembly) 
lack specificity, but the higher level of mutagenesis at SuRA relative to SurB suggests that 
other factors, such as chromatin or DNA methylation, influence access of this enzyme to 
target sites. In contrast to ZFN815, the OPEN-designed ZFN 1853 only showed enhanced 
mutagenesis at its intended SuRB target, which differs in sequence from the SuRA site by 
a single nucleotide. This suggests that the genetic selections used in OPEN yield ZFNs 
with high specificity. No enhancement of mutagenesis was observed with ZFN 2163. 
To measure whether the engineered ZFNs could stimulate incorporation of 
specific DNA sequence changes at SuR loci by homologous recombination (HR) 
(Supplementary Fig. 2b), three donor templates were constructed, each with a missense 
mutation that confers resistance to one or more herbicides (P191A, chlorsulphuron; 
S647T, imazaquin;  
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Figure A.1 The tobacco SuRB locus. a, This diagram is drawn to scale and annotated with 
ZFN sites, Figure A.1 continued | amino substitutions that confer herbicide resistance, 
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PCR primers used to characterize recombinants, and the region used as a donor template. 
b, Sequences at the sites of introduced mutations. The targeted amino acid is underlined, 
|as are sequences in SuRA that differ from SuRB and silent nucleotide changes in the 
donor template that distinguish recombinants from spontaneous mutants. c, ZFN target 
sites. ‘Left’ and ‘right’ denote bases recognized by each ZFA. Underlined bases are either 
SuRA sequences that differ from SuRB or mutated bases in the donor (bottom row) that 
prevent cleavage by the ZFN. 
 
W568L, chlorsulphuron and imazaquin)5,13 (Fig. 1a). Silent nucleotide changes were 
introduced into codons adjacent to each mutation to distinguish the donor template from 
the native locus and spontaneous mutants from those generated by recombination (Fig. 
1b). An additional set of donor templates was made in which the ZFN recognition sites 
were altered to prevent cleavage (Fig. 1c). To test for gene targeting by HR, plasmids 
encoding the 815 ZFNs were electroporated into tobacco protoplasts with donor templates 
bearing the P191A, W568L or S647T mutations (Table 1, rows 1–3). The 
meanZFN-induced herbicide resistance ranged from 5.3% for the P191A donor to 
2.4%for the S647T donor. Both SuRA and SuRB were PCR-amplified from 12 randomly 
selected resistant calli derived from each treatment, using primers specific for the target 
locus (Fig. 1a). DNA sequence analysis revealed that in 9 of 12 lines generated with both 
the P191A and W568L donor template, resistance was due to HR (P191A: 5 in SuRA and 
4 in SuRB; W568L: 4 at SuRA, 5 at SuRB) (Table 2, rows 1-3, Table A.S4). With the 
S647T donor template, only 1 of the 12 herbicide resistant lines had evidence of HR (at 
SuRA) and nine were spontaneous SuRB mutants. For 8 of the 36 resistant lines in the 
gene targeting experiments, no mutations were observed in SuRA or SuRB, and so the 
molecular basis for the resistance is unknown. This resistance could be due to genotypic 
and phenotypic variation (somoclonal variation) typically observed when plant cells are 
grown in culture14. Based on the number of recombinants recovered, the estimated gene 
targeting frequencies range from 4.0% for P191 to 0.2% for S647 (Table 1). 
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One surprising outcome of the above experiment was that gene targeting 
frequencies exceeding 2% were obtained at a distance more than 1.3 kilobases (kb) from 
the cleavage site. This suggests that plant genes can be modified even when DNA 
sequence composition precludes engineering ZFNs near the desired site of  
 
Figure A.2 Activity of engineered ZFAs a, ZFAs as stimulators of recombination in yeast. 
Target sites for each ZFA are listed in vertical text below the chart; H, high-copy plasmid; 
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L, low-copy plasmid. Error bars denote s.d.; Figure A.2 continued | n53. b,  Engineered 
ZFNs as stimulators of mutagenesis by NHEJ in tobacco. ZFNs were expressed in 
protoplasts, and the SuRA and SuRB target sites were analysed by pyrosequencing. The 
number of sequences with insertions/deletions (indels) was divided by the total number of 
reads for a given target and normalized to a Zif268 |control. Values above the x axis 
indicate a higher proportion of sequences with indels than the control. Error bars denote 
95% confidence intervals; n=4. 
 
modification. The high frequencies of recombination observed at both SuRA and SuRB 
with ZFN 815 are consistent with the pyrosequencing data indicating that this enzyme 
cuts promiscuously at both targets (Fig. 2b). SuRA and SuRB differ at the nucleotide 
sequence level by 4% (ref. 5), and it is notable that high-efficiency gene targeting could 
be achieved at SuRA using the SuRB-derived donor template. 
We next tested the ability of the 1853 and 2163 ZFNs to stimulate HR and 
incorporate amino acid sequence changes near their respective target sites.Donor 
templates were used with mutations in the ZFN target site that prevent cleavage. ZFN 815 
was used as a control, and the mutated donor did not substantially alter the overall 
frequency of herbicide resistance or gene targeting (Table 1, compare rows 1 and 4). The 
mutated P191A donor template did, however, cause an increase in the proportion of gene 
targeting events at SuRB relative to SuRA (Table 2, compare rows 1 and 4). Why inability 
to cleave the donor template influences the outcome of recombination is unclear. For the 
1853 ZFN, the mean number of herbicide resistant events at W568L (281 bp from the cut 
site) was 0.6% (Table 1, row 5), more than fivefold lower than gene targeting observed 
with ZFN 815 at much greater distances from the cut site. The 2163 ZFN yielded only 
three, non-targeted herbicide resistant calli in twelve separate experiments, two of which 
had mutations at sites in SuRB previously known to confer herbicide resistance13 (Table 
A.S5 and data not shown). The activity of all three ZFNs in HR parallels activities of 
these enzymes in the yeast and NHEJ assays (Fig. 2). Among the 47 herbicide resistant 
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calli analysed in the various gene targeting experiments, 19 (40.4%) showed 
modifications at multiple SuR loci, including mutations introduced by NHEJ at the ZFN 
cleavage site (Supplementary Tables 4 and 5). This indicates that 
 
Table A.1 Gene targeting frequencies of SuRA and SuRB. 
Number herbicide resistant 
Row ZFN Donor 
DNA1 
Distance 
to 
mutation Neg. 
control 
Pos. 
control 
ZFN + 
donor2 
Freq. 
ZFN-induced 
resistance3 
Freq. gene 
targeting4 
1 815 P191A 188 bp 0 3461 184 5.3% 4.0% 
2 815 W568L 1319 bp 0 2217 75 3.4% 2.6% 
3 815 S647T 1541 bp 0 3600 88 2.4% 0.2% 
4 815 P191A-m 188 bp 0 1804 46 2.5% 2.4% 
5 1853 W568L-m 281 bp 0 1577 10 0.6% 0.5% 
1The letter m in columns 4 and 5 denotes donors with mutated ZFN recognition sites. 
2Values are the mean resistant calli obtained in three separate experiments. 
3Values are the mean resistant calli divided by the number of transformed cells (based on data obtained from the 
positive control construct) and expressed as a percentage. 
4Values are the percentage of ZFN-induced herbicide resistance adjusted according to the frequency of HR as 
determined through molecular analyses of randomly sampled calli (Table 2). 
 
Table A.2 Molecular basis for herbicide resistance in gene targeting experiments 
SuRA SuRB 
ZFN target Mutation site ZFN target Mutation site 
Row ZFN 
 
Donor 
DNA 
NHEJ 
indels/ 
alleles 
examined 
HR events/
alleles 
examined 
Spont. 
mutants/ 
alleles 
examined 
NHEJ indels/ 
alleles 
examined 
HR events/ 
alleles 
examined 
Spont. 
mutants/ 
alleles 
examined 
1 815 P191A 0/24 5/24 0/24 8/24 4/24 0/24 
2 815 W568L 0/24 4/24 0/24 3/24 5/24 0/24 
3 815 S647T 0/24 1/24 0/24 2/24 0/24 9/24 
4 815 P191A-m 3/36 0/36 0/36 3/36 20/36 1/36 
5 1853 W568L-m 0/22 0/22 1/22 2/22 9/22  1/22 
NHEJ-induced mutations, HR events, and spontaneous (Spont.) mutations are expressed in terms of the number of alleles 
of SuRA or SuRB analyzed (compiled from Supplementary Tables 4 and 5).  Note that some plants sustained HR at more 
than one allele and that herbicide resistant somaclonal variants were recovered with no mutations in SuRA or SuRB.  The 
letter m in columns 4 and 5 denotes donors with mutated ZFN recognition sites. 
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transformed cells that sustain a ZFN-induced modification often incur changes at 
multiple alleles. Ten plants were regenerated fromherbicide resistant calli and shown 
to carry the SuRA and SuRB mutations (Supplementary Tables 4 and 5), indicating 
that ZFN-assisted gene targeting can be used to engineer genetically modified whole 
plants. 
Based on the high frequency of gene targeting observed at SuRA and SuRB, 
we reasoned that populations of cells transformed with ZFNs might be screened 
directly for gene targeting events. To test this, protoplasts were transformed with 
plasmids encoding the 815 ZFN, the P191A donor template, as well as a neomycin 
phosphotransferase II (NPTII) gene that confers resistance to kanamycin. In this 
experiment, NPTII was used merely to identify cells that had been transformed. 
Approximately 1,000 transformed cells were transferred to media with herbicide, and 
two calli displayed herbicide resistance, both of which carried mutations introduced 
by the donor template (Table A.S4). Although this experiment identified HR events at 
the SuR loci by examining herbicide resistance, its success suggests that screens, 
perhaps using high throughput DNA sequencing, could be used to identify 
recombinants among populations of transformants for any genetic modification 
introduced by recombination, regardless of whether a selection exists for its 
associated phenotype. 
Current methods for modifying plant genomes are limited to decades-old 
methods of DNA transformation that lack precision and control over the outcome of 
the modified chromosome. Plant biologists have long sought a method to make 
directed mutations in plant genes with high efficiency, as evidenced here with the use 
of ZFNs. Gene targeting offers numerous opportunities for studying plant gene 
function, and it also enables biosynthetic pathways to be harnessed to better produce 
much-needed plant-derived products. The ability to engineer highly functional ZFNs 
using publicly available reagents and to recover HR-induced mutations even at 
considerable distances fromthe ZFNcleavage sitedemonstrates that 
targetedmutagenesis in plants is now practical. 
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METHODS SUMMARY 
ZFA engineering and testing. Engineering of ZFAs by modular assembly or 
OPEN followed established protocols6,7. Assessments of ZFA function are described 
in greater detail in Supplementary Information and are summarized in Table A.S6. 
Plant cell transformation and culture. Tobacco protoplasts were prepared 
from aseptically grown plants and transformed by electroporation as previously 
described4. Before transformation, donor, ZFN-, and NPTII-encoding DNAs were 
linearized by digestion with BglI, AlwNI, or FspI, respectively. Electroporation 
experiments used 20 mg each of donor template and ZFN-encoding DNA. 
Chlorsulphuron (5 p.p.b.) and imazaquin (0.5 p.p.m.) were used for selection, the 
former for the P191A and W568L donor templates and the latter for the S647T donor. 
Transformation frequencies were assessed using SuRB genes with herbicide resistance 
mutations. Numbers of resistant calli were scored 30 days post treatment. All of the 
gene targeting experiments used obligate heterodimeric FokI domains fused to the left 
and right ZFAs15,16. Experiments with homodimeric (wildtype) FokI domains reduced 
plating efficiency relative to experiments with the heterodimeric domains, and no 
gene targeting events were recovered, consistent with high levels of ZFN-induced 
toxicity (Table A.S7). 
Characterization of recombinant plant material. DNA was isolated from 
calli with the PowerPlant DNA isolation kit (Mo Bio Laboratories). The entire coding 
regions of both SuRA and SuRB were PCR-amplified using primers specific to the 5’ 
end of each gene and a common 3’ primer (Fig. 1a). The Expand Long Template PCR 
System (Roche) was used to ensure fidelity of the PCR reactions and to minimize 
strand transfers during amplification. PCR products were sequenced in their entirety 
to identify mutations that confer herbicide resistance and modifications at the ZFN cut 
site. 
Full Methods and any associated references are available in the online version 
of the paper at www.nature.com/nature. 
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SUPPLEMENTARY DATA 
Figure A.S1 Supplementary Figure 1 
Townsend et al.  
 
Legend. A) ZFN architecture. Two engineered zinc finger arrays (ZFAs) recognize 
two 9 bp target sequences. The target sites are separated by a spacer of 5-7 bp. 
Binding of the ZFAs to the target sequences enables the FokI nuclease monomers to 
dimerize and cleave within the spacer. B) The OPEN (Oligomerized Pool Engineering) 
platform, a combinatorial-based selection method for making zinc finger arrays 
(Maeder et al., Mol. Cell, 31:294). OPEN selections use an archive of pre-selected 
zinc finger pools, each containing a collection of fingers targeted to a different three 
base pair subsite at a defined position within the context of a three-finger protein. A 
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total of 192 finger pools (64 potential three bp subsites for each position in a 
three-finger protein) are required to fully enable OPEN. To date, the Zinc Finger 
Consortium has created pools (each containing a maximum of 95 different fingers) 
Figure A.S1 legend | continued targeted to 66 subsites (48 GNN subsites and 18 
TNN subsites (Maeder et al., Mol. Cell, 31:294)). To perform an OPEN selection for 
a target site, appropriate finger pools from the archive are recombined to create a 
small library of variants (953 = 8.6 x 105 members for a three-finger domain). This 
library is then interrogated using a bacterial two-hybrid (B2H) selection system in 
which binding of a zinc-finger domain to its cognate site activates expression of 
selectable marker genes (Hurt et al., Proc. Natl. Acad, Sci. USA, 100:12271; 2003; 
Joung et al., Proc. Natl. Acad, Sci. USA, 97:7382; Maeder et al., Mol. Cell, 31:294). 
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Figure A.S2 Supplementary Figure 2 
Townsend et al.  
 
 
Legend. A) Schematic of the yeast assay for testing ZFN function. Details are provide 
in the text and in the Supplementary Materials and Methods provided online. SSA, 
single-strand annealing. B) Gene modification with ZFNs. The left figure depicts the 
use of ZFNs to introduce mutations through imprecise repair of chromosome breaks 
by non-homologous end-joining (NHEJ). The right figure depicts the use of a donor 
template to introduce mutations at the cleavage site through repair by homologous 
recombination (HR). 
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Table A.S1 Zinc finger arrays selected by modular assembly. 
 
Site 
Name 
ZFA Name 
Target  
Sequence 
F1 subsite & 
RH sequence
F2 subsite & 
RH sequence
F3 subsite & 
RH sequence 
EMSA 
   GTA GTG GAC  
815L pDW1598 tGACGTGGTAg QSGALTR RSDALSR DRSNLTR - 
815L pDW1598CF tGACGTGGTAg QSGELVR RSDALSR DRSTLER - 
815L pDW1598DF tGACGTGGTAg QSSSLVR RSDALSR DRSTLER - 
815L pDW1598CE tGACGTGGTAg QSGELVR RSDALSR DRSTLER - 
815L pDW1598DE tGACGTGGTAg QSSSLVR RSDALSR DPGNLVR - 
815L *pRW128 tGACGTGGTAg QSSSLVR RSDELVR DPGNLVR + 
   GTG GTG AGG  
815R pDW1596 cAGGGTGGTGt RSDALTR RSDALSR RSDHLSQ - 
815R pDW1596A cAGGGTGGTGt RSDALTR RSDALSR RSDHLTN - 
815R pDW1596B cAGGGTGGTGt RSDALTR RSDALSR RSDHLAE - 
815R *pDW1596Q3 cAGGGTGGTGt RSDALTR RSDALSR RSDHLSQ - 
815R *pDW1596R6 cAGGGTGGTGt RSDALTR RSDALSR RSDHLTN - 
815R *pDW1596S4 cAGGGTGGTGt RSDALTR RSDALSR RSDHLAE - 
815R pDW1683 cAGGGTGGTGt RSDALTR RSDALSR RSDKLNR - 
815R pDW1684 cAGGGTGGTGt RSDALTR RSDALSR RSDHLKT - 
815R pDW1687 cAGGGTGGTGt RSDALTR RSDALSR RSDHLTQ - 
815R pDW1688 cAGGGTGGTGt RSDALTR RSDALSR RSDHLKT - 
815R pDW1689 cAGGGTGGTGt RSDALTR RSDALSR RSDKLNR - 
815R *pRW129 cAGGGTGGTGt RSDELVR RSDELVR RSDHLTN + 
   ATA GAG AAC  
1071L pPJ1 tAACGAGATAa QKSSLIA RSDNLVR DSGNLRV - 
   GAT GAG GTA  
1071R pPJ2 cGTAGAGGATa TSGNLVR RSDNLVR QSSSLVR - 
   GCC GCT GGT  
1853L pDW1597 tGGTGCTGCCc ERGTLAR QSSDLTR TSGHLTR - 
1853L pDW1597GI tGGTGCTGCCc DCRDLAR QSSDLTR TADKLSR - 
1853L pDW1597GJ tGGTGCTGCCc DCRDLAR QSSDLTR TQGGLAR - 
1853L pDW1597GK tGGTGCTGCCc DCRDLAR QSSDLTR TSGSLAR - 
1853L pDW1597HI tGGTGCTGCCc GCRELSR QSSDLTR TADKLSR - 
1853L pDW1597HJ tGGTGCTGCCc GCRELSR QSSDLTR TQGGLAR - 
1853L pDW1597HK tGGTGCTGCCc GCRELSR QSSDLTR TSGSLAR - 
1853L *pRW130 tGGTGCTGCCc DCRDLAR TSGELVR TSGHLVR - 
   GCT GCT TGG  
1853R pDW1599 gTGGGCTGCTc QSSDLTR QSSDLTR RSDHLTT - 
1853R *pRW131 gTGGGCTGCTc TSGELVR TSGELVR RSDHLTT - 
   GGC GCG GCA  
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Table A.S1 coninued 
1947L *pFF24 aGCAGCGGGCa DPGHLVR RSDDLVR QSGDLRR + 
1947L pFF32 aGCAGCGGGCa DRSHLTR RSDDLQR QSGDLTR - 
ZFAs used for in vivo experiments are in bold. The SP1 backbone (Liu et al., J. Biol. Chem., 277:3850) was used for 
all ZFAs with the exception of those marked with an asterisk, for which the SP1C backbone was used (Segal et al., 
Proc. Natl. Acad. Sci. USA, 96:2758).  RH, recognition helix; EMSA, Electrophoretic Mobility Shift Assay. 
 
Table A.S2 Zinc finger arrays selected by OPEN. 
Site Name ZFA Name Target Sequence 
F1 subsite & 
RH sequence 
F2 subsite & 
RH sequence 
F3 subsite & 
RH sequence 
Mean B2H 
fold-activation
   GGC GGT GCC  
865L OZ442 aGCCGGTGGCg RPDHLAR LGHHLVR DPSNLRR 7.49 + 0.48 
865L OZ443 aGCCGGTGGCg VPSKLKR EAHHLSR DPSNLRR 7.40 + 0.86 
865L OZ444 aGCCGGTGGCg APSKLDR LPHHLQR DPSNLRR 7.53 + 0.38 
865L OZ445 aGCCGGTGGCg APSKLDR EAHHLSR DPSNLRR 7.18 + 0.31 
865L OZ446 aGCCGGTGGCg SKHKLER LPHHLQR DPSNLRR 7.33 + 0.67 
   TGC GTT GGC  
865R OZ447 cGGCGTTTGCa RHRNLQL HESSLVR DPSHLPR 0.78 + 0.02 
865R OZ448 cGGCGTTTGCa RTRNLTI TNSSLTR KNISLNH 0.71 + 0.03 
865R OZ449 cGGCGTTTGCa RTRNLVL HASSLTR KNVSLTH 0.84 + 0.13 
865R OZ450 cGGCGTTTGCa RQRNLAL TAHSLMR KNISLNH 0.87 + 0.04 
865R OZ451 cGGCGTTTGCa RARNLTL VASSLVR DPSHLPR 0.84 + 0.17 
865R OZ452 cGGCGTTTGCa RHRNLQL HAESLTR KKMTLRN 0.84 + 0.03 
   GCC GCT GGT  
1853L OZ402 tGGTGCTGCCc HRRDLDR LSQTLKR LTQGLRR 6.63 + 0.11 
1853L OZ403 tGGTGCTGCCc VRKDLDR LSQTLKR LVHGLNR 5.75 + 0.38 
1853L OZ404 tGGTGCTGCCc DGSTLNR LSQTLNR IKHHLGR 6.98 + 0.36 
1853L OZ405 tGGTGCTGCCc HRRDLDR LSQTLNR MNHGLAR 8.31 + 0.68 
1853L OZ406 tGGTGCTGCCc VRKDLVR LSQTLKR VKHGLTR 4.88 + 0.05 
1853L OZ407 tGGTGCTGCCc KSRDLAR LSQTLKR IKHHLGR 4.99 + 0.26 
1853L OZ408 tGGTGCTGCCc DLSTLRR LSQTLKR HTHHLGR 10.13 + 0.26 
1853L OZ409 tGGTGCTGCCc DESTLRR LSQTLKR VKHGLGR 7.80 + 0.43 
1853L OZ410 tGGTGCTGCCc LGKDLVR LSQTLKR LSQGLAR 2.22 + 0.17 
1853L OZ411 tGGTGCTGCCc HSRDLRR LSQTLRR VKHGLTR 6.06 + 0.36 
1853L OZ412 tGGTGCTGCCc DGSTLRR LSQTLKR MNHGLAR 7.85 + 0.53 
1853L OZ413 tGGTGCTGCCc HSRDLHR LSQTLKR IRHHLKR 7.28 + 0.56 
   GCT GCT TGG  
1853R OZ414 gTGGGCTGCTc TKQVLDR LSQTLNR RVDHLGG 5.49 + 0.51 
1853R OZ415 gTGGGCTGCTc TAQTLTR LSQTLKR RMDHLAG 6.68 + 0.61 
1853R OZ416 gTGGGCTGCTc TKQVLDR LSQTLKR RMDHLAG 6.70 + 0.34 
1853R OZ417 gTGGGCTGCTc TKQVLDR LSQTLKR RVDHLGG 6.58 + 0.12 
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Table A.S2 continued 
   GGC GCG GCA  
1947L OZ418 aGCAGCGGGCa APSKLTR REDTLTR QGNTLTR 7.40 + 1.27 
1947L OZ419 aGCAGCGGGCa DRAKLTM RPDVLGR QKGDLGR 1.43 + 0.33 
1947L OZ420 aGCAGCGGGCa SKHKLER RDDTLVR QGGVLTR 6.14 + 0.59 
1947L OZ421 aGCAGCGGGCa SPSKLAR RADSLGR QGGVLTR 6.71 + 0.15 
1947L OZ422 aGCAGCGGGCa APSKLKR RTDVLTR QGGILTR 8.00 + 0.57 
1947L OZ423 aGCAGCGGGCa APSKLMR RMDTLGR QGGILTR 8.30 + 1.50 
1947L OZ424 aGCAGCGGGCa SPSKLAR RRDTLER QGGTLMR 5.74 + 0.44 
1947L OZ425 aGCAGCGGGCa APSKLDR RADSLGR QTATLKR 5.31 + 0.67 
1947L OZ426 aGCAGCGGGCa APSKLDR RPDVLTR QGGTLRR 7.08 + 0.65 
1947L OZ427 aGCAGCGGGCa APSKLDR RMDTLGR QTATLKR 6.74 + 0.41 
1947L OZ428 aGCAGCGGGCa APSKLDR REDTLTR QTATLKR 5.75 + 0.39 
       
1947R OZ429 gTGCGGCTGTt RRQHLTL LKEHLTR ANRTLGH 0.89 + 0.03 
1947R OZ430 gTGCGGCTGTt TRQKLTL EQQQLKR ANRSLGR 1.00 + 0.04 
1947R OZ431 gTGCGGCTGTt RKQHLLL EKGHLTR QQRSLVG 1.00 + 0.05 
1947R OZ432 gTGCGGCTGTt RKQHLVL GNRVLAA ANRTLVH 1.20 + 0.07 
1947R OZ433 gTGCGGCTGTt KRQHLVL ERQHLVR QQRSLVG 1.21 + 0.18 
1947R OZ434 gTGCGGCTGTt RNQHLMI ERGHLTR ANRTLVH 0.93 + 0.08 
1947R OZ435 gTGCGGCTGTt TRQKLTT QGGNLVR QQRSLVG 1.03 + 0.18 
1947R OZ436 gTGCGGCTGTt RQRNLAI EQSKLTR ANRTLVH 0.91 + 0.07 
1947R OZ437 gTGCGGCTGTt RKPLLIV ESSKLKR SARGLGV 2.04 + 0.30 
1947R OZ438 gTGCGGCTGTt RKQHLSL ERSKLQR QQRSLVG 1.18 + 0.02 
1947R OZ439 gTGCGGCTGTt RRQHLTL LPEHLKR QQRSLVG 1.07 + 0.03 
1947R OZ440 gTGCGGCTGTt SNRNLKI AASGLAG ANRTLVH 1.20 + 0.15 
1947R OZ441 gTGCGGCTGTt TKQVLDR LSQTLKR RTDGLGH 2.14 + 0.29 
   TTC GGA GAA  
2163L OZ391 aGAAGGATTCc RPNHLAI QSPHLKR QSNNLTR 8.40 + 0.29 
2163L OZ392 aGAAGGATTCc RPNHLTA QSAHLKR LGENLRR 5.74 + 0.34 
2163L OZ393 aGAAGGATTCc RPNHLAI QSPHLKR QSNNLTR 8.10 + 0.05 
2163L OZ394 aGAAGGATTCc RANHLTI QSAHLKR LGENLRR 6.41 + 0.87 
   GAT GGA GGC  
2163R OZ395 aGGCGGAGATc SQQALGV QSAHLKR ESGHLKR 1.70 + 0.23 
2163R OZ396 aGGCGGAGATc TKQHLAV QSAHLKR ESGHLRR 1.89 + 0.04 
2163R OZ397 aGGCGGAGATc SKQALAV QSAHLKR ENSKLRR 1.89 + 0.13 
2163R OZ398 aGGCGGAGATc TNQRLDV QNPHLTN KNVSLVG 0.89 + 0.02 
2163R OZ399 aGGCGGAGATc SKQALAV QSAHLKR ENSKLRR 1.74 + 0.07 
2163R OZ400 aGGCGGAGATc TKQHLAV QSAHLKR ESGHLRR 2.08 + 0.25 
2163R OZ401 aGGCGGAGATc SKQALAV QSAHLKR ESGHLKR 1.75 + 0.15 
ZFAs used for in vivo experiments are in bold. The Zif268 F2 backbone was used for each of the fingers in the OPEN (Maeder et al., 
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ZFAsTable A.S2 | continued Mol. Cell, 31:294).   RH, recognition helix; B2H, bacterial two-hybrid assay.  Standard deviation 
among three replicates is shown for B2H data. The 2163R B2H reporter gave high levels of background making it difficult to 
estimate the activity of the 2163R arrays. 
 
Table A.S3 Frequency of insertion/deletion polymorphism introduced at the ZFN 
target site. 
SuRA 
 ZFN1 Total seq. 
reads 
Seq. reads 
with insertions
Seq. reads 
with deletions
Insertions + 
deletions 
Insertions + 
deletions/total seq. 
reads 
Rep Ratio minus  
Zif268 Ratio2 
815 Rep1 2693 56 89 145 0.0538 0.0459 
815 Rep2 4566 110 165 275 0.0602 0.0523 
815 Rep3 3067 64 101 165 0.0538 0.0459 
815 Rep4 2913 59 81 140 0.0481 0.0401 
Zif268 20224 95 65 160 0.0079  
    Normalized Ratio: 0.0461 +/- 0.0049 
1853 Rep1 1318 48 91 139 0.1055 0.0338 
1853 Rep2 1386 60 53 113 0.0815 0.0099 
1853 Rep3 1234 39 68 107 0.0867 0.0151 
1853 Rep4 1680 42 68 110 0.0655 -0.0061 
Zif268 8057 341 236 577 0.0716  
    Normalized Ratio: 0.0132 +/- 0.0162 
2163 Rep1 2736 25 36 61 0.0223 0.0083 
2163 Rep2 2481 23 23 46 0.0185 0.0045 
2163 Rep3 2503 16 29 45 0.0180 0.0040 
2163 Rep4 2770 16 19 35 0.0126 -0.0014 
Zif268 15495 82 135 217 0.0140  
   Normalized Ratio: 0.0039 +/- 0.0039 
SuRB 
815 Rep1 33946 286 371 657 0.0194 0.0117 
815 Rep2 27370 205 207 412 0.0151 0.0074 
815 Rep3 36676 298 367 665 0.0181 0.0104 
815 Rep4 36354 265 334 599 0.0165 0.0088 
Zif268 22224 96 75 171 0.0077  
    Normalized Ratio: 0.0096 +/- 0.0019
1853 Rep1 14388 838 451 1289 0.0896 0.0410 
1853 Rep2 15238 736 329 1065 0.0699 0.0213 
1853 Rep3 13322 630 335 965 0.0724 0.0238 
1853 Rep4 16670 693 396 1089 0.0653 0.0167 
Zif268 6502 212 104 316 0.0486  
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Table A.S3 continued 
    Normalized Ratio: 0.0257 +/- 0.0104
2163 Rep1 30152 202 337 539 0.0179 -0.0004 
2163 Rep2 31526 252 328 580 0.0184 0.0001 
2163 Rep3 29409 231 351 582 0.0198 0.0015 
2163 Rep4 17409 143 183 326 0.0187 0.0005 
Zif268 16698 98 207 305 0.0183  
   Normalized Ratio: 0.0004 +/- 0.0008
1‘Rep’ refers to a replicate sample.  For each replicate, 106 protoplasts were transformed by electroporation with 30 µg 
of DNA encoding a given ZFN. 
2‘Rep ratio’ refers to the number of sequences with insertions and deletions divided by the total sequence reads 
obtained for a given sample.  This ratio was then subtracted from the ratio obtained for the Zif268 control.   
 
Table A.S4 Sequence analysis of SuRA and SuRB from resistant calli resulting from 
treatment with ZFN 815 and donor DNAs with mutations that confer herbicide 
resistance at varying distances from the 815 cut site. 
Callus1 Donor SuRA at ZFN 
target site 
SuRA at site of 
mutation 
SuRB at ZFN target site SuRB at site 
of mutation 
95.3.1 P191A 
pDW1963 
Both alleles WT Both alleles WT Both alleles WT Both alleles 
WT 
*95.3.2 P191A 
pDW1963 
Both alleles WT Both alleles WT Both alleles WT HR at one 
allele 
95.3.3 P191A 
pDW1963 
Both alleles WT HR at one allele 4 bp deletion at 815 cut site in 
one allele 
Both alleles 
WT 
95.3.4 P191A 
pDW1963 
Both alleles WT HR at one allele 3 bp deletion at cut site at one 
allele and a 1 bp insertion (C) 
at the other 
Both alleles 
WT 
95.3.5 P191A 
pDW1963 
Both alleles WT HR at one allele One allele has an insertion at 
the 815 cut site 
Both alleles 
WT 
95.3.6 P191A 
pDW1963 
Both alleles WT HR at one allele Both alleles WT Both alleles 
WT 
95.3.7 P191A 
pDW1963 
Both alleles WT Both alleles WT The allele without an HR 
event has a 4 bp deletion at the 
815 cut site 
HR at one 
allele 
95.3.8 P191A 
pDW1963 
Both alleles WT Both alleles WT Both alleles WT HR at one 
allele 
95.3.9 W568L 
pDW1963 
Both alleles WT Both alleles WT The allele without the HR 
event has a 5 bp deletion at the 
815 cut site 
HR at one 
allele 
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Table A.S4 continued 
95.3.10 P191A 
pDW1963 
Both alleles WT HR at one allele 1 bp insertion (C or A) at the 
815 cut site in one allele and 
an uncharacterized insertion at 
the 815 cut site in the other 
allele 
Both alleles 
WT 
95.3.11 P191A 
pDW1963 
Both alleles WT Both alleles WT Both alleles WT Both alleles 
WT 
95.3.12 P191A 
pDW1963 
Both alleles WT Both alleles WT Both alleles WT Both alleles 
WT 
      
95.6.1 W568L 
pDW1927 
Both alleles WT Both alleles WT Both alleles WT Both alleles 
WT 
95.6.2 W568L 
pDW1927 
Both alleles WT HR at one allele 2 bp insertion (AG) at 815 site 
in one allele 
Both alleles 
WT 
95.6.3 W568L 
pDW1927 
Both alleles WT HR at one allele Both alleles WT Both alleles 
WT 
*95.6.4 W568L 
pDW1927 
Both alleles WT Both alleles WT The allele without an HR 
event has an 11 bp deletion at 
the 815 cut site 
HR at one 
allele 
95.6.5 W568L 
pDW1927 
Both alleles WT Both alleles WT Both alleles WT HR at one 
allele 
95.6.6 W568L 
pDW1927 
Both alleles WT Both alleles WT Both alleles WT HR at one 
allele 
*95.6.7 W568L 
pDW1927 
Both alleles WT Both alleles WT The other allele has a 1 bp 
insertion (G) at the 815 cut site 
HR at one 
allele 
95.6.8 W568L 
pDW1927 
Both alleles WT HR at one allele Both alleles WT Both alleles 
WT 
*95.6.9 W568L 
pDW1927 
Both alleles WT HR at one allele Both alleles WT Both alleles 
WT 
95.6.10 W568L 
pDW1927 
Both alleles WT Both alleles WT Both alleles WT Both alleles 
WT 
95.6.11 W568L 
pDW1927 
Both alleles WT Both alleles WT Both alleles WT Both alleles 
WT 
*95.6.12 W568L 
pDW1927 
Both alleles WT Both alleles WT Both alleles WT HR at one 
allele 
95.7.1 S647T 
pDW1969 
Both alleles WT Both alleles WT Both alleles WT S647N 
spontaneous 
mutation 
95.7.2 S647T 
pDW1969 
Both alleles WT Both alleles WT Both alleles WT S647N 
spontaneous 
mutation 
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Table A.S4 continued 
95.7.3 S647T 
pDW1969 
Both alleles WT Both alleles WT Both alleles WT Both alleles 
WT 
95.7.4 S647T 
pDW1969 
Both alleles WT Both alleles WT 2 bp insertion (AG) at 815 
cut site in one allele 
Both alleles 
WT 
95.7.5 S647T 
pDW1969 
Both alleles WT Both alleles WT Both alleles WT A199V 
spontaneous 
mutation 
95.7.6 S647T 
pDW1969 
Both alleles WT Both alleles WT Both alleles WT A199V 
spontaneous 
mutation 
95.7.7 S647T 
pDW1969 
Both alleles WT Both alleles WT Both alleles WT A199V 
spontaneous 
mutation 
95.7.8 S647T 
pDW1969 
Both alleles WT Both alleles WT Both alleles WT S647N 
spontaneous 
mutation 
95.7.9 S647T 
pDW1969 
Both alleles WT Both alleles WT Both alleles WT S647N 
spontaneous 
mutation 
95.7.10 S647T 
pDW1969 
Both alleles WT Both alleles WT Both alleles WT S647N 
spontaneous 
mutation 
95.7.11 S647T 
pDW1969 
Both alleles WT Both alleles WT Both alleles WT S647N 
spontaneous 
mutation 
95.7.12 S647T 
pDW1969 
Both alleles WT HR at one allele 2 bp deletion in one allele Both alleles 
WT 
97.2.1 P191A 
pDW1963 
Both alleles WT Both alleles WT The allele without the HR 
event has a 5 bp deletion at 
the 815 cut site 
HR at one 
allele 
*97.4.1 P191A 
pDW1963 
Both alleles WT HR at one allele Both alleles WT Both alleles 
WT 
1The 95.3 series was generated with the P191A donor; the 95.6 series was generated with the W568L donor; the 95.7 
series was generated with the S647T donor.  The 97 series differs from the others in that transformed cells were first 
identified using an NPTII reporter gene, which was introduced along with ZFN 815 and the W568L donor.  The 
transformed cell population was then subjected to herbicide selection.  Asterisks denote those calli from which whole 
plants were regenerated and shown to carry mutations introduced by gene targeting. 
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Table A.S5 Sequence analysis of SuRA and SuRB from resistant calli resulting from 
treatment with ZFNs 815, 1853, 2163 and donor DNAs with mutations in the ZFN 
recognition site that prevent cleavage 
 
Callus ZFN Donor SuRA at ZFN 
target site 
SuRA at site of 
mutation 
SuRB at ZFN  
target site 
SuRB at site of 
mutation 
88.2.1 815 P191A-m 
pDW1964 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
815 target site 
HR at one allele
88.2.2 815 P191A-m 
pDW1964 
One SuRA allele 
has a 4bp 
deletion and an 
‘A’ insertion at 
the 815 breaksite
Both alleles WT Recombinant allele has 
mutations from donor at the 
815 target site 
HR at one allele
*88.2.3 815 P191A-m 
pDW1964 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
815 target site 
HR at one allele
88.2.4 815 P191A-m 
pDW1964 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
815 target site; other allele 
has a 5 bp deletion at the 
815 target site 
HR at one allele
*88.2.5 815 P191A-m 
pDW1964 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
815 target site 
HR at one allele
88.2.6 815 P191A-m 
pDW1964 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
815 target site 
HR at one allele
*88.2 .7 815 P191A-m 
pDW1964 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
815 target site 
HR at one allele
88.2.8 815 P191A-m 
pDW1964 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
815 target site 
HR at one allele
88.2 .9 815 P191A-m 
pDW1964 
One SuRA allele 
has a 1 bp 
insertion (G) at 
815 break site 
Both alleles WT Recombinant alleles have 
mutations from donor at the 
815 target site; one SuRB 
allele also has a ‘G’ 
insertion at the 815 target 
HR at both 
alleles 
88.2.10 815 P191A-m 
pDW1964 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
815 target site 
HR at one allele
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Table A.S5 continued 
86.2-11 815 P191A-m 
pDW1964 
Both alleles WT Both alleles WT Both alleles WT Spontaneous 
missense 
mutation 
(P196Q) 
86.2-12 815 P191A-m 
pDW1964 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
815 target site 
HR at one 
allele 
86.2-13 815 P191A-m 
pDW1964 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
815 target site 
HR at one 
allele 
86.2-14 815 P191A-m 
pDW1964 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
815 target site 
HR at one 
allele 
86.2-15 815 P191A-m 
pDW1964 
Seven bp deletion 
in SuRA 
(CACGAGC) 
Both alleles WT Recombinant allele has 
mutations from donor at the 
815 target site; the other 
allele has a 1 bp deletion 
HR at one 
allele 
86.2-16 815 P191A-m 
pDW1964 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
815 target site 
HR at both 
alleles 
86.2-17 815 P191A-m 
pDW1964 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
815 target site 
HR at one 
allele 
86.2-18 815 P191A-m 
pDW1964 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
815 target site 
HR at both 
alleles 
86.5.1 1853 W568L-m 
pDW1968 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
1853 target site 
HR at one 
allele 
86.5.2 1853 W568L-m 
pDW1968 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
1853 target site; other allele 
has a 5 bp deletion 
HR at one 
allele 
86.5.3 1853 W568L-m 
pDW1968 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
1853 target site 
HR at one 
allele 
*86.5.4 1853 W568L-m 
pDW1968 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
1853 target site 
HR at one 
allele 
86.5.5 1853 W568L-m 
pDW1968 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
1853 target site 
HR at one 
allele 
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Table A.S5 continued 
86.5.6 1853 W568L-m 
pDW1968 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
1853 target site; other allele 
has a 5 bp deletion 
HR at one 
allele 
86.5.7 1853 W568L-m 
pDW1968 
Both alleles WT One allele has a 
V193L 
spontaneous 
mutation 
Both alleles WT Both alleles 
WT 
86.5.8 1853 W568L-m 
pDW1968 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
1853 target site 
HR at one 
allele 
86.5.9 1853 W568L-m 
pDW1968 
Both alleles WT Both alleles WT Both alleles WT One allele 
has a V190L 
spontaneous 
mutation 
86.5.10 1853 W568L-m 
pDW1968 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
1853 target site 
HR at one 
allele 
86.5.24 1853 W568L-m 
pDW1968 
Both alleles WT Both alleles WT Recombinant allele has 
mutations from donor at the 
1853 target site 
HR at one 
allele 
       
86.7.1 2163 S647T 
pDW1969 
Both alleles WT Both alleles WT Both alleles WT One allele 
has a S647N 
spontaneous 
mutation 
86.10.1 2163 S647T-m 
pDW1972 
Both alleles WT Both alleles WT Both alleles WT One allele 
has a W568L 
spontaneous 
mutation 
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APPENDIX B. RAPID “OPEN-SOURCE” ENGINEERING 
OF CUSTOMIZED ZINC-FINGER NUCLEASES FOR 
HIGHLY EFFICIENT GENE MODIFICATION 
 
A paper published in Molecular Cell 2008 
 
Morgan L. Maeder, Stacey Thibodeau-Beganny, Anna Osiak, David A. Wright, 
Reshma M. Anthony, Magdalena Eichtinger, Tao Jiang, Jonathan E. Foley, Ronnie J. 
Winfrey, Jeffrey A. Townsend, Erica Unger-Wallace, Jeffry D. Sander, Felix Müller-Lerch, 
Fengli Fu, Joseph Pearlberg, Carl Göbel, Justin P. Dassie, Shondra M. Pruett-Miller, 
Matthew H. Porteus, Dennis C. Sgroi, A. John Iafrate, Drena Dobbs, Paul B. McCray, Jr., 
Toni Cathomen, Daniel F. Voytas, & J. Keith Joung 
   
SUMMARY 
Custom-made zinc-finger nucleases (ZFNs) can induce targeted genome 
modifications with high efficiency in cell types including Drosophila, C. elegans, plants, 
and humans. A bottleneck in the application of ZFN technology has been the generation of 
highly specific engineered zinc-finger arrays. Here we describe OPEN (Oligomerized Pool 
ENgineering), a rapid, publicly available strategy for constructing multi-finger arrays, 
which we show is more effective than the previously published modular assembly method. 
We used OPEN to construct 37 highly active ZFN pairs which induced targeted alterations 
with high efficiencies (1to 50%)at 11 different target sites located within three endogenous 
human genes (VEGF-A, HoxB13, CFTR), an endogenous plant gene (tobacco SuRA), and a 
chromosomally-integrated EGFP reporter gene. In summary, OPEN provides an 
“open-source” method for rapidly engineering highly active zinc-finger arrays, thereby 
enabling broader practice, development, and application of ZFN technology for biological 
research and gene therapy. 
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INTRODUCTION 
A reliable, publicly available method for creating targeted genome modifications 
with high efficiency would be broadly useful for biological research and gene therapy (1). 
Although strategies have been developed using viral vectors or short double-or 
single-stranded DNA molecules to direct homologous recombination (HR), these methods 
generally have low efficiencies even under optimal cell culture conditions (2). An 
alternative and more efficient strategy involves introducing a double-stranded break (DSB) 
into a target locus of interest. Repair of this DSB by cellular mechanisms greatly increases 
rates of HR-mediated gene targeting with an exogenous DNA molecule (3) or of gene 
mutation by error-prone non-homologous end-joining (NHEJ) (4). However, this approach 
depends on the capability to create “designer” nucleases targeted to specific genomic 
sequences of interest.  Engineered ZFNs are customized endonucleases that induce 
site-specific DSBs and genome modifications (as high as 50%) in Drosophila, somatic C. 
elegans, plant, and human cells (4-16). ZFNs function as dimers with each monomer 
composed of a non-specific cleavage domain from the FokI endonuclease fused to a 
zinc-finger array engineered to bind a target DNA sequence of interest (1,17,18). Because a 
single zinc-finger domain binds a 3 bp subsite, a ZFN dimer can recognize 18or 
24-bptargetsites, depending on the number of zinc-fingers in each ZFN monomer. Publicly 
available zinc-finger engineering methods described in the literature can be grouped into 
two general categories. “Modular assembly” involves joining together single fingers with 
pre-characterized specificities (19-23). Although easy to perform, modular assembly has an 
efficacy rate for making functional ZFN pairs that is less than 6% (24) and can yield ZFNs 
with low activities and/or high toxicities (25,26). Alternative approaches involve 
combinatorial selection-based methods that yield multi-finger domains possessing high 
DNA-binding affinities and specificities (27-29) and high activities and low toxicities 
when expressed as ZFNs in human cells (25,26). However, selection-based methods 
require construction and interrogation of large randomized libraries (typically >108in size) 
 161
and therefore remain intractable for all but a few labs that possess the required expertise.  
Here we describe the development and validation of OPEN (Oligomerized Pool 
ENgineering), a facile, robust, and publicly available platform for engineering zinc-finger 
arrays. OPEN is enabled by an archive of zinc-finger pools constructed by the Zinc Finger 
Consortium, a group of academic laboratories committed to developing engineered 
zinc-finger technology (http://www.zincfingers.org). The Consortium used OPEN to 
rapidly engineer 37 ZFN pairs which induce modifications at 11 different sites located 
within three endogenous human genes (VEGF-A, HoxB13, CFTR), an endogenous plant 
gene (tobacco SuRA), and the EGFP reporter gene with efficiencies ranging from 1 to 50%. 
The publicly available OPEN platform will enable routine practice and further 
development of ZFN technology. 
RESULTS 
OPEN - a rapid and robust strategy for engineering zinc-finger arrays OPEN 
selections require an archive of pre-selected zinc-finger pools, each containing a mixture of 
fingers targeted to a different three base pair subsite at a defined position within a 
three-finger protein (Figure B.1A and Experimental Procedures). Fully enabling OPEN 
will require 192 finger pools (64 potential three bp target subsites for each position in a 
three-finger protein). In this initial report, we created pools (each containing a maximum of 
95 different fingers) targeted to 66 subsites (48 GXX subsites and 18 TXX subsites; Figure 
B.1B). To perform an OPEN selection for a target site, appropriate finger pools from the 
archive are recombined to create a small library of variants (953=8.6 x 105members for a 
three-finger domain) which is interrogated using a bacterial two-hybrid (B2H) selection 
system in which binding of a zinc-finger domain to its cognate site activates expression of 
selectable marker genes (Figures B.1C & B.1D) (28,30). To simplify the identification of 
potential three-finger ZFN sites that can be targeted by OPEN, we created a new version of 
our web-based ZiFiT software (31), ZiFiT 3.0(Figure B.S1). 
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Figure B.1 OPEN Method for Engineering Zinc-finger Arrays. A) OPEN zinc-finger pool 
construction. Zinc-finger domains are shown as spheres and associated 3 bp subsites as 
rectangles. Randomized finger in the library is rainbow colored. Note that the figure 
illustrates how finger pools for the middle position in a three-finger domain were made, but 
that pools for amino- or carboxy-terminal fingers were also obtained by building libraries 
in which finger 1 or finger 3 were randomized, respectively (Experimental Procedures).  B) 
GXX and TXX target subsites for which finger pools have been constructed (highlighted in 
grey).  C) Schematic overview of OPEN selection for a target DNA site. Zinc-fingers and 
associated subsites represented as in (A). Details in Supplemental Experimental procedures. 
D) Schematic of the bacterial two-hybrid (B2H) system. ZFP = zinc-finger protein. X and 
Y = arbitrary interacting proteins. 
 
Comparing ZFNs made by modular assembly and OPEN 
To compare the efficacy of OPEN with modular assembly, we used both strategies 
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to construct multi-finger arrays for five sites in EGFP(ten “half-sites”; Figure B.S2, Tables 
B.S1 and B.S2) and assessed the DNA-binding activities of these proteins using a 
quantitative B2H assay(Supplemental Experimental Procedures). Zinc-finger arrays with 
high affinities and specificities activate transcription by more than three-fold in the B2H 
system (28). None of the modularly assembled arrays we tested activated transcription by 
more than three-fold (Figure B.2A) even though Western blots showed that all proteins 
were expressed (data not shown). By contrast, OPEN selections yielded at least one --in 
most cases many --zinc-finger protein that activated transcription by more than three-fold 
for 9 of the 10 target half-sites (Figure B.2A and Table B.S1).For each of the five full EGFP 
target sites, various pairs of modularly assembled and OPEN-selected ZFNs (Table B.S2) 
were tested in human cells using an assay in which repair of ZFN-induced DSBs by 
error-prone NHEJ leads to insertions and deletions in a chromosomally integrated EGFP 
gene (Figure B.2B). Modular assembly yielded ZFN pairs with activities above 
background for only one of the five sites (EG502) (Figure B.2C). By contrast, OPEN 
yielded ZFN pairs which were active for four of the five full ZFN target sites (EG223, 
EG292, EG382, and EG502). Although both methods produced active ZFN pairs for the 
EG502 site, the pairs made by OPEN were more active than those made by modular 
assembly (Figure B.2C). Western blots verified the expression of all ZFNs tested (data not 
shown). 
 
OPEN selection of zinc-finger arrays that bind to sequences in endogenous human 
and plant genes  
We used ZiFiT 3.0to identify 14 potential ZFN target sites in three endogenous 
human genes (VEGF-A, HoxB13, and CFTR) and one endogenous plant gene (tobacco 
SuRA) (Table B.S2 and Figure B.S2). OPEN selections were performed for the 28 
“half-sites” within these14 full ZFN target sites (Tables B.S1 and B.S2), and 24 of 28 were 
deemed successful (Table B.S1). Using a subset of these finger arrays (Table B.S2),  we 
constructed ZFN pairs for five sites in VEGF-A, four sites in HoxB13, one site in CFTR, 
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and one site in the SuRA gene. 
 
 
Figure B.2 OPEN ZFNs engineered to cleave EGFP gene sequences  A) Quantitative B2H 
assay of modular assembly (MA; red bars) and OPEN (green bars) zinc finger arrays. Mean 
fold-activation values (colored bars) and standard deviations (error bars) from three 
independent assays are shown. B) EGFP-disruption assay for testing ZFN activities in 
human cells.  C) Modularly assembled and OPEN ZFNs assessed using the 
EGFP-disruption assay. Error bars represent standard deviations. Single and double 
asterisks indicate p values <0.05 or <0.01, respectively. 
 
OPEN ZFNs induce highly efficient mutation of endogenous human and plant genes 
To test whether OPEN ZFNs induce mutations by NHEJ at endogenous human 
genes, we employed a CEL I nuclease-based mutation detection assay (Figure B.3A) (9,10). 
We found that all four VF2468 and all four VF2471 ZFN pairs we tested generated 
detectable mutations in the endogenous VEGF-Agene in human 293 cells (Figure B.3B). In 
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addition, mutations could be detected at the endogenous HoxB13gene in 293 cells for all 
ZFN pairs tested at the HX587, HX735 and HX761 sites (Figure B.3C). DNA sequencing 
of HoxB13alleles amplified from cells modified by HX587 ZFN pair B (Supplemental 
Experimental Procedures) revealed mutations at the expected location with an average 
frequency of 9.6% (Figure B.S3A). ZFN pairs targeted to three sites in the VEGF-Agene 
(VF3537, VF3542, VF3552) and to one site in the HoxB13gene(HX508) failed to induce 
detectable levels of mutation (Figure B.3B and C.3C). Due to polymorphisms at the CF877 
site in CFTR alleles of 293 cells, we could not assess the 8CF877 ZFN pairs using the CEL 
I assay (data not shown). However, DNA sequencing revealed ZFN-induced insertions at 
the CF877 cleavage site with an average frequency of 1.2% (Figure B.S3B). We also tested 
whether OPEN ZFNs induced mutations in endogenous plant genes. Tobacco protoplasts 
transformed with a construct encoding the SR2163 ZFN pair were regenerated into 
individual plants (Experimental Procedures). The SR2163 site is present in both SuRA and 
SuRB, and each plant was examined for evidence of cleavage at these loci using DNA 
sequencing. Among 66 transgenic plants surveyed, three had mutations in SuRA, all of 
which were deletions of a single base (Figure B.S3C). In one plant, both alleles of SuRA 
had the same deletion. No mutated alleles of SuRB were detected. This frequency of 
mutagenesis by NHEJ (~2% of potential target alleles) is comparable to what we observed 
for other OPEN ZFNs in human cells. 
 
OPEN ZFNs induce highly efficient gene targeting at an endogenous human gene 
We next tested whether our OPEN ZFNs could induce high efficiency gene 
targeting at the endogenous human VEGF-A gene. For these experiments, we used VF2468 
pair C and VF2471 pair B (Table S2) and directly compared their activities with a 
previously published ZFN pair (10) which cleaves the human IL2Rγ gene. Gene targeting 
frequencies using VEGF-A-or IL2Rγ-specific ZFNs and matched donor templates (Figure 
B.S4) were measured in human K562 cells using a limited-cycle PCR/restriction digest 
assay (Experimental Procedures) (15): mean targeting efficiencies of 7.7%, 4.5% and 4.1% 
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were observed with the VF2468, VF2471, and IL2Rγ ZFNs, respectively (Figure B.4A). 
Efficient gene targeting required both the donor construct and ZFN expression vectors 
(Figure B.4A).  
 
 
Figure B.3 Highly Efficient Mutagenesis of Endogenous Human Genes by OPEN ZFNs A) 
Schematic of CEL I assay for assaying ZFN-induced mutations. (B-C) Mutation of the 
endogenous human VEGF-A gene B) and HoxB13 gene C) by OPEN ZFNs. Colored 
arrows indicate expected CEL I digestion products. Images shown are from representative 
experiments. 
 
Southern blot assays of cells modified by VEGF-A-specific ZFNs confirm that, if 
anything, the PCR-based assay tended to underestimate gene targeting rates (Figures B.4B 
and B.S5).Consistent with previous studies (15), we observed higher rates of gene targeting 
in K562 cells which had been transiently arrested in G2 with vinblastine: 54%, 37%, and 
44% mean efficiencies with VF2468, VF2471, and IL2Rγ ZFNs, respectively (Figure 
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B.4C). Notably, vinblastine treatment greatly reduced the number of viable cells (data not 
shown). Sequencing of VEGF-A and IL2Rγ alleles revealed gene targeting events at the 
expected locations and with the anticipated frequencies (Figure B.S6), but for all three 
target sites, we also observed high frequencies of insertion and deletion events at the ZFN 
cleavage sites (presumably caused by error-prone NHEJ). Unexpectedly, we found that 
1.8% and 9.0% of alleles from cells treated with VF2468 and IL2Rγ ZFNs, respectively, 
contained evidence of both HR-mediated gene targeting and NHEJ-mediated insertion 
events at a single allele. Interestingly, analysis of single cell clones from vinblastine-treated 
populations of VEGF-AZFN-modified cells indicates that gene targeting events are stably 
maintained (even after 35 days) and strikingly can be induced in as many as four copies of 
VEGF-A in polyploid cells(Figure B.S7). 
 
Toxicity profiles of OPEN ZFNs 
We compared the relative toxicities of two pairs of three-finger OPEN VEGF-A ZFNs and 
of a pair of four-finger IL2Rγ ZFNs using cell survival assays in which K562 cells were 
transfected with ZFN expression vectors, a donor plasmid, and a GFP-expression plasmid. 
Previous studies demonstrated that toxic ZFNs reduce both the percentage of GFP-positive 
cells (25,26) and cells that have undergone gene targeting (13)over time.  All three ZFN 
pairs we tested showed significant reductions in the relative number of GFP-positive cells 
by post-transfection day 7 (Figure B.4D, green bars) and analogous decreases in the 
percentage of gene targeting events (Figure B.4D, purple bars).We examined whether 
toxicity profiles of the IL2Rγ and our OPEN VF2468 and VF2471 ZFNs could be improved 
by using obligate heterodimeric FokI nuclease domain variants which significantly reduce 
ZFN-associated toxicity (10,14). Both the variant IL2Rγ ZFN pair and the variant VF2471 
ZFN pair showed no significant toxicity as judged by the GFP toxicity assay (Figure B.4D, 
green bars). In addition, the variant VF2468 ZFN pair revealed minimal toxicity (Figure 
B.4D) similar to that of I-SceI, a highly specific meganuclease used previously as a control 
(13). Comparable effects were also observed in the relative percentage of gene targeting 
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events (Figure B.4D, purple bars). We note that all three variant ZFN pairs induce efficient 
gene targeting (Figure B.4E), demonstrating that the absence of observable toxicity is not 
due to lack of ZFN activity. 
 
 
Figure B.4 Highly Efficient Gene Targeting of Endogenous Human Loci by OPEN ZFNs 
A) OPEN VEGF-A ZFNs and previously described IL2Rγ ZFNs induce efficient gene 
targeting at endogenous genes in human K562 cells. Top part shows representative gel 
images from limited-cycle PCR/restriction digest assays and bottom part shows gene 
targeting frequency means (colored bars) and standard errors (error bars) from multiple 
experiments. B) Gene targeting efficiencies of OPEN VEGF-A ZFNs assessed nine days 
post transfection by limited-cycle PCR/restriction digest and Southern blot assays. C) 
Vinblastine enhances gene targeting by OPEN VEGF-A and four-finger IL2Rγ ZFNs. 
Assays performed four days post-transfection. Data presented as in (A). D) Toxicities of 
OPEN VEGF-A and four-finger IL2Rγ ZFNs in human K562 cells. Means of GFP (green 
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Figure B.4 | continued bars) and gene targeting ratios (purple bars) are shown. Error bars 
represent standard deviations. Single and double asterisks indicate p values <0.05 or <0.01, 
respectively. E) Gene targeting efficiencies of OPEN VEGF-A and four-finger IL2Rγ ZFNs 
in toxicity experiments of (D). Means and standard deviations (error bars) are shown of 
PCR-based assays performed four days post-transfection. 
 
DISCUSSION 
The OPEN reagents and methods we describe in this report provide a rapid, highly 
effective, and publicly available platform for engineering zinc-finger arrays. With OPEN, 
we created 37 ZFN pairs which mediate highly efficient modification at four different sites 
within a chromosomally integrated EGFP reporter gene, six different sites within three 
endogenous human genes (VEGF-A, HoxB13, and CFTR), and one site within an 
endogenous plant gene (SuRA). The absolute rates of gene modification induced by our 
OPEN ZFNs ranged from 1to 50%, and we were able to alter as many as two alleles in a 
single plant cell and four alleles in a single polyploid human cell. We found OPEN to be 
more effective than previously described modular assembly approaches for making 
zinc-finger arrays. In our studies targeting the EGFP gene, only two of 11 (~18%) 
modularly assembled ZFN pairs tested showed activity in human cells, in contrast to 15 of 
20 (75%) OPEN ZFN pairs. In addition, at the one target site for which both methods were 
successful, OPEN ZFNs showed significantly more activity than modularly assembled 
ZFNs. The low efficacy rate observed with modular assembly is consistent with the results 
of a large-scale assessment of this method recently conducted by our groups (24). The 
higher success rate of OPEN is likely attributable to its consideration of context-dependent 
effects on DNA-binding among neighboring zinc-fingers (32,33-35) which are largely 
ignored by modular assembly. 
With the set of zinc finger pools described in this report, we estimate that OPEN can 
be used to engineer three-finger proteins for ~4.1% ((23*21*22)/(64*64*64)) of all 
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possible 9 bp target sites or ~0.16% (4.1%*4.1%) of all possible 18 bp ZFN sites. Because 
ZFNs can bind to sites in which two “half-sites” are separated by “spacer sequences” of 
five, six or seven base pairs (13,36)[K. Wilson and M.H.P., unpublished data), one should 
be able to find approximately five full ZFN sites in any given kb of random sequence 
(0.0016 *1000* 3). Thus, with the pools described in this report, one should be able to 
target multiple ZFN sites within a typical size gene. Important goals for future work will be 
to generate additional finger pools that expand the targeting range of OPEN and to test 
whether the approach can also be used to generate arrays composed of more than 
three-fingers. 
While using ZFNs to modify human genes, we observed two limitations that have 
not been emphasized in previous reports. First, not all zinc-finger arrays that possess 
sequence-specific DNA-binding activities (as measured in the well-established B2H 
method) will function as ZFNs in human cells. ZFNs for one of the four sites targeted in the 
HoxB13 locus, for three of the five sites targeted in the VEGF-A locus, and for one of the 
five sites targeted in an integrated EGFP reporter gene failed to induce mutagenic NHEJ 
repair in human cells. In addition, some ZFNs we made to the HoxB13 gene were active in 
293 cells (Figure B.3C) but not in K562 cells (data not shown). We speculate that the 
transcriptional status and chromatin configuration of a target site may influence ZFN 
access to target sites: HoxB13 is transcriptionally active in 293 cells (data not shown) but 
bears chromatin marks consistent with a repressive state in K562 cells (B. Bernstein, 
personal communication). Additional studies will be needed to determine whether lack of 
ZFN activity results from chromatin effects on DNA accessibility or other reasons such as 
ZFN expression/stability or target site methylation. Second, although the use of vinblastine 
increased the frequency of gene targeting, DNA sequencing reveals that many alleles still 
underwent insertions or deletions caused by error-prone NHEJ and that some alleles 
underwent both a gene targeting event and an insertion. These findings demonstrate 
limitations in relying solely on PCR- or Southern blot-based assays and suggest that DNA 
sequencing should always be performed to verify ZFN-induced gene targeting events. 
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Because OPEN is rapid, reliable, and publicly available, it will foster wider usage 
and larger-scale applications of engineered zinc-finger technology. OPEN selections are 
performed in E. coli and do not require specialized equipment. Although our ZFN 
validation experiments were performed in plant and human cells, OPEN should also be 
useful for generating ZFNs that function well in other organisms such as zebrafish, 
mosquitoes, Drosophila, and C. elegans. The rapidity and effectiveness of OPEN should 
enable genome-scale ZFN projects (e.g. developing ZFNs for all human kinase genes or for 
every zebrafish gene). We note that this report doubles the number of endogenous 
mammalian genes described in the published literature -- from three (IL2Rγ, CCR5, and 
DHFR) (15,37) to six -- that have been successfully modified using ZFNs. In conclusion, 
our publicly available OPEN platform will enable scientists to perform the research and 
development required to move ZFN technology forward for applications in biological 
research and gene therapy. 
 
Experimental Procedures 
Additional details for all methods are provided in Supplemental Experimental 
Procedures. 
 
Construction of zinc-finger pools 
Randomized zinc-finger libraries constructed by cassette mutagenesis were 
introduced into “B2H selection strains” harboring a 9 bp target site as described (38) and 
plated on histidine-deficient selective media (NM media) containing 3-AT, a competitive 
inhibitor of the HIS3 enzyme. Zinc-finger-encoding phagemids were rescued from 
surviving colonies, re-introduced into fresh B2H selection cells, and plated on NM media 
containing 3-AT and streptomycin. 95 surviving colonies were inoculated into a 96-well 
block for growth and plasmids isolated to obtain the final finger pools. 
 
OPEN selections 
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Each OPEN selection was performed in two steps: First, B2H selection strain cells 
were infected with randomized zinc-finger phage libraries consisting of three recombined 
finger pools and then plated on NM media containing 3-AT and streptomycin. Second, zinc 
finger-encoding phagemids were rescued from surviving colonies, re-introduced into fresh 
B2H selection strain cells, and plated on NM media containing a gradient of 3-AT and 
streptomycin. For a small number of the OPEN selections, we performed selections in a 
single step (see Supplemental Experimental Procedures). 
 
CEL I nuclease assay for NHEJ-mediated mutation 
Flp-In T-REx 293 cells (Invitrogen) were transfected with ZFN expression 
plasmids and genomic DNA was isolated three days post-transfection. Limited-cycle PCR 
was performed with radiolabeled nucleotides and VEGF-A- or HoxB13-specific primers. 
PCR products were treated with CEL I nuclease and then separated on 10% polyacrylamide 
gels and visualized using a phosphorimaging screen. 
 
Gene targeting assays 
Human K562 cells were transfected with ZFN expression plasmids and donor 
constructs and genomic DNA harvested four days post-transfection. Limited-cycle PCR 
was performed with radiolabeled nucleotides and VEGF-A- or IL2Rγ-specific primers. 
PCR products digested with SalI (for VEGF-A) or BsrBI (for IL2Rγ) were separated on 
10% polyacrylamide gels and visualized using a phosphorimaging screen. Additional 
details and Southern blot assays are described in Supplemental Experimental Procedures. 
 
Tobacco transformation and assay for mutations 
The transformation of tobacco protoplasts by electroporation, selection for 
kanamycin resistance, and regeneration into plantlets was carried out as previously 
described (16). DNA was prepared from tissue harvested from individual plantlets and 
SuRA and SuRB alleles were amplified by PCR, gel purified, and sequenced to identify 
 173
mutations. 
 
ZFN toxicity assays 
ZFN expression vectors, donor templates, and plasmid pmaxGFP (Amaxa) were 
transfected into K562 cells. Cells were assayed for GFP expression at days 1 and 7 post 
transfection using a FACScan cytometer and for gene targeting efficiencies at days 4 and 7 
post-transfection using the limited-cycle PCR/restriction digest assay. 
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SUPPLEMENTARY MATERIALS 
Supplemental Experimental Procedures 
 
B2H selection media 
NM medium has been previously described (1). NM/CCK medium plates contain 
100 µg/mL carbenicillin, 30 µg/mL chloramphenicol, 30 µg/mL kanamycin, and 1.5% 
Bacto-agar. 
 
Construction of zinc finger pools 
All master randomized zinc finger libraries were constructed in a standard 
framework consisting of three tandem repeats of the middle finger of the murine 
transcription factor Zif268 in which the recognition helix residues have been altered. For 
each library, recognition helix residues –1, 1, 2, 3, 5, and 6 were randomized using 24 
codons (degenerate sequence 5’VNS3’) encoding 16 amino acids (excluding cysteine and 
the aromatics). The theoretical complexity of each library is therefore 246= ~2 x 108 
members. Each library was converted into infectious M13 phage particles as previously 
described (2). 
B2H selection strains each harbor: (1) a single copy episome bearing a target site of 
interest positioned upstream of a promoter which drives co-cistronic expression of two 
selectable markers (the yeast HIS3 gene and the bacterial aadA gene) and (2) a low copy 
number plasmid expressing the RNA polymerase α-subunit/yeast Gal4 hybrid protein 
(α-Gal4). Strains were constructed as previously described (1). The target binding site of 
each strain was verified by DNA sequencing. Zinc finger pools were obtained using two 
selection steps: In a first step, 109 ampicillintransducing- units (ATU) of randomized zinc 
finger phage library were introduced into >3 x 109 B2H selection strain cells harboring a 
target subsite of interest. Transformed cells were plated on histidine-deficient NM/CCK 
medium  plates containing 50 µM isopropyl  β-d-thiogalactoside (IPTG) and 10 mM 
 179
3-aminotriazole (3-AT), a competitive inhibitor of the HIS3 enzyme. After incubation for 
24 hours at 37°C followed by 18 hours at room temperature, surviving colonies were 
scraped from the plates and infected with M13K07 helper phage to rescue the zinc 
finger-encoding phagemids as infectious phage. In a second step, this enriched phage 
library was then used to re-infect fresh B2H selection strain cells and the resulting 
transformants plated on NM/CCK medium plates containing 50 uM IPTG, 10 mM 3-AT, 
and 20 ug/ml streptomycin. After incubation at 37°C for 48 hours, we inoculated 95 
surviving colonies of various sizes into individual wells of a 96- well block containing 1ml 
of Terrific Broth and 50 µg/ml carbenicillin. These cultures were grown overnight at 37°C 
and then a 96-pin replicator was used to inoculate a second block of identical cultures. 
Glycerol was added to a final concentration of 15% to all wells in the first block and this 
was stored at -80°C. The second block was grown overnight at 37°C and then the 95 
cultures were pooled together. Plasmid DNA encoding the finger pools was isolated from 
10 ml of the pooled culture using a QIAgen miniprep kit and for many pools a small 
number of random clones were sequenced with primer OK61. For finger pools against nine 
subsites, sequencing revealed no strong consensus (i.e.—the sequences were diverse and 
did not resemble one another), suggesting that selective pressure for those sites was 
relatively weak under the initial selection conditions. For each of these nine subsites, the 
second step of selection was repeated and plated on higher stringency plates to obtain 
sequences that more closely resembled one another. The higher stringency plates used were 
NM/CCK medium plates containing 50 µM IPTG, 20 mM 3-AT, and 30 µg/ml streptomycin 
(for seven subsites: F1 GAT, F2 GAC, F2 GAG, F2 GCG, F2 TGA, F2 TAG, and F2 GTT) 
or 50 µM IPTG, 25 mM 3- AT, and 40 µg/ml streptomycin (for two subsites: F2 GAA, F2 
TGG). 
 
OPEN selections 
To create libraries for use in OPEN selections, finger pools were amplified by PCR. 
For each amplification, first five and then 20 cycles of PCR were performed  using the 
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following primers and annealing temperatures (primer names; initial annealing temp; final 
annealing temp): for finger 1: OK1424 and OK1425; 55°C; 59°C, for finger 2: OK1426 
and OK1427; 52°C; 57°C, for finger 3: OK1428 and OK1429; 41°C; 56°C. Amplified 
individual finger pools were isolated from 10% polyacrylamide gels and fused together by 
PCR. To do this, equal concentrations of the three finger pool fragments were fused using 
the following PCR conditions: 94°C, 5 minutes; 10 cycles of 94°C, 30 sec; 50°C, 30 sec; 
72°C, 2 min; final extension 72°C, 7 min. This fusion product was purified using a QIAgen 
PCR purification kit and then amplified by PCR using primers OK1430 and OK1432 with 
10 initial cycles of 94°C, 30 sec; 56°C, 30 sec; 72°C, 1 min and 20 additional cycles of 
94°C, 30 sec; 64°C, 30 sec; 72°C, 1 min; final extension 72°C, 7 min. The final PCR 
product (encoding a library of three-finger arrays) was isolated on a 5% polyacrylamide gel 
and treated with Pfu polymerase and T4 polynucleotide kinase to create overhangs. This 
fragment was then ligated with BbsI digested pBR-UV5-GP-FD2 vector backbone which 
results in a plasmid that expresses the zinc finger array as a FLAG-tagged Gal11P fusion in 
the B2H system. This ligation was then introduced into E. coli XL-1 Blue cells by 
electroporation and each library was constructed from >3 x 106 independent transformants, 
ensuring at least three-fold oversampling of the theoretical library complexity of ~8.6 x 105 
(953). Libraries were then converted into infectious M13 phage as previously described 
(1). 
All but six (see below) of the OPEN selections were performed in two stages. In the 
first stage, an OPEN three-finger library was introduced by infection into a B2H selection 
strain harboring the full target DNA sequence of interest. >2.2 x 106 ATU of OPEN phage 
library (a number which ensures adequate oversampling of the maximal theoretical library 
diversity) were used to infect >2 x 108 B2H selection strain cells and the resulting 
transformants were plated on two different NM/CCK medium plates containing 50 µM 
IPTG, 10 mM 3AT, and 20 µg/mL streptomycin or 50 µM IPTG, 25 mM 3AT, and 40 µg/mL 
streptomycin. After 36-48 hours of incubation, colonies were harvested from the highest 
stringency plate yielding at least 1000 colonies. These cells were infected with M13K07 
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helper phage to rescue zinc finger-encoding phagemids,  thereby creating an enriched 
library. In the second stage, 2.5 x 106 ATU of this enriched library were used to infect >2 x 
108 fresh B2H selection strain cells and the resulting transformants plated on a 
245x245mm NM/CCK medium plate containing parallel gradients of 3-AT and 
streptomycin ranging from 0 mM to 80 mM and 0 µg/mL to 100 µg/mL, respectively. 
Gradient plates were poured using the method of Szybalski (3). After incubation at 37°C 
for a minimum of 48 and a maximum of 96 hours, 12 surviving colonies were picked from 
the highest stringency edge of the plate and ZFP-encoding plasmids were isolated by 
plasmid miniprep and sequenced with primer OK61. For six of the sites we targeted using 
OPEN, selections were (for historical reasons) performed in a single step instead of two 
steps. For five sites (EG223L, EG223R, EG292L, EG292R, and EG382L), >3.1 x 106 ATU 
of OPEN phage library were used to infect >4 x 108 B2H selection strain cells and the 
resulting transformants were plated on a series of NM/CCK medium plates containing 50 
µM IPTG, 40 mM 3AT, and 60 µg/mL streptomycin, 50 µM IPTG, 60 mM 3AT, and 
80µg/mL streptomycin, 0 µM IPTG, 40 mM 3AT, and 60 µg/mL streptomycin or 0 µM 
IPTG, 60 mM 3AT, and 80 µg/mL streptomycin. For each target site, we picked colonies 
from the highest stringency plates that yielded colonies. For one site (EG382R), 4.25 x 108 
ATU of OPEN phage library were used to infect >109 B2H selection strain cells and the 
resulting transformants were plated on a 245x245mm NM/CCK medium plate containing 
parallel gradients of 3-AT and streptomycin ranging from 0 mM to 80 mM and 0 µg/mL to 
100 µg/mL, respectively. Colonies were picked from the highest stringency edge of the 
plate. 
 
Construction of modularly assembled zinc finger arrays 
Modularly assembled zinc finger arrays were assembled using the Zinc Finger 
Consortium Modular Assembly Kit v1.0 as previously described (4). For each target 
half-site in the EGFP reporter gene, we assembled three-finger arrays using modules from 
the Barbas, Sangamo, and Toolgen archives but we did not mix and match modules across 
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platforms because: (1) the Barbas group does not suggest use of their modules with others 
(2,5) the Toolgen group discovered that their human zinc fingers worked best with one 
another but not as well with other engineered modules (6), and (3) the Sangamo modules 
were designed to be finger-position-specific and have non-canonical linkers joining them 
that differ from the TGEKP linker used by the Barbas and Toolgen modules (7). 
 
Quantitative bacterial two-hybrid (B2H) assays 
Zinc-finger-encoding plasmids identified from OPEN selections were 
co-transformed with an α-Gal4 expression plasmid into a “B2H reporter strain” harboring a 
single copy bacterial plasmid with a target binding site positioned upstream of a weak 
promoter driving lacZ expression. B2H reporter strains were constructed as described (4). 
β-galactosidase assays were performed in triplicate as described (8). 
 
ZFN expression vectors 
All zinc finger arrays were expressed as ZFNs using the Zinc Finger Consortium 
mammalian expression vector pST1374 (4). Zinc finger arrays were excised directly from 
B2H expression vectors on an XbaI/BamHI fragment and cloned into pST1374. In this 
configuration, zinc finger arrays are joined to the FokI nuclease domain by a four amino 
acid linker of sequence LRGS. We constructed expression vectors encoding the four-finger 
IL2Rγ ZFNs using amino acid sequences obtained from a previously published study (9). 
 
Human cell-based EGFP-disruption assay 
Human 293.EGFP cells harbor an integrated retroviral construct which 
constitutively expresses a β-galactosidase-EGFP fusion protein (Figure 2B). 293.EGFP 
cells were transfected in triplicate in 24-well plates using calcium phosphate precipitation 
as previously described (10). Transfection cocktails included 300 ng each of a CMV 
promoter-controlled zinc finger nuclease expression vector, 100 ng pDS.RedExpress 
(Clontech, Mountain view, CA) and pUC118 to 1.5 µg. 600 ng of pRK5.SceI plasmid (11), 
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which expresses the meganuclease I-SceI, was used in place of GFP-ZFN-encoding 
plasmids for negative controls. 50,000 cells were analyzed by flow cytometry two and five 
days post-transfection to determine the percentage of EGFP-negative cells. The number of 
REx-positive cells at day 2 was used to normalize for transfection efficiency. Statistical 
significance was determined using a two-sided student’s t-test with unequal variance. 
 
CEL I nuclease assay for NHEJ-mediated mutation 
In this assay, limited-cycle PCR is used to amplify a locus of interest from the 
genomic DNA of a population of human cells transfected with ZFN expression vectors 
(Figure 3A). The resulting PCR product is denatured and re-annealed and heteroduplex 
DNA will form if mutated alleles are present in the population. These DNA fragments can 
be cleaved at the site of mismatch by the CEL I enzyme into smaller products of predictable 
size. Specifically, 2 x 106 human Flp-In T-REx 293 cells (Invitrogen) were transfected with 
pairs of ZFN-encoding plasmids (100 or 250 ng of each ZFN-encoding plasmid) using 
Lipofectamine 2000 (Invitrogen). Genomic DNA was isolated from nuclease-treated cells 
at 3 days post-transfection using the QIAgen Blood Mini kit. Limited-cycle PCR (24 cycles) 
was performed using Platinum PCR SuperMix Hi-Fidelity (Invitrogen) or its equivalent 
constituent components (Invitrogen) with 50 ng of genomic DNA as template, 8 µCi of 
each [alpha-32P]-dATP and dCTP, 1 µM each of gene-specific primers (primers OK1681 
and OK1682 for VEGF-A sites VF2468/VF2471, primers OK1706 and OK1718 for 
VEGF-A sites VF3537/VF3542/VF3552, primers OK1733 and OK1734 for HoxB13 sites 
HX508/HX587 or primers OK1736 and OK1738 for HoxB13 sites HX735/HX761) and 
1.25 µl DMSO in a 25 µl reaction volume. PCR products were cleaned up using Sephadex 
G-50 columns (Roche) and then melted/re-annealed using the following conditions: 95°C 
for 10 min; 95°C to 85°C cooling at a rate of -2°C/sec; 85°C to 25°C cooling at a rate of 
-0.1°C/sec; rapid cool to 4°C. Re-annealed PCR products were diluted 1:3.75 in a buffer of 
20 mM Tris-HCl (pH 8.8), 2 mM MgSO4, 60 mM KCl, 0.1% Triton X-100 and treated with 
1 µl CEL I enzyme (Surveyor nuclease S; Transgenomic) and 1µl Surveyor Enhancer S 
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(Transgenomic) in a 15 µl reaction incubated at 42°C for 20 min. Products were visualized 
by electrophoresis on a 0.8mm thick, 10% 1X TBE polyacrylamide gel which was dried 
down and exposed overnight to a phosphorimaging screen. All experiments were 
performed a minimum of two times. 
 
Gene targeting assays 
2 x 106 Flp-In T-REx 293 cells were transfected with pairs of plasmids expressing 
ZFNs (7.5 µg of each ZFN-encoding plasmid) and 50 µg of donor plasmid using 
nucleofection with solution V and program Q001 (Amaxa). 2 x 106 K562 cells were 
transfected with ZFN expression plasmid pairs (5 or 7.5 µg of each) and matched donor 
construct (25 or 50 µg donor plasmid) using nucleofection with solution V and program 
T-16. Genomic DNA was harvested 3 or 4 days post-transfection for 293 or K562 cells, 
respectively, using a QIAgen Blood Mini kit. Transfection efficiencies were monitored by 
including a GFP-encoding plasmid in each transfection and determining the percentage of 
GFP-positive cells by flow cytometry one day post-transfection. For experiments in which 
cells were arrested in G2 phase, 0.2 µM vinblastine was added 24 hours post-transfection 
and then removed by washing three times with phosphate buffered saline 14-18 hours later. 
Limited-cycle PCR assays (24 cycles) were performed using Platinum PCR SuperMix 
Hi-Fidelity (Invitrogen) or its equivalent constituent components (Invitrogen) with 4 ng 
genomic DNA, 8 µCi of each [alpha-32P]-dATP and dCTP, 1 µM each of gene-specific 
primers (OK1776 and OK1777 for VEGF-A or OK1845 and OK1846 for IL2Rγ) and 1.25 
µl DMSO in a 25 µl reaction. Purified PCR product was digested with 25 units SalI or 10 
units BsrBI restriction enzyme for 2 hours and the resulting products were visualized by 
electrophoresis on a 10% 1X TBE polyacrylamide gel. This gel was dried down and 
exposed overnight to a phosphorimaging screen. Quantification of bands was performed 
using Quantity One software (Bio-Rad). 
For Southern blots, 15 µg of genomic DNA (15 µg) was digested with MscI and SalI 
restriction enzymes for 20 hrs, electrophoresed in 0.8% tris-acetate agarose gels (100 mM 
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Tris-HCl, 10 mM EDTA, pH 8.0 with acetic acid), and transferred to Zeta-probe nylon 
membrane (BioRad) using 25 mM sodium phosphate (pH 6.5) according to the procedure 
of Southern (12) as modified for use with the Turbo-Blot downward transfer apparatus 
(Schleicher & Schuell). The VEGF-A DNA probe was generated by PCR amplification of a 
cloned human VEGF-A DNA template using primers OK1823 and OK1824 which was 
subsequently labeled (25 ng) with [alpha-32P]-dCTP) using Rediprime II random priming 
reagents (Amersham). Following hybridization (20 hrs) at 65°C in 5 mL ExpressHyb 
solution (Clontech), the filters were washed with 0.1X SSC/0.1% SDS at 65°C (2 hrs), 
blotted dry and exposed to a phosphorimager screen and/or film. The filters were scanned 
in the Typhoon 8600 phosphoimager and relative band intensities were quantified by 
volume analysis using ImageQuant software (GE Healthcare/Amersham). 
 
Sequencing of modified genomic alleles 
The region encompassing each potential ZFN cleavage site was amplified from 
genomic DNA isolated from populations of human Flp-In T-REx 293 or K562 cells that had 
been transfected with ZFN expression plasmids alone or with ZFN expression and donor 
plasmids. PCR conditions for these amplifications were the same as those used for the CEL 
I (for assessing NHEJ events) or limited-cycle PCR/restriction digest (for assessing gene 
targeting events) assays but with all components doubled to a final volume of 50µl. CF877 
was amplified using primers OK1711 and 1713. PCR reactions were purified using the 
QIAgen Minelute PCR Purification kit and eluted with 15 µl 0.1X EB buffer (QIAgen). 
PCR fragments were cloned into the pCR4Blunt-TOPO plasmid using the Zero Blunt 
TOPO PCR Cloning Kit for Sequencing (Invitrogen). The TOPO cloning reaction used 4 µl 
purified PCR product, 1 µl salt solution and 1 µl TOPO vector. 2 µl of TOPO reaction were 
transformed into One Shot Mach1-T1 chemically competent cells (Invitrogen) or 
chemically competent Top10 cells (Invitrogen) and plated on LB plates containing 50 
µg/ml kanamycin. Plasmid DNAs from transformants were sequenced with a primer 
designed to bind internal to the PCR product (OK1773 or T3 (Invitrogen) for VEGF-A, 
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OS216 for HoxB13, M13 primer (Invitrogen) for CFTR or OK1838 for IL2Rγ). 
 
Tobacco transformation and assay for mutations 
The transformation of tobacco protoplasts by electroporation was carried out as 
previously described (13). Plasmids introduced into protoplasts (10 µg each) included those 
expressing ZFNs that recognize the left (pRW242) and right (pRW246) half sites of target 
2163 in SuRA. Note that these constructs do not express the heterodimeric variants of FokI 
endonuclease. Also transformed into protoplasts was a plasmid expressing neomycin 
phosphotransferase (NPTII) (pDW998). The CaMV 35S promoter was used to drive 
expression of both the ZFNs and NPTII. Plasmid DNAs were linearized with BglII prior to 
transformation. Protoplasts were allowed to recover and then selected for kanamycin 
resistance and regenerated into plantlets as previously described (13). 
DNA was prepared from tissue harvested from individual plantlets using the 
Epicentre MasterPure Plant Leaf DNA Purification Kit following the manufacturer’s 
directions. An initial PCR screen for mutations at the site of ZFN cleavage was performed 
using primers DVO4461 and DVO4462 to amplify a 445 bp fragment from both the SuRA 
and SuRB loci. PCR was performed with 100 ng of genomic DNA and the following PCR 
conditions: 94°C 2 min, followed by 34 cycles of 94°C 15 sec, 61°C 15 sec, 72°C 30 sec, 
and then 72°C for 5 min. The reactions were run out on a 0.8% agarose gel, purified using a 
QIAgen QIAquick Gel Extraction kit, and sequenced with DVO4462. The resulting 
sequences were examined for double peaks, which not only indicate sequence differences 
between SuRA and SuRB, but also identify potential insertion/deletion events at the ZFN 
cleavage site in either or both loci. 
DNA from candidate mutants was then PCR amplified using a set of nested, 
allele-specific primers in two consecutive PCR reactions to confirm the mutation and 
determine if it occurred in SuRA or SuRB. The primary reaction amplified a 2.15 kb 
fragment using approximately 100 ng of genomic DNA as template and primers DVO4565 
and DVO4461 for SuRA and DVO4429 and DVO4461 for SuRB. The second PCR reaction 
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amplified a 2 kb fragment using 1 µl of the primary PCR reaction as template and primers 
DVO4444 and DVO4461 for SuRA and DVO4445 and DVO4461 for SuRB. All PCR 
reactions were performed using a Clontech Advantage cDNA Polymerase kit and the 
following PCR conditions: 94°C 1 min, followed by 34 cycles of 94°C 30 sec, 66°C 30 sec, 
68°C 3 min, and then 68°C for 5 min. The reactions were run out on a 0.8% agarose gel, 
purified with a QIAgen QIAquick Gel Extraction kit and sequenced with primer 
DVO4462. 
 
ZFN toxicity assays 
ZFN expression plasmids and donor templates were transfected into K562 cells 
using nucleofection as described above. For these experiments, 5 µg of each ZFN 
expression plasmid, 25 µg of donor, and 15 ng of pmaxGFP (encoding a GFP variant; 
Amaxa) were included in each transfection. For controls, we transfected: (1) 10 µg of 
plasmid encoding I-SceI meganuclease (14) with 25 µg pUC118 and 15 ng of pmaxGFP, (2) 
10 µg of plasmid encoding CAD (caspase-activated DNase) protein (15) with 25 µg 
pUC118 and 15 ng of pmaxGFP, or (3) 35 µg of pUC118 and 15 ng of pmaxGFP. Cells 
were assayed for GFP expression at post-transfection days 1 and 7 with a FACScan 
cytometer. GFP ratios shown in Figure 4D (green bars) were calculated using the formula: 
 
(%GFP+ in ZFN-transfected cells on day 7 / %GFP+ in ZFN-transfected cells on day 1) 
______________________________________________________________________ 
(%GFP+ in pUC-transfected cells on day 7 / %GFP+ in pUC-transfected cells on day 1) 
 
In addition, genomic DNA was harvested using a QIAgen Blood Mini Prep kit on 
post-transfection days 4 and 7 and assayed for gene targeting using the limited-cycle 
PCR/restriction digest assay as described above. Gene targeting ratios shown in Figure 4D 
(purple bars) were calculated by dividing the gene targeting rate on day 7 by the gene 
targeting rate on day 4. All assays (both GFP and gene targeting) were performed on at least 
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three-independent samples and t-tests of significance were performed by comparing 
experimentally determined ratios to a fixed ratio value of 1 (i.e.--no change in value). 
Variant heterodimer FokI domains were constructed by introducing the “+” and 
“-“ mutations (previously described in Miller et al., 2007) into the wild-type FokI nuclease 
domain(9). 
 
Fluorescence in situ hybridization (FISH) 
Two-color fluorescence in situ hybridization (FISH) was performed on 3:1 
methanolacetic acid fixed cell lines using bacterial artificial chromosome clones 
RP11-710L16 (6p21.1; VEGF-A) labeled in Spectrum Orange (Abbott-Vysis, Downer's 
Grove, Il.), or RP11-142P4 (14q31.1; copy number control) labeled in Spectrum Green 
using standard protocols. Images were captured using an Olympus BX61 fluorescent 
microscope equipped with a CCD camera, and analysis was performed with Cytovision 
software (Applied Imaging, San Jose, CA). 
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SUPPLEMENTAL FIGURES AND TABLES 
A. 
 
B.  
Figure B.S1 ZiFiT 3.0 -- Web-based software for identifying potential sites targetable by 
OPEN selection A) Screen shot of ZiFiT 3.0 input page. We previously described ZiFiT a 
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Figure B.S1 | continued web-based  software program that enables users to rapidly 
identify potential zinc finger nuclease target sites within genes of interest (Sander et al., 
2007; Wright et al., 2006). The original implementations of ZiFiT (versions 1.0 and 2.0) 
were both geared toward making zinc finger nucleases by modular assembly, and the 
output cross-referenced zinc finger modules available in the Zinc Finger Consortium 
Modular Assembly Kit 1.0 (Wright et al., 2006). With the implementation of OPEN, we 
have released ZiFiT Version 3.0 (http://www.zincfingers.org/software-tools.htm), which 
gives users the option of searching for target sites for which OPEN pools are available. 
The user pastes a DNA sequence (limited to 10,000 characters) into the text box at the top 
of the main window. Underneath the main window are three boxes corresponding to 
finger positions in the zinc finger array. Each box contains a list of the 64 possible 
nucleotide triplets. By default, triplets are checked for which OPEN pools are currently 
available from the Zinc Finger Consortium; however, users can manually select or 
deselect triplet pools to customize their search. Target site composition can be further 
restricted by options available under the "Advanced/Basic" toggle near the bottom of the 
screen. By selecting the "Submit" button, the sequence is searched for all target sites 
using the specified pools and an output is returned.  B) Screen shot of ZiFiT 3.0 output 
page. In addition to identifying zinc finger nuclease target sites in the input sequence, it 
may be desirable to identify matching or highly similar sites within a genome of interest. 
ZiFiT Version 3.0 enables the user to BLAST the genome sequence of a desired organism 
to identify duplicate or related target sites. The BLAST search is implemented by a button 
link and an organism selection menu provided for each target site returned in the output 
on the results page. Requests are submitted to the NCBI BLAST servers to provide 
maximum reliability and speed, and results are typically returned to ZiFiT within a 
minute. Note that BLAST scoring methods do not identify all matches near the end of a 
hit if they are separated by mismatches that lower the score of the local alignment. As a 
result, hits to highly similar target sites lacking information at the ends may need to be 
analyzed manually.  
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Figure B.S2  Schematic of target sites in the EGFP, VEGF-A, HoxB13, and CFTR 
genes Using ZFNs made by OPEN selections, we targeted A) five full ZFN sites in the 
EGFP reporter gene (EG223, EG292, EG382, EG502, and EG568), B) six sites in open 
chromatin regions of the human VEGF-A gene (VF2468, VF2471, VF3537, VF3540, 
VF3542, and VF3552), C) five sites in the first coding exon of the human HoxB13 gene 
(HX500, HX508, HX587, HX735, and HX761) and one site in the last coding exon of the 
human HoxB13 gene (HX2119, not shown), and D) one site in exon 10 of the human 
CFTR gene (CF877) positioned within 100 base pairs of the ∆F508 deletion. 
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Figure B.S3  DNA sequence analysis of endogenous human and plant genes mutagenized 
by OPEN ZFNs (A-C) Sequences of A) HoxB13 alleles from human 293 cells transfected 
with HX587 ZFN pair B, B) CFTR alleles from human K562 cells transfected with CF877 
ZFNs, and C) Sequences of SuRA alleles from tobacco plants transfected with SR2163 
ZFNs (matching sequence from the SuRB gene is also shown). Numbers of each allele 
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Figure B.S3 | continued identified are shown in parentheses. ZFN recognition sites are in 
bold orange print. 
 
 
Figure B.S4  Schematics of donor templates and primers used for gene targeting 
experiments at the human VEGF-A and IL2Rγ genes. Donor templates were constructed for 
OPEN ZFN pairs that cleave at the VF2468 and VF2471 sites and for a previously 
described four-finger ZFN pair that cleaves in the IL2Rγ gene (Urnov et al., 2005). Each 
donor template consists of 1.5 kb of genomic DNA sequence centered on the cleavage site 
and introduces either an 11 bp insertion encoding a SalI restriction site at the center of the 
cleavage site (for VEGF-A targets) or a translationally silent point mutation which creates a 
BsrBI restriction site adjacent to the ZFN cleavage site (for IL2Rγ) (Urnov et al., 2005). 
Arrows indicate primers used for limited-cycle PCR/restriction digest assay described in 
the text. 
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Figure B.S5 Comparison of PCR-based and Southern blot methods for assaying gene 
targeting efficiencies. Limited-cycle PCR and Southern blot were used to assess gene 
targeting efficiencies in cells treated with different ZFNs under various conditions. Dotted 
red line represents where data points would fall if the two methods were perfectly 
concordant. 
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Figure B.S6 DNA sequence analysis of endogenous human alleles that have undergone 
gene targeting induced by ZFNs (A-C) Sequences of alleles sequenced from human K562 
cells transfected with A) VF2468 ZFNs and donor, B) VF2471 ZFNs and donor, and C) 
IL2Rγ ZFNs and donor. Data are presented as in Figure S3. 
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Figure B.S6 | continued 
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Figure B.S7 OPEN ZFNs induce stable multi-allelic alterations of an endogenous human 
gene FISH analysis indicated that K562 cells harbor four alleles of the VEGF-A gene (A, 
upper left panel) and we therefore wished to determine how many of these alleles could be 
altered in a single cell. Limiting dilution cloning was used to isolate single cell clones from 
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Figure B.S7 | continued two vinblastine-treated K562 cell populations which had 
undergone high frequencies of gene targeting: 45% and 26% with the VF2468 and VF2471 
ZFN pairs, respectively (B, upper panel). (The VF2468 ZFN-treated cells also showed 
evidence of a 625 bp deletion (blue asterisks), a finding confirmed by sequencing of alleles 
from these cells (data not shown).) Individual clones from VF2468 ZFN-treated cells 
harbored no, one, three, or four alleles that had undergone a gene targeting event with some 
of the clones also containing the 625 bp deletion (B, lower left panel). Genotype analysis of 
individual cell clones from the VF2471 ZFN-treated cells revealed clones in which no, one, 
two, or three VEGF alleles had undergone a gene targeting event (B, lower right panel). All 
individual cell clones were genotyped more than thirty-five days post-transfection, 
demonstrating that gene targeting events we observed are stably maintained. FISH analysis 
of three cell clones in which all four VEGF-A alleles had undergone the VF2468 
ZFN-induced gene targeting event confirmed the continued presence of four copies of 
VEGF-A per cell (A, upper right, and lower left and right panels). FISH was performed 
with a probe for VEGF-A (red) and a control probe for 14q which is present in two copies 
per cell (green). Taken together, these results demonstrate that OPEN ZFNs can be used to 
induce permanent alterations in as many as four alleles in a single human cell. 
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Table B.S1 Sequences and B2H assays of zinc finger arrays selected by OPEN The subset 
of zinc finger arrays we converted to ZFNs for testing in human or plant cells are 
highlighted in green. As noted in the text, a small number of selections were performed in a 
single step on plates with fixed concentrations of IPTG, 3-AT, and streptomycin. For these 
selections, IPTG concentration shown is in µM, 3-AT concentration shown is in mM, and 
streptomycin concentration shown is in µg/ml. Fold-activation of transcription in the B2H 
system was determined by comparing lacZ expression from B2H reporter strains harboring 
a zinc finger array (fused to a fragment of the yeast Gal11P protein) to matched strains 
harboring a control that does not express a zinc finger array. All determinations were 
performed in triplicate and the means and standard deviations of these means are shown. 
Certain target sites cause a higher basal level of lacZ expression in the quantitative B2H 
assay and the finger arrays tested on these sites may exhibit lower apparent fold-activations 
due to this effect (affected values are highlighted in yellow). Certain zinc finger arrays 
(marked by a “+” in the last column) harbor additional mutations outside of the three 
randomized recognition helices that were most likely introduced during library 
construction. The identities of these various mutations are available upon request. 
Although half-site EG502L did not yield OPEN zinc-finger arrays which activated by more 
than three-fold, we note that the basal level of transcription from the B2H reporter bearing 
this site was high, a situation which can artifactually lower the apparent foldactivation 
observed. 25 of the 28 OPEN selections we performed for the human VEGF-A, human 
HoxB13, human CFTR, and tobacco SuRA genes yielded zinc-finger arrays whose 
sequences closely resembled one another. However, one of these 25 selections (for half-site 
VF3540R) yielded fingers with sequences that appeared to bind to an alternative site 
(discussed below). For 22 of the other 24 selections, we obtained at least one zinc-finger 
array which activated lacZ expression by more than three-fold in the quantitative B2H 
assay. The two remaining selections were also deemed to be successful because their 
reporters possessed a high basal level of transcription which can artifactally mask a higher 
true fold-activation. For one selection (site VF3540R), examination of the recognition helix 
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Table B.S1 | continued sequences of the arrays obtained from OPEN selection suggests 
that these finger arrays do not bind to the intended nine base pair site but rather to the site 
that is shifted 3’ in register by 1 bp (i.e.--these arrays bind to the site: 5’- GCG GCG 
GAC-3’ instead of 5’-GGC GGC GGA-3’). For example, for finger 1, the Asp and Glu 
selected at position -1 and the Asn selected at position 3 of the recognition helix would be 
expected to specify cytosine and adenine, respectively, and not the adenine and guanine 
actually present in the subsite. Similarly, for finger 3, the Arg selected at position -1 and the 
Ser and Asp selected at position 3 of the recognition helix would be expected to specify 
guanine and cytosine, respectively, and not the cytosine and guanine actually present. Thus, 
this selection was deemed to be unsuccessful. 
 
ZFN 
Name 
Site Name 
Selection 
conditions 
(IPTG/3-AT/S
trep) 
F1 subsite/ 
RH sequence 
F2 subsite/ 
RH 
sequence 
F3 subsite/ 
RH sequence 
Mean B2H 
fold-activatio
n 
S.D. of B2H 
fold-activatio
n 
Other 
mutations (of 
unknown 
significance) 
present? 
         
   GTA GGG GTC    
OZ001 EG223L 50/40/60 QDSSLRR RQEHLVR DPTSLNR 4.24 0.17  
OZ002 EG223L 50/40/60 QQSSLLR RQEHLVR DPTSLNR 3.50 0.13  
OZ003 EG223L 50/40/60 QPSSLTR RKPHLVN QPTSLQL 0.79 0.03  
OZ004 EG223L 50/40/60 QQSSLLR RGEHLTR DQTVLRR 3.50 0.33  
OZ005 EG223L 50/40/60 QQSSLLR RGEHLTR EPTSLIR 3.17 2.10  
OZ006 EG223L 50/40/60 QPSSLTR RREHLVS DRRPLPR 1.74 0.65  
OZ007 EG223L 0/40/60 QGSALAR RREHLVR DPTSLNR 4.09 0.08  
OZ008 EG223L 0/40/60 QSSSLTR RGEHLTR ESGALRR 2.57 1.15  
OZ009 EG223L 0/40/60 QASALSR RREHLVR ESGALRR 5.23 0.94  
 
OZ010 EG223L 0/40/60 QSQALVR RVEHLNN DRTSLPR 0.76 0.09  
OZ011 EG223L 0/40/60 QQSSLLR RREHLVR DRTSLAR 3.65 0.23  
OZ012 EG223L 0/40/60 QQSSLLR RREHLVR DPTSLNR 4.29 0.38  
         
   GCA GCA GAA    
OZ013 EG223R 50/60/80 SQTQLVR QSTTLKR QRNNLGR 10.81 0.41  
OZ014 EG223R 50/60/80 RRQELGR QGETLKR QHPNLTR 5.57 0.36  
OZ015 EG223R 50/60/80 RRQELRR QGGTLNR QRNNLGR 10.36 1.40  
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OZ016 EG223R 50/60/80 RTQELKR QSGTLKR QGPNLGR 8.43 0.98  
OZ017 EG223R 50/60/80 NNAQLTR QSGTLHR QRPNLGR 6.53 0.55  
OZ018 EG223R 50/60/80 RRQELGR QGGTLKR QHPNLTR 9.05 0.42  
OZ019 EG223R 0/60/80 RRQELGR QSGTLKR QRNNLGR 9.74 0.73  
OZ020 EG223R 0/60/80 RGVELKR QSGTLHR QRPNLTR 11.48 1.63  
OZ021 EG223R 0/60/80 RPQELAR QSGTLKR QHPNLTR 8.39 0.46  
OZ022 EG223R 0/60/80 RRQELVR QSGTLKR QHPNLTR 9.38 0.62  
OZ023 EG223R 0/60/80 HKGQLNR QSGTLKR QRNNLGR 8.74 0.41  
OZ024 EG223R 0/60/80 RQQELDR QSGTLHR QHPNLTR 11.92 0.98  
         
   GGT GAT GAA    
OZ025 EG292L 50/40/60 TSTRLMI LLHNLTR QRNNLGR 4.40 0.13  
OZ026 EG292L 50/40/60 DKTKLNV VRHNLTR QDGNLGR 3.33 0.09  
OZ027 EG292L 50/40/60 TNQKLVV VAHNLRR QHPNLTR 4.89 0.81  
OZ028 EG292L 50/40/60 DRPTLRR QGGNLVR QGDNLGR 1.10 0.04  
OZ029 EG292L 50/40/60 TRQRLTV VNHNLTR LGENLRR 3.69 0.59  
OZ030 EG292L 50/40/60 TNQKLEV VRHNLQR QHPNLTR 5.43 0.40  
OZ031 EG292L 0/40/60 TTTKLAI VRHNLTR LGENLRR 3.48 1.00  
OZ032 EG292L 0/40/60 TKQRLEV VPHNLKR QSVNLRR 4.54 0.67  
OZ033 EG292L 0/40/60 HMSPLRV QRETLKR DVGNLGR 1.05 0.22 + 
 
OZ034 EG292L 0/40/60 TSQRLAV VAHNLRR QRNNLDR 6.25 1.16  
OZ035 EG292L 0/40/60 RRLALNR LSQTLKR AGDNLGR 0.80 0.08  
OZ036 EG292L 0/40/60 TRQRLTV VRHNLTR QRNNLGR 5.39 0.87  
         
   GGC GAC GAC    
OZ037 EG292R 50/60/80 APSKLLR EQGNLLR DGGNLGR 5.65 0.65  
OZ038 EG292R 50/60/80 APSKLDR LGENLRR DGGNLGR 4.74 0.05  
OZ039 EG292R 50/60/80 APSKLDR LGENLRR DGGNLGR 5.57 1.03  
OZ040 EG292R 50/60/80 APSKLQV EKQNLAR DPSNLRR 7.59 0.53  
OZ041 EG292R 50/60/80 APSKLMR DKANLTR DQGNLIR 6.00 0.17  
OZ042 EG292R 0/60/80 APSKLDR LSENLAR DPSNLRR 1.53 92.11  
OZ043 EG292R 0/60/80 APSKLDR DDANLTR DPSNLRR 0.81 0.16  
OZ044 EG292R 0/60/80 APSKLDR LGENLAR DPSNLRR 6.40 1.64  
OZ045 EG292R 0/60/80 APSKLDR LGENLRR DPSNLRR 1.38 0.17  
OZ046 EG292R 0/60/80 APSKLDR DSSNLRR DQGNLIR 8.40 2.07  
         
   GCC GAT GTC    
OZ047 EG382L 50/40/60 KTTNLKR LSQTLKR HAHRLSD 1.06 0.40  
OZ048 EG382L 50/40/60 TNRDLGR LSENLKR DPTSLNR 3.39 0.15  
OZ049 EG382L 50/40/60 VRKDLVR LLHNLTR DRTPLNR 6.02 0.37  
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OZ050 EG382L 50/40/60 HRRDLDR VAHNLTR DSSPLTR 5.50 0.28  
OZ051 EG382L 50/40/60 HQRDLMR VRHNLTR DPTSLNR 7.93 0.07  
OZ052 EG382L 0/40/60 DSPTLRR VRHNLTR DRTSLAR 16.44 1.39  
OZ053 EG382L 0/40/60 DSPTLRR VRHNLTR DRTSLAR 13.84 1.53  
OZ054 EG382L 0/40/60 MRRDLDR VAHNLRR DPTSLNR 6.90 0.57  
OZ055 EG382L 0/40/60 VRKDLDR IKENLMR DRSSLRR 21.18 2.30  
         
   GGC GAC GAG    
OZ056 EG382R 1-step gradient APSKLDR DVSNLAR RRDGLRR 10.15 0.24  
OZ057 EG382R 1-step gradient APSKLDR DRGNLTR RQDLLIR 5.83 0.28  
OZ058 EG382R 1-step gradient APSKLDR DSSNLRR VHWNLMR 9.06 0.25  
OZ059 EG382R 1-step gradient APSKLDR LVENLRR RVENLHR 5.84 1.27  
OZ060 EG382R 1-step gradient APSKLDR DGSNLRR REDNLGR 5.66 0.36  
OZ061 EG382R 1-step gradient APSKLDR DASNLAR VHWNLMR 9.21 0.47  
OZ062 EG382R 1-step gradient APSKLDR DRGNLQR RQDLLIR 6.39 1.12  
OZ063 EG382R 1-step gradient APSKLDR DKANLTR RHDQLTR 5.89 0.33  
OZ064 EG382R 1-step gradient VPSKLKR MRENLAR RIDNLGR 5.20 0.67  
OZ065 EG382R 1-step gradient APSKLDR DNANLKR RRDGLRR 5.37 1.01  
OZ066 EG382R 1-step gradient APSKLTV DGSNLAR RIDNLGR 0.79 0.08  
         
   GAT GCG GTG    
OZ067 EG502L 2-step gradient TKQHLAV RMDMLKR RPDALPR 1.62 0.02  
OZ068 EG502L 2-step gradient TRQNLDT RRDTLER RPDALPR 2.42 0.02  
OZ069 EG502L 2-step gradient TKQRLVV RTDTLAR RPDALPR 2.23 0.49  
OZ070 EG502L 2-step gradient TNQRLAV RTDTLAR RPDALPR 1.88 0.10  
OZ071 EG502L 2-step gradient TRQNLDT RRDTLRR RPDALPR 1.75 0.79  
OZ072 EG502L 2-step gradient EGNNLAR RRDDLQR RGDVLGK 1.33 0.10  
OZ073 EG502L 2-step gradient TKQRLDV RTDTLAR RRDRLGL 2.23 0.14  
OZ074 EG502L 2-step gradient TKQRLDV RTDTLAR RPDALPR 2.02 0.19  
         
   GGC GAC GAG    
OZ075 EG502R 2-step gradient APSKLMR DRANLTR RPDNLPR& 9.47 0.53  
OZ076 EG502R 2-step gradient SPSKLIR DGSNLAR RVDNLPR 10.74 0.53  
OZ077 EG502R 2-step gradient AQSKLAR DGSNLRR RQDGLGS 7.73 1.26  
OZ078 EG502R 2-step gradient SNSKLAR DMSNLSR RTENLTR 5.70 1.08  
OZ079 EG502R 2-step gradient APSKLDR DESNLRR RTSNLTR 10.28 1.61 + 
OZ080 EG502R 2-step gradient APSKLDR DGSNLRR RPDNLPR 8.72 0.51  
OZ081 EG502R 2-step gradient APSKLDR LQENLAR VHWNLMR 9.20 0.69  
OZ082 EG502R 2-step gradient APSKLDR DESNLRR RVDNLPR 9.98 1.62  
         
   GCC GTC GCC    
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OZ083 EG568L 1-step gradient SNKDLTR DHSSLKR DPSNLRR 2.97 0.41  
OZ084 EG568L 1-step gradient DSPTLRR DPSVLKR EHRGLKR 1.31 0.30  
OZ085 EG568L 1-step gradient VRKDLDR DSAVLTR EHRGLKR 1.11 0.12  
OZ086 EG568L 1-step gradient DSPTLRR DREVLRR ERRALKR 3.99 1.47  
OZ087 EG568L 1-step gradient HQRDLMR DSAVLTR EKRRLAG 1.17 0.28  
OZ088 EG568L 1-step gradient HNRDLTR DISVLHR EKRRLAL 1.03 0.07  
OZ089 EG568L 1-step gradient VRKDLAR DREVLRR DHSNLSR 1.37 0.14  
OZ090 EG568L 1-step gradient TARALVR DHSVLKR ERRGLHR 1.54 0.12  
OZ091 EG568L 1-step gradient DRRDLGR DRGGLRR EHRGLNR 1.04 0.05  
OZ092 EG568L 2-step gradient DSPTLRR RTDGLRR DHSNLSR 5.49 0.74  
OZ093 EG568L 2-step gradient DSPTLRR RTDGLRR DHSNLSR 5.55 0.85  
OZ094 EG568L 2-step gradient DSPTLRR RTDGLRR DHSNLSR 5.20 1.08  
OZ095 EG568L 2-step gradient DSPTLRR RTDGLRR DHSNLSR 5.65 0.55  
OZ096 EG568L 2-step gradient DSPTLRR RTDGLRR DHSNLSR 5.13 0.15  
OZ097 EG568L 2-step gradient DSPTLRR RTDGLRR DHSNLSR 5.04 0.51  
OZ098 EG568L 2-step gradient HNTRLAV DREVLRR ERRGLAR 0.78 0.15  
         
   GCC GCT GCT    
OZ099 EG568R 2-step gradient TARALVR LSQTLKR LKHDLGR 10.04 2.23  
OZ100 EG568R 2-step gradient LKKDLLR LSQTLNR LRHDLHR 6.00 0.98  
OZ101 EG568R 2-step gradient DPSTLRR LRDSLKR LGHTLNR 7.01 1.81  
OZ102 EG568R 2-step gradient DPSTLRR LRDSLKR LGHTLNR 7.88 0.86  
OZ103 EG568R 2-step gradient DPSTLRR LRDSLKR LGHTLNR 7.32 1.49  
OZ104 EG568R 2-step gradient DPSTLRR LRDSLKR LGHTLNR 7.62 0.39  
OZ105 EG568R 2-step gradient HRRDLDR VAHSLKR LKHDLRR 2.25 1.63  
OZ106 EG568R 2-step gradient HRRDLDR LRDSLKR LGHTLNR 7.67 0.26  
         
   GTG GAA TTA    
OZ107 CF877L 2-step gradient RKHILDT QGGNLVR QQTGLAA 1.92 0.58  
OZ108 CF877L 2-step gradient RKSVLLV QGGNLVR QTTGLKS 2.31 0.51  
OZ109 CF877L 2-step gradient RTSSLKR RREHLTR QPTGLTA 2.83 0.20  
OZ110 CF877L 2-step gradient RNFILQR QGGNLVR QVNGLKA 1.61 0.15  
OZ111 CF877L 2-step gradient RKGVLRI QGGNLVR QQTGLNV 2.20 1.90  
OZ112 CF877L 2-step gradient RTSSLKR RREHLTR QPTGLTA 2.52 0.55  
OZ113 CF877L 2-step gradient RKSVLHN QGGNLVR QTTGLKS 1.61 0.20  
OZ14 CF877L 2-step gradient RNFILQR QGGNLVR QQTGLAA 2.95 0.18  
OZ115 CF877L 2-step gradient RNFILQR QGGNLVR QVNGLKA 2.71 0.12  
OZ116 CF877L 2-step gradient RRHVLER QGGNLVR QQTGLNV 2.53 0.38  
OZ117 CF877L 2-step gradient RKSVLLV QGGNLVR QQTGLAA 3.87 0.33  
OZ118 CF877L 2-step gradient RNFILQR QGGNLVR QQTGLNV 3.55 0.08  
         
 204
Table B.S1 continued 
   GAG TGG TTA    
OZ119 CF877R 2-step gradient RQSNLSR RKEHLDI QMTGLNA 2.78 0.35  
OZ120 CF877R 2-step gradient RQSNLAR RKEHLVG QASGLNS 2.53 0.01  
OZ121 CF877R 2-step gradient RQSNLSR RKEHLSI QRTGLTA 2.91 0.19  
OZ122 CF877R 2-step gradient TTHNLMR RADHLKV QGTGLRA 4.72 0.59  
OZ123 CF877R 2-step gradient TKHNLVR RREHLNI QTSGLTA 5.03 0.63  
OZ124 CF877R 2-step gradient TKHNLVR RREHLNI QTSGLTA 4.41 0.20  
OZ125 CF877R 2-step gradient TKHNLVR RQEHLNI QPTGLKV 4.00 0.85  
OZ126 CF877R 2-step gradient TAHNLMR RREHLTI QMTGLNA 2.57 0.28  
OZ127 CF877R 2-step gradient RMSNLDR RREHLTI QGTGLRA 1.60 0.02  
OZ128 CF877R 2-step gradient TTHNLMR RKEHLSI QMTGLNA 2.12 0.07  
OZ129 CF877R 2-step gradient RQSNLSR RKEHLDI QMTGLNA 2.55 0.07  
OZ130 CF877R 2-step gradient RPHNLLR RADHLKV QTTGLNA 2.47 0.22  
OZ131 CF877R 2-step gradient KHSNLTR RREHLTI QPTGLRA 2.08 0.12  
OZ132 CF877R 2-step gradient RQSNLSR RSEHLAI QRVGLHA 1.28 0.05  
OZ133 CF877R 2-step gradient KHSNLTR RADHLKV QNTGLHA 3.24 0.05  
OZ134 CF877R 2-step gradient RQSNLSR RNEHLVL QKTGLRV 3.71 0.19  
OZ135 CF877R 2-step gradient KHSNLTR RREHLTI QMTGLNA 2.25 0.07  
OZ136 CF877R 2-step gradient KHSNLTR RREHLTI QMTGLNA 2.16 0.06  
OZ137 CF877R 2-step gradient RHSNLTR RQEHLNI QMTGLNA 2.26 0.04  
OZ138 CF877R 2-step gradient KKTNLTR RREHLTI QQTGLNV 2.52 0.41  
OZ139 CF877R 2-step gradient KHSNLTR RKEHLSI QMTGLNA 2.74 0.03  
OZ140 CF877R 2-step gradient KHSNLTR RKEHLTI QRTGLSI 2.99 0.48  
OZ141 CF877R 2-step gradient KHGNLTR RREHLTI QQTGLNV 2.87 0.08  
OZ142 CF877R 2-step gradient KHSNLTR RKEHLDI QMTGLNA 2.73 0.16  
         
   GCT GAC GAA    
OZ143 VF2471L 2-step gradient QRTDLSR DKGNLSR QHPNLTR 5.71 0.14  
OZ144 VF2471L 2-step gradient TKQGLQR LQENLTR QHPNLTR 9.95 1.57  
OZ145 VF2471L 2-step gradient QRQALDR DNSNLAR QRNNLGR 6.33 0.14  
OZ146 VF2471L 2-step gradient GRQALDR DKANLTR QRNNLGR 6.85 0.97  
OZ147 VF2471L 2-step gradient QTADLRR DSGNLTR QGPNLSR 6.59 1.69 + 
OZ148 VF2471L 2-step gradient QRQALDR DNSNLAR QRNNLGR 5.04 1.01  
OZ149 VF2471L 2-step gradient TKQGLQR LQENLTR QHPNLTR 6.78 0.36  
OZ150 VF2471L 2-step gradient GRQALDR DKANLTR QRNNLGR 5.74 1.02  
OZ151 VF2471L 2-step gradient TKQGLQR LPENLTR QGPNLSR 6.08 1.02  
OZ152 VF2471L 2-step gradient TKQGLQR LGENLRR QRNNLGR 5.79 1.49  
OZ153 VF2471L 2-step gradient ARQGLNR DKANLTR QGPNLSR 6.00 0.34  
OZ154 VF2471L 2-step gradient TKQGLQR LRENLAR QHPNLTR 8.01 0.05  
         
   GTG GAC GAG    
 205
Table B.S1 continued 
OZ155 VF2471R 2-step gradient RHTVLRV DRANLLR RGDNLNR 8.42 0.60  
OZ156 VF2471R 2-step gradient RPFTLAR DRANLLR RADNLGR 9.19 0.80  
OZ157 VF2471R 2-step gradient RPFTLAR DRANLLR RADNLGR 9.36 0.57  
OZ158 VF2471R 2-step gradient RNFILQR DRSNLTR RHDQLTR 6.84 0.46  
OZ159 VF2471R 2-step gradient RPFTLAR DRANLLR RADNLGR 9.80 1.20  
OZ160 VF2471R 2-step gradient RSTLLRV DASNLAR RGDNLNR 9.22 3.83  
OZ161 VF2471R 2-step gradient RPFTLAR DRANLLR RADNLGR 9.02 0.33  
OZ162 VF2471R 2-step gradient RKTILTT DRANLLR RADNLGR 11.54 0.69  
OZ163 VF2471R 2-step gradient RNSVLQL DEGNLSR RIDNLGR 8.88 0.76  
OZ164 VF2471R 2-step gradient RASVLDI DRGNLTR REDNLGR 6.90 0.24  
OZ165 VF2471R 2-step gradient RNFILQR DPSNLAR RRDGLRR 5.40 0.09 + 
OZ166 VF2471R 2-step gradient RNFILQR DRANLRR RHDQLTR 9.67 1.17  
         
   GGT GGT GGA    
OZ167 VF3537L 2-step gradient LRHHLEA HNHHLVR QNSHLRR 5.07 0.60  
OZ168 VF3537L 2-step gradient LRHHLEA MKHHLTR QTTHLRR 4.56 2.10  
OZ169 VF3537L 2-step gradient LRHHLEA MSHHLIR QNSHLRR 5.59 0.12  
         
OZ170 VF3537L 2-step gradient LRHHLEA MKHHLTR QTTHLRR 4.97 0.18  
OZ171 VF3537L 2-step gradient TKQKLQV HNHHLVR QTDHLKR 5.77 0.44  
OZ172 VF3537L 2-step gradient MKHHLAR EAHHLSR QNSHLRR 5.46 0.96  
OZ173 VF3537L 2-step gradient LRHHLEA LPHHLQR QNSHLRR 5.00 0.79  
OZ174 VF3537L 2-step gradient RKQHLDA HNHHLVR QTTHLRR 7.21 0.53  
OZ175 VF3537L 2-step gradient LRHHLEA MKHHLGR QSQHLKR 3.37 0.07  
OZ176 VF3537L 2-step gradient MKHHLDA LPHHLQR QGGHLAR 5.38 0.09  
OZ177 VF3537L 2-step gradient LRHHLEA MSHHLIR QNSHLRR 6.39 0.32  
OZ178 VF3537L 2-step gradient LRHHLEA MSHHLIR QNSHLRR 4.58 0.15 + 
         
   GGC GGC GCC    
OZ179 VF3537R 2-step gradient RGDHLDR LKEHLTR DPSNLRR 14.24 3.89  
OZ180 VF3537R 2-step gradient RGDHLDR LKEHLTR DPSNLRR 8.29 0.66  
OZ181 VF3537R 2-step gradient RGDHLDR LKEHLTR DPSNLRR 5.29 3.37  
OZ182 VF3537R 2-step gradient APSKLDR EASKLKR DPSNLRR 3.28 0.03  
OZ183 VF3537R 2-step gradient RGDHLDR LKEHLTR DPSNLRR 13.74 7.23  
OZ184 VF3537R 2-step gradient APSKLKR ERSHLKR DPSNLRR 1.03 0.11  
OZ185 VF3537R 2-step gradient APSKLKR EQSKLVR DPSNLRR 3.99 0.18  
OZ186 VF3537R 2-step gradient RGDHLDR LKEHLTR DPSNLRR 7.03 5.32  
OZ187 VF3537R 2-step gradient VPSKLKR ERSKLKR DPSNLRR 12.53 0.80  
         
   GGT GGA GGA    
OZ188 VF3540L 2-step gradient IPNHLAR QSAHLKR QNSHLRR 13.95 0.37  
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OZ189 VF3540L 2-step gradient IPNHLAR QSAHLKR QNSHLRR 15.08 1.41  
OZ190 VF3540L 2-step gradient IPNHLAR QSAHLKR QNSHLRR 14.09 0.76  
OZ191 VF3540L 2-step gradient LRHHLEA QSPHLKR QGGHLKR 4.09 2.71  
OZ192 VF3540L 2-step gradient KHSNLTR RNENLAR RIDKLGP 4.45 0.32  
OZ193 VF3540L 2-step gradient IPNHLAR QSAHLKR QQAHLAR 12.73 1.36  
OZ194 VF3540L 2-step gradient IPNHLAR QSAHLKR QMSHLKR 15.85 5.11 + 
OZ195 VF3540L 2-step gradient IPNHLAR QSAHLKR QNSHLRR 14.00 1.17  
OZ196 VF3540L 2-step gradient IPNHLAR QSAHLKR QAGHLTR 13.06 1.05  
OZ197 VF3540L 2-step gradient IPNHLAR QSAHLKR QQAHLAR 10.80 0.44  
OZ198 VF3540L 2-step gradient IPNHLAR QSAHLKR QQAHLAR 14.31 1.08  
OZ199 VF3540L 2-step gradient IPNHLAR QSAHLKR QQAHLAR 14.58 0.60 + 
         
   GGA GGC GGC    
OZ200 VF3540R 2-step gradient EESNLRR RPDVLAR RVDDLGR 15.71 0.65  
OZ201 VF3540R 2-step gradient EESNLRR RPDVLAR RVDDLGR 16.79 1.38  
OZ202 VF3540R 2-step gradient DEANLRR RKDDLKR REDSLPR 8.64 0.32  
OZ203 VF3540R 2-step gradient DEANLRR RKDDLKR REDSLPR 7.92 1.49  
OZ204 VF3540R 2-step gradient DEANLRR RKDDLKR REDSLPR 7.15 0.79  
OZ205 VF3540R 2-step gradient EESNLRR RRESLVR REDSLPR 12.93 0.83  
OZ206 VF3540R 2-step gradient DEANLRR RKDDLKR REDSLPR 10.23 4.44  
OZ207 VF3540R 2-step gradient EESNLRR RRESLVR REDSLPR 11.05 2.29  
OZ208 VF3540R 2-step gradient DEANLRR RKDDLKR REDSLPR 8.34 0.09  
OZ209 VF3540R 2-step gradient DEANLRR RKDDLKR REDSLPR 7.95 0.09  
         
   GCT GCT GAC    
OZ210 VF2468L 2-step gradient LRQTLAR VAHSLKR DPSNLRR 5.98 1.20  
OZ211 VF2468L 2-step gradient LRQTLAR VAHSLKR DPSNLRR 6.68 1.26  
OZ212 VF2468L 2-step gradient LRQTLAR VAHSLKR DPSNLRR 5.93 0.85  
OZ213 VF2468L 2-step gradient TKQVLDR VKHSLQR DPSNLRR 4.38 0.65  
OZ214 VF2468L 2-step gradient LRQTLAR VAHSLKR DPSNLRR 5.68 0.06  
OZ215 VF2468L 2-step gradient TKQVLDR VKHSLQR DPSNLRR 3.63 0.09  
OZ216 VF2468L 2-step gradient MKNTLTR QRSDLTR DPSNLRR 5.47 0.21  
OZ217 VF2468L 2-step gradient TGQILDR VAHSLKR DPSNLRR 7.19 2.15  
OZ218 VF2468L 2-step gradient LRQTLAR VAHSLKR DPSNLRR 6.84 0.43  
OZ219 VF2468L 2-step gradient GRLALLR VAHSLKR DPSNLRR 6.34 0.69  
         
   GGA TGA GAG    
OZ220 VF2468R 2-step gradient RQDRLDR QREHLVT RRDNLNR 9.50 0.19  
OZ221 VF2468R 2-step gradient RQDRLDR QKEHLAG RRDNLNR 9.65 1.51  
OZ222 VF2468R 2-step gradient RQDRLDR QKEHLAV RGDNLKR 10.22 1.00  
OZ223 VF2468R 2-step gradient RQDRLDR QNEHLKV RADNLRR 11.92 3.09  
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OZ224 VF2468R 2-step gradient THAHLTR QREHLNG RADNLGR 11.96 1.07  
OZ225 VF2468R 2-step gradient THAHLTR QREHLTG RRDNLNR 11.54 0.52  
OZ226 VF2468R 2-step gradient RNDRLLR QKEHLTV RRDNLNR 11.55 0.53  
OZ227 VF2468R 2-step gradient RQDRLDR QKEHLAG RRDNLNR 11.59 1.15  
OZ228 VF2468R 2-step gradient THAHLTR QREHLVT RRDNLNR 11.69 1.17  
OZ229 VF2468R 2-step gradient THAHLTR QNEHLTG RGDNLAR 10.69 0.51  
OZ230 VF2468R 2-step gradient THAHLTR QREHLNG RGDNLKR 14.10 0.15  
OZ231 VF2468R 2-step gradient THAHLTR QREHLVT RIDNLGR 12.63 1.65  
   GAG GAG GGG    
OZ232 VF3542L 2-step gradient KLTNLTR REDNLDR RIDKLGG 4.80 0.39  
OZ233 VF3542L 2-step gradient RQMNLDR RQDNLGR RIDKLGG 5.88 1.39  
OZ2034 VF3542L 2-step gradient KHHNLLR RDDNLQR RMEHLPR 5.22 0.47  
OZ235 VF3542L 2-step gradient KPSNLER RPDNLVR RIDKLGG 6.10 0.22  
         
OZ236 VF3542L 2-step gradient KHSNLTR RADNLGR RMEHLPR 4.44 0.41  
OZ237 VF3542L 2-step gradient KQSNLLR REDNLDR RRHGLGR 4.71 0.60  
OZ238 VF3542L 2-step gradient RMSNLDR REDNLGR RDDGLGR 3.13 0.12  
OZ239 VF3542L 2-step gradient RASNLTR REDNLDR RRWGLGR 4.38 0.40  
OZ240 VF3542L 2-step gradient KHSNLTR RDDNLQR RNDKLVP 5.18 0.45  
         
   GAC GCG GCG    
OZ241 VF3542R 2-step gradient EEANLRR RRDDLTR REDVLGR 8.53 1.23  
OZ242 VF3542R 2-step gradient EEANLRR RSDDLRR RLDMLAR 8.72 1.11  
OZ243 VF3542R 2-step gradient EESNLRR RRDDLTR RLDMLAR 11.42 0.12  
OZ244 VF3542R 2-step gradient EESNLRR RRDDLTR RLDMLAR 13.12 1.53  
OZ245 VF3542R 2-step gradient EEANLRR RRDDLTR RLDMLAR 9.96 0.16  
OZ246 VF3542R 2-step gradient EESNLRR RRDDLTR RKDLLHR 10.16 0.55  
OZ247 VF3542R 2-step gradient EQSNLRR RRDDLTR RLDMLAR 8.42 1.54  
OZ248 VF3542R 2-step gradient EESNLRR RRDDLTR RLDMLAR 12.11 0.66  
OZ249 VF3542R 2-step gradient EESNLRR RRDDLLR RIDNLGR 12.25 0.70  
OZ250 VF3542R 2-step gradient EEANLRR RRDDLTR RTDLLGR 8.98 0.60  
OZ251 VF3542R 2-step gradient EEANLRR RRDDLTR RLDMLAR 10.25 1.46  
OZ252 VF3542R 2-step gradient EEANLRR RKEDLAR RLDMLAR 11.82 0.37  
         
   GGC GCC GCC    
OZ253 VF3552L 2-step gradient VPSKLLR DPSVLTR EHRGLKR 4.29 0.30  
OZ254 VF3552L 2-step gradient TPSKLLR DPSVLTR EHRGLKR 7.39 1.10  
OZ255 VF3552L 2-step gradient SNSKLDR DPSVLTR EHRGLKR 3.30 0.23  
OZ256 VF3552L 2-step gradient SPSKLVR DPSVLTR EGGTLRR 2.88 0.10 + 
OZ257 VF3552L 2-step gradient SPSKLVR DPSVLTR EHRGLKR 3.22 0.15  
OZ258 VF3552L 2-step gradient TPSKLLR DSSVLRR ERRGLAR 33.85 27.58  
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OZ259 VF3552L 2-step gradient TPSKLLR DSSVLRR ERRGLAR 20.62 20.68  
OZ260 VF3552L 2-step gradient SPSKLVR DSSVLRR ERRGLAR 14.89 11.80  
OZ261 VF3552L 2-step gradient TPSKLLR DSSVLRR ERRGLAR 49.72 42.09  
OZ262 VF3552L 2-step gradient VPSKLLR DPSVLTR EHRGLKR 4.30 0.30  
         
   GCG GAC GTG    
OZ263 VF3552R 2-step gradient KHDTLHR DRGNLTR RGDALAR 36.42 20.49  
OZ264 VF3552R 2-step gradient KNDTLAR DRANLRR RPDALSR 8.12 0.82  
OZ265 VF3552R 2-step gradient KNDTLAR DRANLRR RPDALSR 8.03 1.21  
OZ266 VF3552R 2-step gradient KHDTLHR DRGNLTR RGDALAR 29.45 48.83  
OZ267 VF3552R 2-step gradient KKHTLVK LRENLAR RMDALMR 30.79 5.40  
OZ268 VF3552R 2-step gradient KNDTLAR DNSNLAR RGDALAR 3.93 0.17  
OZ269 VF3552R 2-step gradient KKHTLTK DRGNLQR RGDALAR 9.93 2.89  
OZ270 VF3552R 2-step gradient RNHTLAR DNSNLAR RGDALAR 4.67 4.12  
OZ271 VF3552R 2-step gradient KNDTLAR ESGNLAR RGDVLGK 8.83 0.45  
OZ272 VF3552R 2-step gradient RSDTLAR DQGNLRR RPDALPR 10.32 1.44  
OZ273 VF3552R 2-step gradient KRHTLTR DSGNLTR RLDVLGN 3.91 0.48  
         
   GGG GCT GCC    
OZ274 HX508L 2-step gradient RSAHLQA LSQTLKR ERRGLAR 2.12 0.23  
OZ275 HX508L 2-step gradient RSAHLQA LSQTLKR EHRGLKR 3.43 0.23  
OZ276 HX508L 2-step gradient RSAHLQA LSQTLKR EHRGLKR 6.31 2.17 + 
OZ277 HX508L 2-step gradient RGEHLTN LSQTLKR EHRGLKR 3.61 0.72  
OZ278 HX508L 2-step gradient RSAHLQA LSQTLKR DPSNLRR 2.75 0.15  
OZ279 HX508L 2-step gradient RRLHLTN LSQTLKR DPSNLRR 1.89 0.04  
OZ280 HX508L 2-step gradient RRLHLTN LSQTLKR DPSNLRR 2.34 0.13  
         
   GCC GAT GCT    
OZ281 HX508R 2-step gradient AKRDLDR LMHNLTR LKHDLRR 5.74 0.65  
OZ282 HX508R 2-step gradient HRRDLDR LMHNLTR LKHDLRR 7.92 0.93  
OZ283 HX508R 2-step gradient AKRDLDR LLHNLTR LKHDLRR 4.79 0.37  
OZ284 HX508R 2-step gradient DGSTLNR VRHNLTR VQNSLTR 8.53 1.36  
OZ285 HX508R 2-step gradient DGSTLNR IRHNLTR LKHDLRR 6.19 0.18  
OZ286 HX508R 2-step gradient AKRDLDR LLHNLTR LKHDLRR 4.87 0.45  
OZ287 HX508R 2-step gradient LKKDLLR IKHNLAR LKHDLRR 14.03 4.08  
OZ288 HX508R 2-step gradient DSSTLAR VRHNLTR LKHDLRR 2.92 1.96  
OZ289 HX508R 2-step gradient DGSTLRR VRHNLTR VSNSLAR 5.88 0.19  
OZ290 HX508R 2-step gradient AKRDLDR VNHNLTR LKHDLRR 9.20 4.01  
OZ291 HX508R 2-step gradient DGSTLNR VRHNLTR LKHDLRR 15.46 14.60  
         
   GGG GCT GCG    
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OZ292 HX761L 2-step gradient KQDHLTK LSQTLKR RLDMLAR 8.12 2.53  
OZ293 HX761L 2-step gradient KQDHLTK LSQTLKR RLDVLAR 5.32 2.71  
OZ294 HX761L 2-step gradient KQDHLRV LSQTLKR RPDGLAR 14.19 1.10  
OZ295 HX761L 2-step gradient KKDHLHR LSQTLKR RLDMLAR 13.99 1.72  
OZ296 HX761L 2-step gradient KQDHLRV LSQTLKR RPDGLAR 13.85 4.18  
OZ297 HX761L 2-step gradient KQDHLTK LSQTLKR RLDMLAR 10.47 2.07  
OZ298 HX761L 2-step gradient KQDHLTK LSQTLKR RLDMLAR 11.51 0.66  
OZ299 HX761L 2-step gradient KQDHLRV LSQTLKR RLDMLAR 9.86 0.62  
OZ300 HX761L 2-step gradient KKDHLHR LSQTLKR RLDMLAR 14.09 0.79  
OZ301 HX761L 2-step gradient KKDHLHR LSQTLNR RLDMLAR 11.23 0.76  
OZ302 HX761L 2-step gradient KKDHLHR LSQTLNR RLDMLAR 6.65 1.55  
         
   GCC TTT GAG    
OZ303 HX761R 2-step gradient AKRDLDR SPNGLII VHWNLKR 4.07 0.06  
OZ304 HX761R 2-step gradient DRRGLVR SPNGLQV SASNLTR 3.31 0.58  
OZ305 HX761R 2-step gradient AKRDLDR SPNGLII VHWNLKR 4.01 0.20  
OZ306 HX761R 2-step gradient AKRDLDR SPNGLEI VHWNLMR 3.32 0.02  
OZ307 HX761R 2-step gradient AKRDLDR SPNGLII VHWNLKR 3.53 0.49  
OZ308 HX761R 2-step gradient LKKDLLR SQLGLQV SASNLHR 2.44 0.07 + 
OZ309 HX761R 2-step gradient MRRDLLR SQLGLSV SASNLTR 2.67 0.05 + 
OZ310 HX761R 2-step gradient MRRDLER SPNGLVI VHWNLMR 2.92 0.08  
OZ311 HX761R 2-step gradient MRRDLLR SQLGLSV SASNLTR 2.81 0.44 + 
OZ312 HX761R 2-step gradient AKRDLDR SPNGLVI VHWNLMR 3.63 0.17  
OZ313 HX761R 2-step gradient MRRDLLR SQLGLSV SASNLTR 2.55 0.38 + 
OZ314 HX761R 2-step gradient MRRDLLR SQLGLSV SASNLTR 2.94 0.14 + 
         
   GGT GCT GTG    
OZ315 HX500L 2-step gradient RQQKLDT LSQTLKR RGDALAR 2.76 0.13  
OZ316 HX500L 2-step gradient TTTKLAI LSQTLKR RGDVLGK 2.88 0.55  
OZ317 HX500L 2-step gradient TTTKLAI LSQTLKR RGDVLGK 3.48 0.71  
OZ318 HX500L 2-step gradient RRSRLDV LSQTLKR RGDALAR 3.15 0.06  
OZ319 HX500L 2-step gradient TTTKLAI LSQTLKR RGDVLGK 4.10 0.16  
OZ320 HX500L 2-step gradient TTTKLAI LSQTLKR RGDVLGK 3.86 0.19 + 
OZ321 HX500L 2-step gradient TNQKLQV LSQTLRR RGDALAR 3.11 0.11  
OZ322 HX500L 2-step gradient RQQKLDT LSQTLKR RGDVLGK 2.90 0.50  
OZ323 HX500L 2-step gradient TTTKLAI LSQTLKR RGDVLGK 4.09 0.22 + 
OZ324 HX500L 2-step gradient TTTKLAI LSQTLNR RGDVLGK 4.93 0.40  
OZ325 HX500L 2-step gradient TTTKLAI LSQTLNR RGDVLGK 5.65 1.02  
         
   TAC GCC GGC    
OZ326 HX500R 2-step gradient DPSNLIR DSAVLTR RKEPLGR 0.96 0.06  
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OZ327 HX500R 2-step gradient PLARLEE DRSVLRN KRVSLQG 1.11 0.22  
OZ328 HX500R 2-step gradient VRSPLPD DVSVLRR KRVSLGA 0.96 0.04  
OZ329 HX500R 2-step gradient PLARLEE DRSVLKR KRVSLQG 1.40 0.17  
OZ330 HX500R 2-step gradient SRLGLVA DHSVLKR KNISLNH 1.01 0.27  
OZ331 HX500R 2-step gradient PLARLEE DHTVLRR KRVSLQG 0.93 0.04  
OZ332 HX500R 2-step gradient DRSNLRK DRTTLKR DGGHLSR 1.19 0.01 + 
         
   GCA GTG TGG    
OZ333 HX587L 2-step gradient NKTDLGR RMDVLTR RSDHLSL 5.73 0.16 + 
OZ334 HX587L 2-step gradient NKTDLGR RMDVLTR RSDHLSL 4.87 0.54 + 
OZ335 HX587L 2-step gradient NKTDLGR RMDVLTR RSDHLSL 5.15 0.34 + 
OZ336 HX587L 2-step gradient NKTDLGR RMDVLTR RSDHLSL 5.40 0.35 + 
OZ337 HX587L 2-step gradient NKTDLGR RMDVLTR RSDHLSL 4.94 0.29 + 
OZ338 HX587L 2-step gradient NKTDLGR RMDVLTR RSDHLSL 5.00 0.52 + 
OZ339 HX587L 2-step gradient NKTDLGR RADSLGR RADHLPQ 2.51 0.33  
OZ340 HX587L 2-step gradient NKTDLGR RRDMLRR RMDHLAG 14.45 2.74  
OZ341 HX587L 2-step gradient NKTDLGR RADSLGR RADHLPQ 3.10 0.16  
OZ342 HX587L 2-step gradient TPTDLNR RRDTLRR RMDHLAG 5.49 0.17  
OZ343 HX587L 2-step gradient NKTDLGR RADSLGR RADHLPQ 3.34 0.22  
OZ344 HX587L 2-step gradient LKHGLLR RKDGLMR RSEHLGI 3.55 0.33  
         
   GCC GGT TGG    
OZ345 HX587R 2-step gradient DESTLRR MKHHLGR RSDHLSL 8.15 0.73  
OZ346 HX587R 2-step gradient AKKDLRR LRQHLVR RSDHLSL 2.32 0.32  
OZ347 HX587R 2-step gradient LKKDLLR LRQSLTR RSDHLSL 3.10 0.99  
OZ348 HX587R 2-step gradient VRKDLDR MKHHLGR RSDHLSL 4.05 0.12 + 
OZ349 HX587R 2-step gradient SKKSLTR EAHHLSR RSDHLSL 7.00 0.27 + 
OZ350 HX587R 2-step gradient DPSTLRR LPHHLQR RMDHLAG 4.66 0.64  
OZ351 HX587R 2-step gradient LAKDLVR HKHRLVT RSDHLSL 3.74 0.29  
OZ352 HX587R 2-step gradient SKKSLTR QAHILKR RSDHLSL 7.03 0.64  
OZ353 HX587R 2-step gradient HRRDLDR QRHHLVR RSDHLSL 4.60 0.16 + 
OZ354 HX587R 2-step gradient DPSTLRR LPHHLKR RSDHLSL 7.25 0.16 + 
OZ355 HX587R 2-step gradient MRRDLLR LGHHLVR RSDHLSL 3.94 0.27  
OZ356 HX587R 2-step gradient DPSTLRR QTHHLQR RSDHLSL 4.48 0.33  
         
   TCT GAG TGG    
OZ357 HX735L 2-step gradient SKPNLKM RQDNLGR RMDHLAG 3.58 0.69  
OZ358 HX735L 2-step gradient SKPNLKM RQDNLGR RSDRLAL 2.29 0.12 + 
OZ359 HX735L 2-step gradient SKPNLKM RADNLGR RSDRLAL 2.20 0.47 + 
OZ360 HX735L 2-step gradient SKPNLKM RADNLGR RSDRLAL 2.32 0.21  
OZ361 HX735L 2-step gradient TKPNLKI RGDNLVR RSDHLSL 2.84 0.36 + 
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OZ362 HX735L 2-step gradient SKPNLKM RQDNLGR RRDRLRI 2.63 0.28  
OZ363 HX735L 2-step gradient SKPNLKM RGDNLGR RSDHLSL 3.01 0.12 + 
OZ364 HX735L 2-step gradient SNRNLKT RQDNLGR RKAGLHI 2.56 0.67  
OZ365 HX735L 2-step gradient TKPLLKI RQDNLGR RSDRLAL 1.70 0.09  
OZ366 HX735L 2-step gradient SNRNLRI RADNLGR RSDRLAL 1.96 0.14  
   GAG GAA GGG    
OZ367 HX735R 2-step gradient KHSNLTR QGANLVR RNDKLVP 4.85 0.88 + 
OZ368 HX735R 2-step gradient KLTNLTR QKVNLAR RIDKLGG 4.72 1.15  
OZ369 HX735R 2-step gradient KHSNLTR QHTNLTR RIDKLGG 5.51 0.94 + 
OZ370 HX735R 2-step gradient KKTNLTR QMSNLDR RIDKLGG 6.88 1.22  
OZ71 HX735R 2-step gradient KLTNLTR QMSNLDR RGDKLGH 4.65 1.24  
OZ372 HX735R 2-step gradient KHSNLTR QRVNLAR RIDKLGG 4.13 0.92  
OZ373 HX735R 2-step gradient KHSNLTR QKVNLAR RGDKLGP 5.25 0.52  
OZ374 HX735R 2-step gradient KHSNLTR QLANLGR RIDKLGG 4.66 0.53 + 
OZ375 HX735R 2-step gradient KHSNLTR QKVNLAR RGDKLGP 4.53 0.96  
OZ376 HX735R 2-step gradient RQSNLSR QMSNLDR RIDKLGG 4.90 1.80 + 
OZ377 HX735R 2-step gradient KHSNLTR QQTNLAR RGDKLGP 5.59 0.65  
         
   GCT GGC TCT    
OZ378 HX2119L 2-step gradient HRPSLVR ERGHLTR QRNALAG 1.22 0.02  
OZ379 HX2119L 2-step gradient KHQTLQR ERGHLNR QRNALAG 1.26 0.37  
OZ380 HX2119L 2-step gradient ATGDLRR ENSGLKR QNNALTG 1.01 0.30  
OZ3081 HX2119L 2-step gradient AKQGLRR LKEHLTR QRNTLQG 1.41 0.06 + 
OZ382 HX2119L 2-step gradient RSLTLLR EQSKLTR ARNLLRG 0.77 0.05  
OZ383 HX2119L 2-step gradient TKQVLDR ENSKLKR QRNALAG 1.46 0.38  
OZ384 HX2119L 2-step gradient NKQALDR LHENLKR QRNALAG 2.47 0.42  
OZ385 HX2119L 2-step gradient HKLTLVR ERGHLIR QRNTLKG 2.69 1.12  
OZ386 HX2119L 2-step gradient GMLALRR LHENLKR ARNALGG 0.95 0.08  
         
   TTC GGT TCT    
OZ387 HX2119R 2-step gradient RPSHLVT EAHHLGR ARHLLKG 1.28 0.21  
OZ388 HX2119R 2-step gradient LHKLLVI EPHHLMR QRNALAG 0.71 0.05  
OZ389 HX2119R 2-step gradient RENHLRI ERHQLVR QRNALGG 0.92 0.04 + 
OZ390 HX2119R 2-step gradient RHHHLDV EKHQLIR QRNTLKG 1.41 0.29  
         
   TTC GGA GAA    
OZ391 SR2163L 2-step gradient RPNHLAI QSPHLKR QSNNLTR 8.40 0.29  
OZ392 SR2163L 2-step gradient RPNHLTA QSAHLKR LGENLRR 5.74 0.34  
OZ393 SR2163L 2-step gradient RPNHLAI QSPHLKR QSNNLTR 8.10 0.05  
OZ394 SR2163L 2-step gradient RANHLTI QSAHLKR LGENLRR 6.41 0.87  
   GAT GGA GGC    
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Table B.S1 continued 
OZ395 SR2163R 2-step gradient SQQALGV QSAHLKR ESGHLKR 1.70 0.23  
OZ395 SR2163R 2-step gradient TKQHLAV QSAHLKR ESGHLRR 1.89 0.04 + 
OZ397 SR2163R 2-step gradient SKQALAV QSAHLKR ENSKLRR 1.89 0.13 + 
OZ398 SR2163R 2-step gradient TNQRLDV QNPHLTN KNVSLVG 0.89 0.02  
OZ399 SR2163R 2-step gradient SKQALAV QSAHLKR ENSKLRR 1.74 0.07 + 
OZ400 SR2163R 2-step gradient TKQHLAV QSAHLKR ESGHLRR 2.08 0.25 + 
OZ401 SR2163R 2-step gradient SKQALAV QSAHLKR ESGHLKR 1.75 0.15  
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Table B.S 3 Primers used in this study 
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APPENDIX C. UNEXPECTED FAILURE RATES FOR 
MODULAR ASSEMBLY OF ENGINEERED ZINC FINGERS 
 
A paper published in Nature Methods 2008 
 
Cherie L. Ramirez, Jonathan E. Foley, David A. Wright, Felix Müller-Lerch, Shamim H. 
Rahman, Tatjana I. Cornu, Ronnie J. Winfrey, Jeffry D. Sander, Fengli Fu, Jeffrey A. 
Townsend, Toni Cathomen, Daniel F. Voytas & J Keith Joung 
 
TO THE EDITOR 
Zinc-finger nucleases (ZFNs) consist of an engineered zinc-finger array fused to a 
nuclease domain. Dimers of ZFNs can create targeted double-strand DNA breaks, which 
can stimulate highly efficient gene targeting in many cell types1 (Figure C.S1 online). We 
found that the modular assembly method of engineering zinc-finger arrays has an 
unexpectedly higher failure rate than previously reported. Modular assembly advocates 
linking individual zinc fingers, each of which typically binds to a 3-bp ‘subsite’ (Figure 
C.S2 online). Two large-scale surveys have suggested that modular assembly is highly 
effective (100% (2) and 60% (3) success rates) for making three-finger arrays designed to 
bind 9-bp target sites. The Zinc Finger Consortium recently assembled an archive of 141 
previously published finger modules3–5 encoded on a standardized platform6. Our initial 
experiences using these reagents suggested that modular assembly was inefficient 
(Supplementary Discussion and TableC.S1 online). 
To perform a larger-scale test, we assembled 168 zinc-finger arrays designed for 
104 diverse target DNA sites (TableC.S2 and Supplementary Methods online). We tested 
these domains for DNA binding using a bacterial two-hybrid (B2H) assay (6), which 
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accurately identifies arrays that lack activity as ZFNs in human cells (Supplementary 
Discussion and Figures. B.S3 and B.S4 online). For 79 of the 104 target sites, we did not 
obtain a single three-finger array that scored positively in the B2H assay (overall failure 
rate of ~76%; Fig. 1a and TableC.S2). Notably, modular assembly was far less effective for 
target sites composed of two, one, or no GXX subsites (where X is any base) compared 
with those composed of three GXX subsites (Figure C.1A). Additionally, because ZFNs 
function as dimers, we would expect failure rates for making a functional ZFN pair to be 
even higher (Supplementary Discussion). Notably, these values are all likely 
underestimates of actual failure rates because not all zinc-finger arrays that are positive in 
the B2H assay will be active as ZFNs in human cells (Figure C.S4). 
One reason for the apparent discrepancy between previously published studies2,3 
and our results is that the former primarily used 9-bp sites composed of two or three GXX 
subsites, whereas we used sites with a more varied number of GXX subsites (Figure C.1B); 
this difference will critically affect the observed failure rate (Figure C.1A). Our study 
represents a more meaningful evaluation because target sites containing one or no GXX 
subsites (underrepresented in previous studies) encompass the majority (>75%) of the 
107,011 potential 9-bp sites that can be targeted with existing modules (Figure C.1B). 
Our results strongly suggest that potential users of modular assembly should expect 
that this method will fail to yield a functional three–zinc finger array for the majority of 
potentially targetable sites. To emphasize this we have modified content on the Zinc Finger 
Consortium website (http://www.zincfigers.org; Supplementary Methods). Highly 
effective but more labor-intensive selection-based methods for engineering zinc finger 
arrays have been previously described (Supplementary Discussion), and at present these 
are the only publicly available alternatives for academic researchers interested in using 
ZFN technology. 
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Figure C.1 Large-scale evaluation of the modular assembly method for engineering 
zinc-finger arrays. A) Data for success and failure of modular assembly as judged by the 
B2H assay for all 104 target DNA sites (see Supplementary Discussion for definition of 
success threshold) and for subsets of target sites containing three, two, one or no GXX 
subsites. ‘Successful’ sites are those for which at least one functional zinc-finger array was 
identified; ‘failed’ sites are those for which we failed to obtain a single successful array (see 
Table C.S2 for details). Predicted failure rates for each set of target sites are indicated above 
the bars. B) Distributions of target DNA sites used in different modular assembly 
evaluation studies according to the number of GXX subsites present. The distribution of all 
107,011 potential 9-bp sites that can be targeted using 141 zinc-finger modules from the 
Zinc Finger Consortium Modular Assembly Kit 1.0 (6) is also shown (far right bar). 
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SUPPLEMENTARY FIGURES & TABLES 
 
Figure C.S1 ZFNs induce highly efficient gene targeting events.  (a) Schematic of a ZFN 
monomer (left) and a pair of ZFNs cleaving DNA as a dimer (right). (b) Schematic 
representing ZFN-enhanced recombination-based genome manipulation. ZFNs introduce 
site-specific double-strand DNA breaks (DSBs) that can be harnessed to mediate gene 
targeting via homologous recombination with an exogenously introduced “donor 
template.”  
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Figure C.S2 Schematic illustrating the “modular assembly” method of engineering 
multi-finger domains Fingers from archives of pre-characterized modules are joined 
together to create three- finger domains capable of recognizing a 9 bp target DNA site. 
Single fingers (colored  spheres) recognize their cognate 3 bp “subsites” (colored 
rectangles).  
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Figure C.S3 Schematic of the bacterial two-hybrid (B2H) reporter used to assess 
DNA-binding activities of zinc finger arrays.  In the B2H assay, the ability of a zinc finger 
array to bind a target DNA site is reflected as increased expression of a lacZ reporter gene 
encoding β-galactosidase (1-3). The B2H requires the expression of two hybrid proteins: 
one a fusion between the test zinc finger array (ZFA) and a fragment of the yeast Gal11P 
protein (GP) and the other a hybrid of the RNA polymerase α-subunit and a fragment of the 
yeast Gal4 protein (G4). If the test ZFA binds to a target DNA site positioned upstream of a 
promoter, RNA polymerase complexes that have incorporated Rα hybrid proteins are 
recruited to the promoter and expression of the downstream lacZ reporter is activated.  
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Figure C.S4 The B2H assay identifies zinc-finger arrays that fail to show significant 
activity as ZFNs in human cells.  23 different zinc-finger arrays (pink and light blue bars) 
which activated transcription in the B2H assay to various levels (fold-activations are 
indicated in parentheses on the x-axis) were tested as homodimeric ZFNs using a 
previously described human cell-based episomal recombination (HR) assay (1). The names 
of these 23 zinc-finger arrays are shown on the x-axis and details about their binding sites 
and the modules used to construct them can be found in Supplementary Tables C.S1 and 
C.S2 online. ZFN activity is reported as a percentage of EGFP-rescue relative to an I-SceI 
control. In addition, the episomal repair activities of control ZFNs previously shown to lack 
or possess significant activity as ZFNs on chromosomal targets in human cells (1) are 
shown for comparison (red and blue bars, respectively). Names of the control ZFNs are 
shown on the x-axis and are as previously described (1). Means of at least three 
independent experiments and standard deviations (error bars) are shown. ZFNs with mean 
episomal repair activities that are significantly higher than that of the inactive EB0 ZFN are 
indicated with one (p<0.05) or two (p<0.01) red asterisks. The expression levels of all 
ZFNs shown were verified by Western blot using an antibody to a HA tag present on all 
proteins (data not shown).  
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Reference for Figure C.S4:  
1. Cornu, T. I. et al. (2008) DNA-binding Specificity Is a Major Determinant of the 
Activity and Toxicity of Zinc-finger Nucleases. Mol Ther 16, 352-8.  
Table C.S1 Small-scale tests of modular assembly using various activity assays.  
Thirty-six three-finger arrays (named “ZFA” for zinc finger array) were assembled using 
modules based on the Zinc Finger Consortium Modular Assembly Kit 1.0 (1), and the 
identities of the three modules used to construct each three-finger array use the Consortium 
numbering scheme (F1, F2, and F3 are the amino-terminal, middle, and carboxy-terminal 
fingers, respectively).  All target binding sites are written 5’ to 3’ (note that the F3 module 
binds to the 5’ most triplet subsite while F1 binds to the 3’ most triplet subsite).  The 
number of GXX subsites in each target site is also indicated. For nine of the arrays, the 
amino acid sequence of the zinc finger backbone differs from the modules in the archive.  
These arrays are noted in the far left column by a double asterisk, and their complete amino 
acid sequences are available upon request. 
Activity of 27 arrays was tested by electrophoretic mobility shift assays (EMSA).  
A plus sign in the far right column indicates that the finger array caused a shift in mobility 
of a double-stranded oligonucleotide corresponding to the intended target sequence on 
polyacrylamide gels.  In all cases, binding could be competed away with an excess of the 
target oligonucleotide.  Western blots were performed for all zinc finger arrays to ensure 
they were expressed.    
Plant single-strand annealing (PSSA) assays (see Supplementary Methods online) 
were used to assess function of seven arrays, five of which were also tested by EMSA.  
The PSSA assay tests the ability of the zinc finger array to function as a ZFN.  A minus 
sign in the table indicates that activity was comparable to negative controls in which plant 
protoplasts were not transformed with the ZFN construct.   
An episomal recombination (HR) assay was used to assess the activity of nine ZFNs 
in human 293T cells (see Supplementary Methods online). A plus sign indicates that ZFN 
activity in stimulating HR was >40% as compared to the activity of a control I-SceI  
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Table C.S1 | continued meganuclease on the same target locus. *EMSA, electrophoretic 
mobility shift assay; a positive value indicates DNA binding that could be competed away 
by an excess of an oligonucleotide corresponding to the target site.  PSSA, plant 
single-strand annealing assay; a positive value indicates reporter gene function that is at 
least two-fold over background controls. HR, episomal recombination assay; a positive 
value indicates at least 40% activity as compared to I-SceI on the same target template. For 
further information on the activity assays, see Supplementary Methods online. **Finger 
arrays with backbone sequences that differ from the ZF finger archive. ***Finger arrays 
previously described (2). 
 
Activity* 
ID#  F1  F2  F3 
Target Sequence 
(F3-F2-F1) 
# GXX 
subsites Assay Results 
ZFA 1  73  72  60 5’-GGT-GCT-GCC-3’ 3 EMSA - 
ZFA 2  72  72  106 5’-TGG-GCT-GCT-3’ 2 EMSA - 
ZFA 3  15  19  43 5’-GCT-GAC-GTG-3’ 3 EMSA - 
ZFA 4  14  30  53 5’-AGG-GTC-GTC-3’ 2 EMSA - 
ZFA 5  12  23  44 5’-GGA-GCG-GGT-3’ 3 EMSA - 
ZFA 6  64  73  63 5’-GAA-GCC-GAT-3’ 3 EMSA - 
ZFA 7  58  72  59 5’-GGA-GCT-GGG-3’ 3 EMSA - 
ZFA 8  67  60  64 5’-GAT-GGT-GTA-3’ 3 EMSA - 
ZFA 9  61  61  63 5’-GAA-GGC-GGC-3’ 3 EMSA - 
ZFA 10  70  61  59 5’-GGA-GGC-GCG-3’ 3 EMSA - 
ZFA 11  10  23  40 5’-GCA-GCG-GGC-3’ 3 EMSA - 
ZFA 12**  15  19  43 5’-GCT-GAC-GTG-3’ 3 EMSA - 
ZFA 13**  4  21  39 5’-GAT-GAT-GAT-3’ 3 EMSA - 
ZFA 14**  15  31  132 5’-AGG-GTG-GTG-3’ 2 EMSA - 
ZFA 15  61  70  71 5’-GCA-GCG-GGC-3’ 3 EMSA + 
ZFA 16  62  68  63 5’-GAA-GTT-GAG-3’ 3 EMSA + 
ZFA 17  60  70  59 5’-GGA-GCG-GGT-3’ 3 EMSA + 
ZFA 18  67  66  65 5’-GAC-GTG-GTA-3’ 3 EMSA + 
ZFA 19  66  66  84 5’-AGG-GTG-GTG-3’ 2 EMSA + 
ZFA 20  62  62  62 5’-GAG-GAG-GAG-3’ 3 EMSA + 
EMSA - 
ZFA 21**  67  31  65 5’-GAC-GTG-GTA-3’ 3 
PSSA - 
EMSA - 
ZFA 22**  8  24  57 5’-TGG-GCT-GCT-3’ 2 
PSSA - 
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Table C.S1 continued 
EMSA - 
ZFA 23  15  31  49 5’-GTG-GTG-GTG-3’ 3 
PSSA - 
EMSA - 
ZFA 24**  8  24  43 5’-GCT-GCT-GCT-3’ 3 
PSSA - 
EMSA - 
ZFA 25**  15  31  84 5’-AGG-GTG-GTG-3’ 2 
PSSA - 
ZFA 26**  15  31  84 5’-AGG-GTG-GTG-3’ 2 PSSA - 
ZFA 27**  13  31  37 5’-GAC-GTG-GTA-3’ 3 PSSA - 
HR - 
ZFA 28***  61  65  65 5’-GAC-GAC-GGC-3’ 3 
EMSA - 
ZFA 29  100  96  75 5’-AAC-CCT-CGT-3’ 0 HR - 
ZFA 30  61  80  61 5’-GGC-ACG-GGC-3’ 2 HR - 
ZFA 31  91  104  85 5’-AGT-TAG-CAG-3’ 0 HR - 
ZFA 32  83  103  104 5’-TAG-CTT-AGC-3’ 0 HR - 
ZFA 33  83  68  74 5’-AAA-GTT-AGC-3’ 1 HR - 
ZFA 34  100  104  72 5’-GCT-TAG-CGT-3’ 1 HR - 
ZFA 35  17  25  119 5’-AGA-GGA-AGA-3’ 1 HR - 
HR + 
ZFA 36*** 60  64  63 5’-GAA-GAT-GGT-3’ 3 
EMSA + 
 
References for Table C.S1:  
1. Wright, D. A. et al. (2006) Standardized reagents and protocols for engineering zinc 
finger nucleases by modular assembly. Nat Protoc 1, 1637-52.  
2. Alwin, S. et al. (2005) Custom zinc-finger nucleases for use in human cells. Mol Ther 12, 
610-7.  
 
 230
Table C.S2 Modularly assembled zinc finger arrays, cognate target binding sites, and their 
activities in the B2H assay.  See legend to Table C.S1 online for descriptive detail 
pertaining to each of this table’s columns.  In addition, the original source of the modules 
used to construct each array (B=Barbas group (1), S=Sangamo Biosciences (2,3), and 
T=Toolgen, Inc (4).) is indicated.  Because the Zinc Finger Consortium Modular 
Assembly Kit 1.0 includes more than one module for certain subsites (3), we were able to 
construct 168 zinc finger arrays that could potentially recognize the 104 different target 
sites.  Additional details regarding the construction of the B2H zinc finger expression 
plasmids and the B2H binding site reporter plasmids are provided in Supplementary 
Methods online. Fold-activation of transcription in the B2H assay was determined for each 
zinc finger array using β-galactosidase assays as previously described (5). β-galactosidase 
assays for each zinc finger array were performed a minimum of four times and means and 
standard errors of the mean are shown.  The expression of all zinc finger arrays that failed 
to activate transcription by more than 1.57-fold in the B2H assay were verified by Western 
blot using a monoclonal antibody which detects a FLAG epitope present on all arrays (data 
not shown). 
ID# F1 F2 F3 
Module 
Source
Target Sequence 
(F3-F2-F1) 
# GXX 
subsites 
B2H fold 
activation 
(mean) 
SEM 
ZFA 37  75  75  74  B  5'-AAA-AAC-AAC-3' 0  1.152  0.030 
ZFA 38  91  78  74  B  5'-AAA-ACA-CAG-3' 0  1.097  0.030 
ZFA 39  73  91  74  B  5'-AAA-CAG-GCC-3' 1  1.325  0.095 
ZFA 40  100  101  74  B  5'-AAA-CTA-CGT-3' 0  1.347  0.037 
ZFA 41  83  68  74  B  5'-AAA-GTT-AGC-3' 1  1.166  0.106 
ZFA 42  91  93  75  B  5'-AAC-CCA-CAG-3' 0  0.974  0.075 
ZFA 43  68  93  75  B  5'-AAC-CCA-GTT-3' 1  0.980  0.010 
ZFA 44  100  96  75  B  5'-AAC-CCT-CGT-3' 0  0.900  0.105 
ZFA 45  64  86  77  B  5'-AAT-ATA-GAT-3' 1  1.606  0.037 
ZFA 46  90  75  78  B  5'-ACA-AAC-CAC-3' 0  0.850  0.022 
ZFA 47  85  75  79  B  5'-ACC-AAC-AGT-3' 0  1.001  0.028 
ZFA 48  86  83  79  B  5'-ACC-AGC-ATA-3' 0  1.036  0.028 
ZFA 49  83  100  79  B  5'-ACC-CGT-AGC-3' 0  1.235  0.016 
ZFA 50  63  59  79  B  5'-ACC-GGA-GAA-3' 2  1.386  0.068 
ZFA 51  91  83  80  B  5'-ACG-AGC-CAG-3' 0  0.955  0.027 
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ZFA 52  72  91  80  B  5'-ACG-CAG-GCT-3' 1  1.236  0.007 
ZFA 53  70  95  80  B  5'-ACG-CCG-GCG-3' 1  1.266  0.040 
ZFA 54  100  65  80  B  5'-ACG-GAC-CGT-3' 1  1.799  0.060 
ZFA 55  71  73  80  B  5'-ACG-GCC-GCA-3' 2  1.295  0.031 
ZFA 56  82  59  82  B  5'-AGA-GGA-AGA-3' 1  1.287  0.021 
ZFA 57  119  117  119  T  5'-AGA-GGA-AGA-3' 1  0.911  0.012 
ZFA 58  119  114  119  T  5'-AGA-GGA-AGA-3' 1  1.928  0.082 
ZFA 59  119  129  119  T  5'-AGA-GGA-AGA-3' 1  1.974  0.066 
ZFA 60  119  118  119  T  5'-AGA-GGA-AGA-3' 1  2.371  0.047 
ZFA 61  64  69  83  B  5'-AGC-GTC-GAT-3' 2  1.206  0.019 
ZFA 62  103  88  85  B  5'-AGT-ATT-CTT-3' 0  1.015  0.022 
ZFA 64  91  104  85  B  5'-AGT-TAG-CAG-3' 0  0.879  0.092 
ZFA 65  85  93  86  B  5'-ATA-CCA-AGT-3' 0  0.989  0.017 
ZFA 66  78  81  87  B  5'-ATG-ACT-ACA-3' 0  0.956  0.043 
ZFA 67  92  90  87  B  5'-ATG-CAC-CAT-3' 0  1.122  0.068 
ZFA 68  78  96  88  B  5'-ATT-CCT-ACA-3' 0  1.064  0.135 
ZFA 69  95  72  88  B  5'-ATT-GCT-CCG-3' 1  1.256  0.016 
ZFA 70  63  98  90  B  5'-CAC-CGC-GAA-3' 1  1.099  0.011 
ZFA 71  60  67  90  B  5'-CAC-GTA-GGT-3' 2  1.476  0.023 
ZFA 72  86  98  92  B  5'-CAT-CGC-ATA-3' 0  0.985  0.027 
ZFA 74  90  100  93  B  5'-CCA-CGT-CAC-3' 0  1.173  0.034 
ZFA 75  73  64  93  B  5'-CCA-GAT-GCC-3' 2  1.085  0.006 
ZFA 76  103  85  94  B  5'-CCC-AGT-CTT-3' 0  1.376  0.153 
ZFA 77  66  100  94  B  5'-CCC-CGT-GTG-3' 1  1.431  0.069 
ZFA 78  80  79  95  B  5'-CCG-ACC-ACG-3' 0  1.090  0.020 
ZFA 79  74  91  95  B  5'-CCG-CAG-AAA-3' 0  1.123  0.009 
ZFA 80  100  98  95  B  5'-CCG-CGC-CGT-3' 0  1.146  0.074 
ZFA 81  86  63  95  B  5'-CCG-GAA-ATA-3' 1  0.907  0.048 
ZFA 82  91  80  96  B  5'-CCT-ACG-CAG-3' 0  1.013  0.037 
ZFA 83  90  81  96  B  5'-CCT-ACT-CAC-3' 0  1.113  0.042 
ZFA 84  70  87  96  B  5'-CCT-ATG-GCG-3' 1  1.239  0.104 
ZFA 85  58  67  96  B  5'-CCT-GTA-GGG-3' 2  1.504  0.009 
ZFA 86 101 92 98 B 5'-CGC-CAT-CTA-3' 0 1.052 0.052
ZFA 87 88 81 101 B 5'-CTA-ACT-ATT-3' 0 0.884 0.013
ZFA 88 83 59 101 B 5'-CTA-GGA-AGC-3' 1 1.303 0.089
ZFA 89 80 83 103 B 5'-CTT-AGC-ACG-3' 0 1.037 0.086
ZFA 90 94 88 103 B 5'-CTT-ATT-CCC-3' 0 1.031 0.018
ZFA 91 91 60 103 B 5'-CTT-GGT-CAG-3' 1 1.044 0.032
ZFA 92 69 70 63 B 5'-GAA-GCG-GTC-3' 3 2.309 0.129
ZFA 93 14 23 36 S 5'-GAA-GCG-GTC-3' 3 1.620 0.059
 232
Table C.S2 continued 
ZFA 94  109  130  124  T  5'-GAA-GCG-GTC-3'  3  1.339  0.165 
ZFA 95  109  130  122  T  5'-GAA-GCG-GTC-3'  3  2.279  0.123 
ZFA 96  87  94  65  B  5'-GAC-CCC-ATG-3'  1  1.074  0.034 
ZFA 97  72  61  65  B  5'-GAC-GGC-GCT-3'  3  1.118  0.045 
ZFA 98  8  26  37  S  5'-GAC-GGC-GCT-3'  3  0.930  0.039 
ZFA 101  4  24  38  S  5'-GAG-GCT-GAT-3'  3  1.327  0.126 
ZFA 102  112  139  113  T  5'-GAG-GCT-GAT-3'  3  1.142  0.091 
ZFA 103  112  139  136  T  5'-GAG-GCT-GAT-3'  3  1.185  0.087 
ZFA 104  112  139  115  T  5'-GAG-GCT-GAT-3'  3  2.399  0.120 
ZFA 105  66  72  62  B  5'-GAG-GCT-GTG-3'  3  4.553  0.295 
ZFA 106  15  24  38  S  5'-GAG-GCT-GTG-3'  3  3.038  0.153 
ZFA 107  138  139  136  T  5'-GAG-GCT-GTG-3'  3  0.959  0.026 
ZFA 108  138  139  113  T  5'-GAG-GCT-GTG-3'  3  1.004  0.037 
ZFA 109  138  139  115  T  5'-GAG-GCT-GTG-3'  3  3.277  0.153 
ZFA 110  68  59  64  B  5'-GAT-GGA-GTT-3'  3  2.647  0.158 
ZFA 111  16  25  39  S  5'-GAT-GGA-GTT-3'  3  1.571  0.111 
ZFA 112  111  118  112  T  5'-GAT-GGA-GTT-3'  3  1.645  0.071 
ZFA 113  111  129  112  T  5'-GAT-GGA-GTT-3'  3  2.013  0.083 
ZFA 114  111  117  112  T  5'-GAT-GGA-GTT-3'  3  2.489  0.136 
ZFA 115  111  114  112  T  5'-GAT-GGA-GTT-3'  3  3.840  0.308 
ZFA 116  58  60  64  B  5'-GAT-GGT-GGG-3'  3  2.390  0.065 
ZFA 117  11  28  39  S  5'-GAT-GGT-GGG-3'  3  0.959  0.098 
ZFA 118  131  140  112  T  5'-GAT-GGT-GGG-3'  3  1.985  0.067 
ZFA 119  133  140  112  T  5'-GAT-GGT-GGG-3'  3  2.444  0.103 
ZFA 120  134  140  112  T  5'-GAT-GGT-GGG-3'  3  6.665  0.290 
ZFA 121  60  78  71  B  5'-GCA-ACA-GGT-3'  2  1.388  0.014 
ZFA 122  100  80  71  B  5'-GCA-ACG-CGT-3'  1  1.274  0.031 
ZFA 123  81  90  71  B  5'-GCA-CAC-ACT-3'  1  0.851  0.023 
ZFA 124  59  73  71  B  5'-GCA-GCC-GGA-3'  3  1.574  0.099 
ZFA 125  9  33  40  S  5'-GCA-GCC-GGA-3'  3  0.953  0.111 
ZFA 126  71  70  71  B  5'-GCA-GCG-GCA-3'  3  3.276  0.111 
ZFA 127  5  23  40  S  5'-GCA-GCG-GCA-3'  3  0.887  0.068 
ZFA 128  58  72  71  B  5'-GCA-GCT-GGG-3'  3  1.186  0.045 
ZFA 129  11  24  40  S  5'-GCA-GCT-GGG-3'  3  1.157  0.039 
ZFA 130  65  69  71  B  5'-GCA-GTC-GAC-3'  3  0.867  0.046 
ZFA 131  2  30  40  S  5'-GCA-GTC-GAC-3'  3  0.897  0.052 
ZFA 132  72  69  71  B  5'-GCA-GTC-GCT-3'  3  1.365  0.049 
ZFA 133  8  30  40  S  5'-GCA-GTC-GCT-3'  3  1.116  0.092 
ZFA 134  61  69  71  B  5'-GCA-GTC-GGC-3'  3  1.077  0.024 
ZFA 135  10  30  40  S  5'-GCA-GTC-GGC-3'  3  0.999  0.039 
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ZFA 136  70  66  71  B  5'-GCA-GTG-GCG-3'  3  1.915  0.050 
ZFA 137  7  31  40  S  5'-GCA-GTG-GCG-3'  3  0.819  0.051 
ZFA 138  95  79  73  B  5'-GCC-ACC-CCG-3'  1  1.000  0.032 
ZFA 139  59  87  73  B  5'-GCC-ATG-GGA-3'  2  0.974  0.043 
ZFA 140  103  63  73  B  5'-GCC-GAA-CTT-3'  2  1.137  0.057 
ZFA 141  66  71  73  B  5'-GCC-GCA-GTG-3'  3  1.061  0.036 
ZFA 142  15  22  41  S  5'-GCC-GCA-GTG-3'  3  0.914  0.023 
ZFA 143  59  61  73  B  5'-GCC-GGC-GGA-3'  3  1.182  0.049 
ZFA 144  9  26  41  S  5'-GCC-GGC-GGA-3'  3  0.814  0.021 
ZFA 145  132  116  130  T  5'-GCG-GAA-AGG-3'  2  1.342  0.134 
ZFA 146  132  124  130  T  5'-GCG-GAA-AGG-3'  2  1.736  0.063 
ZFA 147  132  122  130  T  5'-GCG-GAA-AGG-3'  2  1.759  0.054 
ZFA 148  132  123  130  T  5'-GCG-GAA-AGG-3'  2  2.136  0.064 
ZFA 149  102  59  70  B  5'-GCG-GGA-CTG-3'  2  1.522  0.088 
ZFA 150  59  66  70  B  5'-GCG-GTG-GGA-3'  3  1.751  0.124 
ZFA 151  9  31  42  S  5'-GCG-GTG-GGA-3'  3  2.774  0.116 
ZFA 152  114  138  130  T  5'-GCG-GTG-GGA-3'  3  1.029  0.046 
ZFA 153  129  138  130  T  5'-GCG-GTG-GGA-3'  3  1.272  0.039 
ZFA 154  118  138  130  T  5'-GCG-GTG-GGA-3'  3  1.384  0.059 
ZFA 155  117  138  130  T  5'-GCG-GTG-GGA-3'  3  1.953  0.050 
ZFA 156  60  66  70  B  5'-GCG-GTG-GGT-3'  3  2.229  0.208 
ZFA 157  12  31  42  S  5'-GCG-GTG-GGT-3'  3  3.298  0.266 
ZFA 158  70  106  70  B  5'-GCG-TGG-GCG-3'  2  2.713  0.181 
ZFA 159  7  34  42  S  5'-GCG-TGG-GCG-3'  2  0.856  0.034 
ZFA 160  78  86  72  B  5'-GCT-ATA-ACA-3'  1  0.988  0.024 
ZFA 161  62  100  72  B  5'-GCT-CGT-GAG-3'  2  1.703  0.012 
ZFA 163  100  104  72  B  5'-GCT-TAG-CGT-3'  1  1.343  0.143 
ZFA 164  61  74  59  B  5'-GGA-AAA-GGC-3'  2  1.392  0.084 
ZFA 165  92  90  59  B  5'-GGA-CAC-CAT-3'  1  1.182  0.016 
ZFA 166  80  101  59  B  5'-GGA-CTA-ACG-3'  1  1.085  0.034 
ZFA 167  66  70  59  B  5'-GGA-GCG-GTG-3'  3  1.640  0.043 
ZFA 168  15  23  44  S  5'-GGA-GCG-GTG-3'  3  2.599  0.092 
ZFA 169  138  130  117  T  5'-GGA-GCG-GTG-3'  3  1.027  0.068 
ZFA 170  138  130  118  T  5'-GGA-GCG-GTG-3'  3  1.732  0.041 
ZFA 171  138  130  129  T  5'-GGA-GCG-GTG-3'  3  2.296  0.121 
ZFA 172  138  130  114  T  5'-GGA-GCG-GTG-3'  3  2.316  0.046 
ZFA 173  61  80  61  B  5'-GGC-ACG-GGC-3'  2  1.341  0.109 
ZFA 174  63  95  61  B  5'-GGC-CCG-GAA-3'  2  1.171  0.030 
ZFA 175  66  73  61  B  5'-GGC-GCC-GTG-3'  3  1.116  0.072 
ZFA 176  15  33  45  S  5'-GGC-GCC-GTG-3'  3  0.868  0.017 
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Table C.S2 continued 
ZFA 177  73  58  61  B  5'-GGC-GGG-GCC-3'  3  1.203  0.035 
ZFA 178  6  27  45  S  5'-GGC-GGG-GCC-3'  3  1.258  0.053 
ZFA 180  61  70  58  B  5'-GGG-GCG-GGC-3'  3  2.191  0.105 
ZFA 181  10  23  51  S  5'-GGG-GCG-GGC-3'  3  6.162  0.147 
ZFA 182  73  72  58  B  5'-GGG-GCT-GCC-3'  3  1.363  0.053 
ZFA 183  6  24  51  S  5'-GGG-GCT-GCC-3'  3  1.494  0.054 
ZFA 184  108  139  134  T  5'-GGG-GCT-GCC-3'  3  2.022  0.253 
ZFA 185  79  88  60  B  5'-GGT-ATT-ACC-3'  1  1.078  0.016 
ZFA 186  72  63  60  B  5'-GGT-GAA-GCT-3'  3  1.589  0.094 
ZFA 187  8  18  46  S  5'-GGT-GAA-GCT-3'  3  0.944  0.081 
ZFA 188  139  122  140  T  5'-GGT-GAA-GCT-3'  3  1.176  0.125 
ZFA 189  139  124  140  T  5'-GGT-GAA-GCT-3'  3  1.800  0.124 
ZFA 190  139  123  140  T  5'-GGT-GAA-GCT-3'  3  2.189  0.234 
ZFA 191  139  116  140  T  5'-GGT-GAA-GCT-3'  3  2.431  0.090 
ZFA 192  98  103  67  B  5'-GTA-CTT-CGC-3'  1  1.274  0.034 
ZFA 193  61  68  67  B  5'-GTA-GTT-GGC-3'  3  1.056  0.098 
ZFA 194  10  32  47  S  5'-GTA-GTT-GGC-3'  3  0.854  0.028 
ZFA 195  91  101  69  B  5'-GTC-CTA-CAG-3'  1  1.132  0.035 
ZFA 196  81  65  66  B  5'-GTG-GAC-ACT-3'  2  1.387  0.028 
ZFA 197  73  61  66  B  5'-GTG-GGC-GCC-3'  3  1.104  0.036 
ZFA 198  6  26  49  S  5'-GTG-GGC-GCC-3'  3  0.984  0.055 
ZFA 199  66  82  68  B  5'-GTT-AGA-GTG-3'  2  1.683  0.046 
ZFA 200  138  119  111  T  5'-GTT-AGA-GTG-3'  2  2.872  0.107 
ZFA 201  12  20  50  S  5'-GTT-GAG-GGT-3'  3  0.671  0.015 
ZFA 202  140  136  111  T  5'-GTT-GAG-GGT-3'  3  3.477  0.076 
ZFA 203  140  113  111  T  5'-GTT-GAG-GGT-3'  3  4.735  0.489 
ZFA 204  101  71  68  B  5'-GTT-GCA-CTA-3'  2  1.009  0.043 
ZFA 205  73  70  68  B  5'-GTT-GCG-GCC-3'  3  5.065  0.290 
ZFA 206  6  23  50  S  5'-GTT-GCG-GCC-3'  3  1.232  0.014 
ZFA 207  83  103  104  B  5'-TAG-CTT-AGC-3'  0  0.849  0.100 
ZFA 208  70  59  104  B  5'-TAG-GGA-GCG-3'  2  2.185  0.068 
ZFA 209  3  20  56  S  5'-TGA-GAG-GAG-3'  2  1.704  0.068 
ZFA 210  86  105  105  B  5'-TGA-TGA-ATA-3'  0  1.001  0.030 
 
References for Table C.S2:  
1. Mandell, J.G. & Barbas, C.F., 3rd  (2006) Zinc Finger Tools: custom 
DNA-binding domains for transcription factors and nucleases. Nucleic Acids Res 
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designs for all 16 GNN DNA triplet targets. J Biol Chem 277, 3850-3856.  
3. Wright, D.A. et al. (2006) Standardized reagents and protocols for engineering 
zinc finger nucleases by modular assembly. Nat Protoc 1, 1637-1652.  
4. Bae, K.H. et al. (2003) Human zinc fingers as building blocks in the construction 
of artificial transcription factors. Nat Biotechnol 21, 275-280.  
5. Cornu, T. I. et al. (2008) DNA-binding Specificity Is a Major Determinant of the 
Activity and Toxicity of Zinc-finger Nucleases. Mol Ther 16, 352-8.  
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SUPPLEMENTARY DISCUSSION 
Small-scale surveys suggest a low success rate for modular assembly  
Motivated by a desire to use ZFNs for genome modification, our labs constructed 
the 36 zinc finger arrays listed in TableC.S1 online. These arrays are highly biased for 
GXX subsites, and collectively include 22 3-GXX arrays, 8 2-GXX arrays, 2 1-GXX arrays 
and 4 arrays without GXX subsites.  Using three different assays to test for function (see 
legend to TableC.S1 online), seven arrays were deemed functional. Six of these sites were 
composed of three GXX subsites and one was composed of two GXX subsites.  Since six 
of the seven arrays were only tested by EMSA, it is difficult to extrapolate how many of 
these arrays would function in vivo when challenged with the diverse sequence targets 
present in a genome.   
 
The B2H assay accurately identifies zinc finger arrays that fail to show ZFN function 
in human cells  
In previously published studies from our groups, we observed a general correlation 
between failure to activate in the B2H assay and failure to show ZFN function in human 
cells (1).  To further assess this correlation, we tested the activities of 23 ZFNs using a 
human cell-based episomal homologous recombination (HR) assay (Supplementary 
Methods online).  The zinc finger arrays in these 23 ZFNs each activated transcription to 
different levels in the B2H system ranging from 0.85- to 5.07-fold.  As shown in Figure 
C.S4 online, we found that zinc finger arrays which activated transcription by 1.57-fold or 
less in the B2H system all failed to show significant activity as ZFNs in human cells (nine 
out of nine ZFNs tested; pink bars in Figure C.S4 online). Conversely, many (although not 
all) of the zinc finger arrays which activated transcription by >1.57-fold in the B2H system 
showed significant activity as ZFNs in the episomal repair assay (light blue bars with  red 
asterisks in Figure C.S4 online). We conclude that zinc finger arrays that activate 
transcription by 1.57-fold or less in the B2H system are unlikely to function as ZFNs in 
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human cells and we used this threshold level to interpret the results of our experiments.  
 
Predicted failure rates for identifying zinc finger arrays needed to engineer a ZFN 
pair  
Analysis of our results shows that modular assembly is far less effective for target 
sites composed of two, one, or no GXX subsites (71%, 88% and 100% failure rates, 
respectively; Figure C.1A) compared with those that contain three GXX subsites (41% 
failure rate; Figure C.1A). Because ZFNs function as dimers, the failure rates for making a 
ZFN pair will therefore be ~65%, ~92%, ~99%, and 100% for ZFN targets composed of 
pairs of 3-GXX, 2-GXX, 1-GXX, and 0-GXX 9 bp “half-sites”, respectively.  These 
failure rates are calculated by multiplying estimated success rates for each monomer in the 
ZFN pair and subtracting this percentage from 100%.  
 
Alternative selection-based strategies for engineering multi-finger arrays 
A fundamental flaw with the modular assembly method (and a likely cause of its 
low success rate) is its assumption that zinc finger domains behave as independent modular 
units. A number of studies have shown that zinc fingers can cross over and interact with 
adjacent fingers and neighboring finger binding sites (2-5). Various engineering strategies 
have been described in the literature that account for these context-dependent effects on 
zinc finger DNA-binding. Greisman and Pabo first described a sequential optimization 
strategy in which combinations of fingers that work well together are identified using serial 
selections from randomized libraries (6). Isalan, Klug, and Choo described a “bipartite” 
optimization strategy in which “halves” of a three-finger domain are first optimized by 
randomization and selection and then joined together to create a final protein (7).  Finally, 
Joung and colleagues described a domain shuffling approach in which pools of fingers are 
first identified for each subsite in parallel and then shuffled together to create a recombined 
library for use in a final stringent selection (8).  A limitation of all of these different 
approaches is that they require specialized expertise in the construction of multiple very 
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large randomized libraries and in the interrogation of these libraries using selection 
methods.  
 
References for Supplementary Discussion:  
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3. Isalan, M., Klug, A. & Choo, Y. (1998) Comprehensive DNA recognition 
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12026-33.  
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engineer zinc fingers illustrated by targeting the HIV-1 promoter. Nat Biotechnol 
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Highly specific zinc finger proteins obtained by directed domain shuffling and 
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SUPPLEMENTARY METHODS 
Construction of B2H zinc finger expression vectors and reporter strains  
104 B2H reporter strains each harboring a single copy target site-reporter plasmid 
were constructed as previously described. (1)  B2H expression vectors encoding different 
three-finger arrays were constructed essentially as previously described (1) using the Zinc 
Finger Modular Assembly Kit 1.0 which includes 141 modules made by the Barbas group, 
Sangamo Biosciences, and Toolgen, Inc. (1)  For each target site, we made three-finger 
arrays using modules from the Barbas, Sangamo, and Toolgen collections but we did not 
mix and match modules across these different sets.  We chose not to make “crossplatform” 
arrays because: 1: the Barbas website software does not advocate use of their modules with 
others (2), 2: the Toolgen group discovered that their human zinc fingers worked best with 
one another and not as well with other engineered modules, and 3: the Sangamo modules 
are position-specific and have linkers joining them that differ from the canonical TGEKP 
linker used by the Barbas and Toolgen modules(4). 15 of the arrays we constructed were 
toxic when expressed in the B2H assay and these proteins were not included in our analysis. 
After setting aside these toxic proteins, we characterized the remaining 168 zinc finger 
arrays.  All expression and reporter plasmids were confirmed to be correct by DNA 
sequencing prior to use in B2H assays.  
 
B2H assays, verification of protein expression, and re-verification of DNA sequences  
The activities of three-finger arrays were tested in the B2H assay by 
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co-transforming a target site reporter strain with a B2H zinc finger array-Gal11P expression 
vector and a compatible plasmid encoding an E. coli RNA polymerase alpha-Gal4 hybrid 
protein (1).
 
 Fold-activation was calculated as the ratio of the level of β-galactosidase (lacZ) 
reporter activity in the presence and absence of the zinc finger array as previously 
described (5). All β-galactosidase measurements were performed at least four independent 
times.  The expression of each zinc finger array that failed to activate transcription by 
more than 1.57-fold in the B2H assay was verified by performing Western blot on cell 
extracts from the β-galactosidase assays using a monoclonal antibody against the FLAG 
epitope present on all zinc finger array-Gal11P fusion proteins.  For zinc finger arrays that 
exhibited less than 1.57-fold transcriptional activation in the B2H assay, we re-sequenced 
the zinc finger coding sequences and the reporter plasmid binding sites from the same cells 
used for β-galactosidase assays to re-confirm the identities of the zinc finger recognition 
helices and binding sites tested in these cells.  We performed this additional re-sequencing 
control on >80% of our samples (94 of the 115 zinc finger array/binding site combinations) 
that were negative in the B2H assay and found that all helices and binding sites were 
correct as expected.  
 
Plant single-strand annealing (PSSA) assays  
Zinc finger arrays were fused to the FokI nuclease domain and the resulting ZFNs 
were transiently expressed in tobacco protoplasts.  Plasmids encoding these ZFNs were 
co-transformed with a target plasmid carrying a non-functional β-glucuronidase (GUS) 
gene. The GUS gene was rendered non-functional by a direct duplication of part of its 
coding sequence. Between the direct repeats, a recognition site was inserted for the given 
ZFN being tested. After expression of the ZFN and cleavage of the GUS reporter, repair by 
single strand annealing can restore GUS function.  This can be measured by standard GUS 
activity assays. We routinely observe GUS activity 25-fold above background when the 
assay is performed with a ZFN based on the transcription factor Zif268.    
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Episomal recombination (HR) assay in human cells  
For the episomal HR assay, 293T cells in 24-well plates were transfected by 
calcium phosphate precipitation with 20 ng of the respective target plasmid, 1 µg of the 
donor plasmid (pUC.Zgfp/REx), and 100 ng of a CMV-driven endonuclease expression 
vector encoding the ZFNs, I-SceI (pRK5.LHA-Sce1) or a control vector (pCMV.Luc). Two 
days after transfection, 50,000 cells were analyzed by flow cytometry (FACSCalibur, BD 
Bioscience) to determine the percentage of EGFP-positive cells. The number of 
DsRedExpress (REx)-positive cells was used to normalize for transfection efficiency. All 
experiments were repeated at least three times. ZFN activity is indicated as the fraction of 
EGFP-positive cells relative to the number of EGFP-positive cells measured in the 
presence of I-SceI.  
 
Revisions to the Zinc Finger Consortium website  
We have previously described ZiFiT, a web-based software program that enables 
users to rapidly identify potential zinc finger target sites within genes of interest (6). ZiFiT 
identifies target sites for which zinc finger arrays might be made using modular assembly 
and the Zinc Finger Consortium Modular Assembly Kit 1.0 (1). Given the results of this 
current study, we have revised the ZiFiT program by adding the following section to its 
instructions:  
 
Scoring  
To assess the effectiveness of modular assembly, we generated a large number of 
zinc finger arrays and tested their activity using a bacterial cell-based two-hybrid (B2H) 
assay (Ramirez et al., 2008).  In the B2H assay, productive interaction of a zinc finger 
array with its cognate binding site activates transcription of a linked reporter gene. A total 
of 168 three finger arrays were assembled that recognize 104 different target DNA sites that 
varied in their GXX, AXX, CXX, and TXX subsite composition. Transcriptional activation 
of >1.57-fold over negative controls was determined to be indicative of target site 
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recognition by a given protein. After measuring the activity of the 168 zinc finger arrays, it 
was found that the subsite composition of binding sites critically affected success rates.  
Modular assembly was far less effective for target sites composed of one or no GXX 
subsites (12% and 0% success rates, respectively) compared with those that contain three 
or two (59% and 29% success rates, respectively).  Based on these results, we provide 
users of ZiFiT with an approximation of the likelihood that a given three finger protein will 
recognize its target.  For example, three finger proteins comprised of three GXX subsites 
will receive a score of 0.59, reflecting the success rate observed in our survey.  Most users 
will be interested in the likelihood that two arrays will function together as a ZFN.  This 
can be approximated by multiplying the success rate of individual arrays.  For example, 
the likelihood of success that a ZFN with all GXX subsites will recognize its target is 0.59 
X 0.59 = 0.35 or 35%.  Because multiple modules are often available for given subsites, 
investigators may increase their likelihood of success by making multiple different proteins 
against a single target.  One note of caution: the scoring function is a prediction for the 
activity of a given three finger array in the B2H assay; the protein may behave differently 
when tested for activity in a eukaryotic cell.  
We have also revised the output that ZiFiT currently provides to users to include guidance 
about the likelihood of success for different target DNA binding sites.      
 
References for Supplementary Methods:  
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ABSTRACT 
Engineered zinc finger nucleases can stimulate gene targeting at specific genomic 
loci in insect, plant and human cells. Although several platforms for constructing artificial 
zinc finger arrays using ‘‘modular assembly’’ have been described, standardized reagents 
and protocols that permit rapid, cross-platform ‘‘mixing-and-matching’’ of the various zinc 
finger modules are not available. Here we describe a comprehensive, publicly available 
archive of plasmids encoding more than 140 well-characterized zinc finger modules 
together with complementary web-based software (termed ZiFiT) for identifying potential 
zinc finger target sites in a gene of interest. Our reagents have been standardized on a single 
platform, enabling facile mixing-and-matching of modules and transfer of assembled 
arrays to expression vectors without the need for specialized knowledge of zinc finger 
sequences or complicated oligonucleotide design. We also describe a bacterial cell-based 
reporter assay for rapidly screening the DNA-binding activities of assembled multi-finger 
arrays. This protocol can be completed in approximately 24–26 d. 
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INTRODUCTION 
Zinc finger nucleases (ZFNs) can be used to introduce targeted double-stranded 
breaks (DSBs) into chromosomal DNA sequences, thereby stimulating homologous 
recombination and gene targeting events at specific genomic loci in insect, plant and human 
cells (1–7). ZFNs consist of an engineered Cys2His2 zinc finger DNA-binding domain 
(typically three (8–10) or four6 fingers) fused to a non-specific nuclease domain from the 
FokI restriction enzyme (Figure D.1). ZFNs bind as dimers to their target DNA sites, with 
each monomer using its zinc finger domain to recognize a "half-site" (Figure D.1). 
Dimerization of ZFNs is mediated by the FokI nuclease domain, which cleaves within a 
spacer sequence (typically five or six base pairs in length) that separates the two inverted 
half-sites (5,10,11) (Figure D.1). Because each zinc finger recognizes a three base pair 
‘sub-site,’ a three-finger ZFN binds to a nine base pair half-site and a four-finger ZFN binds 
to a twelve base pair half-site. In principle, ZFN-mediated gene targeting can be used to 
effect correction, mutation, deletion or insertion at any endogenous gene, provided that 
appropriate zinc finger domains can be engineered to target the locus of interest. Therefore, 
although ZFN-based technology has potentially important uses in biological research and 
gene therapy, further application, development and refinement of this approach will require 
a rapid and facile method for engineering the zinc finger arrays needed to target specific 
DNA sequences of interest. 
Several recent reports have demonstrated that ‘‘modular assembly’’ methods can 
yield three-finger arrays that can in turn be used to generate active ZFNs (1–3,7,12). These 
modular assembly approaches involve the joining together of individual, pre-characterized 
finger modules to create multi-finger arrays capable of recognizing extended DNA 
sequences. Three different sets of modules, each with well-characterized DNA-binding 
specificities, have been described in the literature: 
1. Carlos Barbas and colleagues have constructed a set of modules that target all 
GNN, most ANN and CNN and a few TNN triplet subsites (13–17). These modules were 
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selected by phage display and in some cases optimized by targeted mutagenesis. The 
DNA-binding specificities of these domains were each verified using an in vitro 
ELISA-based specificity assay. All of these modules are based on a consensus human zinc 
finger framework18 and are designed to be used at any position (amino terminal, middle or 
carboxy terminal) in the context of a multi-finger domain. The Barbas group has described 
web-based software for using this set of modules (19). 
2. Researchers at Sangamo Biosciences used results from phage display selections 
together with targeted mutagenesis to construct a set of modules that target all GNN and a 
small number of ANN, CNN and TNN triplet subsites (20–22). In vitro SELEX was used to 
characterize the DNA-binding specificities of most of these fingers (22). These modules 
were generated by altering fingers from the three-finger Sp1 zinc finger domain and have 
been noted to show position-dependence in their behavior (e.g., amino-terminal fingers 
should only be used in that position) (22). 
 
 
Figure D.1 Schematic of a) a zinc finger nuclease and b) a zinc finger nuclease dimer 
bound to its target cleavage site. Individual zinc finger domains are depicted as colored 
spheres with F1 representing the amino-terminal finger, F2 the middle finger and F3 the 
carboxy-terminal finger in a three-finger array. The FokI DNA cleavage domain is 
represented as a purple colored octagon. Note that the spacer sequence between the two 
9-bp ‘half-sites’ can be five or six base pairs. 
 
3. Scientists at ToolGen, Inc. identified a set of naturally occurring human zinc 
fingers that recognize a range of different triplet subsites (23). The DNA-binding 
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specificities of these modules were determined using a yeast-based one-hybrid reporter 
assay. Because these modules are derived from different human transcription factors, their 
sequences show little similarity to one another outside of the well conserved zinc finger 
motif residues. A number of studies have shown that many of these modules can function at 
different positions within the context of a multi-finger domain (23–29). 
Although modular assembly has been used successfully to create zinc finger arrays 
and ZFNs, published reports suggest that the process does not always yield functional 
domains. Barbas and colleagues made a series of 80 different three-finger domains using 
their modules and found that all of these multi-finger arrays were able to bind to their 
intended target DNA site in an in vitro ELISA-based DNA-binding assay (30). In 
smaller-scale surveys, Cathomen and colleagues found that two out of four ZFNs they 
made using the Barbas modules (7) and Porteus found that six out of six proteins made 
using the Sangamo modules (12) could stimulate gene targeting in human cells. However, 
these results may reflect a publication bias because unsuccessful attempts may not always 
be reported. For example, our own collective experience has revealed that success rates for 
modular assembly using various published modules may be lower than has been previously 
described (D.A.W. & D.F.V., unpublished data; M.H.P., unpublished data; A.S.H., S.T.-B., 
M.E. and J.K.J., unpublished data). We hypothesize that the most likely reason why 
modular assembly does not always work is the failure of the method to account for 
context-dependent effects on DNA-binding that can occur with zinc finger domains 
(31–35). Although the overall success rate of modular assembly across a broad range of 
potential binding sites remains to be determined, the relative ease of this method compared 
with other more labor-intensive selection-based approaches makes it a reasonable potential 
strategy for constructing ZFNs. 
Given the imperfect success rate of modular assembly, multi-finger domains 
constructed using this approach should ideally be screened for DNA-binding activity  
before being tested as ZFNs in cells. In vitro tests (36) or mammalian cell-based reporter 
assays (7) have been used for this purpose, but these methods can be time consuming and 
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labor intensive. We prefer the use of a bacterial cell-based two-hybrid (B2H) reporter 
system (31,37–39), which tests the ability of a zinc finger domain to bind a given target 
DNA sequence. The B2H reporter assay is rapid, easy to perform and does not require 
protein purification or mammalian cell culture or transfection. In the B2H reporter system, 
binding of a multi-finger domain to its target site leads to transcriptional activation of a 
readily assayable lacZ reporter gene (Figure D.2). Previous work has shown that 
multi-finger domains that activate reporter gene expression efficiently in the B2H also 
possess excellent DNA-binding affinities and specificities for their target sites31. We have 
also found that multi-finger domains that work well in the B2H also yield ZFNs that 
mediate gene targeting with high efficiency in human cells (S. Pruett, J.K.J. & M.H.P., 
unpublished data). 
In this protocol, we describe standardized reagents, software tools and protocols for 
constructing ZFNs by modular assembly that enable the user to leverage the potential 
strengths of all three published module sets. We have constructed a set of plasmids 
encoding a comprehensive archive of more than 140 zinc finger modules derived from the 
Barbas, Sangamo and ToolGen module sets (TableD.S1 online). We designed these 
plasmids on a standardized framework, which permits any combination of modules to be 
rapidly assembled into arrays using only standard restriction digest–based subcloning 
techniques (Figure D.3). Although our assembly method requires two subcloning steps to 
construct a three-finger array, our strategy and reagents allow researchers to avoid the need 
for specialized knowledge of zinc finger sequences and for complicated oligonucleotide 
design or costly gene synthesis (17,19–21,40). In addition, we describe a complementary 
web-based ZiFiT (Zinc Finger Targeter) program, which simplifies and automates the 
process of identifying target DNA sites that can potentially be targeted by multi-finger 
domains made using our archive of modules. Following assembly, sequences encoding 
these multi-finger arrays can then be transferred (again using only restriction enzymes) to a 
B2H expression vector that permits rapid testing of DNA-binding activities in the B2H 
reporter system. Coding sequences for finger arrays that work well in the B2H system can 
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be rapidly transferred by simple restriction digest to compatible vectors that permit their 
expression as ZFNs in plant or human cells. In addition, all of the reagents described in our 
manuscript are available as a kit to scientists for noncommercial research through Addgene, 
a non-profit plasmid distribution service.  
 
 
 
Figure D.2 Schematic of the bacterial two-hybrid reporter system. Co-expression of the 
zinc finger-Gal11P and alpha-Gal4 hybrid proteins in a B2H reporter strain leads to 
activated expression of a Figure D.2 | continued lacZ reporter gene if the multi-finger 
domain interacts with a target DNA-binding site located just upstream of the promoter39. 
This activation is mediated by recruitment of RNA polymerase complexes (that have 
incorporated alpha-Gal4) to the promoter by promoter-bound zinc finger-Gal11P proteins 
via interaction of Gal11P and Gal4. A three-finger array is depicted as three colored 
spheres (as in Figure. 1) and Gal11P represents a fragment of the yeast Gal11P protein (aa 
263–352)39. The alpha-Gal4 hybrid protein consists of a portion of the E. coli RNA 
polymerase alpha-subunit (aa 1–248, encompassing the amino-terminal domain and 
inter-domain linker) and a fragment of yeast Gal4 (aa 58–97) (39). 
 
We note that the zinc finger module reagents we describe should also be useful for 
other applications of engineered zinc finger proteins (32,41–46). For example, many 
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groups have shown that multi-finger domains built from these modules can be fused to 
transcriptional regulatory domains (e.g., the NF-KB p65 domain or the KRAB repression 
domain) to create artificial transcription factors capable of regulating specific endogenous 
genes (20,21,40,47–50). In addition, various sets of these modules have been linked 
together in random combinations to generate libraries of artificial zinc finger transcription 
factors (24,26,28,29,42,51). These libraries have been screened to identify members 
capable of inducing specific cellular phenotypes, an approach that may be useful for 
functional genomics studies (52). The reagents we describe here should greatly simplify the 
construction of both specific individual and combinatorial libraries of zinc finger arrays for 
these applications. 
Our standardized framework has also been adopted by the international group of 
scientists who participate in the Zinc Finger Consortium (http://www.zincfingers.org). All 
members of the Consortium have committed to ensuring that future vectors developed by 
their labs will be compatible with the plasmid frameworks described in this protocol. By 
standardizing all of the steps, from modular assembly to functional testing, to expression in 
the ultimate target cells, we believe our reagents and protocols will define the limitations 
and strengths of modular assembly and spur the further development of engineered zinc 
finger and ZFN technologies. We encourage scientists to report both positive and negative 
attempts at designing zinc finger proteins using modular-assembly (or other techniques) on 
the Zinc Finger Consortium newsgroup (http://www.zincfingers.org/ listserv.htm). 
 
MATERIALS 
REAGENTS 
• Plasmids and expression vectors (see REAGENT SETUP) 
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• Bacterial strain KJBAC1 (F- lacIq DhisB463 D(gpt-proAB-arg-lac)XIII zaj::Tn10; 
strain available through Addgene as part of the Zinc Finger Consortium Expression 
Vector Kit v1.0) 
 
Figure D.3 Overview of restriction digest-based modular assembly. Plasmids pc3XB-F1, 
-F2 and -F3 encode individual hypothetical finger modules from the archive cloned into 
plasmid pc3XB. Each finger coding sequence is flanked on the 5’ end by unique XbaI and 
XmaI sites and on the 3’ end by unique AgeI, BsgI and BamHI sites. The configuration of 
unique flanking restriction sites in all pc3XB-based plasmids permits any two fingers 
(e.g., F1 and F2) to be joined together by ligating a finger F1-encoding vector backbone 
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Figure D.3 continued (linearized by digestion with AgeI and BamHI) to a finger 
F2-encoding fragment (released from the plasmid by digestion with XmaI and BamHI). 
The resulting plasmid encodes a two-finger (F1 followed by F2) array which again is 
flanked on the 5’ end by XbaI and XmaI and on the 3’ end by AgeI, BsgI and BamHI. 
(Note that ligation of  
compatible XmaI Figure D.3 | continued | and AgeI overhangs destroys both sites.) A 
third finger (F3) can be added to the array by ligating an F1/F2-encoding 
AgeI/BamHI-digested vector backbone to a F3-encoding XmaI/BamHI-digested fragment. 
Note that plasmid maps are not to scale. 
 
• Bacterial strain Transformax EPI300 (F– mcrA D(mrr-hsdRMS-mcrBC) 
F80dlacZDM15 DlacX74 recA1 endA1 araD139 D(ara, leu)7697 galU galK l– 
rpsL nupG trfA dhfr; Epicentre) 
• Bacterial strain XL1 Blue (recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ 
proAB lacIq lacZDM15 Tn10 (TetR)]; Stratagene) 
• Restriction enzymes (all from New England Biolabs): AgeI, BamHI, BsaI, BsgI, 
EcoRI, HindIII, NotI, XbaI, XhoI, XmaI 
• 10_ restriction enzyme buffers (New England Biolabs and Promega) 
• 32 mM S-adenosyl methionine (SAM) (New England Biolabs) 
• T4 DNA ligase and associated reaction buffer (Promega) 
• Calf intestinal phosphatase, CIP (Promega) 
• Cloned Pfu polymerase and associated 10_ reaction buffer (Stratagene) 
• 100% ethanol 
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• QIAquick gel extraction kit (Qiagen) 
• QIAprep spin miniprep kit (Qiagen) 
• LB medium and LB agar medium (Difco) 
• SOB medium (Difco) 
• SOC medium (SOB medium with 0.4% glucose) 
• Sterile 10% glycerol and sterile 50% glycerol 
• Ampicillin (100 mg ml–1 stock solution) 
• Chloramphenicol (30 mg ml–1 stock solution in 100% ethanol) 
• Kanamycin (30 mg ml–1 stock solution) 
• Filter-sterilized 1 M IPTG (isopropyl-beta-D-thiogalactopyranoside; Sigma) 
• Sterile 100 mM ZnSO4 
• ONPG (o-nitrophenyl-beta-D-galactopyranoside; 4 mg ml–1) 
• Z-buffer and Z-buffer with b-mercaptoethanol (see REAGENT SETUP) 
• Popculture reagent (Novagen, cat. no. 71092) 
• R-lysozyme (30,000 units/µl) and associated dilution buffer (Novagen, cat. no. 
71110) 
• Lysis master mix (10:1 mixture of Popculture reagent to diluted R-lysozyme, 400 
units/ml) 
• Sterile 1 M MgCl2 .Solution A with 15% glycerol (10 mM MnCl2, 50 mMCaCl2, 
10 mM MES, pH 6.3 (with KOH), 15% glycerol; filter sterilize and store at 4 °C) 
• Sequencing primer T7-1: 5¢AATACGACTCACTATAG3¢ 
• Sequencing primer OK163: 5¢CGCCAGGGTTTTCCCAGTCACGAC3¢ 
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EQUIPMENT 
• Electroporation cuvettes, 2 mm gap (BioRad) 
• Electroporator (Micropulser, BioRad) 
• Sterile 13 ml culture tubes (VWR, cat. no. 60818-667) 
• Standard orbital shaker or roller wheel for growing bacterial cultures 
• 96-well microtiter plates (Corning-Costar, cat. no. 3596) 
• Deep-well 96-well blocks (optional; Greiner, cat. no. 780271) 
• Microtiter plate reader with temperature control option 
• Sterile 250-ml centrifuge bottles 
 
REAGENT SETUP 
Plasmids and expression vectors The following kits of plasmids (together with 
detailed sequence and map information) are available through Addgene 
(http://www.addgene.org): The ‘‘Zinc Finger Consortium Modular Assembly Kit v1.0’’ 
which consists of the 141 different zinc finger modules (pc3XB-based plasmids, AMP®, 
high copy Co1EI origin of replication). The ‘‘Zinc Finger Consortium Expression Vector 
Kit v1.0’’ contains the following plasmids: pGP-FB expression plasmid: AMP®, low-copy 
Co1EI origin of replication.  pGP-FB-origBA expression plasmid: positive control for 
B2H b-galactosidase assay; AMP®, ColEI origin of replication. pBAC-lacZ reporter 
plasmid: CAM®, primary F' and secondary oriV origins of replication. pBAC-BA-lacZ 
reporter plasmid: positive control reporter plasmid with binding site for the zinc finger 
array encoded by positive control plasmid pGP-FB-origBA; CAM®, primary F' and 
secondary oriV origins of replication. pAC-KAN-alphaGal4 expression plasmid: KAN®, 
p15A origin of replication. pDW1775 plant ZFN expression vector: AMP®, pST1374 
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ColEI origin of replication. High-copy mammalian ZFN expression vector: AMP®, 
high-copy ColEI origin of replication.  
Z-buffer To prepare 1 l, use 16.1 g of Na2HPO4-7H20, 5.5 g of NaH2PO4-H20, 
0.75 g of KCl and 0.246 g ofMgSO4-7H20 dissolved in ddH20; filter sterilize and store at 
22–28 °C. 
Z-buffer with ß-mercaptoethanol Prepare fresh by adding 2.7 µl of 
b-mercaptoethanol to every 1 ml of Z-buffer. 
 
PROCEDURE 
Identification of potential ZFN target sites using ZiFiT software ● TIMING <1d  
1| Visit the ZiFiT software website at http://bindr.gdcb.iastate.edu/ZiFiT/ (the site can 
also be accessed from the Zinc Finger Consortium website at http://www.zincfingers.org). 
From the Introduction page, select ZiFiT from the menu and login. First time users will 
need to create an account.  
2| Select the option to design zinc finger nucleases. ZiFiT can also be used to design zinc 
finger arrays for other applications (e.g., fusion to transcriptional regulatory domains).  
3| Check boxes to select the desired module set(s) (Barbas, Sangamo and/or ToolGen). 
Each module set recognizes different sets of nucleotide triplets. A more complete 
description of the module sets is provided in the online instructions, which can be 
accessed from the menu (see also TableD.S1).  
4| Paste the target nucleotide sequence to be analyzed into the text box labeled ‘sequence’. 
Sequences may be entered as raw data or in FASTA format. Spaces and numbers are 
ignored.  
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5| Select the number of fingers desired for each array from the Left Array and Right 
Array drop down boxes. We recommend the use of three-fingers in each array when using 
modular assembly. Note that each finger recognizes three base pairs.  
6| Select the number of nucleotides between the two arrays from the Spacer drop down 
box. The double-strand cleavage occurs in the spacer. For the ZFNs encoded by the 
expression vectors described in this protocol, (6) spacers six base pairs in length work 
best, although spacers five base pairs in length also work (5,6,10,53,54).  
7| If you wish, choose the Advanced button to manually set limits on the number of GNN, 
TNN, ANN and/or CNN triplets for a given site. Such limits may be desirable, for 
example, because most success has been achieved with predominantly GNN fingers.  
8| Click Submit. The output provides the nucleotide position and sequence of the target 
site as well as a list of fingers for array assembly. Each finger is color-coded to match the 
nucleotide triplet it recognizes (note that along the primary strand of DNA [i.e.—the one 
primarily contacted by the zinc finger array], the amino-terminal finger binds the 3’ most 
DNA triplet while the carboxy-terminal finger binds the 5’ most triplet). If multiple 
fingers exist for a given triplet, all potential fingers are listed. The identity of each finger 
is indicated by a standard designation, which can be found in TableD.S1.  
 
? TROUBLESHOOTING 
  
Assembly of multi-finger arrays ● TIMING 6–7 d  
 
9| Linking together F1 and F2. Using the output from ZiFiT as a guide, assemble desired 
modules into a three-finger domain. (Note that for simplicity in the steps below, we use 
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the naming convention F1, F2, and F3 to specify finger positions within the context of a 
hypothetical three-finger domain where F1 is the amino-terminal finger, F2 is the middle 
finger and F3 is the carboxy-terminal finger. This convention for finger position is used 
throughout this protocol.) Digest 1 mg of plasmid encoding F1 (pc3XB-F1) with AgeI 
and BamHI (as tabulated below) at 37 °C for 3 h. once digestion is complete, add 0.5 
units calf intestinal phosphatase (CIP) and incubate at 37 °C for 5 min.  
 
Component  Amount  
F1 Plasmid DNA (pc3XB-F1)     5.0 ml (1.0 mg)  
AgeI (5 U/ml)     0.5 ml  
BamHI (20 U/ml)     0.5 ml  
10x Buffer(NEB 4)     2.0 ml  
Nuclease-free Water    12.0 ml  
Total    20.0 ml  
 
Also digest 2 mg of plasmid encoding F2 (pc3XB-F2) with XmaI and BamHI (as 
tabulated below) at 37 °C for 3 h (do not treat this digest with CIP).  
 
Component  Amount  
F2 Plasmid DNA (pc3XB-F2)    5.0 ml (2.0 mg)  
XmaI (10 U/ml)    0.5 ml  
BamHI (20 U/ml)    0.5 ml  
10xBuffer(NEB 4)    2.0 ml  
Nuclease-free Water  12.0 ml  
Total  20.0 ml  
 
■ PAUSE POINT Digests, once completed and before addition of CIP, can be stored at 
4 °C overnight or frozen indefinitely at –20 °C. 
10| Purify the digested vector backbone from pc3XB-F1 and the DNA fragment from 
pc3XB-F2 by electrophoresis on TAE 1.5%agarose gels. Purify the DNAs using a 
QIAquick Gel Extraction kit. 
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■ PAUSE POINT Purified DNAs can be stored indefinitely at –20 °C. 
11| Ligate purified pc3XB-F1 vector and pc3XB-F2 fragment together using T4 DNA 
ligase and buffer supplied by the manufacturer, as described in the table below. A 2:1 
insert:vector ratio is typically used. As a control, we ligate pc3XB-F1vector alone without 
any added fragment. Incubate ligations at 15 °C overnight. 
 
Component  Volume  
Vector DNA (pc3XB-F1)  5.5 ml  
Insert (F2 fragment) DNA  5.5 ml  
10X Ligation Enzyme Buffer   2 ml  
Nuclease-free Water   6 ml  
T4 DNA Ligase (1–3 Weiss units/ml)   1 ml  
Total   20 ml  
 
■ PAUSE POINT Completed ligations can be stored indefinitely at –20 °C.  
12| Transform 1 ml of each of the ligations into 100 ml cells by electroporation. Use all 
100 ml of cells in a 2 mm gap electroporation cuvette at 2.5 kV, 200 Ohms, 25 mF. (See 
Box 1 for preparation of electrocompetent cells.)  
13| Add 1 ml of SOC medium immediately following electroporation and transfer 
resuspended cells to a sterile 13 ml culture tube. Allow the cells to recover by growing 
them at 37 °C for 20 min.  
14| Transfer the 1 ml of culture to a sterile microfuge tube and centrifuge for 30 s at 
16,000gin a microcentrifuge. Remove all but approximately 100-200 ml of the media and 
resuspend the cells. Plate the cells on an LB agar plate containing 100 µg ml
–1 
ampicillin. 
Incubate overnight (~18 h) at 37 °C.  
15| If the transformation of the actual ligation (i.e., the ligation with the fragment) yields 
 259
at least three-fold more colonies than that of the control ligation, inoculate single colonies 
from the actual ligation/transformation plate into 3 ml of LB containing 100 mgml
–1 
ampicillin and grow overnight (14–18 h) at 37 °C for plasmid miniprep isolation. We 
typically inoculate at least two colonies from each actual ligation plate.  
 ? TROUBLESHOOTING  
 
16| Isolate plasmid DNA from overnight cultures using a QIAprep Spin Miniprep Kit.  
■ PAUSE POINT Purified DNAs can be stored indefinitely at 20 °C. 
  
17| Digest candidate plasmid DNAs with XbaI and BamHI at 37 °C for 3 h, as detailed 
below, and visualize digestion products on a 1.5% agarose gel. The desired plasmid 
should yield a ~200 bp fragment. We will refer to this plasmid as pc3XB-F1/F2 in the 
protocol steps below. 
Component  Amount  
Candidate plasmid DNA  
XbaI(20 U/ml)  
BamHI (20 U/ml)  
10xBuffer(NEB 2)  
Nuclease-free water  
  5.0 µl (0.5-2.0 µg) 
  0.5 µl  
  0.5 µl  
  2.0 µl  
12.0 µl  
Total  20.0 µl  
 
18| Linking together F1/F2 and F3. Digest 1 µg of plasmid encoding the F1-F2 array 
(pc3XB-F1/F2) with AgeI and BamHI at 37 °C for 3 h, as detailed below, and once 
digestion is complete add 0.5 units CIP to the reaction and incubate at 37 °Cfor 5min.  
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Component  Amount  
 F1/F2 Plasmid DNA (pc3XB-F1/F2) 
AgeI (5 U/µl) 
BamHI (20 U/µl) 
10x Buffer (NEB 4) 
Nuclease-free water 
  5.0 µl (1.0 µg) 
  0.5 µl 
  0.5 µl 
  2.0 µl 
12.0 µl 
Total  20.0 µl  
 
Digest 2 mg of plasmid encoding F3 (pc3XB-F3) with XmaI and BamHI at 37 °C for 3 h, as 
detailed below.  
Component  Amount  
F3 Plasmid DNA (pc3XB-F3)  
XmaI (10 U/µl) 
BamHI (20 U/µl) 
10x Buffer (NEB 4) 
Nuclease-free water 
  5.0 µl (1.0 µg) 
  0.5 µl 
  0.5 µl 
  2.0 µl 
12.0 µl 
Total  20.0 µl  
 
 
■ PAUSE POINT Digests, once completed and before addition of CIP, can be stored at 
4 °C overnight or frozen indefinitely at –20 °C. 
19| Purify the digested vector backbone from pc3XB-F1/F2 and the DNA fragment from 
pc3XB-F3 by electrophoresis on TAE1.5% agarose gels. Purify the DNAs using a 
QIAquick Gel Extraction kit. 
■ PAUSE POINT Purified DNAs can be stored indefinitely at –20 °C. 
20| Ligate purified pc3XB-F1/F2 vector and pc3XB-F3 fragment together using T4 DNA 
ligase and buffer supplied by the manufacturer, as detailed below. A 2:1 insert:vector 
ratio is typically used. As a control, ligate pc3XB-F1/F2 vector alone without any added 
fragment. Incubate ligations at 15 °C overnight. 
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Component  Amount  
Vector DNA (pc3XB-F1/F2) 
Insert (F3 fragment) DNA 
10X Ligation Enzyme Buffer 
Nuclease-free water 
T4 DNA Ligase (1-3 Weiss units/µl) 
  5.5 µl (1.0 µg)
  5.5 µl 
  2.0 µl 
  6.0 µl 
  1.0 µl 
Total  20.0 µl  
 
■ PAUSE POINT Completed ligations can be stored indefinitely at 20 °C.  
21| Transform 1 µl of each of the ligations into 100 µl cells by electroporation and plate 
on LB plates containing ampicillin as in Steps 12, 13 and 14 above. Incubate overnight 
(14-18 h) at 37 °C.  
22| If the transformation of the actual ligation yields at least three-fold more colonies than 
that of the control ligation, use single colonies from the actual ligation/transformation 
plate to inoculate two 3-ml cultures of LB containing 100 µg ml
–1 
ampicillin and grow 
overnight (14–18 h) at 37 °C for plasmid miniprep isolation.  
? TROUBLESHOOTING  
23| Isolate plasmid DNA from overnight cultures using a QIAprep Spin Miniprep Kit 
■ PAUSE POINT Purified DNAs can be stored indefinitely at –20 °C.  
24| Digest candidate plasmid DNAs with XbaI and BamHI at 37 °C for 3 h and visualize 
digestion on a 1.5% agarose gel, as detailed below. The desired plasmid should yield a 
~300 bp fragment upon digestion with XbaI and BamHI. Although no PCR is used to 
construct the multi-finger array plasmid, we recommend that it be sequenced to verify the 
presence of the desired modules (particularly when constructing multiple arrays). 
Sequencing can be performed using primer T7-1 which is a sense-strand primer that binds 
B34 base pairs upstream of the XbaI site. We will refer to the sequence-verified plasmid 
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as pc3XB-F1/F2/F3 in the protocol steps below.  
 
Component  Amount  
Candidate plasmad DNA 
XbaI (20 U/µl) 
BamHI (20 U/µl) 
10x Buffer (NEB 2) 
Nuclease-free water 
  5.0 µl (0.5-2.0 µg) 
  0.5 µl 
  0.5 µl 
  2.0 µl 
12.0 µl 
Total  20.0 µl  
 
■ PAUSE POINT Purified DNAs can be stored indefinitely at –20 °C.  
 
Testing the DNA-binding activity of a three-finger domain using the B2H reporter 
assay ● TIMING 12–14 d  
25| Constructing a low-copy expression vector encoding a zinc finger-Gal11P hybrid 
protein. An overview of the strategy for making this expression plasmid is shown in 
Figure D.4. Digest the pc3XB-F1/F2/F3 plasmid constructed in Step 24 above with XbaI 
and BsgI, at 37 °C for 3 h, as detailed below.  Purify the ~300 bp fragment by 
electrophoresis through a 1.5% agarose gel and isolate the DNA using a QIAquick Gel 
Extraction kit.  
 
Component  Amount  
F1/F2/F3 Plasmid DNA (pc3XB-F1/F2/F3)    5.0 µl (0.5-2.0 µg) 
XbaI(20 U/µl)    0.5 µl  
BsgI(3 U/µl)    0.5 µl  
10xBuffer(NEB 4)    2.0 µl  
SAM (1 mM)    1.6 µl  
Nuclease-free Water  10.4 µl  
Total  20.0 µl  
 
A final concentration of 80 µM S-adenosyl methionine (SAM) is a required buffer 
component for the restriction endonuclease BsgI. 32 mM SAM is supplied with BsgI and 
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a sample should be diluted in water to 1 mM prior to use.  
■ PAUSE POINT Purified DNA can be stored indefinitely at –20 °C.  
 
 
Figure D.4 Strategy for constructing B2H expression vectors and transformation of B2H 
reporter strains. Zinc finger arrays assembled in the pc3XB plasmid can be cloned 
directly into vectors designed to express zinc finger arrays as a Gal11P hybrid protein (for 
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use in B2H assays) using the unique XbaI and BsgI restriction sites. To perform B2H 
assays, the resulting plasmid (pGP-FB-F1/F2/F3) is co-transformed with the 
pAC-KAN-alphaGal4 plasmid into a ‘‘B2H reporter strain’’ harboring reporter plasmid 
pBAC-ZFBS-lacZ (ZFBS ¼ zinc finger binding site). Note that the pGP-FB-F1/F2/F3, 
Figure D.4 | continued the pAC-KAN-alphaGal4 and the pBAC-ZFBS-lacZ plasmids 
confer resistance to ampicillin, kanamycin and chloramphenicol, respectively. Note that 
plasmid maps are not to scale.. 
 
 
Component  Amount  
Plasmid DNA (pGP-FB)   5.0 µl (0.5-2.0 µg) 
XbaI (20 U/µl)    0.5 µl  
BsgI (3 U/µl)    0.5 µl  
10xBuffer(NEB 4)    2.0 µl  
SAM (1 mM)    1.6 µl  
Nuclease-free Water  10.4 µl  
Total  20.0 µl  
 
A final concentration of 80 mM S-adenosyl methionine (SAM) is a required buffer 
component for the restriction endonuclease BsgI. 32 mM SAM is supplied with BsgI and 
a sample should be diluted in water to 1 mM prior to use. 
■ PAUSE POINT Purified DNA can be stored indefinitely at –20 °C. 
27| Ligate the DNA fragments purified in Steps 25 and 26 together, as detailed below. As 
a control, ligate pGP-FB vector alone without any added fragment. Incubate ligations at 
15 °C overnight. 
 
 
 
 
 
Component  Amount  
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Vector DNA (pGP-FB) 
Insert (F3 fragment) DNA 
10X Ligation Enzyme Buffer 
Nuclease-free water 
T4 DNA Ligase (1-3 Weiss units/µl) 
  5.5 µl 
  5.5 µl 
  2.0 µl 
  6.0 µl 
  1.0 µl 
Total  20.0 µl  
Transform E.coli strain XL1 Blue with the actual and control ligations and plate on LB 
plates supplemented with 100 µg ml
–1 
ampicillin.  
▲CRITICAL STEP Cells used for transformation in this step must express the lacI
q 
allele of lac repressor. This ensures repression of the strong lacUV5 promoter, which 
directs expression of the zinc finger-Gal11P hybrid protein encoded by plasmid pGP-FB 
(Figure D.4).  
28| If the transformation of the actual ligation yields at least three-fold more colonies than 
that of the control ligation, use single colonies from the actual ligation/transformation 
plate to inoculate two 10-ml cultures of LB containing 100 µg ml
–1 
ampicillin and grow 
overnight (14–18 h) at 37 °C for plasmid miniprep isolation.  
? TROUBLESHOOTING  
29| Isolate plasmid DNA from 10 ml of overnight culture using a QIAprep Spin Miniprep 
Kit. 
▲CRITICAL STEP Plasmid DNA should be isolated from a 10 ml culture because the 
pGP-FB plasmid is a low copy number plasmid. 
■ PAUSE POINT Purified DNAs can be stored indefinitely at –20 °C. 
30| Digest candidate plasmid DNAs with XbaI and BamHI at 37 °C for 3 h, as detailed 
below. 
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Component  Amount  
Candidate plasmid DNA    5.0 µl (0.5-2.0 µg) 
XbaI (20 U/µl)    0.5 µl  
BsgI (3 U/µl)    0.5 µl  
10xBuffer(NEB 4)    2.0 µl  
Nuclease-free Water  12.0 µl  
Total  20.0 µl  
 
Visualize digestion on a 1.5% agarose gel. The desired plasmid should yield a ~300 bp 
fragment. This plasmid expresses a zinc finger-Gal11p fusion protein from a strong 
lacUV5 promoter that can be repressed by lac repressor. We will refer to this plasmid as 
pGP-FB-F1/F2/F3 in the protocol steps below.  
31| Construction of a single-copy reporter vector bearing a target DNA-binding site for a 
multi-finger domain positioned upstream of a lacZ reporter gene. Digest single-copy 
vector pBAC-lacZ with BsaI, at 50 °C for 1 h, as detailed below.  
 
Component  Amount  
Plasmid DNA (pBAC-lacZ)   5.0 µl (0.5-2.0 µg) 
BsaI (10 U/µl)    0.5 µl  
10xBuffer(NEB 3)    2.0 µl  
Nuclease-free Water  12.5 µl  
Total  20.0 µl  
 
Purify the ~11,100 bp vector backbone by electrophoresis through a 0.8% agarose gel and 
isolate the DNA using a QIAquick Gel Extraction kit.  
▲CRITICAL STEP BsaI digests should be incubated at 50 °C. 
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 ■ PAUSE POINT Purified DNA can be stored indefinitely at –20 °C.  
32| Incubate purified, BsaI-digested pBAC-lacZ vector backbone with Pfu polymerase in 
the presence of the dCTP only (i.e., omit dATP, dGTP and dTTP) at 72 °C for 10 min. 
The combined 5' to 3' polymerase activity and 3' to 5' exonuclease activity of Pfu will 
generate the extended overhangs illustrated in the bottom part of Figure D.5 (see also ref. 
55)  
 
Component  Volume  
Vector DNA (BsaI-digested vector)     10.0 µl  
10 mM dCTP       2.0 µl  
10� Pfu reaction buffer       2.0 µl  
Nuclease-free water       4.8 µl  
Cloned Pfu polymerase       1.2 µl  
Total     20.0 µl  
 
33| Design and synthesize a pair of oligonucleotides bearing the target DNA-binding site 
for a multi-finger domain of interest (see Box 2 and top part of Figure D.5). Anneal 50 
fmol of each of these oligonucleotides together in 100 µl of annealing buffer (40 mM Tris, 
pH 8, 20 mM MgCl2, 50 mM NaCl) by heating to 95 °C for 2 min and then allowing the 
mixture to cool slowly (over ~1 h) to 25 °C. Annealed oligonucleotides will form a short 
double-stranded DNA fragment with the overhangs shown in Figure A,5.  
 
34| Ligate the pBAC-lacZ vector backbone from Step 32 to the annealed oligonucleotides 
from Step 33, as detailed below. As a control, perform a ligation with the pBAC-lacZ 
vector backbone only. Incubate ligation reactions at 15 °C overnight.  
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Component  Volume  
Vector DNA (pBAC-lacZ)       5.5 µl  
Insert DNA (annealed oligos)       5.5 µl  
10X Ligation Enzyme Buffer       2.0 µl  
Nuclease-free water       6.0 µl  
T4 DNA Ligase (1–3 Weiss units/µl)       1.0 µl  
Total     20.0 µl  
 
Transform both ligations into E. coli strain Transformax EPI300 (Epicentre) using 
standard chemical transformation. Plate transformations on LB plates supplemented with 
12.5 µg ml
–1 
chloramphenicol and incubate overnight (14–18 h) at 37 °C.  
▲CRITICAL STEP The pBAC-lacZ plasmid is a mini-F’ that can be replicated in 
standard E.coli strains, but because it is maintained as a single copy episome, it gives low 
DNA yields. pBAC-lacZ also contains a second, higher copy number origin of replication 
(oriV) that is only active in the presence of a trans-acting factor encoded by the trfA gene. 
Transformax EPI300 cells express trfA from an inducible promoter that we have found is 
inducible with arabinose (S.T.B. and J.K.J., unpublished data). When the trfA gene is 
induced in Transformax EPI300cells, the copy number of pBAC-lacZ plasmid is 
increased in the cells and reasonable yields of plasmid can be obtained using a standard 
miniprep procedure.  
35| If the transformation of the actual ligation yields at least three-fold more colonies than 
that of the control ligation, use single colonies from the actual ligation/transformation 
plate to inoculate two 3 ml cultures of LB containing 12.5 µg ml
–1 
chloramphenicol and 
grow overnight (14–18 h) at 37 °C.  
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? TROUBLESHOOTING  
36| Inoculate 1 ml of each overnight culture into 9 ml of LB containing 14 µg ml
–1 
chloramphenicol and 1.1 mM arabinose.  Grow cultures for 6 h at 37 °C and then 
harvest cells and isolate plasmid DNA using a QIAprep Spin Miniprep Kit. 
▲CRITICAL STEP Subculturing the cells containing the plasmids in arabinose is 
critical to induce expression of the trfA gene product, which in turn increases the copy 
number of the pBAC-lacZ plasmid.’ 
■ PAUSE POINT Plasmids can be stored indefinitely at –20 °C. 
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Figure D.5 Strategy for constructing B2H reporter vectors. The top half of the figure 
illustrates the design and annealing of oligonucleotides comprising the zinc finger binding 
site as described in Box 2. The bottom half of the figure illustrates digestion of the 
plasmid pBAC-lacZ with BsaI and generation of extended overhangs by treatment with 
Pfu polymerase in the presence of a single deoxynucleotide (dCTP). Treatment with Pfu 
under these conditions will generate the specific overhangs shown that are 
complementary to the overhangs of the annealed oligonucleotide cassette. Ligation of the 
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Figure D.5 | continued vector backbone to the annealed oligonucleotides will generate 
the desired pBAC-ZFBS-lacZ reporter vector. Note that plasmid maps are not to scale. 
 
37| Digest the candidate reporter plasmids (and the original pBAC-lacZ plasmid as a 
control) with EcoRI and HindIII at 37 °C for 3 h, as detailed below. 
 
Component  Amount  
Candidate plasmid DNA  
EcoRI (20 U/µl)  
HindIII (20 U/µl)  
10xBuffer (NEB 2)  
Nuclease-free water  
   5.0 µl (0.5–2.0 µg) 
   0.5 µl 
   0.5 µl  
   2.0 µl  
 12.0 µl  
Total   20.0 µl  
 
Visualize the digestions on a 2% agarose gel. Candidates that have taken up the annealed 
oligonucleotides should yield fragments of sizes 159, 3,007 and 7,963 base pairs, whereas 
the original pBAC-lacZ plasmid should yield fragments of sizes 182, 3,007 and 7,963 
base pairs. 
38| Confirm the sequence of the target DNA binding site in the candidate reporter plasmid 
by sequencing with primer OK163(this primer is an anti-sense primer that anneals ~150 
bp downstream of the binding site). We will refer to the sequence-confirmed reporter 
plasmid as the pBAC-ZFBS-lacZ plasmid (ZFBS = Zinc Finger Binding Site) in 
subsequent steps of the protocol. 
39| Transformation of E. coli cells with B2H reporter and expression vectors. Transform 
strain KJBAC1 (which constitutively expresses high levels of lac repressor) with the 
pBAC-ZFBS-lacZ reporter plasmid. Also transform strain KJBAC1 with the positive 
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control reporter plasmid pBAC-BA-lacZ (containing a binding site for the zinc finger 
array encoded by positive control expression plasmid pGP-FB-origBA). Plate 
transformations on LB plates containing 12.5 µg ml
–1 
chloramphenicol and incubate 
overnight at 37 °C. We refer to the resulting KJBAC1 transformants as the "ZFBS B2H 
reporter strain" (Figure D.4) and the positive control "BA B2H reporter strain." 
40| Pick colonies from each of the transformation plates and inoculate each into a 3 ml 
LB culture with 12.5 µg ml
–1 
chloramphenicol. Grow cultures overnight (12–16 h) with 
agitation at 37 °C. 
41| Make chemically competent cells from each of the B2H reporter strain overnight 
cultures (see Box 3 for protocol).Also prepare glycerol stocks of each of the B2H reporter 
strains for long-term storage at –80 °C. 
■ PAUSE POINT Competent B2H reporter strain cells can be stored and frozen 
indefinitely at -80 °C. 
42| Doubly transform the ZFBS B2H reporter strain with the pGP-FB-F1/F2/F3 
expression vector prepared in Step 30 above and the compatible pAC-KAN-alphaGal4 
expression plasmid encoding the alpha-Gal4 hybrid protein (Figure D.4). As a positive 
control, doubly transform the BA B2H reporter strain with the pGP-FB-origBA and 
pAC-KAN-alphaGal4 expression plasmids. As a negative control for assaying basal 
transcription of the lacZ reporter gene, doubly transform both the ZFBS and BA B2H 
reporter strains with the pGP-FB (expressing the Gal11P fragment with no accompanying 
zinc finger domain) and pAC-KAN-alphaGal4 plasmids. Plate all transformations on LB 
plates containing 100 µg ml
-1 
ampicillin, 30 µg ml
-1 
kanamycin and 12.5 µg ml
-1 
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chloramphenicol and incubate overnight (14-18h ) at 37 °C.  
  
 
The pAC-KAN- alphaGal4 expresses the alpha-Gal4 hybrid protein from a strong tandem 
lpp/lacUV5promoter (that is repressed by lac repressor) and confers resistance to 
kanamycin.  The p15A origin of replication present in plasmid pAC-KAN-alphaGal4 is 
compatible with the BAC reporter and zinc finger-Gal11P expression plasmids.  
▲CRITICAL STEP The order in which KJBAC1 is transformed with plasmids is 
important. Although one can readily obtain transformants of KJBAC1 that harbor 
pAC-KAN-alphaGal4, we have sometimes encountered difficulties with introducing the 
reporter and zinc finger-Gal11P expression plasmids into these cells. However, the 
procedure works consistently as described (i.e., transforming KJBAC1 first with the 
reporter plasmid and then double-transforming with the zinc finger-Gal11P expression 
plasmid and pAC-KAN-alphaGal4; Figure D.4).  
■ PAUSE POINT Transformants of the B2H reporter strain can be stored at 4 °C but 
should be assayed for β-galactosidase activity within a few days. We find that 
transformants often do not grow well, or at all, when left at 4 °C for more than a week.  
? TROUBLESHOOTING  
43| β-galactosidase assay of doubly transformed B2H reporter strain cells. For each 
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transformant to be assayed, inoculate two overnight cultures (each from an independent 
colony) in LB containing 100 µg ml
–1 
ampicillin, 30 µg ml
–1 
kanamycin, 12.5 µg ml
–1 
chloramphenicol, 10 mMZnSO4 and 500 mM IPTG. Grow overnight (14–18 h) with 
agitation at 37 °C. Cultures can be grown either in standard sterile glass or plastic culture 
tubes or in 96-well blocks. For growth in deep well blocks, we recommend shaking on a 
platform with a sufficiently small throw radius to ensure uniform and adequate agitation 
of each well in the block (e.g., the Microtitertron orbital shaker, Appropriate Technical 
Resources)
56
.  
44| Subculture saturated overnight cultures from Step 43 by diluting them 1:40 into 
pre-warmed LB-containing 100 µg ml
–1 
ampicillin, 30 µg ml
–1 
kanamycin, 12.5 µg ml
–1 
chloramphenicol, 10 mM ZnSO4 and 500 mM IPTG. Monitor the growth of cultures by 
measuring OD600 (relative to a media only blank) on a spectrophotometer and harvest 
them for lysis when they reach log phase (OD600 = 0.3-0.8). Record the OD600 value at 
which cultures are lysed.  
? TROUBLESHOOTING  
45| Lyse log-phase subcultures from Step 44 in a 96-well microtiter plate by adding 100 
µl of culture to 11 µl of Lysis MasterMix
56 
(already in the plate) and mixing well by 
pipetting up and down. Allow lysis to proceed for a minimum of 15 min at22–28 °C. 
■ PAUSE POINT The activity of β-galactosidase is stable in the cell lysates for at least 
18 h when stored at room temperature
56
.  Lysates should be covered to prevent 
evaporation. 
46| Set up b-galactosidase assay by adding 15 µl of lysate to a microtiter plate well 
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containing 135 µl of Z buffer with β-mercaptoethanol and 30 µl of 4mg ml
–1 
ONPG and 
mixing well. Perform duplicate assays for each lysate. 
47| Place microtiter plate containing b-galactosidase assay reactions in a microtiter plate 
reader with temperature control(e.g., Biorad Model 680 Microplate Reader). Incubate 
reactions at 28 °C and take timed serial measurements of absorbance at 420 nm. Calculate 
the velocity of ONPG cleavage (v) by plotting A420 vs. time and calculating the slope of 
the line. 
▲CRITICAL STEP Many microtiter plate readers can be programmed to take 
absorbance 
 
 
measurements at fixed intervals and to calculate the velocity of ONPG cleavage. We 
typically take measurements every 10–30 s. Reactions should not be allowed to proceed 
for more than 30 min as substrate can become limiting. 
48| Calculate the units of b-galactosidase for each assay using the following formula:  
V x 1,000 = OD600 
 
We include the 1,000 multiplier to make all units larger than 1. The final value obtained 
for each B2H reporter strain transformant is the average of duplicate cultures, which in 
turn are measured in duplicate. 
▲CRITICAL STEP If a microtiter plate reader is not available, the b-galactosidase 
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assay can be performed in glass tubes as an endpoint assay using a standard 
spectrophotometer as previously described
57
. 
49| Calculate the fold-activation mediated by each zinc finger protein tested by comparing 
b-galactosidase units obtained in the presence of the zinc finger-Gal11P hybrid protein 
with the units obtained in the presence of the Gal11P control. In our experience, zinc 
finger domains that mediate three-fold activation or higher will have a high probability of 
generating active ZFNs in human cell-based gene targeting assays. The zinc finger array 
encoded by positive control plasmid pGP-FB-origBA should activate expression of the 
lacZ reporter gene on plasmid pBAC-BA-lacZ approximately three-fold. 
 
Construction of ZFN expression vectors ● TIMING 3–5 d 
50| As outlined in Figure D.6, DNA sequences encoding zinc finger arrays that show 
significant activity in the B2H system can be transferred by standard restriction 
digest-based subcloning techniques to specially designed expression vectors that permit 
their expression as zinc finger nucleases in plant or human cells. Digest the desired 
pGP-FB-F1/F2/F3 plasmid with XbaI and BamHI(these unique sites flank the zinc finger 
coding sequence) at 37 °C for 3 h, as detailed below. 
 
 
Component  Amount  
Plasmid DNA (pGP-FB-F1/F2/F3)    5.0 ml (0.5–2.0 mg) 
XbaI(20 U/ml)    0.5 ml  
BamHI (20 U/ml)    0.5 ml  
10xBuffer(NEB 2)    2.0 ml  
Nuclease-free water  12.0 ml  
Total  20.0 ml  
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Isolate the B300 bp fragment by electrophoresis on a 1.5% agarose gel followed by 
purification using a QIAquick Gel Extraction kit.  
51| Digest the recipient ZFN expression vector with XbaI and BamHI at 37 °C for 3 h, as 
detailed below.  
 
Component  Amount  
Expression vector DNA    5.0 ml (0.5–2.0 mg) 
XbaI(20 U/ml)    0.5 ml  
BamHI (20 U/ml)    0.5 ml  
10xBuffer(NEB 2)    2.0 ml  
Nuclease-free water  12.0 ml  
Total  20.0 ml  
 
Once digestion is complete, add 0.5 units CIP and incubate at 37 °C for 5 min. Isolate 
vector backbone by electrophoresis on a 1.5% agarose gel. Purify the vector using a 
QIAquick Gel Extraction kit. For expression in plants, use vector pDW1775 (see Figure 
D.6). For expression in mammalian cells, use vector pST1374 (see Figure D.6).  
52| Ligate the purified expression vector backbone from Step 51 to the purified zinc 
finger-encoding fragment from Step 50, as detailed below. As a control, also perform a 
ligation with only the vector backbone. Incubate ligation reactions at 15 °C overnight.  
 
Component  Volume  
Expression vector DNA    5.5 ml 
Insert DNA (FB-F1/F2/F3 fragment)   5.5 ml  
10X ligation Enzyme Buffer   2.0 ml  
Nuclease-free water   6.0 ml  
T4 DNA Ligase (1-3 Weiss units/µl)   1.0 ml  
Total  20.0 ml  
Transform both ligations into E.colistrain XL1 Blue and plate on LB plates supplemented 
with 100 mgml
–1 
ampicillin.  
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53| If the transformation of the actual ligation yields at least three-fold more colonies than 
that of the control ligation, use single colonies from the actual ligation/transformation 
plate to inoculate two 3 ml cultures of LB containing 100 µg ml
–1 
ampicillin and grow 
overnight (14–18 h) at 37 °C.  
? TROUBLESHOOTING  
54| Isolate plasmid DNA from overnight cultures using a QIAprep Spin Miniprep Kit. 
■ PAUSE POINT Plasmids can be stored indefinitely at –20 °C.  
55| Digest the candidate expression plasmids with XhoI and BamHI (for the plant 
expression vector) or with NotI and BamHI (for the mammalian expression vector).  
Component  Amount  
Candidate expression vector DNA (plant)   5.0 ml (0.5–2.0 mg) 
XhoI (20 U/ml)    0.5 ml  
BamHI (20 U/ml)    0.5 ml  
10x Buffer (NEB 2)  2.0 ml  
Nuclease-free water  12.0 ml  
Total  20.0 ml  
 
Visualize the digestions on a 1.5% agarose gel. Candidates that have the zinc finger array 
sequence successfully cloned in should yield a ~400 bp or a ~340 bp fragment for the 
plant or mammalian expression vectors, respectively. In both of these vectors, the zinc 
finger array is expressed as a ZFN (i.e., is fused to the amino-terminal domain of the FokI 
nuclease domain by a four amino acid linker of sequence LRGS) and harbors an SV40 
nuclear localization signal. An in-frame AcV5 or FLAG epitope tag is also encoded by 
the plant or mammalian expression vectors, respectively. Following insertion of the DNA 
fragment encoding the assembled zinc finger arrays, each of these ZFN-encoding 
plasmids is ready for use in their respective cell type.  
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Figure D.6 Strategy for constructing plant or human ZFN expression vectors. Zinc finger 
arrays tested in the B2H system can be directly cloned from a pGP-FB-F1/F2/F3 
expression vector using the unique XbaI and BamHI sites into a vector designed to 
express ZFNs in either plant (pDW1775) or human (pST1374) cells. The epitope tag (tag) 
in the plant ZFN expression vector is AcV5 whereas it is FLAG in the human ZFN 
expression vector. The nuclear localization signal (NLS) in both vectors is the SV40 NLS. 
Restriction sites referred to in the text are shown. Note that plasmid maps are not to scale. 
? TROUBLESHOOTING  
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See Table D.1 for troubleshooting advice.  
Table D.1 Troubleshooting table 
Step(s)  Problem  Possible reason  Solution  
Step 8  No ZFN target sites identified 
using ZiFiT  
Incomplete coverage of DNA 
triplets by module set  
Consider using modules from 
all three collections instead of 
just one or consider expanding 
the DNA search space  
 
Too many ZFN target sites 
identified using ZiFiT  
 Consider targeting sites that 
contain primarily GNN target 
sub-sites  
Steps 15, 22, 
28, 35 and 53  
No colonies obtained from 
ligation/transformation Too 
many colonies from vector 
backbone only control reaction 
Clones from transformations 
are missing restriction sites or 
have other mutations  
Low quality competent cells 
Insufficient digestion of 
vector CIP can degrade the 
ends of DNA when left too 
long or when too much 
enzyme is used  
Consider purchasing 
commercially available 
competent bacterial cells 
Re-digest vector using higher 
concentrations of enzymes or 
screen additional colonies from 
the actual 
ligation/transformation plate 
Watch the CIP reaction time 
closely or reduce the amount of 
CIP enzyme used and run out 
the DNA on an agarose gel 
immediately after the CIP 
reaction is finished  
Step 42  
No colonies obtained with 
double transformation of the 
B2H reporter strain  
Too little DNA used for 
transformation and/or low 
quality competent cells  
Use larger amounts of DNA for 
transformation and plate a 
larger portion of the 
transformation  
Step 44  Cells do not grow when 
subcultured  
Toxic effects of Gal11P-zinc 
finger hybrid protein  
Consider using lower 
concentrations of IPTG in the 
medium (e.g., 0, 100, 250 µM). 
Also consider omitting IPTG 
from the overnight culture and 
only adding it to the subculture. 
 No activity for the ZF array in 
the B2H assay  
Target site may not be 
suitable for modular design  
Consider other targets, 
particularly those with primarily 
GNN sub-sites; consider 
generating ZF arrays using a 
selection protocol that accounts 
for context dependent effects on 
DNA binding  
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● TIMING 
Identification of potential ZFN target sites using ZiFiT software requires less than 1 d. 
Assembly of multi-finger arrays requires 6–7 d. Testing the DNA-binding activity of a three-finger 
domain using the B2H reporter assay requires 12–14 d. Construction of ZFN expression vectors 
requires 3–5 d. Note that because our protocol has simplified all of the required steps, the length of 
time needed to perform any of these steps does not change appreciably even if one processes more 
than a single multi-finger array. 
 
ANTICIPATED RESULTS 
As noted in the Introduction, modular assembly will not always yield a functional 
zinc finger domain. Screening multi-finger arrays for function is therefore critical before 
testing these assembled domains as ZFNs in either plant or human cells. The B2H system 
provides a rapid and effective method for identifying proteins that possess both good 
affinities and specificities
31
. Although E.coli and human genomes differ in their sequence 
composition and chromatin is present in human cells, our collective experience to date 
suggests that many of the proteins that show at least three-fold transcriptional activation in 
the B2H system will also show activity in human cells. (Presumably, the B2H system also 
will serve as a reliable screen for activity in plant cells as well although this remains to be 
determined.)  
We believe that the B2H system provides a rapid and effective alternative to other 
assays for assessing zinc finger activity. Various in vitro methods have been described for 
testing binding of zinc finger arrays to target sites (e.g., gel shift assays (58,59)) or activity 
of ZFNs (e.g., restriction digest assays with purified target DNA (36)). Although these 
assays provide useful functional readouts, they only measure the affinity of a zinc finger 
array for its target site but do not account for its specificity in the context of genomic DNA 
sequences. A mammalian cell-based reporter assay for zinc finger binding has also been 
described (7). However, this assay requires transient transfections of human cells and is 
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subject to variability in results depending upon the absolute and relative concentrations of 
expression and reporter plasmids introduced into the cells. By contrast, the B2H system 
only requires transformations of bacterial cells and the reporter episome in this assay is 
strictly maintained at single copy. Thus, the B2H system requires a zinc finger array to be 
able to find its specific, single copy target sequence in the presence of competing 
chromosomal E.coli DNA, thereby providing a stringent test for both DNA-binding affinity 
and specificity.  
Depending upon the specific application, certain ZFNs generated by modular 
assembly may not provide sufficiently high rates of gene targeting and/or may exhibit toxic 
effects. Both of these issues have been observed with ZFNs created by modular assembly 
(7,12). Because four-finger ZFNs have been reported to work well in human cells (6), one 
possible alternative approach is to simply add an additional fourth finger to one or both of 
the ZFNs. However, certain target sites may require zinc finger arrays with greater 
affinities and/or specificities than can be achieved with modular assembly. In these cases, 
one may need to consider the use of more labor-intensive selection protocols that account 
for context-dependent effects on DNA-binding (31,59,60). In our experience, multi-finger 
domains identified by such selection methods can exhibit higher efficiencies of gene 
targeting and reduced toxicities relative to domains created by modular assembly (S. Pruett, 
J.K.J., & M.H.P., unpublished data).  
Another potential reason for the inability of modular assembled ZFNs to mediate 
high efficiency gene targeting can be poor expression levels. The codons we used to encode 
our zinc finger plasmids have not been fully optimized for plant or human expression. The 
steady-state levels of ZFN expression can be monitored using Western blots with an 
antibody directed against an epitope tag encoded in all of our expression vectors (AcV5 or 
FLAG for plants or mammalian cells, respectively). If the expression level of a ZFN is 
problematic, one can consider recoding potentially promising zinc finger arrays using fully 
optimized codon sets.  
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SUPPLEMENTAL INFORMATION 
Table D.S1 List of zinc finger modules cloned in the standardized pc3XB plasmid vector 
framework.  All zinc finger modules shown have been cloned into plasmid pc3XB 
(described in the text, also see Figure 3). Each module is assigned a unique ID (ID #) which 
is used by the ZiFiT software in its outputs. Plasmids encoding each module are named 
according to the convention pc3XB-“ID#” as described in the text (also see Figure 3). 
Original source and a reference are provided for each module (Source/Reference). 
Published DNA-binding specificities (Target Sequence) for each module are also shown 
(abbreviation: R=G or A). Finger position indicates whether a module was designed to 
function at a particular position within the context of a three-finger domain (F1 indicates 
the amino-terminal position, F2 the middle position, and F3 the carboxy-terminal position). 
The full amino acid sequence for each module is shown (Finger Sequence) with the 
recognition helix residues (-1, 1, 2, 3, 4, 5, and 6, numbered relative to the start of the finger 
alpha-helix) highlighted in bold. 
 
ID# Source/Reference 
Target 
Sequence  
Finger Finger Sequence 
ZF1 SGMO;ref.1 GAA F1 PGEKPHICHIQGCGKVYGQRSNLVRHLRWH 
ZF2 SGMO;ref.1 GAC F1 PGEKPHICHIQGCGKVYGDRSNLTRHLRWH 
ZF3 SGMO;ref.1 GAG F1 PGEKPHICHIQGCGKVYGRSDNLARHLRWH 
ZF4 SGMO;ref.1 GAT F1 PGEKPHICHIQGCGKVYGQSSNLARHLRWH 
ZF5 SGMO;ref.1 GCA F1 PGEKPHICHIQGCGKVYGQSGSLTRHLRWH 
ZF6 SGMO;ref.1 GCC F1 PGEKPHICHIQGCGKVYGERGTLARHLRWH 
ZF7 SGMO;ref.1 GCG F1 PGEKPHICHIQGCGKVYGRSDDLTRHLRWH 
ZF8 SGMO;ref.1 GCT F1 PGEKPHICHIQGCGKVYGQSSDLTRHLRWH 
ZF9 SGMO;ref.1 GGA F1 PGEKPHICHIQGCGKVYGQSGHLARHLRWH 
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Table D.S1 continued 
ZF10 SGMO;ref.1 GGC F1 PGEKPHICHIQGCGKVYGDRSHLTRHLRWH 
ZF11 SGMO;ref.1 GGG F1 PGEKPHICHIQGCGKVYGRSDHLARHLRWH 
ZF12 SGMO;ref.1 GGT F1 PGEKPHICHIQGCGKVYGQSSHLTRHLRWH 
ZF13 SGMO;ref.1 GTA F1 PGEKPHICHIQGCGKVYGQSGALTRHLRWH 
ZF14 SGMO;ref.1 GTC F1 PGEKPHICHIQGCGKVYGDRSALARHLRWH 
ZF15 SGMO;ref.1 GTG F1 PGEKPHICHIQGCGKVYGRSDALTRHLRWH 
ZF16 SGMO;ref.1 GTT F1 PGEKPHICHIQGCGKVYGTTSALTRHLRWH 
ZF17 SGMO;ref.2 AGA F1 PGEKPHICHIQGCGKVYGKNWKLQAHLRWH
ZF18 SGMO;ref.1 GAA F2 PGERPFMCTWSYCGKRFTQSGNLARHKRTH
ZF19 SGMO;ref.1 GAC F2 PGERPFMCTWSYCGKRFTDRSNLTRHKRTH 
ZF20 SGMO;ref.1 GAG F2 PGERPFMCTWSYCGKRFTRSDNLARHKRTH
ZF21 SGMO;ref.1 GAT F2 PGERPFMCTWSYCGKRFTTSGNLVRHKRTH 
ZF22 SGMO;ref.1 GCA F2 PGERPFMCTWSYCGKRFTQSGDLTRHKRTH 
ZF23 SGMO;ref.1 GCG F2 PGERPFMCTWSYCGKRFTRSDDLQRHKRTH
ZF24 SGMO;ref.1 GCT F2 PGERPFMCTWSYCGKRFTQSSDLTRHKRTH 
ZF25 SGMO;ref.1 GGA F2 PGERPFMCTWSYCGKRFTQSGHLQRHKRTH
ZF26 SGMO;ref.1 GGC F2 PGERPFMCTWSYCGKRFTDRSHLARHKRTH
ZF27 SGMO;ref.1 GGG F2 PGERPFMCTWSYCGKRFTRSDHLTRHKRTH 
ZF28 SGMO;ref.1 GGT F2 PGERPFMCTWSYCGKRFTTSGHLVRHKRTH 
ZF29 SGMO;ref.1 GTA F2 PGERPFMCTWSYCGKRFTQSGALARHKRTH
ZF30 SGMO;ref.1 GTC F2 PGERPFMCTWSYCGKRFTDRSALARHKRTH
ZF31 SGMO;ref.1 GTG F2 PGERPFMCTWSYCGKRFTRSDALSRHKRTH 
ZF32 SGMO;ref.1 GTT F2 PGERPFMCTWSYCGKRFTTSGALTRHKRTH 
ZF33 SGMO;ref.1 GCC F2 PGERPFMCTWSYCGKRFTDRSDLTRHKRTH 
ZF34 SGMO;ref.3 TGG F2 PGERPFMCTWSYCGKRFTRSDHLTTHKRTH 
ZF35 SGMO;ref.2 TTG F2 PGERPFMCTWSYCGKRFTRADALMVHKRTH
 293
Table D.S1 continued 
ZF36 SGMO;ref.1 GAA F3 PGEKKFACPECPKRFMQSGNLARHIKTH 
ZF37 SGMO;ref.1 GAC F3 PGEKKFACPECPKRFMDRSNLTRHIKTH 
ZF38 SGMO;ref.1 GAG F3 PGEKKFACPECPKRFMRSDNLTRHIKTH 
ZF39 SGMO;ref.1 GAT F3 PGEKKFACPECPKRFMTSANLSRHIKTH 
ZF40 SGMO;ref.1 GCA F3 PGEKKFACPECPKRFMQSGDLTRHIKTH 
ZF41 SGMO;ref.1 GCC F3 PGEKKFACPECPKRFMDRSDLTRHIKTH 
ZF42 SGMO;ref.1 GCG F3 PGEKKFACPECPKRFMRSDDLTRHIKTH 
ZF43 SGMO;ref.1 GCT F3 PGEKKFACPECPKRFMQSSDLQRHIKTH 
ZF44 SGMO;ref.1 GGA F3 PGEKKFACPECPKRFMQSGHLQRHIKTH 
ZF45 SGMO;ref.1 GGC F3 PGEKKFACPECPKRFMDRSHLARHIKTH 
ZF46 SGMO;ref.1 GGT F3 PGEKKFACPECPKRFMTSGHLVRHIKTH 
ZF47 SGMO;ref.1 GTA F3 PGEKKFACPECPKRFMQRASLTRHIKTH 
ZF48 SGMO;ref.1 GTC F3 PGEKKFACPECPKRFMDRSALARHIKTH 
ZF49 SGMO;ref.1 GTG F3 PGEKKFACPECPKRFMRSDALTRHIKTH 
ZF50 SGMO;ref.1 GTT F3 PGEKKFACPECPKRFMQSSALTRHIKTH 
ZF51 SGMO;ref.1 GGG F3 PGEKKFACPECPKRFMRSDHLSRHIKTH 
ZF52 SGMO;ref.3 AAG F3 PGEKKFACPECPKRFMRSDNLTQHIKTH 
ZF53 SGMO;ref.4 AGG F3 PGEKKFACPECPKRFMRSDHLTQHIKTH 
ZF54 SGMO;ref.5 CGG F3 PGEKKFACPECPKRFMRSDNLTEHIKTH 
ZF55 SGMO;ref.2 CTG F3 PGEKKFACPECPKRFMRSDALREHIKTH 
ZF56 SGMO;ref.6 TGA F3 PGEKKFACPECPKRFMQSGHLTKHIKTH 
ZF57 SGMO;ref.7 TGG F3 PGEKKFACPECPKRFMRSDHLTTHIKTH 
ZF58 Barbas;ref.8 GGG N/A PGEKPYKCPECGKSFSRSDKLVRHQRTH 
ZF59 Barbas;ref.8 GGA N/A PGEKPYKCPECGKSFSQRAHLERHQRTH 
ZF60 Barbas;ref.8 GGT N/A PGEKPYKCPECGKSFSTSGHLVRHQRTH 
ZF61 Barbas;ref.8 GGC N/A PGEKPYKCPECGKSFSDPGHLVRHQRTH 
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ZF62 Barbas;ref.8 GAG N/A PGEKPYKCPECGKSFSRSDNLVRHQRTH 
ZF63 Barbas;ref.8 GAA N/A PGEKPYKCPECGKSFSQSSNLVRHQRTH 
ZF64 Barbas;ref.8 GAT N/A PGEKPYKCPECGKSFSTSGNLVRHQRTH 
ZF65 Barbas;ref.8 GAC N/A PGEKPYKCPECGKSFSDPGNLVRHQRTH 
ZF66 Barbas;ref.8 GTG N/A PGEKPYKCPECGKSFSRSDELVRHQRTH 
ZF67 Barbas;ref.8 GTA N/A PGEKPYKCPECGKSFSQSSSLVRHQRTH 
ZF68 Barbas;ref.8 GTT N/A PGEKPYKCPECGKSFSTSGSLVRHQRTH 
ZF69 Barbas;ref.8 GTC N/A PGEKPYKCPECGKSFSDPGALVRHQRTH 
ZF70 Barbas;ref.8 GCG N/A PGEKPYKCPECGKSFSRSDDLVRHQRTH 
ZF71 Barbas;ref.8 GCA N/A PGEKPYKCPECGKSFSQSGDLRRHQRTH 
ZF72 Barbas;ref.8 GCT N/A PGEKPYKCPECGKSFSTSGELVRHQRTH 
ZF73 Barbas;ref.8 GCC N/A PGEKPYKCPECGKSFSDCRDLARHQRTH 
ZF74 Barbas;ref.9 AAA N/A PGEKPYKCPECGKSFSQRANLRAHQRTH 
ZF75 Barbas;ref.9 AAC N/A PGEKPYKCPECGKSFSDSGNLRVHQRTH 
ZF76 Barbas;ref.9 AAG N/A PGEKPYKCPECGKSFSRKDNLKNHQRTH 
ZF77 Barbas;ref.9 AAT N/A PGEKPYKCPECGKSFSTTGNLTVHQRTH 
ZF78 Barbas;ref.9 ACA N/A PGEKPYKCPECGKSFSSPADLTRHQRTH 
ZF79 Barbas;ref.9 ACC N/A PGEKPYKCPECGKSFSDKKDLTRHQRTH 
ZF80 Barbas;ref.9 ACG N/A PGEKPYKCPECGKSFSRTDTLRDHQRTH 
ZF81 Barbas;ref.9 ACT N/A PGEKPYKCPECGKSFSTHLDLIRHQRTH 
ZF82 Barbas;ref.9 AGA N/A PGEKPYKCPECGKSFSQLAHLRAHQRTH 
ZF83 Barbas;ref.9 AGC N/A PGEKPYKCPECGKSFSERSHLREHQRTH 
ZF84 Barbas;ref.9 AGG N/A PGEKPYKCPECGKSFSRSDHLTNHQRTH 
ZF85 Barbas;ref.9 AGT N/A PGEKPYKCPECGKSFSHRTTLTNHQRTH 
ZF86 Barbas;ref.9 ATA N/A PGEKPYKCPECGKSFSQKSSLIAHQRTH 
ZF87 Barbas;ref.9 ATG N/A PGEKPYKCPECGKSFSRRDELNVHQRTH 
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ZF88 Barbas;ref.9 ATT N/A PGEKPYKCPECGKSFSHKNALQNHQRTH 
ZF89 Barbas;ref.10 CAA N/A PGEKPYKCPECGKSFSQSGNLTEHQRTH 
ZF90 Barbas;ref.10 CAC N/A PGEKPYKCPECGKSFSSKKALTEHQRTH 
ZF91 Barbas;ref.10 CAG N/A PGEKPYKCPECGKSFSRADNLTEHQRTH 
ZF92 Barbas;ref.10 CAT N/A PGEKPYKCPECGKSFSTSGNLTEHQRTH 
ZF93 Barbas;ref.10 CCA N/A PGEKPYKCPECGKSFSTSHSLTEHQRTH 
ZF94 Barbas;ref.10 CCC N/A PGEKPYKCPECGKSFSSKKHLAEHQRTH 
ZF95 Barbas;ref.10 CCG N/A PGEKPYKCPECGKSFSRNDTLTEHQRTH 
ZF96 Barbas;ref.10 CCT N/A PGEKPYKCPECGKSFSTKNSLTEHQRTH 
ZF97 Barbas;ref.10 CGA N/A PGEKPYKCPECGKSFSQSGHLTEHQRTH 
ZF98 Barbas;ref.10 CGC N/A PGEKPYKCPECGKSFSHTGHLLEHQRTH 
ZF99 Barbas;ref.10 CGG N/A PGEKPYKCPECGKSFSRSDKLTEHQRTH 
ZF100 Barbas;ref.10 CGT N/A PGEKPYKCPECGKSFSSRRTCRAHQRTH 
ZF101 Barbas;ref.10 CTA N/A PGEKPYKCPECGKSFSQNSTLTEHQRTH 
ZF102 Barbas;ref.10 CTG N/A PGEKPYKCPECGKSFSRNDALTEHQRTH 
ZF103 Barbas;ref.10 CTT N/A PGEKPYKCPECGKSFSTTGALTEHQRTH 
ZF104 Barbas;ref.11 TAG N/A PGEKPYKCPECGKSFSREDNLHTHQRTH 
ZF105 Barbas;ref.11 TGA N/A PGEKPYKCPECGKSFSQAGHLASHQRTH 
ZF106 Barbas;ref.11 TGG N/A PGEKPYKCPECGKSFSRSDHLTTHQRTH 
ZF107 ToolGen;ref.12 GAC N/A PGEKPYKCKQCGKAFGCPSNLRRHGRTH 
ZF108 ToolGen;ref.12 GCC N/A PGEKPYTCSDCGKAFRDKSCLNRHRRTH 
ZF109 ToolGen;ref.12 GTC N/A PGEKPFMCTWSYCGKRFTDRSALARHKRTH
ZF110 ToolGen;ref.12 GAC N/A PGEKPYKCKECGKAFNHSSNFNKHHRIH 
ZF111 ToolGen;ref.12 GTT N/A PGEKPFKCPVCGKAFRHSSSLVRHQRTH 
ZF112 ToolGen;ref.12 GAT N/A PGEKPYRCKYCDRSFSISSNLQRHVRNIH 
ZF113 ToolGen;ref.12 GAG N/A PGEKPYGCHLCGKAFSKSSNLRRHEMIH 
 296
Table D.S1 continued 
ZF114 ToolGen;ref.12 GGA N/A PGEKPYKCKECGQAFRQRAHLIRHHKLH 
ZF115 ToolGen;ref.12 GAG N/A PGEKPYKCHQCGKAFIQSFNLRRHERTH 
ZF116 ToolGen;ref.12 GAA N/A PGEKPFQCNQCGASFTQKGNLLRHIKLH 
ZF117 ToolGen;ref.12 GGA N/A PGEKPYKCGQCGKFYSQVSHLTRHQKIH 
ZF118 ToolGen;ref.12 GGA N/A PGEKPYVCRECGRGFRQHSHLVRHKRTH 
ZF119 ToolGen;ref.12 AGA N/A PGEKPYKCEECGKAFRQSSHLTTHKIIH 
ZF120 ToolGen;ref.12 CGA N/A PGEKPYECDHCGKSFSQSSHLNVHKRTH 
ZF121 ToolGen;ref.12 CAA N/A PGEKPYMCSECGRGFSQKSNLIIHQRTH 
ZF122 ToolGen;ref.12 GAA N/A PGEKPYKCEECGKAFTQSSNLTKHKKIH 
ZF123 ToolGen;ref.12 GAA N/A PGEKPFECKDCGKAFIQKSNLIRHQRTH 
ZF124 ToolGen;ref.12 GAA N/A PGEKPYECEKCGKAFNQSSNLTRHKKSH 
ZF125 ToolGen;ref.12 CAA N/A PGEKPYVCSKCGKAFTQSSNLTVHQKIH 
ZF126 ToolGen;ref.12 GTA N/A PGEKPYKCPDCGKSFSQSSSLIRHQRTH 
ZF127 ToolGen;ref.12 GTA N/A PGEKPYKCEECGKAFNQSSTLTRHKIVH 
ZF128 ToolGen;ref.12 CGA N/A PGEKPYECHDCGKSFRQSTHLTQHRRIH 
ZF129 ToolGen;ref.12 GGA N/A PGEKPYECHDCGKSFRQSTHLTRHRRIH 
ZF130 ToolGen;ref.12 GCG N/A PGEKPYVCDVEGCTWKFARSDELNRHKKRH
ZF131 ToolGen;ref.12 GGG N/A PGEKPFLCQYCAQRFGRKDHLTRHMKKSH 
ZF132 ToolGen;ref.12 AGG N/A PGEKPFQCKTCQRKFSRSDHLKTHTRTH 
ZF133 ToolGen;ref.12 GGG N/A PGEKPYVCDVEGCTWKFARSDKLNRHKKRH
ZF134 ToolGen;ref.12 GGG N/A PGEKPYKCMECGKAFNRRSHLTRHQRIH 
ZF135 ToolGen;ref.12 GAG N/A PGEKPYICRKCGRGFSRKSNLIRHQRTH 
ZF136 ToolGen;ref.12 GAG N/A PGEKPYECKECGKAFSSGSNFTRHQRIH 
ZF137 ToolGen;ref.12 AAT N/A PGEKPYECDHCGKAFSVSSNLNVHRRIH 
ZF138 ToolGen;ref.12 GTG N/A PGEKPYTCKQCGKAFSVSSSLRRHETTH 
ZF139 ToolGen;ref.12 GCT N/A PGEKPYECNYCGKTFSVSSTLIRHQRIH 
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Table D.S1 continued 
ZF140 ToolGen;ref.12 GGT N/A PGEKPYRCEECGKAFRWPSNLTRHKRIH 
ZF141 ToolGen;ref.12 RGA N/A PGEKPYACHLCGKAFTQCSHLRRHEKTH 
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